Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Physical measures,X4270.Volume level set by participant (left),GAST,Gastrin,35903,0.0808690769114484,0.015359227340082,0.0507649913248876,0.110973162498009,1.44405697088093e-07
Physical measures,X4270.Volume level set by participant (left),ANXA10,Annexin A10,36639,0.092345349382306,0.0231459773743207,0.0469792337286374,0.137711465035975,6.67933547748655e-05
Physical measures,X4270.Volume level set by participant (left),IL1A,Interleukin-1 alpha,36697,0.110626940150326,0.0321013847139266,0.0477082261110304,0.173545654189623,0.00057170285746585
Physical measures,X4270.Volume level set by participant (left),CHGA,Chromogranin-A,35931,0.0735848871746378,0.0219814061010755,0.0305013312165297,0.116668443132746,0.000819623812705539
Physical measures,X4270.Volume level set by participant (left),LXN,Latexin,36731,-0.0866066441671899,0.0266896311548685,-0.138918321230732,-0.0342949671036476,0.00117982093607462
Physical measures,X4270.Volume level set by participant (left),APOBR,Apolipoprotein B receptor,35748,-0.168050737045261,0.0529310930116718,-0.271795679348138,-0.0643057947423847,0.00150584352102128
Physical measures,X4270.Volume level set by participant (left),TGFA,Protransforming growth factor alpha,36820,0.131848163785933,0.0415811142653981,0.0503491798257529,0.213347147746113,0.00152587062150058
Physical measures,X4270.Volume level set by participant (left),OMD,Osteomodulin,36865,-0.13269501689166,0.043088587571631,-0.217148648532056,-0.0482413852512628,0.00208021653257136
Physical measures,X4270.Volume level set by participant (left),CASP4,Caspase-4,35798,0.0395219332557818,0.0129051711018067,0.0142277978962407,0.0648160686153228,0.00220389043602592
Physical measures,X4270.Volume level set by participant (left),NEB,Nebulin,35706,-0.173102367333157,0.0567819404406824,-0.284394970596895,-0.0618097640694198,0.0023087502189182
Physical measures,X4270.Volume level set by participant (left),TFF2,Trefoil factor 2,36853,0.0973987086988111,0.0323762518600507,0.0339412550531118,0.16085616234451,0.00263534986673228
Physical measures,X4270.Volume level set by participant (left),TFF1,Trefoil factor 1,36790,0.0701716372024079,0.0233479809181784,0.0244095946027784,0.115933679802037,0.00266037872914775
Physical measures,X4270.Volume level set by participant (left),CLUL1,Clusterin-like protein 1,36822,-0.12417639959235,0.0418249836120019,-0.206153367471874,-0.0421994317128268,0.00299746353250938
Physical measures,X4270.Volume level set by participant (left),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,35696,0.243754756188586,0.0822502988308272,0.0825441704801644,0.404965341897007,0.00305193012445196
Physical measures,X4270.Volume level set by participant (left),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,36697,-0.184219097323664,0.062356048559057,-0.306436952499416,-0.0620012421479127,0.00314342694024059
Physical measures,X4270.Volume level set by participant (left),CHI3L1,Chitinase-3-like protein 1,36663,0.0688894490842448,0.0233188538317929,0.0231844955739307,0.114594402594559,0.00314420173088193
Physical measures,X4270.Volume level set by participant (left),UPK3A,Uroplakin-3a,35680,0.129108316092715,0.0438398049637317,0.0431822983638006,0.215034333821629,0.00324100201494889
Physical measures,X4270.Volume level set by participant (left),OFD1,Oral-facial-digital syndrome 1 protein,35798,0.0970350962294725,0.0334395586331516,0.0314935613084955,0.16257663115045,0.0037224591515281
Physical measures,X4270.Volume level set by participant (left),CXCL14,C-X-C motif chemokine 14,36697,0.0923596138267523,0.0320922965920376,0.0294587125063587,0.155260515147146,0.00401415526638829
Physical measures,X4270.Volume level set by participant (left),IL15,Interleukin-15,36820,0.161310426440541,0.0560858501665092,0.0513821601141833,0.271238692766899,0.00403694906859184
Physical measures,X4270.Volume level set by participant (left),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35903,-0.229005523774763,0.0819664412529918,-0.389659748630627,-0.0683512989188992,0.00522253941264103
Physical measures,X4270.Volume level set by participant (left),AHNAK,Neuroblast differentiation-associated protein AHNAK,35748,-0.197845576309529,0.0710101645608633,-0.337025498848821,-0.0586656537702369,0.00534901932397855
Physical measures,X4270.Volume level set by participant (left),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,36933,0.188342578006306,0.067805657434171,0.0554434894353307,0.321241666577281,0.00548799915834536
Physical measures,X4270.Volume level set by participant (left),AMPD3,AMP deaminase 3,35903,-0.0826415483748646,0.0298144186328137,-0.14107780889518,-0.0242052878545497,0.00558898483394277
Physical measures,X4270.Volume level set by participant (left),GM2A,Ganglioside GM2 activator,35739,0.143370605481022,0.0520558869903478,0.0413410669799399,0.245400143982103,0.00590043087417812
Physical measures,X4270.Volume level set by participant (left),LRRN1,Leucine-rich repeat neuronal protein 1,36697,-0.133010901580798,0.0484487581919336,-0.227970467636988,-0.0380513355246082,0.00605823754222434
Physical measures,X4270.Volume level set by participant (left),CSF2RB,Cytokine receptor common subunit beta,35725,-0.138730893167419,0.05095318255898,-0.23859913098302,-0.038862655351818,0.00649202956925114
Physical measures,X4270.Volume level set by participant (left),CUZD1,CUB and zona pellucida-like domain-containing protein 1,35741,0.159286928932269,0.0586251227621367,0.0443816883184808,0.274192169546057,0.00660414840910723
Physical measures,X4270.Volume level set by participant (left),GDF15,Growth/differentiation factor 15,36933,0.11054335795262,0.0408798407470717,0.030418870088359,0.19066784581688,0.00686385580151814
Physical measures,X4270.Volume level set by participant (left),S100A16,Protein S100-A16,36628,-0.08511512115738,0.0315839996447328,-0.147019760461056,-0.0232104818537037,0.00705721455912103
Physical measures,X4270.Volume level set by participant (left),PI3,Elafin,36728,0.0908820605972898,0.0338174652070475,0.0245998287914766,0.157164292403103,0.00721624793759161
Physical measures,X4270.Volume level set by participant (left),WFDC2,WAP four-disulfide core domain protein 2,36465,0.125174092593118,0.0467112927746967,0.0336199587547123,0.216728226431523,0.00738455444370249
Physical measures,X4270.Volume level set by participant (left),DDX53,Probable ATP-dependent RNA helicase DDX53,35741,0.166284397578972,0.0621928425373295,0.0443864262058064,0.288182368952138,0.00752079861224827
Physical measures,X4270.Volume level set by participant (left),SEPTIN3,Neuronal-specific septin-3,35903,0.0756056264158121,0.0286188145193313,0.0195127499579228,0.131698502873701,0.00826543930639134
Physical measures,X4270.Volume level set by participant (left),DKK3,Dickkopf-related protein 3,36933,-0.161658618749602,0.0618617890925942,-0.282907725371086,-0.0404095121281172,0.00898664848335262
Physical measures,X4270.Volume level set by participant (left),APLP1,Amyloid-like protein 1,36828,-0.0976850435590935,0.0374271893017008,-0.171042334590427,-0.02432775252776,0.00907185308014244
Physical measures,X4270.Volume level set by participant (left),IL13RA1,Interleukin-13 receptor subunit alpha-1,36760,0.222886309735692,0.0854715941531034,0.0553619851956089,0.390410634275774,0.00913255630413614
Physical measures,X4270.Volume level set by participant (left),DNAJA4,DnaJ homolog subfamily A member 4,35903,-0.0775134552425207,0.0298810621193034,-0.136080336996355,-0.0189465734886861,0.00950545060974081
Physical measures,X4270.Volume level set by participant (left),CLEC4M,C-type lectin domain family 4 member M,35922,0.115929238317022,0.0447184930506057,0.0282809919378351,0.203577484696209,0.00955088231086773
Physical measures,X4270.Volume level set by participant (left),SOX2,Transcription factor SOX-2,35886,0.239552120577302,0.0927203287719918,0.0578202761841983,0.421283964970406,0.00979856516407394
Physical measures,X4270.Volume level set by participant (left),BCAN,Brevican core protein,36763,-0.142240019627121,0.0556904185163345,-0.251393239919137,-0.0330867993351053,0.0106650725795101
Physical measures,X4270.Volume level set by participant (left),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35916,0.0721562359879369,0.0283786865213005,0.016534010406188,0.127778461569686,0.0110247032995083
Physical measures,X4270.Volume level set by participant (left),GLYR1,Putative oxidoreductase GLYR1,35874,-0.0991254332198802,0.0390573319662989,-0.175677803873826,-0.0225730625659344,0.0111730291188614
Physical measures,X4270.Volume level set by participant (left),OCLN,Occludin,35903,0.124604010031697,0.0491054352074989,0.0283573570249994,0.220850663038395,0.011187862753434
Physical measures,X4270.Volume level set by participant (left),FGFR2,Fibroblast growth factor receptor 2,36864,0.212241951121519,0.0842290287330975,0.0471530548046479,0.37733084743839,0.0117616508097668
Physical measures,X4270.Volume level set by participant (left),REG4,Regenerating islet-derived protein 4,36837,0.0913894880973481,0.036314504752935,0.0202130587815954,0.162565917413101,0.0118692648923679
Physical measures,X4270.Volume level set by participant (left),NTRK3,NT-3 growth factor receptor,36894,-0.208814241800953,0.0842741048637667,-0.373991487333936,-0.0436369962679704,0.0132408753978343
Physical measures,X4270.Volume level set by participant (left),YOD1,Ubiquitin thioesterase OTU1,35706,-0.0883123838052998,0.0357383530241012,-0.158359555732538,-0.0182652118780615,0.0134959257212479
Physical measures,X4270.Volume level set by participant (left),RYR1,Ryanodine receptor 1,35706,-0.158287988357005,0.0642645894820556,-0.284246583741834,-0.032329392972176,0.0138011124246769
Physical measures,X4270.Volume level set by participant (left),KIF20B,Kinesin-like protein KIF20B,35680,0.0705259518581098,0.0286551276682222,0.0143619016283943,0.126690002087825,0.013873243317263
Physical measures,X4270.Volume level set by participant (left),SPOCK1,Testican-1,36763,-0.180699649419655,0.073441068875337,-0.324644144415316,-0.0367551544239946,0.0138976449898175
Physical measures,X4270.Volume level set by participant (left),MYBPC1,"Myosin-binding protein C, slow-type",35916,-0.0743480830112853,0.0303047482984411,-0.13374538967623,-0.0149507763463408,0.014178568429745
Physical measures,X4270.Volume level set by participant (left),THBS4,Thrombospondin-4,36818,-0.100147101319936,0.041171152646372,-0.180842560506825,-0.0194516421330469,0.015019590838261
Physical measures,X4270.Volume level set by participant (left),RRM2,Ribonucleoside-diphosphate reductase subunit M2,36654,0.0906787263223314,0.0373225535191438,0.0175265214248095,0.163830931219853,0.015139114672436
Physical measures,X4270.Volume level set by participant (left),ABO,Histo-blood group ABO system transferase,35926,0.0364563596374739,0.0150723879154804,0.00691447932313221,0.0659982399518155,0.0156002406923387
Physical measures,X4270.Volume level set by participant (left),TMED4,Transmembrane emp24 domain-containing protein 4,35706,0.0929959459982845,0.038473805182335,0.017587287840908,0.168404604155661,0.0156710107788676
Physical measures,X4270.Volume level set by participant (left),CD209,CD209 antigen,36875,0.116371539517949,0.0481742552906217,0.0219499991483304,0.210793079887567,0.0157308848962302
Physical measures,X4270.Volume level set by participant (left),ACP1,Low molecular weight phosphotyrosine protein phosphatase,35725,-0.117839880749575,0.0490073982782649,-0.213894381374974,-0.021785380124176,0.0162208434592405
Physical measures,X4270.Volume level set by participant (left),MZB1,Marginal zone B- and B1-cell-specific protein,36849,0.0841032559158606,0.0351741866360831,0.0151618501091377,0.153044661722584,0.0168242600578406
Physical measures,X4270.Volume level set by participant (left),COL3A1,Collagen alpha-1(III) chain,35931,-0.220954304456382,0.0924369121101268,-0.40213065219223,-0.0397779567205333,0.016860765556627
Physical measures,X4270.Volume level set by participant (left),ACAN,Aggrecan core protein,36769,-0.163424763595908,0.0692563795137535,-0.299167267442865,-0.0276822597489516,0.0183146058502419
Physical measures,X4270.Volume level set by participant (left),STX7,Syntaxin-7,35725,-0.104947862728164,0.044587886081447,-0.1923401194478,-0.0175556060085276,0.0186155670384451
Physical measures,X4270.Volume level set by participant (left),FSTL3,Follistatin-related protein 3,36817,0.13385088992429,0.0568889665359016,0.0223485155139231,0.245353264334657,0.0186557074549071
Physical measures,X4270.Volume level set by participant (left),HBQ1,Hemoglobin subunit theta-1,36888,-0.0687552678835936,0.029352194963554,-0.126285570012159,-0.0112249657550279,0.019184331239047
Physical measures,X4270.Volume level set by participant (left),MYL4,Myosin light chain 4,35748,-0.0960013161485303,0.0410101790020466,-0.176381266992542,-0.0156213653045189,0.0192664127234277
Physical measures,X4270.Volume level set by participant (left),ROBO4,Roundabout homolog 4,35748,-0.290154666478897,0.124299544029733,-0.533781772777173,-0.046527560180621,0.0196091423935689
Physical measures,X4270.Volume level set by participant (left),DPP6,Dipeptidyl aminopeptidase-like protein 6,36770,-0.132711276517021,0.0570059723933541,-0.244442982407995,-0.0209795706260471,0.0199370268372849
Physical measures,X4270.Volume level set by participant (left),ASS1,Argininosuccinate synthase,35706,0.0677850574140931,0.0291726350325876,0.0106066927502215,0.124963422077965,0.0201784649692556
Physical measures,X4270.Volume level set by participant (left),ITGB5,Integrin beta-5,36864,0.11432257911995,0.0494069216537275,0.0174850126786436,0.211160145561255,0.0206996248647646
Physical measures,X4270.Volume level set by participant (left),KLK8,Kallikrein-8,36607,0.121249087886497,0.0524974824970155,0.018354022192347,0.224144153580648,0.0209367133092483
Physical measures,X4270.Volume level set by participant (left),NCAN,Neurocan core protein,36894,-0.112283315053526,0.0486603293227299,-0.207657560526076,-0.0169090695809751,0.021053814169762
Physical measures,X4270.Volume level set by participant (left),PSMD1,26S proteasome non-ATPase regulatory subunit 1,35903,-0.100917604710288,0.0438125629204079,-0.186790228034287,-0.0150449813862884,0.0212871162927885
Physical measures,X4270.Volume level set by participant (left),FABP6,Gastrotropin,36686,0.0761711868969118,0.033252352538313,0.0109965759218182,0.141345797872005,0.022008384876147
Physical measures,X4270.Volume level set by participant (left),NCAM1,Neural cell adhesion molecule 1,36863,-0.141824661302749,0.0621096613653398,-0.263559597578815,-0.0200897250266833,0.022430773204132
Physical measures,X4270.Volume level set by participant (left),DRAXIN,Draxin,36763,-0.0974162465386095,0.0428286754232909,-0.18136045036826,-0.0134720427089593,0.0229604089686702
Physical measures,X4270.Volume level set by participant (left),BPIFB1,BPI fold-containing family B member 1,36819,0.0675991387748014,0.0297852015030655,0.00922014382879301,0.12597813372081,0.0232624397031025
Physical measures,X4270.Volume level set by participant (left),SERPINI2,Serpin I2,35894,0.0886585330983227,0.0392194470330621,0.0117884169135209,0.165528649283124,0.0238175035581425
Physical measures,X4270.Volume level set by participant (left),MSMB,Beta-microseminoprotein,36829,0.0587988556406042,0.0260928878541805,0.00765679544641046,0.109940915834798,0.0242594470174548
Physical measures,X4270.Volume level set by participant (left),COMP,Cartilage oligomeric matrix protein,36727,-0.128491336038782,0.0570735164469475,-0.240355428274799,-0.0166272438027652,0.0243933383890788
Physical measures,X4270.Volume level set by participant (left),SPINK1,Serine protease inhibitor Kazal-type 1,36836,0.0965557835786183,0.0429221947256729,0.0124282819162993,0.180683285240937,0.0245056440668188
Physical measures,X4270.Volume level set by participant (left),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,35748,-0.124158227197192,0.055207371486621,-0.232364675310969,-0.0159517790834148,0.0245492157944204
Physical measures,X4270.Volume level set by participant (left),PDGFRA,Platelet-derived growth factor receptor alpha,36828,-0.147803651274451,0.0658003222676551,-0.276772282919055,-0.0188350196298468,0.0247167986637593
Physical measures,X4270.Volume level set by participant (left),MEGF11,Multiple epidermal growth factor-like domains protein 11,35706,-0.148988228077627,0.0664684622794167,-0.279266414145284,-0.01871004200997,0.0250280782294151
Physical measures,X4270.Volume level set by participant (left),DNAJB2,DnaJ homolog subfamily B member 2,35779,-0.0924776965410046,0.0413511916019524,-0.173526032080831,-0.011429361001178,0.0253591223051513
Physical measures,X4270.Volume level set by participant (left),BOLA2_BOLA2B,BolA-like protein 2,35748,-0.0948879855272984,0.0424656380895532,-0.178120636182823,-0.0116553348717742,0.0254860827202885
Physical measures,X4270.Volume level set by participant (left),RANBP1,Ran-specific GTPase-activating protein,35748,-0.0959940413937213,0.0429861190530944,-0.180246834737786,-0.0117412480496564,0.0255733251077018
Physical measures,X4270.Volume level set by participant (left),IL6,Interleukin-6,36770,0.0545767243701921,0.0246021568175352,0.00635649700782309,0.102796951732561,0.026559056426673
Physical measures,X4270.Volume level set by participant (left),CENPF,Centromere protein F,35798,-0.0867721635998068,0.0391426702633472,-0.163491797315967,-0.0100525298836463,0.0266695037297223
Physical measures,X4270.Volume level set by participant (left),HLA_A,,35903,-0.147045885200096,0.0667122264691529,-0.277801849079636,-0.0162899213205567,0.0275453980344568
Physical measures,X4270.Volume level set by participant (left),TPBGL,Trophoblast glycoprotein-like,35741,0.116019392264971,0.0527700028427568,0.0125901866931679,0.219448597836774,0.0279422481222191
Physical measures,X4270.Volume level set by participant (left),RBP5,Retinol-binding protein 5,36770,0.0766529187099345,0.0350782879225891,0.00789947438165982,0.145406363038209,0.028905048349044
Physical measures,X4270.Volume level set by participant (left),CXCL6,C-X-C motif chemokine 6,36908,0.0545458518712981,0.0249674338834164,0.00560968145980194,0.103482022282794,0.0289423274683662
Physical measures,X4270.Volume level set by participant (left),GAS2,Growth arrest-specific protein 2,35798,-0.0943134571343975,0.0432993005011497,-0.179180086116651,-0.00944682815214411,0.0294282771642466
Physical measures,X4270.Volume level set by participant (left),SETMAR,Histone-lysine N-methyltransferase SETMAR,36744,-0.140989498518979,0.0648031965680115,-0.268003763792281,-0.0139752332456765,0.0296118769761236
Physical measures,X4270.Volume level set by participant (left),CA3,Carbonic anhydrase 3,36932,-0.0652634470123915,0.0299988028361975,-0.124061100571339,-0.00646579345344438,0.0296202212394577
Physical measures,X4270.Volume level set by participant (left),HSP90B1,Endoplasmin,36596,-0.06448185895577,0.0296641069974173,-0.122623508670708,-0.00634020924083202,0.029756767393837
Physical measures,X4270.Volume level set by participant (left),CD14,Monocyte differentiation antigen CD14,36672,0.10096855604896,0.046519966622965,0.00978942146794859,0.192147690629971,0.0300052988560173
Physical measures,X4270.Volume level set by participant (left),TNFSF11,Tumor necrosis factor ligand superfamily member 11,36820,-0.0668988748935851,0.0308538559771021,-0.127372432608705,-0.00642531717846508,0.030170499339839
Physical measures,X4270.Volume level set by participant (left),PLIN1,Perilipin-1,36639,0.117595729597171,0.0543174678843661,0.0111334925438138,0.224057966650529,0.0304216056732986
Physical measures,X4270.Volume level set by participant (left),ACHE,Acetylcholinesterase,35779,-0.147865729141943,0.0684943603298589,-0.282114675388466,-0.0136167828954191,0.0309015971066551
Physical measures,X4270.Volume level set by participant (left),CD5,T-cell surface glycoprotein CD5,36881,0.116488487453542,0.0539727758552713,0.0107018467772104,0.222275128129874,0.0309367649133962
Physical measures,X4270.Volume level set by participant (left),FGF21,Fibroblast growth factor 21,36880,0.0348671710275774,0.0161631373997948,0.00318742172397962,0.0665469203311751,0.0310207494661086
Physical measures,X4270.Volume level set by participant (left),NOS3,"Nitric oxide synthase, endothelial",36639,0.0770955098118144,0.0357812884086157,0.00696418453092765,0.147226835092701,0.0312226293596795
Physical measures,X4270.Volume level set by participant (left),AMFR,E3 ubiquitin-protein ligase AMFR,36639,-0.0658345599495288,0.0305563598507771,-0.125725025257052,-0.00594409464200558,0.0312307104908541
Physical measures,X4270.Volume level set by participant (left),KDR,Vascular endothelial growth factor receptor 2,36864,0.162564841111846,0.0756539914469,0.0142830178759219,0.31084666434777,0.0316819521196457
Physical measures,X4270.Volume level set by participant (left),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,35706,-0.102230019214526,0.0476865747686561,-0.195695705761092,-0.00876433266795967,0.0320866283316918
Physical measures,X4270.Volume level set by participant (left),SAG,S-arrestin,35680,0.0891363919847027,0.041651595560387,0.00749926468634424,0.170773519283061,0.0323881446157078
Physical measures,X4270.Volume level set by participant (left),GIMAP7,GTPase IMAP family member 7,35779,-0.146599819010446,0.0685600792670844,-0.280977574373932,-0.012222063646961,0.0325317172756768
Physical measures,X4270.Volume level set by participant (left),GGT1,Glutathione hydrolase 1 proenzyme,36823,0.0812306902380069,0.0380038825706974,0.00674308039944012,0.155718300076574,0.0325946343419905
Physical measures,X4270.Volume level set by participant (left),MUC13,Mucin-13,36639,0.0788442295759667,0.0369457210896144,0.00643061624032246,0.151257842911611,0.0328708090433927
Physical measures,X4270.Volume level set by participant (left),TPRKB,EKC/KEOPS complex subunit TPRKB,35678,0.0724316257677787,0.0340466932902144,0.00570010691895853,0.139163144616599,0.0334228282182928
Physical measures,X4270.Volume level set by participant (left),CLSTN1,Calsyntenin-1,36639,0.0777030027019221,0.036611797387887,0.00594387982166371,0.149462125582181,0.033841396376324
Physical measures,X4270.Volume level set by participant (left),MEGF10,Multiple epidermal growth factor-like domains protein 10,36822,-0.104225013714127,0.049200795065618,-0.200658572042739,-0.00779145538551622,0.0341768172961104
Physical measures,X4270.Volume level set by participant (left),CD164,Sialomucin core protein 24,36836,-0.148893631271402,0.0705983676518175,-0.287266431868964,-0.0105208306738397,0.0349749942745254
Physical measures,X4270.Volume level set by participant (left),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,35741,0.0857692606876413,0.0407993188009783,0.00580259583772386,0.165735925537559,0.0355718703291012
Physical measures,X4270.Volume level set by participant (left),TNXB,Tenascin-X,36836,-0.15514525956396,0.0739403426078319,-0.30006833107531,-0.0102221880526093,0.0359159022944045
Physical measures,X4270.Volume level set by participant (left),MYOM3,Myomesin-3,35779,-0.049958972941371,0.023886402888067,-0.0967763226019824,-0.00314162328075973,0.0365193974273542
Physical measures,X4270.Volume level set by participant (left),GHRL,Appetite-regulating hormone,36828,-0.0472722035709305,0.0226114960677284,-0.0915907358636782,-0.00295367127818277,0.0365945192951426
Physical measures,X4270.Volume level set by participant (left),OMG,Oligodendrocyte-myelin glycoprotein,36770,-0.0608692440480845,0.0291367391228601,-0.11797725272889,-0.0037612353672786,0.0367330023102724
Physical measures,X4270.Volume level set by participant (left),NPTXR,Neuronal pentraxin receptor,36828,-0.114493138082117,0.0549428384736651,-0.2221811014905,-0.00680517467373319,0.0372061676781866
Physical measures,X4270.Volume level set by participant (left),CXCL8,Interleukin-8,36763,0.0587742096116244,0.0282142046815763,0.00347436843573481,0.114074050787514,0.0372717279031846
Physical measures,X4270.Volume level set by participant (left),KLK14,Kallikrein-14,36888,0.0834367883897606,0.0401389272036118,0.00476449107068151,0.16210908570884,0.0376780015979816
Physical measures,X4270.Volume level set by participant (left),CARHSP1,Calcium-regulated heat-stable protein 1,36639,-0.0757046591691689,0.036450262487472,-0.147147173644614,-0.00426214469372377,0.037842206565118
Physical measures,X4270.Volume level set by participant (left),LTBP2,Latent-transforming growth factor beta-binding protein 2,36933,-0.116359923498004,0.0561976249050785,-0.226507268311958,-0.00621257868405029,0.0384340782485948
Physical measures,X4270.Volume level set by participant (left),CLC,Galectin-10,36816,-0.0552107750960483,0.0266826086455143,-0.107508688041256,-0.00291286215084018,0.0385640523906317
Physical measures,X4270.Volume level set by participant (left),NPC2,NPC intracellular cholesterol transporter 2,35785,0.133620075142643,0.0645895056734836,0.00702464402261496,0.260215506262671,0.038607692919026
Physical measures,X4270.Volume level set by participant (left),DOCK9,Dedicator of cytokinesis protein 9,35680,0.0389536831023936,0.0188455218279256,0.0020164603196594,0.0758909058851279,0.0387738110342982
Physical measures,X4270.Volume level set by participant (left),C9orf40,Uncharacterized protein C9orf40,35894,-0.0538181674802688,0.0260494371686922,-0.104875064330905,-0.0027612706296321,0.0388667391759728
Physical measures,X4270.Volume level set by participant (left),CAT,Catalase,35829,-0.0808575476773125,0.039138867634274,-0.157569728240489,-0.00414536711413557,0.0388753172746175
Physical measures,X4270.Volume level set by participant (left),MMP7,Matrilysin,36693,0.081234758806797,0.0393342428212536,0.00413964287714003,0.158329874736454,0.0389343398186113
Physical measures,X4270.Volume level set by participant (left),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",36873,-0.0528203766483067,0.025750166997867,-0.103290703964126,-0.00235004933248727,0.040275162453645
Physical measures,X4270.Volume level set by participant (left),RARRES2,Retinoic acid receptor responder protein 2,36880,0.0800273883923585,0.0391774223652651,0.00323964055643887,0.156815136228278,0.0411170435241519
Physical measures,X4270.Volume level set by participant (left),TOP1,DNA topoisomerase 1,35894,0.0404502752155446,0.019809502249008,0.00162365080748898,0.0792768996236002,0.0411942739348439
Physical measures,X4270.Volume level set by participant (left),CDC25A,M-phase inducer phosphatase 1,35678,0.122327549610241,0.0599995828067243,0.00472836730906082,0.23992673191142,0.0415098216304863
Physical measures,X4270.Volume level set by participant (left),CD27,CD27 antigen,36864,0.0875353783260636,0.0432706566414473,0.00272489130882686,0.1723458653433,0.0431105487178807
Physical measures,X4270.Volume level set by participant (left),TMED1,Transmembrane emp24 domain-containing protein 1,35798,0.0839272832997059,0.0415017273984374,0.00258389759876855,0.165270669000643,0.0431897506586742
Physical measures,X4270.Volume level set by participant (left),GALNT7,N-acetylgalactosaminyltransferase 7,36770,-0.181385967745417,0.0898218835125758,-0.357436859430066,-0.00533507606076852,0.0434812179585443
Physical measures,X4270.Volume level set by participant (left),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35798,0.083925418686171,0.0416124380807246,0.00236504004795079,0.165485797324391,0.0437531538902912
Physical measures,X4270.Volume level set by participant (left),SCLY,Selenocysteine lyase,36873,0.0832203542488854,0.0412929181132655,0.00228623474688497,0.164154473750886,0.0439010748071207
Physical measures,X4270.Volume level set by participant (left),SPARCL1,SPARC-like protein 1,36832,-0.13518671328114,0.067168964661642,-0.266837884017958,-0.00353554254432137,0.044187923252749
Physical measures,X4270.Volume level set by participant (left),PTN,Pleiotrophin,36697,-0.0785581074020104,0.039097581165907,-0.155189366487188,-0.00192684831683268,0.0445428846219059
Physical measures,X4270.Volume level set by participant (left),DPP4,Dipeptidyl peptidase 4,36669,-0.135970579748102,0.0676716409366769,-0.268606995983989,-0.00333416351221505,0.0445444314756261
Physical measures,X4270.Volume level set by participant (left),TEK,Angiopoietin-1 receptor,36864,0.170282299455219,0.0848882713164273,0.00390128767502118,0.336663311235416,0.044895803414019
Physical measures,X4270.Volume level set by participant (left),ADM,Pro-adrenomedullin,36888,0.14064271017329,0.0702552867174063,0.0029423482071736,0.278343072139406,0.0453326081885495
Physical measures,X4270.Volume level set by participant (left),REN,Renin,36828,0.0443790017335192,0.0221751337756294,0.000915739533285685,0.0878422639337528,0.0453958700031664
Physical measures,X4270.Volume level set by participant (left),F2,Prothrombin,35953,-0.286427926243456,0.143533414406216,-0.567753418479639,-0.00510243400727306,0.046023146993446
Physical measures,X4270.Volume level set by participant (left),TNFSF12,Tumor necrosis factor ligand superfamily member 12,36908,-0.13379803319179,0.0671733724281162,-0.265457843150898,-0.00213822323268262,0.0464247687098219
Physical measures,X4270.Volume level set by participant (left),LAMA1,Laminin subunit alpha-1,35706,0.0846587825458072,0.042531248475085,0.00129753553464067,0.168020029556974,0.0465767744572421
Physical measures,X4270.Volume level set by participant (left),PIGR,Polymeric immunoglobulin receptor,36711,0.106049013420896,0.0532952779802435,0.00159026857961897,0.210507758262173,0.0466448755638833
Physical measures,X4270.Volume level set by participant (left),GPR37,Prosaposin receptor GPR37,36697,0.0553111230518295,0.0279271665644206,0.000573876585565097,0.110048369518094,0.0476783473319825
Physical measures,X4270.Volume level set by participant (left),SPARC,SPARC,36864,0.0523111045378352,0.0264209279627277,0.000526085730888894,0.104096123344781,0.0477491507251014
Physical measures,X4270.Volume level set by participant (left),PON2,Serum paraoxonase/arylesterase 2,36697,0.107134257618944,0.0541787282838329,0.00094395018263134,0.213324565055256,0.048030403874605
Physical measures,X4270.Volume level set by participant (left),TPK1,Thiamin pyrophosphokinase 1,35916,-0.158774655537943,0.0803842113343688,-0.316327709753305,-0.00122160132257987,0.0482866580297524
Physical measures,X4270.Volume level set by participant (left),CCS,Copper chaperone for superoxide dismutase,36763,-0.0802549095097353,0.0407907886965807,-0.160204855355033,-0.000304963664437108,0.0491648017512103
Physical measures,X4270.Volume level set by participant (left),TCL1A,T-cell leukemia/lymphoma protein 1A,36759,-0.0365619044397504,0.0186092783564771,-0.0730360900184455,-8.77188610553387e-05,0.0494839410122342
Physical measures,X4270.Volume level set by participant (left),TRPV3,Transient receptor potential cation channel subfamily V member 3,35706,-0.0939122539076003,0.0479637676521066,-0.187921238505729,9.67306905287485e-05,0.0502746358054542
Physical measures,X4270.Volume level set by participant (left),PDCD1LG2,Programmed cell death 1 ligand 2,36770,0.116459923062017,0.059498411420199,-0.000156963321573042,0.233076809445607,0.0503416146769731
Physical measures,X4270.Volume level set by participant (left),DPEP2,Dipeptidase 2,36770,-0.126095722402881,0.064458779425207,-0.252434930076286,0.000243485270525062,0.0504756404246493
Physical measures,X4270.Volume level set by participant (left),CRTAC1,Cartilage acidic protein 1,36933,-0.121111008883101,0.0619131683067372,-0.242460818764306,0.000238800998104319,0.0504842484504329
Physical measures,X4270.Volume level set by participant (left),FGF9,Fibroblast growth factor 9,35662,-0.108424527992488,0.0554853808395707,-0.217175874438047,0.000326818453070546,0.0507312842200722
Physical measures,X4270.Volume level set by participant (left),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,35748,-0.067647609300878,0.0347564872856864,-0.135770324380823,0.000475105779067342,0.0516577549727014
Physical measures,X4270.Volume level set by participant (left),CAPN3,Calpain-3,35874,-0.109732101673796,0.0563972893995325,-0.22027078889688,0.000806585549287697,0.0517329156237379
Physical measures,X4270.Volume level set by participant (left),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,35706,-0.155584092125643,0.0799985721831239,-0.312381293604566,0.00121310935327967,0.0518377475988028
Physical measures,X4270.Volume level set by participant (left),NHLRC3,NHL repeat-containing protein 3,35611,0.135118596271315,0.069530342225599,-0.00116087449085928,0.271398067033489,0.0520231209068622
Physical measures,X4270.Volume level set by participant (left),RICTOR,Rapamycin-insensitive companion of mTOR,35725,-0.0857689004271989,0.0441782322824808,-0.172358235700861,0.000820434846463589,0.0522492419648404
Physical measures,X4270.Volume level set by participant (left),ATP6V1D,V-type proton ATPase subunit D,36770,-0.134369101561543,0.0692449044024855,-0.270089114190414,0.00135091106732871,0.0523571349802353
Physical measures,X4270.Volume level set by participant (left),CHP1,Calcineurin B homologous protein 1,35680,0.0593226334800613,0.0306101614713553,-0.000673283003794982,0.119318549963918,0.052666026986003
Physical measures,X4270.Volume level set by participant (left),IL4,Interleukin-4,36697,-0.0410438018337975,0.0211925727040478,-0.0825812443337311,0.000493640666136066,0.0528186951462676
Physical measures,X4270.Volume level set by participant (left),ZP3,Zona pellucida sperm-binding protein 3,35748,0.0162201499316847,0.00839668196987355,-0.000237346729267431,0.0326776465926369,0.0534355127077238
Physical measures,X4270.Volume level set by participant (left),PENK,Proenkephalin-A,35779,0.132792474681222,0.0688013998912559,-0.00205826910563925,0.267643218468084,0.0536393582178901
Physical measures,X4270.Volume level set by participant (left),BACH1,Transcription regulator protein BACH1,36820,0.0523947180834769,0.0271471130588405,-0.000813623511850492,0.105603059678804,0.0536402890692497
Physical measures,X4270.Volume level set by participant (left),RAD51,DNA repair protein RAD51 homolog 1,35798,-0.0822089022514446,0.04262710801122,-0.165758033953436,0.00134022945054663,0.0538284368075049
Physical measures,X4270.Volume level set by participant (left),EPPK1,Epiplakin,35748,0.0587642742150086,0.0304795171688839,-0.0009755794360038,0.118504127866021,0.0538992574084787
Physical measures,X4270.Volume level set by participant (left),GZMB,Granzyme B,36820,-0.054498246512446,0.0282892815657981,-0.10994523838141,0.000948745356518226,0.0540837562889267
Physical measures,X4270.Volume level set by participant (left),COL5A1,Collagen alpha-1(V) chain,35779,-0.105789540118283,0.0549821881496595,-0.213554628891616,0.0019755486550492,0.0543889665893176
Physical measures,X4270.Volume level set by participant (left),KLHL41,Kelch-like protein 41,35903,-0.088000950183592,0.0458398474210991,-0.177847051128946,0.00184515076176217,0.0549321311865173
Physical measures,X4270.Volume level set by participant (left),ULBP2,UL16-binding protein 2,36763,0.0930134986706309,0.0484984456749493,-0.00204345485226969,0.188070452193532,0.0551656625955709
Physical measures,X4270.Volume level set by participant (left),CAPG,Macrophage-capping protein,36775,-0.063424452528291,0.0330967063165605,-0.12829399690875,0.00144509185216762,0.0553597530164849
Physical measures,X4270.Volume level set by participant (left),MYL3,Myosin light chain 3,35748,-0.0581328166357715,0.0305008519214762,-0.117914486401865,0.00164885313032199,0.0567016165251665
Physical measures,X4270.Volume level set by participant (left),FGF16,Fibroblast growth factor 16,35725,0.0952224220177903,0.0499996671107094,-0.00277692551920018,0.193221769554781,0.0568940693511933
Physical measures,X4270.Volume level set by participant (left),COMMD9,COMM domain-containing protein 9,35874,-0.103340406197144,0.0542782800029306,-0.209725835002888,0.00304502260859982,0.0569661828407414
Physical measures,X4270.Volume level set by participant (left),HBZ,Hemoglobin subunit zeta,35916,-0.0372594032023572,0.0195878581577238,-0.0756516051914959,0.00113279878678139,0.0571918728587015
Physical measures,X4270.Volume level set by participant (left),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,36888,0.104932284181252,0.0552776868477985,-0.0034119820404334,0.213276550402937,0.0576971867403949
Physical measures,X4270.Volume level set by participant (left),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,36888,-0.130312859806173,0.0686755506447838,-0.264916939069949,0.00429121945760347,0.0577974699628324
Physical measures,X4270.Volume level set by participant (left),FLT4,Vascular endothelial growth factor receptor 3,36864,0.107711178802371,0.056797293033143,-0.003611515542589,0.219033873147332,0.0579428842241168
Physical measures,X4270.Volume level set by participant (left),TSNAX,Translin-associated protein X,35706,-0.107280682540085,0.056605921897691,-0.218228289459559,0.00366692437938936,0.058107510446395
Physical measures,X4270.Volume level set by participant (left),DNAJC9,DnaJ homolog subfamily C member 9,35894,-0.0546311381032217,0.0288624730923888,-0.111201585364304,0.00193930915786031,0.0584264029098374
Physical measures,X4270.Volume level set by participant (left),VMO1,Vitelline membrane outer layer protein 1 homolog,36770,0.0511175069243489,0.0270845394969967,-0.00196819048976458,0.104203204338462,0.0591539478737407
Physical measures,X4270.Volume level set by participant (left),IL34,Interleukin-34,36628,0.0978106039092565,0.0520406891787201,-0.00418914688103487,0.199810354699548,0.0602150140476787
Physical measures,X4270.Volume level set by participant (left),ADGRG2,Adhesion G-protein coupled receptor G2,36828,-0.129813233443183,0.0692011733849214,-0.265447533277629,0.00582106639126326,0.0607096329318157
Physical measures,X4270.Volume level set by participant (left),RBKS,Ribokinase,36642,-0.067824175105238,0.0361886684246655,-0.138753965217582,0.00310561500710636,0.060944383206447
Physical measures,X4270.Volume level set by participant (left),CLGN,Calmegin,35741,0.0917907476860674,0.0490857643055868,-0.00441735035288268,0.187998845725017,0.0615273885422734
Physical measures,X4270.Volume level set by participant (left),IL17A,Interleukin-17A,36685,0.0793581159934716,0.0425393882516295,-0.00401908497972221,0.162735316966665,0.0621475076791707
Physical measures,X4270.Volume level set by participant (left),TLR2,Toll-like receptor 2,35798,0.17595218521239,0.0945285071180361,-0.00932368873896119,0.36122805916374,0.0627368727618769
Physical measures,X4270.Volume level set by participant (left),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,36763,0.105822769430534,0.0570742474389528,-0.00604275554981359,0.217688294410882,0.0637602167315728
Physical measures,X4270.Volume level set by participant (left),TPP1,Tripeptidyl-peptidase 1,36756,0.0765051280016154,0.0412640024197688,-0.00437231674113144,0.157382572744362,0.0637723051583269
Physical measures,X4270.Volume level set by participant (left),ACYP1,Acylphosphatase-1,35739,-0.0632836419771539,0.0341547771757678,-0.130227005241659,0.00365972128735104,0.0639490198347367
Physical measures,X4270.Volume level set by participant (left),VGF,Neurosecretory protein VGF,35903,-0.130556113598229,0.070476314325286,-0.26868968967579,0.00757746247933133,0.0640005304254244
Physical measures,X4270.Volume level set by participant (left),PLA2G15,Phospholipase A2 group XV,36864,0.130469669865531,0.0704591352194117,-0.00763023516451608,0.268569574895578,0.0641063372949309
Physical measures,X4270.Volume level set by participant (left),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35798,0.0563686723399428,0.0304742125695378,-0.00336078429635123,0.116098128976237,0.0643990010418732
Physical measures,X4270.Volume level set by participant (left),TCN1,Transcobalamin-1,35757,0.121334425408652,0.0656731968551422,-0.0073850404274272,0.25005389124473,0.0647126584398533
Physical measures,X4270.Volume level set by participant (left),HAVCR1,Hepatitis A virus cellular receptor 1,36881,0.0532912298029108,0.0288678960606598,-0.00328984647598234,0.109872306081804,0.0649251429223202
Physical measures,X4270.Volume level set by participant (left),ACTN2,Alpha-actinin-2,35706,-0.0690076441429464,0.0373997632377471,-0.142311180088931,0.00429589180303785,0.0650631748588175
Physical measures,X4270.Volume level set by participant (left),PRDX2,Peroxiredoxin-2,35792,-0.0635706600844387,0.0344662295666439,-0.131124470035061,0.00398314986618328,0.0651648431508441
Physical measures,X4270.Volume level set by participant (left),PREB,Prolactin regulatory element-binding protein,36697,0.118649641687901,0.0643612540890095,-0.00749841632655728,0.24479769970236,0.0652962179827104
Physical measures,X4270.Volume level set by participant (left),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,35748,-0.199969560469853,0.108734303050532,-0.413088794448897,0.0131496735091908,0.0659507096780298
Physical measures,X4270.Volume level set by participant (left),IL19,Interleukin-19,36640,0.0488365111646059,0.0266028000628137,-0.00330497695850898,0.100977999287721,0.0664321683409485
Physical measures,X4270.Volume level set by participant (left),RBFOX3,RNA binding protein fox-1 homolog 3,35903,-0.101348908336024,0.0553241753407553,-0.209784292003904,0.00708647533185672,0.0670091636560878
Physical measures,X4270.Volume level set by participant (left),C1RL,Complement C1r subcomponent-like protein,35934,0.197567796893216,0.107901458620254,-0.0139190620024825,0.409054655788915,0.0671443726365297
Physical measures,X4270.Volume level set by participant (left),RABEPK,Rab9 effector protein with kelch motifs,36654,-0.061804170731121,0.0338262375976767,-0.128103596422567,0.00449525496032545,0.0677235639416847
Physical measures,X4270.Volume level set by participant (left),CASQ2,Calsequestrin-2,35706,0.0831533266291924,0.045538909336594,-0.00610293567053193,0.172409588928917,0.0678984389718352
Physical measures,X4270.Volume level set by participant (left),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,35725,-0.0867004124509045,0.04756704987725,-0.179931830210315,0.00653100530850542,0.0683947187950716
Physical measures,X4270.Volume level set by participant (left),SLC12A2,Solute carrier family 12 member 2,35706,-0.147255221075464,0.0811097267494891,-0.306230285504463,0.0117198433535346,0.0694921314976078
Physical measures,X4270.Volume level set by participant (left),DEFB116,Beta-defensin 116,35680,0.0534143126186375,0.0294364365060185,-0.00428110293315873,0.111109728170434,0.0696370602447709
Physical measures,X4270.Volume level set by participant (left),CCL17,C-C motif chemokine 17,36813,0.0369066188493092,0.0203533794941121,-0.00298600495915058,0.076799242657769,0.0698261526602803
Physical measures,X4270.Volume level set by participant (left),LY96,Lymphocyte antigen 96,36763,0.0945570025858235,0.052166571117702,-0.00768947680487234,0.196803481976519,0.0699335226317427
Physical measures,X4270.Volume level set by participant (left),PSMG4,Proteasome assembly chaperone 4,35725,-0.0679149213298351,0.0375924665705529,-0.141596155808119,0.00576631314844857,0.0708691584294167
Physical measures,X4270.Volume level set by participant (left),CDA,Cytidine deaminase,35893,-0.083994411593487,0.0464989041291474,-0.175132263686616,0.00714344049964184,0.0709048186070152
Physical measures,X4270.Volume level set by participant (left),AMBP,Protein AMBP,36881,0.165369499531663,0.0917148951082672,-0.0143916948805403,0.345130693943867,0.0714144585486174
Physical measures,X4270.Volume level set by participant (left),DDI2,Protein DDI1 homolog 2,35779,-0.0502362847360229,0.0279193125382522,-0.104958137310997,0.00448556783895137,0.0720109885988563
Physical measures,X4270.Volume level set by participant (left),CD300LF,CMRF35-like molecule 1,36888,0.056375677420005,0.0313487157804735,-0.00506780550972298,0.117819160349733,0.0721622020848835
Physical measures,X4270.Volume level set by participant (left),FAM3D,Protein FAM3D,35894,0.0458946284818391,0.0255256597824372,-0.00413566469173789,0.0959249216554161,0.0722251831955344
Physical measures,X4270.Volume level set by participant (left),IKZF2,Zinc finger protein Helios,36654,-0.0407032449569622,0.0226718800548424,-0.0851401298644534,0.00373363995052886,0.0726434504222714
Physical measures,X4270.Volume level set by participant (left),BLVRB,Flavin reductase,36836,-0.0476994570435696,0.0265879038513398,-0.0998117485921955,0.00441283450505627,0.0728481527980442
Physical measures,X4270.Volume level set by participant (left),IL3RA,Interleukin-3 receptor subunit alpha,36697,-0.104111362457069,0.0580392171716028,-0.217868228113411,0.00964550319927207,0.0728836734238046
Physical measures,X4270.Volume level set by participant (left),VCAM1,Vascular cell adhesion protein 1,36839,-0.121424774927966,0.0679032311077616,-0.254515107899179,0.0116655580432462,0.0737828345867943
Physical measures,X4270.Volume level set by participant (left),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,36837,0.107222511192799,0.0600200272864223,-0.010416742288589,0.224861764674186,0.0740667849053762
Physical measures,X4270.Volume level set by participant (left),PNMA2,Paraneoplastic antigen Ma2,35680,0.0902003592269678,0.0505937995885206,-0.00896348796653269,0.189364206420468,0.0746600646454319
Physical measures,X4270.Volume level set by participant (left),CLEC4G,C-type lectin domain family 4 member G,36820,0.0999934788345822,0.056275978529731,-0.0103074390836906,0.210294396752855,0.0756342351872907
Physical measures,X4270.Volume level set by participant (left),C2CD2L,Phospholipid transfer protein C2CD2L,36624,-0.0802619070662403,0.0452503518397906,-0.16895259667223,0.00842878253974923,0.0761487862605886
Physical measures,X4270.Volume level set by participant (left),LEP,Leptin,36828,0.0505218032967541,0.028539850928052,-0.00541630452222779,0.106459911115736,0.0767304870973007
Physical measures,X4270.Volume level set by participant (left),CTF1,Cardiotrophin-1,36697,0.0406005401099636,0.0229365640691464,-0.00435512546556335,0.0855562056854905,0.0767472682566988
Physical measures,X4270.Volume level set by participant (left),NLGN2,Neuroligin-2,35680,0.0840390835171967,0.0474886910179066,-0.00903875087790032,0.177116917912294,0.0768299303359745
Physical measures,X4270.Volume level set by participant (left),LEFTY2,Left-right determination factor 2,36880,-0.0662066383174892,0.0374562092717639,-0.139620808490146,0.00720753185516818,0.0771717599948049
Physical measures,X4270.Volume level set by participant (left),MMP1,Interstitial collagenase,36542,0.0376784907155894,0.0213234241780864,-0.00411542067345987,0.0794724021046387,0.0772697479459583
Physical measures,X4270.Volume level set by participant (left),BRDT,Bromodomain testis-specific protein,35706,0.109508696416626,0.061994829704803,-0.012001169804788,0.23101856263804,0.0773728453052128
Physical measures,X4270.Volume level set by participant (left),PSME2,Proteasome activator complex subunit 2,36722,-0.0933418869172906,0.0528647602769159,-0.196956817060046,0.0102730432254645,0.0774912490692108
Physical measures,X4270.Volume level set by participant (left),ST13,Hsc70-interacting protein,35779,-0.0731226485046999,0.0414869949079893,-0.154437158524359,0.00819186151495906,0.0780238559807382
Physical measures,X4270.Volume level set by participant (left),NPPC,C-type natriuretic peptide,36820,0.0675362482512266,0.038331469881768,-0.00759343271703875,0.142665929219492,0.0781261321802734
Physical measures,X4270.Volume level set by participant (left),ACVRL1,Serine/threonine-protein kinase receptor R3,36748,0.128239296190208,0.0728196058292752,-0.0144871312351712,0.270965723615588,0.0782696450997477
Physical measures,X4270.Volume level set by participant (left),BGLAP,Osteocalcin,35931,0.0424544082862942,0.0241350460913214,-0.00485028205269572,0.0897590986252841,0.0786168512877528
Physical measures,X4270.Volume level set by participant (left),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35903,-0.0809397662394675,0.0460565399227943,-0.171210584488144,0.00933105200920926,0.0788952669040736
Physical measures,X4270.Volume level set by participant (left),CNTN4,Contactin-4,36836,-0.13563736809934,0.0771999784685464,-0.286949325897691,0.0156745896990111,0.0789644779351553
Physical measures,X4270.Volume level set by participant (left),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35916,0.0958023576018111,0.0546129429841228,-0.0112390106470697,0.202843725850692,0.0794407825027664
Physical measures,X4270.Volume level set by participant (left),PHLDB2,Pleckstrin homology-like domain family B member 2,35678,0.040797831615962,0.0232643872410404,-0.00480036737647725,0.0863960306084012,0.079536003103585
Physical measures,X4270.Volume level set by participant (left),BST2,Bone marrow stromal antigen 2,36894,0.0641954461754064,0.0366133070865566,-0.00756663571424464,0.135957528065057,0.0795840738428355
Physical measures,X4270.Volume level set by participant (left),MFAP3L,Microfibrillar-associated protein 3-like,35741,-0.0618054102971133,0.0352853548087137,-0.130964705722192,0.0073538851279655,0.0798914892047291
Physical measures,X4270.Volume level set by participant (left),PLAU,Urokinase-type plasminogen activator,36836,-0.112993397476402,0.0645746548263013,-0.239559720935953,0.0135729259831485,0.0801911995001324
Physical measures,X4270.Volume level set by participant (left),SART1,U4/U6.U5 tri-snRNP-associated protein 1,35706,-0.105421298937296,0.0603300863412323,-0.223668268166111,0.0128256702915194,0.0806136797569037
Physical measures,X4270.Volume level set by participant (left),TG,Thyroglobulin,35874,-0.0329275196954182,0.0188637824254203,-0.0699005332492421,0.00404549385840563,0.0809366090227566
Physical measures,X4270.Volume level set by participant (left),SNX15,Sorting nexin-15,35779,-0.0716274162785083,0.0410357360952233,-0.152057459025146,0.0088026264681294,0.0809464877509158
Physical measures,X4270.Volume level set by participant (left),LAP3,Cytosol aminopeptidase,36697,0.0687467563554026,0.0394325473878362,-0.00854103652475637,0.146034549235562,0.0813045087955084
Physical measures,X4270.Volume level set by participant (left),STAB2,Stabilin-2,35931,0.134489659004972,0.0773114129861173,-0.0170407104478175,0.286020028457762,0.0819778673462549
Physical measures,X4270.Volume level set by participant (left),BRD3,Bromodomain-containing protein 3,35706,0.080490275124447,0.0462732196107488,-0.0102052353126207,0.171185785561515,0.0820016833163091
Physical measures,X4270.Volume level set by participant (left),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35916,0.0430322500618064,0.0247442689023586,-0.00546651698681647,0.0915310171104293,0.0820665842674486
Physical measures,X4270.Volume level set by participant (left),DMP1,Dentin matrix acidic phosphoprotein 1,35748,-0.0618365742494029,0.0356456838269867,-0.131702114550297,0.00802896605149107,0.0828310149708898
Physical measures,X4270.Volume level set by participant (left),NOTCH3,Neurogenic locus notch homolog protein 3,36933,-0.0943858274986926,0.0544347125837857,-0.201077864162913,0.0123062091655273,0.0829708439622039
Physical measures,X4270.Volume level set by participant (left),C19orf12,Protein C19orf12,36639,0.052156863889683,0.0300847234940154,-0.00680919415858718,0.111122921937953,0.0830187685965568
Physical measures,X4270.Volume level set by participant (left),ASGR1,Asialoglycoprotein receptor 1,36763,0.11113310737051,0.0644159057726333,-0.0151220679438511,0.237388282684871,0.084524477025182
Physical measures,X4270.Volume level set by participant (left),GJA8,Gap junction alpha-8 protein,35678,0.0628540874757455,0.0364613273056196,-0.0086101140432689,0.13431828899476,0.0847814837144084
Physical measures,X4270.Volume level set by participant (left),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,35706,-0.102926263539004,0.0597116514627939,-0.21996110040608,0.0141085733280723,0.0848055991611738
Physical measures,X4270.Volume level set by participant (left),DENND2B,DENN domain-containing protein 2B,35706,0.078741299662404,0.0456940365028142,-0.0108190118831118,0.16830161120792,0.0848945708315066
Physical measures,X4270.Volume level set by participant (left),GNLY,Granulysin,36836,-0.0604802964339089,0.0351172513103726,-0.129310109002239,0.00834951613442153,0.0850667279289365
Physical measures,X4270.Volume level set by participant (left),RCC1,Regulator of chromosome condensation,35874,0.0715109290085983,0.0415829001927789,-0.00999155536924833,0.153013413386445,0.085529762525881
Physical measures,X4270.Volume level set by participant (left),PPIE,Peptidyl-prolyl cis-trans isomerase E,35798,0.0587992414245552,0.0342029417163119,-0.00823852433941617,0.125837007188527,0.0856379145595839
Physical measures,X4270.Volume level set by participant (left),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35926,-0.0997353053303697,0.058024674387217,-0.213463667129315,0.0139930564685756,0.0856889578373632
Physical measures,X4270.Volume level set by participant (left),MBL2,Mannose-binding protein C,35845,0.0346603362547479,0.0201817743793807,-0.00489594152883837,0.0742166140383341,0.0859512642812853
Physical measures,X4270.Volume level set by participant (left),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",35748,-0.06973358931197,0.0406394201546774,-0.149386852815138,0.00991967419119771,0.0862257884240137
Physical measures,X4270.Volume level set by participant (left),RGMA,Repulsive guidance molecule A,36894,-0.0999251915646386,0.0583577117645064,-0.214306306623071,0.0144559234937939,0.0868839428813428
Physical measures,X4270.Volume level set by participant (left),CD274,Programmed cell death 1 ligand 1,36763,0.0938198018180631,0.0548679163136142,-0.0137213141566208,0.201360917792747,0.0873214855333096
Physical measures,X4270.Volume level set by participant (left),SYTL4,Synaptotagmin-like protein 4,35916,0.0492127497749723,0.0287968582007107,-0.00722909229842075,0.105654591848365,0.0875040835039417
Physical measures,X4270.Volume level set by participant (left),HNMT,Histamine N-methyltransferase,36733,0.0699332011195977,0.0409332105043704,-0.0102958914689682,0.150162293708164,0.0875901713167211
Physical measures,X4270.Volume level set by participant (left),ATF4,Cyclic AMP-dependent transcription factor ATF-4,35678,-0.110038185750422,0.0645601231305209,-0.236576027086243,0.0164996555853994,0.0883487860928867
Physical measures,X4270.Volume level set by participant (left),PRSS8,Prostasin,36790,0.0775842075813736,0.0455213246565128,-0.0116375887453915,0.166806003908139,0.0883568859052828
Physical measures,X4270.Volume level set by participant (left),ADAMTSL4,ADAMTS-like protein 4,35748,-0.162495166275748,0.0954050587268009,-0.349489081380278,0.0244987488287815,0.0885755886214868
Physical measures,X4270.Volume level set by participant (left),KIRREL1,Kin of IRRE-like protein 1,35680,0.065292923006047,0.0383443351540561,-0.00986197389590301,0.140447819907997,0.0886525145889346
Physical measures,X4270.Volume level set by participant (left),FAP,Prolyl endopeptidase FAP,36933,-0.117203896974145,0.0688664399280902,-0.252182119233202,0.0177743252849114,0.0888140154876334
Physical measures,X4270.Volume level set by participant (left),LEG1,Protein LEG1 homolog,35580,0.0557808416008239,0.0328534693789795,-0.00861195838197592,0.120173641583624,0.0895814945449142
Physical measures,X4270.Volume level set by participant (left),MAPK13,Mitogen-activated protein kinase 13,35678,0.0921676961724165,0.0543135941007437,-0.0142869482650411,0.198622340609874,0.0897532855275019
Physical measures,X4270.Volume level set by participant (left),ARG2,"Arginase-2, mitochondrial",35874,0.0874252021548554,0.0515793425225446,-0.0136703091893322,0.188520713499043,0.0901286084734433
Physical measures,X4270.Volume level set by participant (left),CREB3,Cyclic AMP-responsive element-binding protein 3,35678,0.0677211799287979,0.0400101513174156,-0.0106987166533366,0.146141076510932,0.0905797058575497
Physical measures,X4270.Volume level set by participant (left),ROBO2,Roundabout homolog 2,36894,-0.132374412378421,0.0782807394036541,-0.285804661609583,0.0210558368527411,0.0908731841972619
Physical measures,X4270.Volume level set by participant (left),CDH4,Cadherin-4,35680,0.0796492739340512,0.0471290231261635,-0.0127236113932293,0.172022159261332,0.0910710598311108
Physical measures,X4270.Volume level set by participant (left),IMPACT,Protein IMPACT,35903,-0.0692057740494841,0.0410613703529834,-0.149686059941332,0.0112745118423633,0.0919535329042537
Physical measures,X4270.Volume level set by participant (left),CCL14,C-C motif chemokine 14,36794,0.0765680097321638,0.0454863282382834,-0.0125851936148718,0.165721213079199,0.0923544021181777
Physical measures,X4270.Volume level set by participant (left),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,36865,-0.0720739881454183,0.0428242171479232,-0.156009453755348,0.0118614774645112,0.0924120454392111
Physical measures,X4270.Volume level set by participant (left),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,36770,-0.159631082271142,0.0949075396372069,-0.345649859960068,0.026387695417783,0.0926170144792628
Physical measures,X4270.Volume level set by participant (left),HLA_E,,36820,0.102369908466177,0.060973874187679,-0.0171388849416734,0.221878701874028,0.0932097340252406
Physical measures,X4270.Volume level set by participant (left),ADGRB3,Adhesion G protein-coupled receptor B3,36748,0.0923857567801514,0.0550496875927583,-0.0155116309016549,0.200283144461958,0.0933445821736309
Physical measures,X4270.Volume level set by participant (left),HDDC2,5'-deoxynucleotidase HDDC2,35894,-0.082474255223459,0.049172735391105,-0.178852816590025,0.0139043061431069,0.0935431153734456
Physical measures,X4270.Volume level set by participant (left),DPY30,Protein dpy-30 homolog,36864,0.0545516165478411,0.0325345889061111,-0.00921617770813658,0.118319410803819,0.0936366880581945
Physical measures,X4270.Volume level set by participant (left),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,36873,-0.0896472519863222,0.0535003939954726,-0.194508024217448,0.0152135202448041,0.0938499998379754
Physical measures,X4270.Volume level set by participant (left),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",36820,0.0723459649835616,0.0431917316939149,-0.0123098291365115,0.157001759103635,0.0939760912269165
Physical measures,X4270.Volume level set by participant (left),CCL23,C-C motif chemokine 23,36865,0.0744580749127394,0.0444557680483264,-0.0126752304619804,0.161591380287459,0.0939985633703868
Physical measures,X4270.Volume level set by participant (left),AGR2,Anterior gradient protein 2 homolog,36576,0.0319894996149764,0.0190995561516538,-0.00544563044226491,0.0694246296722178,0.0939997923913763
Physical measures,X4270.Volume level set by participant (left),BOC,Brother of CDO,36697,-0.136800530403793,0.0816986995622601,-0.296929981545823,0.0233289207382365,0.0940835432211593
Physical measures,X4270.Volume level set by participant (left),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",35748,-0.115219275594491,0.0688554659660049,-0.250175988887861,0.0197374376988787,0.0943062109532444
Physical measures,X4270.Volume level set by participant (left),SELL,L-selectin,35953,-0.156180871946504,0.0933409056442493,-0.339129047009233,0.0267673031162243,0.0943281785197393
Physical measures,X4270.Volume level set by participant (left),LCN15,Lipocalin-15,35903,0.0593232501371394,0.0354957246854497,-0.0102483702463419,0.128894870520621,0.0947132919337855
Physical measures,X4270.Volume level set by participant (left),CBLN4,Cerebellin-4,36888,-0.0942228270068615,0.0563917997412225,-0.204750754499658,0.0163051004859345,0.094789934601948
Physical measures,X4270.Volume level set by participant (left),ADGRV1,Adhesion G-protein coupled receptor V1,35680,0.0546935891398032,0.0327461413839262,-0.00948884797269211,0.118876026252298,0.0949221315001325
Physical measures,X4270.Volume level set by participant (left),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,36697,-0.147873169143244,0.0886838859239366,-0.321693585554159,0.0259472472676721,0.0954729290892619
Physical measures,X4270.Volume level set by participant (left),NELL2,Protein kinase C-binding protein NELL2,36865,-0.106990392012042,0.0642506660547284,-0.23292169747931,0.0189409134552259,0.0959131448015738
Physical measures,X4270.Volume level set by participant (left),FNDC1,Fibronectin type III domain-containing protein 1,35903,0.0792166685152436,0.0476072526387683,-0.0140935466567423,0.172526883687229,0.0961667071922464
Physical measures,X4270.Volume level set by participant (left),CSPG4,Chondroitin sulfate proteoglycan 4,35931,-0.108389804043308,0.0653792770783161,-0.236533187116808,0.0197535790301913,0.0973919476903777
Physical measures,X4270.Volume level set by participant (left),NAPRT,Nicotinate phosphoribosyltransferase,35903,-0.108130518801448,0.0652364620044704,-0.23599398433021,0.0197329467273143,0.0974618501458835
Physical measures,X4270.Volume level set by participant (left),KITLG,Kit ligand,36828,-0.0845945991401077,0.0510476307072153,-0.18464795532625,0.0154587570460343,0.097526229507635
Physical measures,X4270.Volume level set by participant (left),PCARE,Photoreceptor cilium actin regulator,35680,0.0443392123288932,0.0267835610943304,-0.00815656741599434,0.0968349920737807,0.0978788805756673
Physical measures,X4270.Volume level set by participant (left),KRT19,"Keratin, type I cytoskeletal 19",36810,0.045488746309379,0.0275718148156752,-0.00855201072934445,0.0995295033481024,0.0990194171270452
Physical measures,X4270.Volume level set by participant (left),EZR,Ezrin,36894,-0.123381155259496,0.0750181983326373,-0.270416823991465,0.0236545134724728,0.100076036913112
Physical measures,X4270.Volume level set by participant (left),GFRAL,GDNF family receptor alpha-like,35709,-0.0587539375313432,0.0357258055153881,-0.128776516341504,0.0112686412788174,0.100104766098807
Physical measures,X4270.Volume level set by participant (left),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,36856,0.0471040079342916,0.0286687170475412,-0.00908667747888917,0.103294693347472,0.100414557948697
Physical measures,X4270.Volume level set by participant (left),GLI2,Zinc finger protein GLI2,35725,-0.112698755425179,0.068633943608931,-0.247221284898684,0.0218237740483253,0.100632675862408
Physical measures,X4270.Volume level set by participant (left),EPO,Erythropoietin,36820,0.0419240770696941,0.0255761030344697,-0.00820508487786645,0.0920532390172547,0.101215085071283
Physical measures,X4270.Volume level set by participant (left),GAMT,Guanidinoacetate N-methyltransferase,35706,-0.103187791630753,0.0629572041607308,-0.226583911785786,0.0202083285242791,0.101258498492538
Physical measures,X4270.Volume level set by participant (left),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35916,0.0404859923717671,0.0247521139194081,-0.00802815091027291,0.089000135653807,0.101958030349846
Physical measures,X4270.Volume level set by participant (left),IDO1,"Indoleamine 2,3-dioxygenase 1",35748,-0.0549435654741401,0.0336033326471923,-0.120806097462637,0.0109189665143567,0.102083888617296
Physical measures,X4270.Volume level set by participant (left),SLK,STE20-like serine/threonine-protein kinase,35798,0.0446767031366296,0.0273398797025599,-0.00890946108038786,0.098262867353647,0.102280890272622
Physical measures,X4270.Volume level set by participant (left),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,35678,0.0456972423369542,0.0279858816157045,-0.00915508562982673,0.100549570303735,0.1025454007126
Physical measures,X4270.Volume level set by participant (left),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35874,0.0544751258215195,0.03343355856065,-0.0110546489573544,0.120004900600393,0.103285124870998
Physical measures,X4270.Volume level set by participant (left),PAEP,Glycodelin,36763,-0.0334113023534272,0.0205116019929884,-0.0736140422596844,0.00679143755283009,0.103376298488098
Physical measures,X4270.Volume level set by participant (left),KLK7,Kallikrein-7,35626,-0.0933963867602469,0.0575327580872213,-0.206160592611201,0.019367819090707,0.104561465434859
Physical measures,X4270.Volume level set by participant (left),CPM,Carboxypeptidase M,36845,0.0899475587251331,0.0554426823174175,-0.0187200986170052,0.198615216067271,0.104769171079222
Physical measures,X4270.Volume level set by participant (left),FASLG,Tumor necrosis factor ligand superfamily member 6,36908,-0.0805181746901794,0.049631315371589,-0.177795552818494,0.016759203438135,0.104774439633266
Physical measures,X4270.Volume level set by participant (left),DYNLT1,Dynein light chain Tctex-type 1,35741,0.0470322261948396,0.0289920171224885,-0.00979212736523791,0.103856579754917,0.104798544593181
Physical measures,X4270.Volume level set by participant (left),VSIG2,V-set and immunoglobulin domain-containing protein 2,35874,0.0543583102751655,0.033531897284839,-0.011364208403119,0.12008082895345,0.105045000726063
Physical measures,X4270.Volume level set by participant (left),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,36908,-0.0846464906996169,0.0522338812256637,-0.187024897901918,0.017731916502684,0.105159696632531
Physical measures,X4270.Volume level set by participant (left),FABP4,"Fatty acid-binding protein, adipocyte",36933,0.0599645793081069,0.0370160966713685,-0.0125869701677754,0.132516128783989,0.105281725841076
Physical measures,X4270.Volume level set by participant (left),ATP5PO,"ATP synthase subunit O, mitochondrial",36639,-0.0739316851670814,0.0456552388584906,-0.163415953329723,0.0155525829955602,0.105414943741047
Physical measures,X4270.Volume level set by participant (left),FARSA,Phenylalanine--tRNA ligase alpha subunit,35741,0.0513697044849834,0.0317257156136218,-0.0108126981177153,0.113552107087682,0.105456319050089
Physical measures,X4270.Volume level set by participant (left),FZD10,Frizzled-10,35741,0.0609528644982167,0.0377294787322582,-0.0129969138170094,0.134902642813443,0.106245553223584
Physical measures,X4270.Volume level set by participant (left),FAM171B,Protein FAM171B,35874,-0.129544457378132,0.0802486307098484,-0.286831773569435,0.027742858813171,0.106512072859128
Physical measures,X4270.Volume level set by participant (left),CD58,Lymphocyte function-associated antigen 3,36813,-0.170308066164659,0.105542624646369,-0.377171610471542,0.0365554781422247,0.106646418449061
Physical measures,X4270.Volume level set by participant (left),CRHBP,Corticotropin-releasing factor-binding protein,36822,0.109732460409651,0.0680918246634014,-0.0237275159306159,0.243192436749918,0.107104227918457
Physical measures,X4270.Volume level set by participant (left),SNAPIN,SNARE-associated protein Snapin,35903,-0.0610386245009659,0.037885015333581,-0.135293254554785,0.0132160055528529,0.107193047385157
Physical measures,X4270.Volume level set by participant (left),INSL5,Insulin-like peptide INSL5,35894,0.0366032956258974,0.022817113496971,-0.00811824682816584,0.0813248380799607,0.108716335418691
Physical measures,X4270.Volume level set by participant (left),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,36585,0.0473419078050299,0.0295259392358874,-0.0105289330973094,0.105212748707369,0.10888899189758
Physical measures,X4270.Volume level set by participant (left),RGS8,Regulator of G-protein signaling 8,36697,0.0475409069369437,0.0296621909079553,-0.0105969872426487,0.105678801116536,0.109033232716835
Physical measures,X4270.Volume level set by participant (left),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35798,0.0493572408353432,0.0308118496536912,-0.0110339844858915,0.109748466156578,0.109227447668888
Physical measures,X4270.Volume level set by participant (left),MB,Myoglobin,36933,-0.0568996101824784,0.0355626541964761,-0.126602412407572,0.0128031920426147,0.109643388914015
Physical measures,X4270.Volume level set by participant (left),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,36654,0.0237344660380509,0.0148464011763972,-0.00536448026768759,0.0528334123437894,0.109936764766894
Physical measures,X4270.Volume level set by participant (left),ATP5F1D,"ATP synthase subunit delta, mitochondrial",35706,0.066582129389009,0.0416641166381855,-0.0150795392218346,0.148243797999853,0.110076181426801
Physical measures,X4270.Volume level set by participant (left),GMPR,GMP reductase 1,36908,-0.0631768551239519,0.0395574073487809,-0.140709373527562,0.0143556632796587,0.110285972473447
Physical measures,X4270.Volume level set by participant (left),FSTL1,Follistatin-related protein 1,35748,-0.154802568522863,0.0970366810572765,-0.344994463395125,0.0353893263493989,0.110693515360488
Physical measures,X4270.Volume level set by participant (left),NRN1,Neuritin,35903,-0.100710119210634,0.0634039600377739,-0.224981880884671,0.023561642463403,0.112245665506104
Physical measures,X4270.Volume level set by participant (left),PCDH7,Protocadherin-7,35894,-0.0938633325019915,0.0591406158351582,-0.209778939538902,0.0220522745349186,0.112532378799861
Physical measures,X4270.Volume level set by participant (left),SLC39A14,Zinc transporter ZIP14,36639,-0.0878842735318708,0.0553763519144451,-0.196421923284183,0.0206533762204416,0.112546936413078
Physical measures,X4270.Volume level set by participant (left),TIE1,Tyrosine-protein kinase receptor Tie-1,36933,0.0704725695316674,0.0445646225387315,-0.0168740906442462,0.157819229707581,0.113837356825968
Physical measures,X4270.Volume level set by participant (left),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,35748,0.0975946168212844,0.0617227531468187,-0.0233819793464803,0.218571212989049,0.113885777791413
Physical measures,X4270.Volume level set by participant (left),PARD3,Partitioning defective 3 homolog,35798,0.0469449078726862,0.0296982888162188,-0.0112637382071027,0.105153553952475,0.113988222582819
Physical measures,X4270.Volume level set by participant (left),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35894,0.0859183241862795,0.0543611031913185,-0.0206294380687048,0.192466086441264,0.114037103810768
Physical measures,X4270.Volume level set by participant (left),SLC4A1,Band 3 anion transport protein,35931,-0.0671297482365841,0.0424737131651706,-0.150378226040318,0.0161187295671502,0.114039132311612
Physical measures,X4270.Volume level set by participant (left),HSPA2,Heat shock-related 70 kDa protein 2,35874,-0.102320914307408,0.0648468329128595,-0.229420706816613,0.0247788782017965,0.11463915754655
Physical measures,X4270.Volume level set by participant (left),ADD1,Alpha-adducin,35779,-0.0522256425929334,0.0331107028812341,-0.117122620240152,0.0126713350542853,0.114773659419604
Physical measures,X4270.Volume level set by participant (left),NAP1L4,Nucleosome assembly protein 1-like 4,35876,-0.091277071863588,0.0579358681094227,-0.204831373358057,0.0222772296308806,0.115191976777839
Physical measures,X4270.Volume level set by participant (left),DGCR6,Protein DGCR6,35680,-0.083494013383563,0.053010862768018,-0.187395304408878,0.0204072776417523,0.115296946425092
Physical measures,X4270.Volume level set by participant (left),CLSPN,Claspin,36624,-0.0861370951548916,0.0548630435144059,-0.193668660443127,0.0213944701333439,0.116448734344345
Physical measures,X4270.Volume level set by participant (left),KLK12,Kallikrein-12,36654,0.0217925484298248,0.0138809493557881,-0.00541411230751999,0.0489992091671695,0.116466624365244
Physical measures,X4270.Volume level set by participant (left),TMPRSS11D,Transmembrane protease serine 11D,35888,0.0852611945666261,0.054308627273041,-0.0211837148885343,0.191706104021786,0.116476748686263
Physical measures,X4270.Volume level set by participant (left),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",36624,-0.0642005634696512,0.0410187572437724,-0.144597327667445,0.0161962007281427,0.117590028442513
Physical measures,X4270.Volume level set by participant (left),IL31,Interleukin-31,35725,0.063318598664696,0.0404856896653523,-0.0160333530793945,0.142670550408787,0.117871956983132
Physical measures,X4270.Volume level set by participant (left),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,36624,0.0641592583188962,0.0410390511047605,-0.0162772818464344,0.144595798484227,0.118007985551401
Physical measures,X4270.Volume level set by participant (left),EHD3,EH domain-containing protein 3,35748,0.031199257632948,0.0200075228205039,-0.0080154870952395,0.0704140023611356,0.118955638412483
Physical measures,X4270.Volume level set by participant (left),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,36772,0.0160371414442393,0.0102896004856887,-0.00413047550771048,0.0362047583961891,0.119138149210637
Physical measures,X4270.Volume level set by participant (left),DKKL1,Dickkopf-like protein 1,36770,-0.0332934608989479,0.0213639762197475,-0.075166854289653,0.00857993249175713,0.119182013201404
Physical measures,X4270.Volume level set by participant (left),PRKD2,Serine/threonine-protein kinase D2,35706,-0.0779077807935923,0.0500343994336842,-0.175975203683613,0.0201596420964286,0.119499075089187
Physical measures,X4270.Volume level set by participant (left),PSMD9,26S proteasome non-ATPase regulatory subunit 9,36770,-0.051345051486462,0.0329926499188098,-0.116010645327329,0.0133205423544053,0.119688713295928
Physical measures,X4270.Volume level set by participant (left),KLK13,Kallikrein-13,36633,0.065573081072227,0.0421865462957356,-0.0171125496674148,0.148258711811869,0.120141120281488
Physical measures,X4270.Volume level set by participant (left),SMOC1,SPARC-related modular calcium-binding protein 1,36888,-0.0885036119519964,0.0569777483272616,-0.200179998673429,0.0231727747694363,0.120392309849601
Physical measures,X4270.Volume level set by participant (left),LTB,Lymphotoxin-beta,35874,0.0965788995245352,0.0622817310419182,-0.0254932933176244,0.218651092366695,0.121026304069774
Physical measures,X4270.Volume level set by participant (left),SNX18,Sorting nexin-18,35894,-0.0798340128642212,0.0515125953617241,-0.1807986997732,0.0211306740447581,0.121237746011245
Physical measures,X4270.Volume level set by participant (left),TADA3,Transcriptional adapter 3,35874,0.086358167168481,0.055815780928311,-0.0230407634510085,0.195757097787971,0.121862457840502
Physical measures,X4270.Volume level set by participant (left),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,36697,-0.107872163819664,0.0697261454078887,-0.244535408819126,0.0287910811797976,0.12188532244678
Physical measures,X4270.Volume level set by participant (left),GASK1A,Golgi-associated kinase 1A,35706,0.0814993168542772,0.0527412983837074,-0.0218736279777894,0.184872261686344,0.122330634558095
Physical measures,X4270.Volume level set by participant (left),DPP7,Dipeptidyl peptidase 2,36783,0.0487112345654507,0.0315424748510356,-0.0131120161425791,0.110534485273481,0.122555921259322
Physical measures,X4270.Volume level set by participant (left),AMOT,Angiomotin,35779,-0.0880444716200321,0.0570623893554487,-0.199886754756712,0.0237978115166473,0.122890735092402
Physical measures,X4270.Volume level set by participant (left),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,36807,0.0896729756773749,0.0581495138530315,-0.0243000714745667,0.203646022829317,0.123088323799826
Physical measures,X4270.Volume level set by participant (left),SLC28A1,Sodium/nucleoside cotransporter 1,35678,0.058851431513801,0.0381649082560656,-0.0159517886680876,0.13365465169569,0.123115138102481
Physical measures,X4270.Volume level set by participant (left),SNAP25,Synaptosomal-associated protein 25,35680,0.0728934399086221,0.0473342734460532,-0.0198817360456422,0.165668615862886,0.12361606506071
Physical measures,X4270.Volume level set by participant (left),CCL16,C-C motif chemokine 16,36933,0.0546695670086267,0.0355960171194348,-0.0150986265454656,0.124437760562719,0.124620037902281
Physical measures,X4270.Volume level set by participant (left),AKAP12,A-kinase anchor protein 12,35779,-0.157943995311422,0.102855208875647,-0.35954020470769,0.043652214084846,0.124685685075195
Physical measures,X4270.Volume level set by participant (left),IL17C,Interleukin-17C,36697,0.039728419255201,0.0258730742980961,-0.0109828063690674,0.0904396448794693,0.124700263424831
Physical measures,X4270.Volume level set by participant (left),IL1R1,Interleukin-1 receptor type 1,36823,0.123467300012777,0.0804449264821356,-0.034204755892209,0.281139355917763,0.124873143192509
Physical measures,X4270.Volume level set by participant (left),RNASE6,Ribonuclease K6,35866,0.100652072040256,0.0655810281477511,-0.0278867431293362,0.229190887209848,0.124886731593289
Physical measures,X4270.Volume level set by participant (left),CSNK2A1,Casein kinase II subunit alpha,35903,-0.0766282272995011,0.049983463823007,-0.174595816392595,0.0213393617935927,0.125305394484342
Physical measures,X4270.Volume level set by participant (left),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",35785,-0.0568458060725193,0.0371740958974686,-0.129707034031558,0.0160154218865191,0.126268356924358
Physical measures,X4270.Volume level set by participant (left),TPM3,Tropomyosin alpha-3 chain,35706,-0.0799620286695129,0.0523039943112806,-0.182477857519623,0.022553800180597,0.126364131576212
Physical measures,X4270.Volume level set by participant (left),MNAT1,CDK-activating kinase assembly factor MAT1,35798,-0.0787217157409812,0.0516808509131521,-0.180016183530759,0.022572752048797,0.127749592559002
Physical measures,X4270.Volume level set by participant (left),FGF12,Fibroblast growth factor 12,35725,-0.0738221436850059,0.0484697897582623,-0.1688229316112,0.0211786442411881,0.12779344550484
Physical measures,X4270.Volume level set by participant (left),PALLD,Palladin,35725,-0.0876761383061806,0.0575758107369166,-0.200524727350537,0.0251724507381759,0.127858518604798
Physical measures,X4270.Volume level set by participant (left),DUOX2,Dual oxidase 2,36697,0.0385492333623668,0.0253406261106186,-0.0111183938144456,0.0882168605391791,0.128241190448277
Physical measures,X4270.Volume level set by participant (left),IL10,Interleukin-10,36697,0.0354674476894184,0.0233707052613223,-0.0103391346227733,0.08127403000161,0.129156708897598
Physical measures,X4270.Volume level set by participant (left),NCAM2,Neural cell adhesion molecule 2,36836,-0.104339045269302,0.0688571377530327,-0.239299035265246,0.0306209447266422,0.129738468647848
Physical measures,X4270.Volume level set by participant (left),ZBTB16,Zinc finger and BTB domain-containing protein 16,36654,0.0396296558641942,0.0261831566448875,-0.0116893311597853,0.0909486428881738,0.130181041954601
Physical measures,X4270.Volume level set by participant (left),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",36697,0.0495043120809291,0.0327333589856485,-0.014653071530942,0.1136616956928,0.130486851847333
Physical measures,X4270.Volume level set by participant (left),SMPD1,Sphingomyelin phosphodiesterase,36867,0.0572971281360332,0.0379187613041988,-0.0170236440201965,0.131617900292263,0.130817016533501
Physical measures,X4270.Volume level set by participant (left),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,36807,0.0251446789286999,0.0166422677399803,-0.00747416584166137,0.0577635236990612,0.130857340484632
Physical measures,X4270.Volume level set by participant (left),BAMBI,BMP and activin membrane-bound inhibitor homolog,36654,0.0971585403689041,0.0643057554349449,-0.0288807402835878,0.223197821021396,0.130860366665237
Physical measures,X4270.Volume level set by participant (left),ANXA2,Annexin A2,35616,-0.0461034098595237,0.0305143504335805,-0.105911536709341,0.013704716990294,0.130869185658653
Physical measures,X4270.Volume level set by participant (left),SCGN,Secretagogin,36697,0.0640691997719875,0.0424192699804589,-0.0190725693897119,0.147210968933687,0.130988720031652
Physical measures,X4270.Volume level set by participant (left),GPR158,Probable G-protein coupled receptor 158,35903,0.0900400258054162,0.059623173511039,-0.0268213942762201,0.206901445887053,0.131051881732333
Physical measures,X4270.Volume level set by participant (left),TPPP2,Tubulin polymerization-promoting protein family member 2,35798,0.0412202785006191,0.027354492098628,-0.0123945260126919,0.09483508301393,0.131886070947074
Physical measures,X4270.Volume level set by participant (left),RBM19,Probable RNA-binding protein 19,35706,-0.0744083772057705,0.0493942740733151,-0.171221154389468,0.0224043999779271,0.132008670287321
Physical measures,X4270.Volume level set by participant (left),VASH1,Tubulinyl-Tyr carboxypeptidase 1,36820,0.0353503548515388,0.0234837977788744,-0.010677888795055,0.0813785984981326,0.132286273411627
Physical measures,X4270.Volume level set by participant (left),CD69,Early activation antigen CD69,36798,0.0335819571244612,0.0223362951867025,-0.0101971814414757,0.0773610956903981,0.132759347391604
Physical measures,X4270.Volume level set by participant (left),AGRN,Agrin,36865,0.0792697348120987,0.0527309888410393,-0.0240830033163383,0.182622472940536,0.132806600318065
Physical measures,X4270.Volume level set by participant (left),LETM1,Mitochondrial proton/calcium exchanger protein,35903,0.0643878025382859,0.0428386115577651,-0.0195758761149338,0.148351481191506,0.132877889337879
Physical measures,X4270.Volume level set by participant (left),PTPRH,Receptor-type tyrosine-protein phosphatase H,35894,-0.0673044956430839,0.0447931183033144,-0.15509900751758,0.0204900162314123,0.132998842862257
Physical measures,X4270.Volume level set by participant (left),LGMN,Legumain,36865,0.0785270570749974,0.0523271622748708,-0.0240341809837493,0.181088295133744,0.133475905000645
Physical measures,X4270.Volume level set by participant (left),VEGFB,Vascular endothelial growth factor B,35725,0.111878267808718,0.0745991847146228,-0.0343361342319431,0.258092669849378,0.133733990862953
Physical measures,X4270.Volume level set by participant (left),LBR,Delta(14)-sterol reductase LBR,36894,0.0426632834274241,0.028479309895112,-0.0131561639669954,0.0984827308218437,0.134162606557301
Physical measures,X4270.Volume level set by participant (left),PAXX,Protein PAXX,35779,-0.0730556111090439,0.0489153028456606,-0.168929604686539,0.0228183824684507,0.135351045062138
Physical measures,X4270.Volume level set by participant (left),PITHD1,PITH domain-containing protein 1,35662,0.0419793767286688,0.02813241928714,-0.0131601650741257,0.0971189185314632,0.135693833181539
Physical measures,X4270.Volume level set by participant (left),GZMH,Granzyme H,36697,-0.0353342594432869,0.0236829437187426,-0.0817528291320223,0.0110843102454486,0.135748871425129
Physical measures,X4270.Volume level set by participant (left),BTLA,B- and T-lymphocyte attenuator,35678,0.0373455438946782,0.0250418855859573,-0.011736551853798,0.0864276396431544,0.135925340705394
Physical measures,X4270.Volume level set by participant (left),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,36908,0.0686028896282217,0.0460733723532561,-0.0217009201841603,0.158906699440604,0.136530332339443
Physical measures,X4270.Volume level set by participant (left),GRSF1,G-rich sequence factor 1,35638,0.0415432705406041,0.0279274299856549,-0.0131944922312794,0.0962810333124877,0.136920240507542
Physical measures,X4270.Volume level set by participant (left),RARRES1,Retinoic acid receptor responder protein 1,36654,0.0823193736392037,0.0553809165235577,-0.0262272227469694,0.190865970025377,0.13720999734189
Physical measures,X4270.Volume level set by participant (left),SLC44A4,Choline transporter-like protein 4,35741,-0.0459248730567525,0.030908771933923,-0.106506066047242,0.0146563199337365,0.137374896852254
Physical measures,X4270.Volume level set by participant (left),CLNS1A,Methylosome subunit pICln,35741,-0.0913093640479029,0.061484030047251,-0.211818062940515,0.029199334844709,0.137567954636697
Physical measures,X4270.Volume level set by participant (left),CTSS,Cathepsin S,35068,0.141124875492869,0.0950541294363569,-0.0451812182023902,0.327430969188129,0.137682547675123
Physical measures,X4270.Volume level set by participant (left),RUVBL1,RuvB-like 1,36654,-0.027769050600442,0.0187136035644692,-0.0644477135868016,0.00890961238591767,0.13787864823664
Physical measures,X4270.Volume level set by participant (left),SH3GL3,Endophilin-A3,35756,-0.039135560999881,0.0263941648686122,-0.090868124142361,0.012597002142599,0.138192785642915
Physical measures,X4270.Volume level set by participant (left),AOC1,Amiloride-sensitive amine oxidase [copper-containing],36697,0.0503264086073249,0.033946681422206,-0.0162090869801988,0.116861904194849,0.138245767656769
Physical measures,X4270.Volume level set by participant (left),UPB1,Beta-ureidopropionase,35916,0.0366401927193282,0.0247191727855779,-0.0118093859404044,0.0850897713790609,0.138318544620415
Physical measures,X4270.Volume level set by participant (left),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,35706,0.0637067078158299,0.0430713244925116,-0.0207130881894928,0.148126503821153,0.139162529365608
Physical measures,X4270.Volume level set by participant (left),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",35748,-0.131024802810663,0.0886381388710837,-0.304755554997988,0.0427059493766607,0.139402613894246
Physical measures,X4270.Volume level set by participant (left),PDIA2,Protein disulfide-isomerase A2,35678,-0.0814388635492349,0.0550945631387294,-0.189424207301145,0.0265464802026747,0.139412172664833
Physical measures,X4270.Volume level set by participant (left),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",36654,-0.0578671226671211,0.0393486379198017,-0.134990452989932,0.0192562076556902,0.141434531502765
Physical measures,X4270.Volume level set by participant (left),TSPYL1,Testis-specific Y-encoded-like protein 1,35725,-0.0827143907621183,0.0564230144477819,-0.193303499079771,0.0278747175555342,0.142704893714039
Physical measures,X4270.Volume level set by participant (left),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,36608,0.0328463422891068,0.0224492034442192,-0.0111540964615628,0.0768467810397763,0.143471302858985
Physical measures,X4270.Volume level set by participant (left),COL1A1,Collagen alpha-1(I) chain,36933,-0.10753527338513,0.0735472204174597,-0.251687825403351,0.0366172786330906,0.143747416486655
Physical measures,X4270.Volume level set by participant (left),FCRL1,Fc receptor-like protein 1,36828,-0.0591186785980949,0.0404831082627682,-0.138465570793121,0.0202282135969308,0.144240696765275
Physical measures,X4270.Volume level set by participant (left),PDGFRB,Platelet-derived growth factor receptor beta,36933,-0.0795995620741608,0.0545277746425992,-0.186474000373655,0.0272748762253336,0.14438607436845
Physical measures,X4270.Volume level set by participant (left),RPL14,60S ribosomal protein L14,35748,-0.0828689020902137,0.0568763880215669,-0.194346622612485,0.0286088184320573,0.14516428612164
Physical measures,X4270.Volume level set by participant (left),AREG,Amphiregulin,36770,0.0654142800975554,0.0449318552288499,-0.0226521561509904,0.153480716346101,0.145474074745198
Physical measures,X4270.Volume level set by participant (left),APOE,Apolipoprotein E,35953,0.0458124133445238,0.0314786516950411,-0.0158857439777566,0.107510570666804,0.145619225797297
Physical measures,X4270.Volume level set by participant (left),SEMA4C,Semaphorin-4C,36770,-0.0971909455936064,0.0668685782341178,-0.228253358932477,0.0338714677452644,0.146136925913951
Physical measures,X4270.Volume level set by participant (left),SIT1,Signaling threshold-regulating transmembrane adapter 1,36697,0.0506892072816229,0.0349786534476818,-0.0178689534758334,0.119247368039079,0.147338371148755
Physical measures,X4270.Volume level set by participant (left),NCR1,Natural cytotoxicity triggering receptor 1,36802,-0.070945433807519,0.0489966955774051,-0.166978957139233,0.025088089524195,0.147668441971107
Physical measures,X4270.Volume level set by participant (left),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,36837,-0.0442175621897965,0.0306448862264006,-0.104281539193542,0.0158464148139485,0.149089126036763
Physical measures,X4270.Volume level set by participant (left),ZNF174,Zinc finger protein 174,35725,0.0855506661964023,0.0592972786617592,-0.0306719999806457,0.20177333237345,0.149141180305566
Physical measures,X4270.Volume level set by participant (left),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",36770,0.029591978167623,0.0205362665035695,-0.0106591041793732,0.0698430605146193,0.149636782970197
Physical measures,X4270.Volume level set by participant (left),RAB6B,Ras-related protein Rab-6B,36639,-0.0584542774444546,0.0405841415407366,-0.137999194864298,0.021090639975389,0.149818069295952
Physical measures,X4270.Volume level set by participant (left),CA1,Carbonic anhydrase 1,36673,-0.045126577004335,0.0313472196202554,-0.106567127460036,0.0163139734513657,0.150030419206439
Physical measures,X4270.Volume level set by participant (left),ITGAX,Integrin alpha-X,35798,0.0579349230881213,0.0402588763090433,-0.0209724744776035,0.136842320653846,0.150181046974897
Physical measures,X4270.Volume level set by participant (left),PLXDC1,Plexin domain-containing protein 1,36654,-0.0863744335995082,0.0600437274869479,-0.204060139473926,0.0313112722749098,0.15032697266514
Physical measures,X4270.Volume level set by participant (left),TPPP3,Tubulin polymerization-promoting protein family member 3,36639,0.0692661747411462,0.0482617408230369,-0.0253268372720061,0.163859186754299,0.151266682358774
Physical measures,X4270.Volume level set by participant (left),MME,Neprilysin,36770,0.0335608471839438,0.0234005400633528,-0.0123042113402276,0.0794259057081153,0.151559014530883
Physical measures,X4270.Volume level set by participant (left),HYOU1,Hypoxia up-regulated protein 1,36933,0.115831501038274,0.0809705917260173,-0.0428708587447201,0.274533860821268,0.152603082533141
Physical measures,X4270.Volume level set by participant (left),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,36697,-0.0797907581107497,0.0558111121562911,-0.18918053793708,0.0295990217155808,0.152857083364538
Physical measures,X4270.Volume level set by participant (left),DUSP3,Dual specificity protein phosphatase 3,36639,0.0320732672753692,0.0224405535979012,-0.0119102177765172,0.0760567523272555,0.152973006980708
Physical measures,X4270.Volume level set by participant (left),ODAM,Odontogenic ameloblast-associated protein,36628,-0.0500574438145482,0.0350235717607676,-0.118703644465653,0.0185887568365564,0.152974395024981
Physical measures,X4270.Volume level set by participant (left),FGF19,Fibroblast growth factor 19,36865,0.0353631822765755,0.0247539494259297,-0.0131545585982466,0.0838809231513976,0.153163564819817
Physical measures,X4270.Volume level set by participant (left),TGFBR1,TGF-beta receptor type-1,35725,0.147991064446191,0.103800918121423,-0.0554587350717987,0.35144086396418,0.153996940897522
Physical measures,X4270.Volume level set by participant (left),RAB6A,Ras-related protein Rab-6A,36820,-0.0560203074559975,0.0393084639011437,-0.133064896702239,0.0210242817902442,0.154155888767126
Physical measures,X4270.Volume level set by participant (left),CA6,Carbonic anhydrase 6,36819,-0.0429994223572062,0.0302026086926799,-0.102196535394859,0.0161976906804465,0.154574570417628
Physical measures,X4270.Volume level set by participant (left),SFTPD,Pulmonary surfactant-associated protein D,36828,-0.0394725375115689,0.0277499675136412,-0.0938624738383057,0.0149173988151679,0.154940751873731
Physical measures,X4270.Volume level set by participant (left),ITGAM,Integrin alpha-M,36836,-0.0843325493273056,0.0593953050802134,-0.200747347284524,0.0320822486299126,0.155691547364551
Physical measures,X4270.Volume level set by participant (left),IL2RG,Cytokine receptor common subunit gamma,35874,-0.0864476877046232,0.0609098896444012,-0.20583107140765,0.0329356959984032,0.155866475384512
Physical measures,X4270.Volume level set by participant (left),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",35741,0.0383546494976904,0.0270494992420202,-0.0146623690166691,0.09137166801205,0.156255006403064
Physical measures,X4270.Volume level set by participant (left),PSCA,Prostate stem cell antigen,35894,-0.0117473131137032,0.00828726399227789,-0.0279903505385678,0.0044957243111615,0.156379212799848
Physical measures,X4270.Volume level set by participant (left),TCOF1,Treacle protein,35916,-0.0983858608974285,0.0694226265923587,-0.234454209018452,0.0376824872235946,0.156470346288531
Physical measures,X4270.Volume level set by participant (left),TBC1D17,TBC1 domain family member 17,36639,-0.0570186246788244,0.0402841243656182,-0.135975508435436,0.0219382590777873,0.156989638772472
Physical measures,X4270.Volume level set by participant (left),CCL11,Eotaxin,36908,0.0715668004805201,0.0505964745145913,-0.0276022895680788,0.170735890529119,0.157266615445127
Physical measures,X4270.Volume level set by participant (left),KHDC3L,KH domain-containing protein 3,35678,0.0461681938881302,0.0327068238228138,-0.0179371808045848,0.110273568580845,0.15812261144561
Physical measures,X4270.Volume level set by participant (left),DCTPP1,dCTP pyrophosphatase 1,36828,-0.0852787068119994,0.0604473984051589,-0.203755607686111,0.033198194062112,0.158346714125413
Physical measures,X4270.Volume level set by participant (left),LDLRAP1,Low density lipoprotein receptor adapter protein 1,35903,0.0323139881137597,0.0229191048180542,-0.0126074573296265,0.0772354335571459,0.158611179288961
Physical measures,X4270.Volume level set by participant (left),ATP6AP2,Renin receptor,36654,0.0661994203267013,0.047076276425185,-0.0260700814666612,0.158468922120064,0.159701616932119
Physical measures,X4270.Volume level set by participant (left),ADRA2A,Alpha-2A adrenergic receptor,35706,0.0438355595824835,0.0311747905191325,-0.0172670298350162,0.104938148999983,0.159735628330291
Physical measures,X4270.Volume level set by participant (left),LAMP1,Lysosome-associated membrane glycoprotein 1,35744,0.104493512811367,0.0743715859178141,-0.0412747955875491,0.250261821210282,0.160062987395435
Physical measures,X4270.Volume level set by participant (left),CBLN1,Cerebellin-1,35680,0.0339502026200024,0.0241798402239704,-0.0134422842189796,0.0813426894589844,0.160345731109073
Physical measures,X4270.Volume level set by participant (left),EIF5A,Eukaryotic translation initiation factor 5A-1,36697,0.0862946235104574,0.0614736075199581,-0.0341936472286604,0.206782894249575,0.160429637949018
Physical measures,X4270.Volume level set by participant (left),CD46,Membrane cofactor protein,36756,0.0908452620380383,0.0647554985225482,-0.0360755150661561,0.217766039142233,0.160688776821712
Physical measures,X4270.Volume level set by participant (left),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",35680,-0.0746345322271019,0.0532468851056677,-0.17899842703421,0.0297293625800067,0.161061849624037
Physical measures,X4270.Volume level set by participant (left),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,35706,-0.0799172691949208,0.0570244194392342,-0.19168513129582,0.0318505929059782,0.161125149835281
Physical measures,X4270.Volume level set by participant (left),ZPR1,Zinc finger protein ZPR1,35680,0.0323047660329948,0.0230741460113993,-0.0129205601493478,0.0775300922153374,0.161548691428006
Physical measures,X4270.Volume level set by participant (left),CLEC4D,C-type lectin domain family 4 member D,36820,0.0417417232372246,0.029819672535804,-0.0167048349329512,0.1001882814074,0.161612448993287
Physical measures,X4270.Volume level set by participant (left),SERPINE1,Plasminogen activator inhibitor 1,36933,0.0387557195643972,0.027696427378639,-0.0155292780977352,0.0930407172265296,0.161761957145796
Physical measures,X4270.Volume level set by participant (left),KCTD5,BTB/POZ domain-containing protein KCTD5,35770,-0.0721421847116782,0.051588106866283,-0.173254874169593,0.0289705047462364,0.162032154993863
Physical measures,X4270.Volume level set by participant (left),SLITRK1,SLIT and NTRK-like protein 1,35725,-0.0970020489834048,0.0693696839177586,-0.232966629462212,0.0389625314954021,0.162060028110438
Physical measures,X4270.Volume level set by participant (left),REG3A,Regenerating islet-derived protein 3-alpha,36933,0.0401471334057661,0.0287373953835597,-0.0161781615460109,0.0964724283575431,0.162443260619605
Physical measures,X4270.Volume level set by participant (left),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,35706,0.0508282274670169,0.0363824112669102,-0.0204812986161271,0.122137753550161,0.162444673764647
Physical measures,X4270.Volume level set by participant (left),ACP5,Tartrate-resistant acid phosphatase type 5,36872,0.0813095818410802,0.0582487694962373,-0.0328580063715449,0.195477170053705,0.162784343530564
Physical measures,X4270.Volume level set by participant (left),SPRING1,SREBP regulating gene protein,35678,0.0503093519774779,0.0360663083284754,-0.020380612346334,0.12099931630129,0.163089965389952
Physical measures,X4270.Volume level set by participant (left),TLR1,Toll-like receptor 1,35725,-0.11398402913351,0.0817194505938014,-0.274154152297361,0.046186094030341,0.163117195381808
Physical measures,X4270.Volume level set by participant (left),LGALS7_LGALS7B,Galectin-7,36819,0.063238477948782,0.0453489175402767,-0.0256454004301604,0.152122356327724,0.163211221241445
Physical measures,X4270.Volume level set by participant (left),CFHR5,Complement factor H-related protein 5,35826,0.0721951489937558,0.0517941095274624,-0.0293213056800704,0.173711603667582,0.163398376593796
Physical measures,X4270.Volume level set by participant (left),WDR46,WD repeat-containing protein 46,35874,-0.0885085615673974,0.0635966882194425,-0.213158070477505,0.0361409473427099,0.164054616737116
Physical measures,X4270.Volume level set by participant (left),USP47,Ubiquitin carboxyl-terminal hydrolase 47,35706,0.035354487986653,0.025443536187201,-0.0145148429402611,0.085223818913567,0.164719993697529
Physical measures,X4270.Volume level set by participant (left),CASP9,Caspase-9,35725,0.0497308871547956,0.0358228195402717,-0.0204818391441369,0.119943613453728,0.165109510190453
Physical measures,X4270.Volume level set by participant (left),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35916,-0.0583593795323837,0.0420832801940224,-0.140842608712668,0.0241238496479002,0.165561181608359
Physical measures,X4270.Volume level set by participant (left),IGSF8,Immunoglobulin superfamily member 8,36828,0.0861742147502746,0.062164103589371,-0.0356674282848925,0.208015857785442,0.165714879880313
Physical measures,X4270.Volume level set by participant (left),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,36763,-0.0881338010488839,0.0636171267367548,-0.212823369452923,0.0365557673551556,0.165977594010909
Physical measures,X4270.Volume level set by participant (left),AMOTL2,Angiomotin-like protein 2,35836,0.0616641696789211,0.0446390015871428,-0.0258282734318787,0.149156612789721,0.167203506536373
Physical measures,X4270.Volume level set by participant (left),PRDX1,Peroxiredoxin-1,36582,-0.0288326093160294,0.0209365744679871,-0.0698682952732842,0.0122030766412254,0.168510483516747
Physical measures,X4270.Volume level set by participant (left),CX3CL1,Fractalkine,36763,0.0768214920814368,0.0558223852444054,-0.0325903829975979,0.186233367160471,0.168807517864562
Physical measures,X4270.Volume level set by participant (left),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35903,0.0484069208717019,0.0351910454705564,-0.0205675282505886,0.117381369993993,0.169008010613709
Physical measures,X4270.Volume level set by participant (left),C7orf50,Uncharacterized protein C7orf50,35903,-0.138393713066062,0.100761644734047,-0.335886536744794,0.0590991106126693,0.169650293770628
Physical measures,X4270.Volume level set by participant (left),TRIM5,Tripartite motif-containing protein 5,36820,0.0314376199309101,0.0229193804768416,-0.0134843658036994,0.0763596056655197,0.170209369047696
Physical measures,X4270.Volume level set by participant (left),MAMDC4,Apical endosomal glycoprotein,35874,-0.0551950856000631,0.0402635072471016,-0.134111559804382,0.0237213886042561,0.170468906820125
Physical measures,X4270.Volume level set by participant (left),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",36933,0.0845557218560049,0.0616843528501785,-0.036345609730345,0.205457053442355,0.170483089941925
Physical measures,X4270.Volume level set by participant (left),CCL28,C-C motif chemokine 28,36801,-0.044728770068488,0.0326356353262411,-0.108694615307921,0.0192370751709446,0.170555733682456
Physical measures,X4270.Volume level set by participant (left),CST6,Cystatin-M,36637,0.0519556223546168,0.0379214178972376,-0.0223703567239689,0.126281601433202,0.170701245956652
Physical measures,X4270.Volume level set by participant (left),ITGB1BP1,Integrin beta-1-binding protein 1,36654,0.0630393077614496,0.0460504817734922,-0.0272196365145951,0.153298252037494,0.17106631473808
Physical measures,X4270.Volume level set by participant (left),C4BPB,C4b-binding protein beta chain,36864,0.0641813279192502,0.0469644786578818,-0.0278690502501981,0.156231706088699,0.171792984974245
Physical measures,X4270.Volume level set by participant (left),INSL3,Insulin-like 3,35903,-0.0380119703077329,0.0278351755730916,-0.0925689144309925,0.0165449738155268,0.172107476183023
Physical measures,X4270.Volume level set by participant (left),IGFBP4,Insulin-like growth factor-binding protein 4,36742,0.0568763643085038,0.041669263662267,-0.0247953924695395,0.138548121086547,0.172310198143555
Physical measures,X4270.Volume level set by participant (left),IL18,Interleukin-18,36812,0.0538450542206106,0.0395037517711886,-0.0235822992509191,0.13127240769214,0.172911319065767
Physical measures,X4270.Volume level set by participant (left),JCHAIN,Immunoglobulin J chain,36697,0.0411838262838804,0.030243562359907,-0.0180935559415374,0.100461208509298,0.173321296206094
Physical measures,X4270.Volume level set by participant (left),PRDX6,Peroxiredoxin-6,36888,-0.0388063009220129,0.0285419161169262,-0.0947484565111883,0.0171358546671625,0.173988500573086
Physical measures,X4270.Volume level set by participant (left),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,35741,-0.0741777672957706,0.0546444054736656,-0.181280802024155,0.032925267432614,0.174680901929357
Physical measures,X4270.Volume level set by participant (left),PARP1,Poly [ADP-ribose] polymerase 1,36820,-0.0428175679902207,0.0315446058452983,-0.104644995447005,0.0190098594665641,0.174705204476979
Physical measures,X4270.Volume level set by participant (left),PCYT2,Ethanolamine-phosphate cytidylyltransferase,35894,0.0411253793863238,0.0302976692656071,-0.0182580523742662,0.100508811146914,0.174706982725805
Physical measures,X4270.Volume level set by participant (left),PGM2,Phosphoglucomutase-2,35741,-0.051120545191299,0.0376632999676867,-0.124940613127965,0.022699522745367,0.174731465865298
Physical measures,X4270.Volume level set by participant (left),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",35725,-0.0865560775210185,0.063812573725073,-0.211628722022162,0.0385165669801246,0.175015340884556
Physical measures,X4270.Volume level set by participant (left),SYT1,Synaptotagmin-1,35903,-0.0722643151721511,0.0533262406910731,-0.176783746926654,0.0322551165823521,0.175419834739204
Physical measures,X4270.Volume level set by participant (left),TNN,Tenascin-N,35931,0.0664001378697287,0.0490333168600314,-0.0297051631759328,0.16250543891539,0.175723090982967
Physical measures,X4270.Volume level set by participant (left),BPIFA2,BPI fold-containing family A member 2,35532,-0.0281440619597818,0.0208123392329923,-0.0689362468564467,0.0126481229368832,0.176334769260944
Physical measures,X4270.Volume level set by participant (left),CA14,Carbonic anhydrase 14,36888,-0.0701380673138201,0.0521703598756567,-0.172391972670107,0.0321158380424669,0.178857264977583
Physical measures,X4270.Volume level set by participant (left),CCL20,C-C motif chemokine 20,36908,0.0280201683317484,0.0208427494065019,-0.0128316205049953,0.0688719571684921,0.17887139756372
Physical measures,X4270.Volume level set by participant (left),DTX2,Probable E3 ubiquitin-protein ligase DTX2,35741,0.048532976303269,0.0361100571059685,-0.0222427356244294,0.119308688230967,0.178985491867262
Physical measures,X4270.Volume level set by participant (left),KLF4,Krueppel-like factor 4,35680,-0.0717531099737562,0.0533897542944241,-0.176397028390827,0.0328908084433151,0.179011890892638
Physical measures,X4270.Volume level set by participant (left),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,36763,-0.0707534756585233,0.0526809762917339,-0.174008189190322,0.0325012378732752,0.179294284659168
Physical measures,X4270.Volume level set by participant (left),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35916,0.0404840761466647,0.030165209684273,-0.0186397348345104,0.0996078871278399,0.179615926672461
Physical measures,X4270.Volume level set by participant (left),TAGLN3,Transgelin-3,35678,-0.0500627013020706,0.037311042150426,-0.123192343916906,0.0230669413127644,0.179718769844257
Physical measures,X4270.Volume level set by participant (left),PDRG1,p53 and DNA damage-regulated protein 1,35741,-0.0585438531488874,0.0436888644973293,-0.144174027563653,0.0270863212658781,0.180286105602297
Physical measures,X4270.Volume level set by participant (left),SUMF1,Formylglycine-generating enzyme,35725,0.0447114318796186,0.0333897943112814,-0.020732564970493,0.11015542872973,0.180592949464845
Physical measures,X4270.Volume level set by participant (left),MDK,Midkine,36844,0.0485163915427974,0.0362444222396698,-0.0225226760469554,0.11955545913255,0.180744243828925
Physical measures,X4270.Volume level set by participant (left),BAP18,Chromatin complexes subunit BAP18,35903,0.0445423209201828,0.0333113601982266,-0.0207479450683414,0.109832586908707,0.181218683928484
Physical measures,X4270.Volume level set by participant (left),GLRX,Glutaredoxin-1,36781,-0.0436650321089205,0.0326672477452378,-0.107692837689587,0.0203627734717455,0.181373453229045
Physical measures,X4270.Volume level set by participant (left),GZMA,Granzyme A,36908,-0.0705606533548043,0.052825795543324,-0.174099212619719,0.0329779059101107,0.181679107048719
Physical measures,X4270.Volume level set by participant (left),FTCD,Formimidoyltransferase-cyclodeaminase,35885,0.0353788678865981,0.026495433973385,-0.0165521827012366,0.0873099184744327,0.181829613084687
Physical measures,X4270.Volume level set by participant (left),UROD,Uroporphyrinogen decarboxylase,35779,-0.0446276211074073,0.0334334863735794,-0.110157254399623,0.0209020121848084,0.181982072481732
Physical measures,X4270.Volume level set by participant (left),ZNF830,Zinc finger protein 830,35874,-0.0382081538442292,0.0286743857501468,-0.094409949914517,0.0179936422260585,0.182746740224575
Physical measures,X4270.Volume level set by participant (left),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",36820,0.0270236240525251,0.0202862964805094,-0.0127375170492733,0.0667847651543234,0.182863128640281
Physical measures,X4270.Volume level set by participant (left),RASSF2,Ras association domain-containing protein 2,36654,0.0475725791215446,0.0357169440256232,-0.0224326311686769,0.117577789411766,0.182922887836156
Physical measures,X4270.Volume level set by participant (left),KRT6C,"Keratin, type II cytoskeletal 6C",35706,0.0813385687596079,0.0611071284436284,-0.0384314029899036,0.20110854050912,0.183208812738023
Physical measures,X4270.Volume level set by participant (left),RNASE4,Ribonuclease 4,35702,0.100767132953414,0.0757230749930229,-0.0476500940329113,0.249184359939738,0.183323791975834
Physical measures,X4270.Volume level set by participant (left),LY6D,Lymphocyte antigen 6D,36792,0.0640246119437132,0.0481208487303078,-0.03029225156769,0.158341475455116,0.183394744881813
Physical measures,X4270.Volume level set by participant (left),IGF1R,Insulin-like growth factor 1 receptor,36770,-0.116741996683221,0.0878090544984025,-0.28884774350009,0.0553637501336475,0.183723642411025
Physical measures,X4270.Volume level set by participant (left),C1R,Complement C1r subcomponent,35953,0.149644562509595,0.112565990230229,-0.0709847783416536,0.370273903360845,0.183762872528451
Physical measures,X4270.Volume level set by participant (left),CD248,Endosialin,35931,-0.0716198339106965,0.0538772955005036,-0.177219333091684,0.0339796652702904,0.183789486329976
Physical measures,X4270.Volume level set by participant (left),DCN,Decorin,36697,-0.108200683772379,0.0814206659163529,-0.267785188968431,0.0513838214236727,0.183918307335305
Physical measures,X4270.Volume level set by participant (left),ADGRE2,Adhesion G protein-coupled receptor E2,36865,-0.087339871850547,0.0657879422716178,-0.216284238702918,0.0416044950018239,0.184350812052115
Physical measures,X4270.Volume level set by participant (left),RBPMS2,RNA-binding protein with multiple splicing 2,35748,0.0286002942391999,0.0215434447874961,-0.0136248575442925,0.0708254460226923,0.184368557925672
Physical measures,X4270.Volume level set by participant (left),UBAC1,Ubiquitin-associated domain-containing protein 1,36770,-0.0731182598620001,0.055105150817546,-0.18112435546439,0.03488783574039,0.184586361697082
Physical measures,X4270.Volume level set by participant (left),CD3G,T-cell surface glycoprotein CD3 gamma chain,35725,0.0332558952460726,0.0250731500679186,-0.0158874788870478,0.082399269379193,0.184768572827742
Physical measures,X4270.Volume level set by participant (left),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",35706,0.0495612861400436,0.0373933326789506,-0.0237296459106996,0.122852218190787,0.185083590261519
Physical measures,X4270.Volume level set by participant (left),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,36654,0.0399263945152645,0.0301469259789865,-0.0191615804035491,0.099014369434078,0.185412962083485
Physical measures,X4270.Volume level set by participant (left),PON3,Serum paraoxonase/lactonase 3,36865,-0.0854608719730556,0.0645536069227554,-0.211985941541656,0.041064197595545,0.185584203019091
Physical measures,X4270.Volume level set by participant (left),MKI67,Proliferation marker protein Ki-67,35725,-0.0770668018653692,0.058214383361601,-0.191166993254107,0.0370333895233688,0.185600987553418
Physical measures,X4270.Volume level set by participant (left),SPINK2,Serine protease inhibitor Kazal-type 2,35779,0.0770163850699049,0.0582610820668127,-0.0371753357810478,0.191208105920858,0.18624132862913
Physical measures,X4270.Volume level set by participant (left),TSHB,Thyrotropin subunit beta,36828,-0.0312052752214127,0.0236073790600657,-0.0774757381791415,0.0150651877363161,0.186259686207988
Physical measures,X4270.Volume level set by participant (left),FHIP2A,FHF complex subunit HOOK interacting protein 2A,35706,-0.0617360591355538,0.0467307141738675,-0.153328258916334,0.0298561406452266,0.186513658910233
Physical measures,X4270.Volume level set by participant (left),PRAP1,Proline-rich acidic protein 1,35931,0.0705223344383333,0.0534011123676461,-0.034143845802253,0.17518851467892,0.186674495279725
Physical measures,X4270.Volume level set by participant (left),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,36863,-0.0663729357587257,0.0502655923805588,-0.164893496824621,0.0321476253071696,0.186726003470465
Physical measures,X4270.Volume level set by participant (left),ADH1B,All-trans-retinol dehydrogenase,35779,0.0400877117183389,0.0304113112136415,-0.0195184582603985,0.0996938816970763,0.187487844521095
Physical measures,X4270.Volume level set by participant (left),IL22,Interleukin-22,35874,0.042558604991307,0.0323149455799224,-0.020778688345341,0.105895898327955,0.187885670771516
Physical measures,X4270.Volume level set by participant (left),CLASP1,CLIP-associating protein 1,35678,0.0397966189822102,0.0302190480035773,-0.0194327151048014,0.0990259530692218,0.187905899347727
Physical measures,X4270.Volume level set by participant (left),CSF2,Granulocyte-macrophage colony-stimulating factor,35706,-0.0823069560781921,0.0625872216363101,-0.20497791048536,0.0403639983289756,0.188530672137709
Physical measures,X4270.Volume level set by participant (left),SPINK4,Serine protease inhibitor Kazal-type 4,36820,0.0372329202676695,0.0283362347628373,-0.0183060998674916,0.0927719404028306,0.188896339268147
Physical measures,X4270.Volume level set by participant (left),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35874,0.0421263877504928,0.0321309488385229,-0.020850271973012,0.105103047473998,0.189874316618664
Physical measures,X4270.Volume level set by participant (left),NPY,Pro-neuropeptide Y,36888,0.0376183583776784,0.028702165342612,-0.018637885693841,0.0938746024491979,0.190016759275894
Physical measures,X4270.Volume level set by participant (left),CD79B,B-cell antigen receptor complex-associated protein beta chain,36908,0.0517936105566654,0.0395710132636651,-0.0257655754401182,0.129352796553449,0.190614840319261
Physical measures,X4270.Volume level set by participant (left),TERF1,Telomeric repeat-binding factor 1,35725,-0.0977836523257218,0.074772528217423,-0.244337807631871,0.0487705029804272,0.191004720699176
Physical measures,X4270.Volume level set by participant (left),BTN3A2,Butyrophilin subfamily 3 member A2,36820,0.0635760862926009,0.0486257406656528,-0.0317303654120786,0.15888253799728,0.191096832818553
Physical measures,X4270.Volume level set by participant (left),CHAD,Chondroadherin,35779,-0.0558828876716363,0.0427621864792002,-0.139696773170869,0.0279309978275961,0.191316272551747
Physical measures,X4270.Volume level set by participant (left),F13B,Coagulation factor XIII B chain,35905,0.115100122295774,0.0886266955489711,-0.0586082009802095,0.288808445571757,0.194089094632623
Physical measures,X4270.Volume level set by participant (left),CNPY2,Protein canopy homolog 2,36697,0.0406244893696234,0.0312846765900253,-0.0206934767468262,0.101942455486073,0.194140827648947
Physical measures,X4270.Volume level set by participant (left),IGBP1,Immunoglobulin-binding protein 1,35903,-0.047934978434199,0.0369344491817633,-0.120326498830455,0.0244565419620569,0.194387211476463
Physical measures,X4270.Volume level set by participant (left),SIAE,Sialate O-acetylesterase,36852,0.0534274869040169,0.0411784401439199,-0.027282255778066,0.1341372295861,0.194511156001231
Physical measures,X4270.Volume level set by participant (left),BGN,Biglycan,36646,-0.0213807338302497,0.0164875129185831,-0.0536962591506726,0.0109347914901732,0.194745874947768
Physical measures,X4270.Volume level set by participant (left),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35798,0.0392343121483662,0.0302781252329629,-0.020110813308241,0.0985794376049734,0.195090644619692
Physical measures,X4270.Volume level set by participant (left),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",36837,-0.0705238148270146,0.0544608058679908,-0.177266994328277,0.0362193646742473,0.195377912791603
Physical measures,X4270.Volume level set by participant (left),COX6B1,Cytochrome c oxidase subunit 6B1,35916,0.0880206458614737,0.068041424027202,-0.0453405452318421,0.22138183695479,0.195836613843561
Physical measures,X4270.Volume level set by participant (left),MAMDC2,MAM domain-containing protein 2,35916,-0.0762241900711126,0.0589772409819377,-0.191819582395711,0.0393712022534854,0.19625134157907
Physical measures,X4270.Volume level set by participant (left),MAG,Myelin-associated glycoprotein,35741,0.058322220309839,0.045171944352857,-0.0302147906217606,0.146859231241439,0.196709061403078
Physical measures,X4270.Volume level set by participant (left),SUSD4,Sushi domain-containing protein 4,35874,0.0676348106058844,0.0523934625957131,-0.0350563760817133,0.170325997293482,0.196782454912562
Physical measures,X4270.Volume level set by participant (left),F11R,Junctional adhesion molecule A,36836,0.0433589539048192,0.0336246442555055,-0.0225453488359716,0.10926325664561,0.197263613727334
Physical measures,X4270.Volume level set by participant (left),TEX33,Testis-expressed protein 33,35798,-0.073174246733144,0.0567814913576282,-0.184465969794095,0.0381174763278071,0.197547940086224
Physical measures,X4270.Volume level set by participant (left),CD300C,CMRF35-like molecule 6,36894,0.068359753903105,0.0530736880114389,-0.0356646745993152,0.172384182405525,0.197779149398612
Physical measures,X4270.Volume level set by participant (left),INSL4,Early placenta insulin-like peptide,35874,0.0563079142990082,0.0437464975885666,-0.0294352209745824,0.142051049572599,0.198089735137389
Physical measures,X4270.Volume level set by participant (left),AK1,Adenylate kinase isoenzyme 1,36828,-0.0377610497385965,0.0293414930577446,-0.095270376131776,0.019748276654583,0.198150570962949
Physical measures,X4270.Volume level set by participant (left),GHRHR,Growth hormone-releasing hormone receptor,36639,-0.0438690192243614,0.0340951637415439,-0.110695540157787,0.0229575017090647,0.198251453492858
Physical measures,X4270.Volume level set by participant (left),ENTR1,Endosome-associated-trafficking regulator 1,35748,-0.0500427175116679,0.0389214145031847,-0.12632868993791,0.0262432549145742,0.198580176751358
Physical measures,X4270.Volume level set by participant (left),SAA4,Serum amyloid A-4 protein,35953,0.0910084134776434,0.0707991442369213,-0.0477579092267223,0.229774736182009,0.198680848497158
Physical measures,X4270.Volume level set by participant (left),MYOM2,Myomesin-2,35706,-0.0582507504031236,0.0453171634694519,-0.147072390803249,0.0305708899970022,0.198697745362516
Physical measures,X4270.Volume level set by participant (left),GSTA1,Glutathione S-transferase A1,36816,0.0301664944582745,0.0234841942682037,-0.0158625263074047,0.0761955152239537,0.198990529807127
Physical measures,X4270.Volume level set by participant (left),DEFB103A_DEFB103B,Beta-defensin 103,35668,0.0693502763344463,0.0540395093279415,-0.0365671619483191,0.175267714617212,0.199424044556619
Physical measures,X4270.Volume level set by participant (left),EDDM3B,Epididymal secretory protein E3-beta,35874,0.0531155068946349,0.0414098369377241,-0.0280477735033044,0.134278787292574,0.199649265691104
Physical measures,X4270.Volume level set by participant (left),NME1,Nucleoside diphosphate kinase A,35725,-0.128907113223992,0.100512177375338,-0.325910980879654,0.0680967544316701,0.199711985320667
Physical measures,X4270.Volume level set by participant (left),CTSD,Cathepsin D,36329,0.0654606674132327,0.0510579928044379,-0.0346129984834657,0.165534333309931,0.199854635769516
Physical measures,X4270.Volume level set by participant (left),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,36763,-0.0226484485587697,0.0177256198239085,-0.0573906634136304,0.0120937662960909,0.201385987685329
Physical measures,X4270.Volume level set by participant (left),VSTM1,V-set and transmembrane domain-containing protein 1,36639,-0.0487037492316372,0.0381434004513558,-0.123464814116295,0.0260573156530202,0.201691822936884
Physical measures,X4270.Volume level set by participant (left),IL1R2,Interleukin-1 receptor type 2,36817,0.121037477881935,0.0948511324701891,-0.0648707417596355,0.306945697523506,0.201966712792166
Physical measures,X4270.Volume level set by participant (left),UBE2B,Ubiquitin-conjugating enzyme E2 B,35874,-0.0979205907369712,0.0767599451704464,-0.248370083271046,0.0525289017971036,0.202115508982216
Physical measures,X4270.Volume level set by participant (left),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,35713,-0.0817106495629782,0.0641269313592158,-0.207399435027041,0.0439781359010848,0.202637359421464
Physical measures,X4270.Volume level set by participant (left),MOG,Myelin-oligodendrocyte glycoprotein,36888,0.0715756709232585,0.0562283360381865,-0.0386318677115869,0.181783209558104,0.203075457042217
Physical measures,X4270.Volume level set by participant (left),NGF,Beta-nerve growth factor,36763,0.198379383720499,0.155923094796453,-0.107229882080549,0.503988649521548,0.203309224009705
Physical measures,X4270.Volume level set by participant (left),RLN2,Prorelaxin H2,35771,0.0567902130881032,0.0447095645360644,-0.0308405334025831,0.144420959578789,0.204057361997299
Physical measures,X4270.Volume level set by participant (left),ACTA2,"Actin, aortic smooth muscle",36697,-0.0536566762894182,0.0422928181493514,-0.136550599862147,0.0292372472833105,0.204589330653762
Physical measures,X4270.Volume level set by participant (left),ENSA,Alpha-endosulfine,35874,0.0549292652450727,0.0433113350774865,-0.0299609515068009,0.139819481996946,0.204755669347148
Physical measures,X4270.Volume level set by participant (left),FOLR1,Folate receptor alpha,36836,0.0809712098807692,0.0638619660388295,-0.0441982435553366,0.206140663316875,0.204868822238576
Physical measures,X4270.Volume level set by participant (left),GMPR2,GMP reductase 2,35779,-0.0437566555159145,0.034534791468961,-0.111444846795078,0.0239315357632491,0.205188991713601
Physical measures,X4270.Volume level set by participant (left),AIF1L,Allograft inflammatory factor 1-like,35748,0.0499576038684737,0.0394515947008147,-0.0273675217451232,0.12728272948207,0.205450272850519
Physical measures,X4270.Volume level set by participant (left),CCNE1,G1/S-specific cyclin-E1,35725,-0.0320840283313948,0.0253370037921731,-0.0817445557640541,0.0175764991012646,0.205453981716024
Physical measures,X4270.Volume level set by participant (left),CEP85,Centrosomal protein of 85 kDa,36654,0.0369131965284796,0.0291554589303121,-0.0202315029749321,0.0940578960318913,0.205523340804451
Physical measures,X4270.Volume level set by participant (left),DCUN1D1,DCN1-like protein 1,35680,0.0365669697497408,0.0288857266170097,-0.0200490544195983,0.0931829939190798,0.205587824698022
Physical measures,X4270.Volume level set by participant (left),SCP2,Non-specific lipid-transfer protein,36654,-0.0331819927172629,0.02630262932857,-0.0847351462012601,0.0183711607667344,0.207151440775663
Physical measures,X4270.Volume level set by participant (left),TIMP1,Metalloproteinase inhibitor 1,36737,0.0833232937716638,0.0660570002993181,-0.0461484268149998,0.212795014358327,0.207209277924348
Physical measures,X4270.Volume level set by participant (left),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35903,-0.110681646703463,0.087873831039181,-0.282914355540257,0.0615510621333322,0.207874908943433
Physical measures,X4270.Volume level set by participant (left),CPXM1,Probable carboxypeptidase X1,36864,0.0339854604813042,0.027045878498283,-0.0190244613753305,0.0869953823379389,0.208942027968401
Physical measures,X4270.Volume level set by participant (left),PPME1,Protein phosphatase methylesterase 1,36770,-0.0407563657634701,0.0324982359428701,-0.104452908211495,0.0229401766845554,0.209840700420539
Physical measures,X4270.Volume level set by participant (left),LPO,Lactoperoxidase,36582,0.0404517273120324,0.0322783611264828,-0.0228138604958739,0.103717315119939,0.21016713722136
Physical measures,X4270.Volume level set by participant (left),MED21,Mediator of RNA polymerase II transcription subunit 21,35706,-0.0572050274384209,0.0456550820884731,-0.146688988331828,0.0322789334549864,0.210257017161717
Physical measures,X4270.Volume level set by participant (left),KHK,Ketohexokinase,35748,0.0462585397486343,0.0369242281416866,-0.0261129474090715,0.11863002690634,0.210324532354043
Physical measures,X4270.Volume level set by participant (left),BOLA1,BolA-like protein 1,35680,-0.0527588330760828,0.0421749238518558,-0.13542168382572,0.0299040176735546,0.21099689282547
Physical measures,X4270.Volume level set by participant (left),DCUN1D2,DCN1-like protein 2,35678,0.0332447066301071,0.0265968850306032,-0.0188851880298753,0.0853746012900894,0.211363904245492
Physical measures,X4270.Volume level set by participant (left),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,35680,-0.0494297069022633,0.0395717290409155,-0.126990295822458,0.028130882017931,0.211667498599938
Physical measures,X4270.Volume level set by participant (left),IGSF9,Protein turtle homolog A,35916,-0.0325813401692623,0.026161940530971,-0.0838587436099654,0.0186960632714409,0.213038582001616
Physical measures,X4270.Volume level set by participant (left),GOT1,"Aspartate aminotransferase, cytoplasmic",35931,-0.06748382051712,0.0542343437122888,-0.173783134193206,0.0388154931589661,0.213432297278418
Physical measures,X4270.Volume level set by participant (left),BSND,Barttin,35678,0.0819082055939589,0.0658351852976028,-0.0471287575893426,0.21094516877726,0.21349293365823
Physical measures,X4270.Volume level set by participant (left),TRIM40,E3 ubiquitin ligase TRIM40,35741,0.0381682579239356,0.0306842358364761,-0.0219728443155576,0.0983093601634288,0.21357928110531
Physical measures,X4270.Volume level set by participant (left),ADGRE5,Adhesion G protein-coupled receptor E5,36901,-0.0764703473738524,0.0615604358115703,-0.19712880156453,0.0441881068168254,0.214200747052034
Physical measures,X4270.Volume level set by participant (left),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,36551,0.0637692780790005,0.051381063729748,-0.0369376068313056,0.164476162989307,0.214606672782377
Physical measures,X4270.Volume level set by participant (left),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,36864,0.0468945745111498,0.0378264750887166,-0.0272453166627348,0.121034465685034,0.215113625705085
Physical measures,X4270.Volume level set by participant (left),ARID3A,AT-rich interactive domain-containing protein 3A,35680,-0.0724944890798729,0.0585089015110922,-0.187171936041614,0.0421829578818678,0.215377947387911
Physical measures,X4270.Volume level set by participant (left),CHGB,Secretogranin-1,36865,0.0547933922773921,0.0442287499603971,-0.0318949576449862,0.14148174219977,0.215433903745168
Physical measures,X4270.Volume level set by participant (left),IL17F,Interleukin-17F,36697,-0.0316188431025377,0.0255387215708177,-0.0816747373813404,0.0184370511762651,0.215727145252146
Physical measures,X4270.Volume level set by participant (left),PCDH17,Protocadherin-17,36828,-0.0640658581691629,0.0517560422178848,-0.165507700916217,0.0373759845778913,0.215812338078572
Physical measures,X4270.Volume level set by participant (left),EDNRB,Endothelin receptor type B,35725,-0.0620414754276015,0.0501828779793031,-0.160399916267036,0.0363169654118327,0.216388712353328
Physical measures,X4270.Volume level set by participant (left),SORBS1,Sorbin and SH3 domain-containing protein 1,35903,-0.0636370852426006,0.0515228848076005,-0.164621939465497,0.0373477689802963,0.216828108664545
Physical measures,X4270.Volume level set by participant (left),CCL4,C-C motif chemokine 4,36841,0.0340288046199801,0.0275963162145477,-0.0200599751605333,0.0881175844004935,0.217579254197307
Physical measures,X4270.Volume level set by participant (left),HEPH,Hephaestin,35916,-0.10901603637641,0.0886078921947061,-0.282687505078034,0.0646554323252143,0.218620477623238
Physical measures,X4270.Volume level set by participant (left),CTRC,Chymotrypsin-C,36826,0.0350690207795403,0.02851107358564,-0.020812683448314,0.0909507250073947,0.218729775575739
Physical measures,X4270.Volume level set by participant (left),CEP20,Centrosomal protein 20,36654,0.0325944138425287,0.0265083741673716,-0.0193619995255196,0.084550827210577,0.218889723743582
Physical measures,X4270.Volume level set by participant (left),CHEK2,Serine/threonine-protein kinase Chk2,36697,-0.068612885688021,0.0558268935204596,-0.178033596988122,0.0408078256120798,0.219099394203928
Physical measures,X4270.Volume level set by participant (left),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35894,0.0384381839474892,0.0312937916714727,-0.0228976477285973,0.0997740156235757,0.219377299819331
Physical measures,X4270.Volume level set by participant (left),ATP6V1G2,V-type proton ATPase subunit G 2,35706,0.0281351483887214,0.0229217620305471,-0.016791505191151,0.0730618019685937,0.219700652988938
Physical measures,X4270.Volume level set by participant (left),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",36654,0.0293883477294194,0.0239551924399695,-0.0175638294529208,0.0763405249117595,0.219934657002777
Physical measures,X4270.Volume level set by participant (left),SERPINA12,Serpin A12,36572,-0.0224314720115804,0.0183007369637852,-0.0583009164605994,0.0134379724374387,0.22034540717368
Physical measures,X4270.Volume level set by participant (left),SERPIND1,Heparin cofactor 2,35940,0.0947943467977785,0.0774098454916857,-0.0569289503659254,0.246517643961482,0.220777269141056
Physical measures,X4270.Volume level set by participant (left),TSC1,Hamartin,35725,-0.0368767792378627,0.0301400107391139,-0.095951200286526,0.0221976418108006,0.221179102885986
Physical measures,X4270.Volume level set by participant (left),MATN3,Matrilin-3,36748,-0.0723461791303917,0.0591961084802613,-0.188370551751704,0.0436781934909205,0.221691258956071
Physical measures,X4270.Volume level set by participant (left),FLT1,Vascular endothelial growth factor receptor 1,36752,0.104320237239609,0.0853912642214515,-0.0630466406344357,0.271687115113654,0.221869272049055
Physical measures,X4270.Volume level set by participant (left),IRAK1,Interleukin-1 receptor-associated kinase 1,36697,0.0342882779719089,0.0280835010365358,-0.0207553840597013,0.0893319400035192,0.222147008419632
Physical measures,X4270.Volume level set by participant (left),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,35678,0.0411290248664157,0.0337071683055771,-0.0249370250125155,0.107195074745347,0.222438656519761
Physical measures,X4270.Volume level set by participant (left),LRRC38,Leucine-rich repeat-containing protein 38,35741,0.0553208832219514,0.0453544671772221,-0.033573872445404,0.144215638889307,0.222605525662511
Physical measures,X4270.Volume level set by participant (left),IL4R,Interleukin-4 receptor subunit alpha,36820,0.0583055235305871,0.0478599651544092,-0.0355000081720549,0.152111055233229,0.223165726939977
Physical measures,X4270.Volume level set by participant (left),PAK4,Serine/threonine-protein kinase PAK 4,36639,0.0388534964649228,0.0319145964792343,-0.0236991126343764,0.101406105564222,0.223482719882793
Physical measures,X4270.Volume level set by participant (left),IL6R,Interleukin-6 receptor subunit alpha,36753,-0.0670777399064918,0.0551158611827108,-0.175104827824605,0.0409493480116214,0.22363023644115
Physical measures,X4270.Volume level set by participant (left),NOS1,"Nitric oxide synthase, brain",36639,-0.0439430949127135,0.0361190631151637,-0.114736458618434,0.0268502687930074,0.223788252099068
Physical measures,X4270.Volume level set by participant (left),EXOSC10,Exosome component 10,35706,-0.0460137446114781,0.0378395892312537,-0.120179339504735,0.0281518502817792,0.224020924848553
Physical measures,X4270.Volume level set by participant (left),KLK15,Kallikrein-15,35852,0.0498539647192311,0.0410177624174458,-0.0305408496189626,0.130248779057425,0.22424760999297
Physical measures,X4270.Volume level set by participant (left),NENF,Neudesin,35874,0.0234487576477241,0.0192933314945892,-0.0143661720816707,0.061263687377119,0.22426360310186
Physical measures,X4270.Volume level set by participant (left),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,36914,0.0790875341729227,0.0650855062087387,-0.0484800579962051,0.206655126342051,0.224352616528163
Physical measures,X4270.Volume level set by participant (left),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,35680,0.0427154221186527,0.0351719206891053,-0.0262215424319936,0.111652386669299,0.224610584578175
Physical measures,X4270.Volume level set by participant (left),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,35741,0.0840747008311481,0.0692692912564608,-0.0516931100315152,0.219842511693811,0.224891978627804
Physical measures,X4270.Volume level set by participant (left),BCR,Breakpoint cluster region protein,36820,0.0264989694295455,0.0218696842181399,-0.0163656116380087,0.0693635504970998,0.225674022852678
Physical measures,X4270.Volume level set by participant (left),CD99L2,CD99 antigen-like protein 2,36836,0.0943629705978111,0.0779370235245787,-0.0583935955103632,0.247119536705985,0.226025152624007
Physical measures,X4270.Volume level set by participant (left),CIRBP,Cold-inducible RNA-binding protein,35894,0.029094865369621,0.0240759230306173,-0.0180939437703889,0.0762836745096309,0.226911836305218
Physical measures,X4270.Volume level set by participant (left),DEFB4A_DEFB4B,Beta-defensin 4A,36698,0.015453379437756,0.0128122659787649,-0.00965866188062308,0.0405654207561351,0.227801767268575
Physical measures,X4270.Volume level set by participant (left),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",36697,-0.0208924123190496,0.0173229355950623,-0.0548453660853717,0.0130605414472724,0.227834345761226
Physical measures,X4270.Volume level set by participant (left),AGBL2,Cytosolic carboxypeptidase 2,35680,-0.032578708356895,0.0270271308328102,-0.085551884789203,0.020394468075413,0.228089991807816
Physical measures,X4270.Volume level set by participant (left),ERC2,ERC protein 2,35741,0.036528634849468,0.0303318840833084,-0.0229218579538164,0.0959791276527524,0.228517879173348
Physical measures,X4270.Volume level set by participant (left),BTC,Probetacellulin,36654,0.0313350719715711,0.0260364169809701,-0.0196963053111304,0.0823664492542725,0.228817469546968
Physical measures,X4270.Volume level set by participant (left),CFHR2,Complement factor H-related protein 2,35910,0.0460854637866027,0.0383069342764312,-0.0289961273952025,0.121167054968408,0.228996303133292
Physical measures,X4270.Volume level set by participant (left),PLXNA4,Plexin-A4,36820,0.028296951608948,0.0235330179550276,-0.0178277635829061,0.074421666800802,0.22923193667673
Physical measures,X4270.Volume level set by participant (left),SORCS2,VPS10 domain-containing receptor SorCS2,36654,-0.0622896860562984,0.0518169753349138,-0.163850957712729,0.0392715856001326,0.229359220069965
Physical measures,X4270.Volume level set by participant (left),CTSF,Cathepsin F,36864,0.056637730501726,0.0471645012156704,-0.0358046918809879,0.14908015288444,0.229844522415415
Physical measures,X4270.Volume level set by participant (left),SPON2,Spondin-2,36789,0.0652647912005195,0.0543971187833104,-0.041353561614769,0.171883144015808,0.230260690308893
Physical measures,X4270.Volume level set by participant (left),PADI4,Protein-arginine deiminase type-4,36628,-0.0319995763789689,0.0266733502158762,-0.0842793428020863,0.0202801900441485,0.230300557488046
Physical measures,X4270.Volume level set by participant (left),CPQ,Carboxypeptidase Q,35915,0.0712678972823889,0.0594785500005229,-0.0453100607186359,0.187845855283414,0.23087686245412
Physical measures,X4270.Volume level set by participant (left),MST1,Hepatocyte growth factor-like protein,35794,-0.0398347608799274,0.0333111362236961,-0.105124587878372,0.025455066118517,0.231802314886026
Physical measures,X4270.Volume level set by participant (left),ARMCX2,Armadillo repeat-containing X-linked protein 2,35680,0.0451552668866227,0.0377696607455989,-0.0288732681747512,0.119183801947997,0.231918536550232
Physical measures,X4270.Volume level set by participant (left),LRRC59,Leucine-rich repeat-containing protein 59,35916,0.0536450075331009,0.0448994922660157,-0.0343579973082899,0.141648012374492,0.232215236928343
Physical measures,X4270.Volume level set by participant (left),ACTN4,Alpha-actinin-4,36697,0.0680105512171477,0.0569366547249105,-0.0435852920436768,0.179606394477972,0.232322157023885
Physical measures,X4270.Volume level set by participant (left),SPAG1,Sperm-associated antigen 1,35903,0.0454877445948116,0.0380831310043375,-0.0291551921736899,0.120130681363313,0.232350918704041
Physical measures,X4270.Volume level set by participant (left),ZBP1,Z-DNA-binding protein 1,35725,-0.0655870889755315,0.0549174837399915,-0.173225357105915,0.0420511791548519,0.232410167089559
Physical measures,X4270.Volume level set by participant (left),HDGFL2,Hepatoma-derived growth factor-related protein 2,35903,-0.0428314401794833,0.0358834502808149,-0.113163002729881,0.0275001223709139,0.232666293806308
Physical measures,X4270.Volume level set by participant (left),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,36763,-0.0315075827115762,0.0264061289157996,-0.0832635953865435,0.020248429963391,0.232831587188441
Physical measures,X4270.Volume level set by participant (left),SLURP1,Secreted Ly-6/uPAR-related protein 1,35886,0.0665903001884861,0.0558237658730828,-0.0428242809227563,0.176004881299728,0.232963971701126
Physical measures,X4270.Volume level set by participant (left),ADGRD1,Adhesion G-protein coupled receptor D1,35779,0.070499710016135,0.0592059784803844,-0.0455440078054185,0.186543427837688,0.233793416030861
Physical measures,X4270.Volume level set by participant (left),TGM2,Protein-glutamine gamma-glutamyltransferase 2,36822,-0.0289915857243033,0.0243631848680582,-0.0767434280656974,0.0187602566170907,0.234093189706654
Physical measures,X4270.Volume level set by participant (left),UBXN1,UBX domain-containing protein 1,35779,-0.0399405675039533,0.0335937318502094,-0.105784281930364,0.0259031469224571,0.234510434127069
Physical measures,X4270.Volume level set by participant (left),NOMO1,Nodal modulator 1,36836,0.0958594913164627,0.0807119643748001,-0.0623359588581456,0.254054941491071,0.234998848082245
Physical measures,X4270.Volume level set by participant (left),SNCG,Gamma-synuclein,36763,0.0335579480420623,0.0282670640028469,-0.0218454974035176,0.0889613934876423,0.235195922313223
Physical measures,X4270.Volume level set by participant (left),NFYA,Nuclear transcription factor Y subunit alpha,35706,-0.0699126788573892,0.0589803258420832,-0.185514117507872,0.0456887597930938,0.235920022326348
Physical measures,X4270.Volume level set by participant (left),KRT18,"Keratin, type I cytoskeletal 18",36770,0.0284571678128455,0.0240476672495251,-0.0186762599962237,0.0755905956219148,0.236701666886914
Physical measures,X4270.Volume level set by participant (left),APCS,Serum amyloid P-component,35887,0.0760726729601133,0.0643015748623676,-0.0499584137701271,0.202103759690354,0.236827089781819
Physical measures,X4270.Volume level set by participant (left),KIFBP,KIF-binding protein,36770,0.0281944617727095,0.0238476814575608,-0.0185469938841097,0.0749359174295288,0.237134649732917
Physical measures,X4270.Volume level set by participant (left),NECAP2,Adaptin ear-binding coat-associated protein 2,35706,-0.0395489866032387,0.0334679587462502,-0.105146185745889,0.0260482125394116,0.237369117922235
Physical measures,X4270.Volume level set by participant (left),AHSP,Alpha-hemoglobin-stabilizing protein,36813,-0.0258672705013893,0.0219128219805455,-0.0688164015832585,0.01708186058048,0.237853076239019
Physical measures,X4270.Volume level set by participant (left),C3,Complement C3,35567,0.049716984036789,0.0421450706137593,-0.0328873543661793,0.132321322439757,0.238178295427721
Physical measures,X4270.Volume level set by participant (left),TMEM106A,Transmembrane protein 106A,35874,-0.0372767175729131,0.0316219444691927,-0.0992557287325308,0.0247022935867046,0.238510138771819
Physical measures,X4270.Volume level set by participant (left),LTA4H,Leukotriene A-4 hydrolase,36888,-0.0409233184312702,0.0347224223849406,-0.108979266305754,0.0271326294432133,0.238600018335955
Physical measures,X4270.Volume level set by participant (left),PGLYRP4,Peptidoglycan recognition protein 4,35706,-0.0423915544462869,0.0361673456218401,-0.113279551865094,0.0284964429725197,0.24120193196158
Physical measures,X4270.Volume level set by participant (left),CRELD2,Protein disulfide isomerase CRELD2,36853,0.0422371724687347,0.0360402749687628,-0.0284017664700404,0.11287611140751,0.24125613637921
Physical measures,X4270.Volume level set by participant (left),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",36639,0.0736260776825026,0.0628250175937999,-0.0495109568013452,0.19676311216635,0.241265522360776
Physical measures,X4270.Volume level set by participant (left),PSME1,Proteasome activator complex subunit 1,36745,-0.0611101125814147,0.0521473239130737,-0.163318867451039,0.0410986422882098,0.241284484590178
Physical measures,X4270.Volume level set by participant (left),PCNA,Proliferating cell nuclear antigen,35678,0.0414663740925164,0.0353885833682071,-0.0278952493091696,0.110827997494202,0.241342767883357
Physical measures,X4270.Volume level set by participant (left),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,36763,0.0323672243806553,0.0276450144158063,-0.021817003874325,0.0865514526356356,0.24170963062012
Physical measures,X4270.Volume level set by participant (left),HEPACAM2,HEPACAM family member 2,35903,0.0605733043839134,0.0517470214665385,-0.040850857690502,0.161997466458329,0.241814862276693
Physical measures,X4270.Volume level set by participant (left),CBLIF,Cobalamin binding intrinsic factor,36807,0.0275803232680123,0.0236111069078608,-0.0186974462713949,0.0738580928074195,0.242799790600409
Physical measures,X4270.Volume level set by participant (left),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,36697,0.0274439359124494,0.0235037338174458,-0.0186233823697444,0.0735112541946431,0.242988506112835
Physical measures,X4270.Volume level set by participant (left),PRCP,Lysosomal Pro-X carboxypeptidase,36887,0.0685594070641568,0.0587431733927856,-0.0465772127857029,0.183696026914017,0.243204461931879
Physical measures,X4270.Volume level set by participant (left),CCL3,C-C motif chemokine 3,36820,0.0366080153214031,0.0314090672790313,-0.0249537565454983,0.0981697871883046,0.243843501038036
Physical measures,X4270.Volume level set by participant (left),TGOLN2,Trans-Golgi network integral membrane protein 2,35926,0.0902586274739795,0.0774820531455058,-0.061606196691212,0.242123451639171,0.244101897694379
Physical measures,X4270.Volume level set by participant (left),SIGLEC9,Sialic acid-binding Ig-like lectin 9,36881,0.0738761461810848,0.0634819131901081,-0.050548403671527,0.198300696033697,0.244567414420086
Physical measures,X4270.Volume level set by participant (left),TNR,Tenascin-R,36763,-0.0518240646350332,0.0445332054823038,-0.139109147380349,0.0354610181102821,0.244575265632644
Physical measures,X4270.Volume level set by participant (left),RAPGEF2,Rap guanine nucleotide exchange factor 2,35798,-0.0482759028106614,0.0416504442196866,-0.129910773481247,0.0333589678599245,0.246468381977428
Physical measures,X4270.Volume level set by participant (left),FGA,Fibrinogen alpha chain,35809,0.0839345951913387,0.0724960829180068,-0.0581577273279547,0.226026917710632,0.246995194569644
Physical measures,X4270.Volume level set by participant (left),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,36654,0.0484408547675537,0.0419403163220021,-0.0337621652235704,0.130643874758678,0.248129491544283
Physical measures,X4270.Volume level set by participant (left),ICA1,Islet cell autoantigen 1,36697,0.0282789419006574,0.0245899027537592,-0.0199172674967107,0.0764751512980255,0.250171264486859
Physical measures,X4270.Volume level set by participant (left),MRPL24,"39S ribosomal protein L24, mitochondrial",35706,0.0682536139169459,0.0593585779939994,-0.0480891989512929,0.184596426785185,0.250246840945878
Physical measures,X4270.Volume level set by participant (left),PLG,Plasminogen,35750,0.118687967604791,0.103254167870543,-0.0836902014214732,0.321066136631055,0.250402587061265
Physical measures,X4270.Volume level set by participant (left),DNM1,Dynamin-1,35894,0.022582032659846,0.0196572367944722,-0.0159461514573196,0.0611102167770115,0.250683704529575
Physical measures,X4270.Volume level set by participant (left),NTRK2,BDNF/NT-3 growth factors receptor,36828,-0.0861594413742176,0.0750624528779388,-0.233281849014978,0.0609629662665424,0.25107194870824
Physical measures,X4270.Volume level set by participant (left),PRTG,Protogenin,36888,-0.0855958038237144,0.0745905947041759,-0.231793369443899,0.0606017617964703,0.251193580970598
Physical measures,X4270.Volume level set by participant (left),GLB1,Beta-galactosidase,36763,0.05345665974545,0.0466007754137073,-0.0378808600654163,0.144794179556316,0.251368494874499
Physical measures,X4270.Volume level set by participant (left),MUC2,Mucin-2,35931,0.0265140639336036,0.0231386637561725,-0.0188377170284945,0.0718658448957018,0.251886743594685
Physical measures,X4270.Volume level set by participant (left),SATB1,DNA-binding protein SATB1,35903,0.0836439114144723,0.0730268255544738,-0.0594886666722964,0.226776489501241,0.252090124643456
Physical measures,X4270.Volume level set by participant (left),MRC1,Macrophage mannose receptor 1,35926,0.0811799716632258,0.0708948366467409,-0.0577739081643864,0.220133851490838,0.252218426431834
Physical measures,X4270.Volume level set by participant (left),FBLN2,Fibulin-2,35931,-0.0771241164367474,0.0674712598347934,-0.209367785712943,0.0551195528394477,0.253051743166223
Physical measures,X4270.Volume level set by participant (left),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,35725,0.0816288820946999,0.0715470795710683,-0.058603393864594,0.221861158053994,0.253948627930229
Physical measures,X4270.Volume level set by participant (left),BLNK,B-cell linker protein,35725,-0.0642293257126493,0.0563111304665355,-0.174599141427059,0.0461404900017603,0.254071974311558
Physical measures,X4270.Volume level set by participant (left),GBP6,Guanylate-binding protein 6,35706,0.0539167622554701,0.0473902268741438,-0.0389680824178517,0.146801606928792,0.255279707761407
Physical measures,X4270.Volume level set by participant (left),CA2,Carbonic anhydrase 2,36790,-0.0300804394888819,0.0264437925090561,-0.0819102728066318,0.021749393828868,0.255355335541429
Physical measures,X4270.Volume level set by participant (left),TFAP2A,Transcription factor AP-2-alpha,35680,0.043391338164251,0.0381460439834195,-0.0313749080432512,0.118157584371753,0.255369028675593
Physical measures,X4270.Volume level set by participant (left),TAFA5,Chemokine-like protein TAFA-5,36770,0.0572538856706544,0.0503411536078302,-0.0414147754006927,0.155922546742002,0.255441475794283
Physical measures,X4270.Volume level set by participant (left),ASGR2,Asialoglycoprotein receptor 2,35926,0.0905098574705318,0.0796702996027816,-0.06564392975092,0.246663644691984,0.255973925029626
Physical measures,X4270.Volume level set by participant (left),PALM2,Paralemmin-2,35903,0.0662147695547658,0.0583524398357327,-0.0481560125232703,0.180585551632802,0.2565253906447
Physical measures,X4270.Volume level set by participant (left),SUSD2,Sushi domain-containing protein 2,36836,-0.0736068385904389,0.0649617910209071,-0.200931948991417,0.053718271810539,0.257216656980551
Physical measures,X4270.Volume level set by participant (left),CTSH,Pro-cathepsin H,36668,0.0293351009306017,0.0259086092860367,-0.0214457732700302,0.0801159751312337,0.257564416209703
Physical measures,X4270.Volume level set by participant (left),CCL21,C-C motif chemokine 21,36865,0.0484168867901093,0.0428044578921331,-0.0354798506784716,0.13231362425869,0.258040862909114
Physical measures,X4270.Volume level set by participant (left),GRIK2,"Glutamate receptor ionotropic, kainate 2",35903,0.0562234111917771,0.0497458041353425,-0.0412783649134943,0.153725187297048,0.258426425212435
Physical measures,X4270.Volume level set by participant (left),CCL13,C-C motif chemokine 13,36897,0.0302955552025825,0.0268160749464381,-0.0222639516924361,0.0828550620976012,0.258615288095811
Physical measures,X4270.Volume level set by participant (left),GNPDA1,Glucosamine-6-phosphate isomerase 1,35748,-0.0752676200505637,0.066657845878809,-0.205916997973029,0.055381757871902,0.258870128294311
Physical measures,X4270.Volume level set by participant (left),CNTN1,Contactin-1,36933,-0.075307102826039,0.0667288049312429,-0.206095560491275,0.055481354839197,0.259120748889775
Physical measures,X4270.Volume level set by participant (left),USO1,General vesicular transport factor p115,36770,0.0247216731721329,0.0219152578393052,-0.0182322321929053,0.0676755785371711,0.259331330367852
Physical measures,X4270.Volume level set by participant (left),GP6,Platelet glycoprotein VI,36813,0.024778764246137,0.0219798180733451,-0.0183016791776195,0.0678592076698934,0.259633577194171
Physical measures,X4270.Volume level set by participant (left),GBA,Lysosomal acid glucosylceramidase,35741,0.046768324868107,0.0415059627012647,-0.0345833620263718,0.128120011762586,0.259874417752478
Physical measures,X4270.Volume level set by participant (left),CD72,B-cell differentiation antigen CD72,35779,-0.0567718437616458,0.0504517869316619,-0.155657346147703,0.0421136586244115,0.260515992180121
Physical measures,X4270.Volume level set by participant (left),NIT1,Deaminated glutathione amidase,35748,-0.059397554829331,0.0528025324672988,-0.162890518465237,0.0440954088065746,0.260672737011881
Physical measures,X4270.Volume level set by participant (left),VNN1,Pantetheinase,35926,0.0336475523806873,0.0299125609643731,-0.0249810671094839,0.0922761718708585,0.260686941124962
Physical measures,X4270.Volume level set by participant (left),VNN2,Vascular non-inflammatory molecule 2,36770,-0.0465680196132979,0.0414142260198473,-0.127739902612199,0.0346038633856028,0.260859927546805
Physical measures,X4270.Volume level set by participant (left),RNASEH2A,Ribonuclease H2 subunit A,35903,0.0487827843287725,0.043397845028073,-0.0362769919262507,0.133842560583796,0.261018008201846
Physical measures,X4270.Volume level set by participant (left),TK1,"Thymidine kinase, cytosolic",35798,0.0566869089808285,0.050487344734712,-0.0422682866992071,0.155642104660864,0.26156565115312
Physical measures,X4270.Volume level set by participant (left),PRAME,Melanoma antigen preferentially expressed in tumors,35678,0.0988489059381853,0.0880409878660256,-0.073711430279225,0.271409242155596,0.261580997584459
Physical measures,X4270.Volume level set by participant (left),COL18A1,Collagen alpha-1(XVIII) chain,36888,0.0883439589851174,0.078743376240441,-0.0659930584461469,0.242680976416382,0.261930453598541
Physical measures,X4270.Volume level set by participant (left),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35903,0.0254366180199225,0.0226754984610246,-0.0190073589636856,0.0698805950035306,0.262001832976507
Physical measures,X4270.Volume level set by participant (left),CA13,Carbonic anhydrase 13,36769,0.0211270440903883,0.0188405171450022,-0.015800369513816,0.0580544576945927,0.262169272073121
Physical measures,X4270.Volume level set by participant (left),AFM,Afamin,35953,-0.121614405978128,0.108463199564567,-0.33420227712468,0.090973465168423,0.262221143364645
Physical measures,X4270.Volume level set by participant (left),GOLM2,Protein GOLM2,36894,0.0886503675700039,0.0790652104154409,-0.0663174448442602,0.243618179984268,0.262224512666594
Physical measures,X4270.Volume level set by participant (left),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,36763,0.0521699049006303,0.046533737834875,-0.0390362212557247,0.143376031056985,0.262272361752218
Physical measures,X4270.Volume level set by participant (left),MMP12,Macrophage metalloelastase,36831,0.038798012807453,0.0346069850376107,-0.029031677866264,0.10662770348117,0.262279064345924
Physical measures,X4270.Volume level set by participant (left),TXNDC15,Thioredoxin domain-containing protein 15,36864,0.0748061720713737,0.0669114582769115,-0.0563402861513728,0.20595263029412,0.263607373104219
Physical measures,X4270.Volume level set by participant (left),AZU1,Azurocidin,36646,0.0266043957891158,0.0238083075237153,-0.0200598869573662,0.0732686785355978,0.263841549972363
Physical measures,X4270.Volume level set by participant (left),DDT,D-dopachrome decarboxylase,35931,-0.0575818159435126,0.0515335483977359,-0.158587570803075,0.0434239389160496,0.26387788600883
Physical measures,X4270.Volume level set by participant (left),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,35706,0.0485880736581465,0.0435077091540071,-0.0366870362837074,0.1338631836,0.264134202667337
Physical measures,X4270.Volume level set by participant (left),GNAS,Neuroendocrine secretory protein 55,35903,0.0272677442864642,0.0244460482249085,-0.0206465102343565,0.075181998807285,0.264708118937857
Physical measures,X4270.Volume level set by participant (left),DOC2B,Double C2-like domain-containing protein beta,35741,-0.0716513084827457,0.0642730993850713,-0.197626583277485,0.0543239663119941,0.264979360721908
Physical measures,X4270.Volume level set by participant (left),PGLYRP1,Peptidoglycan recognition protein 1,36901,0.0473107484367585,0.0424413072959662,-0.0358742138633353,0.130495710736852,0.264999399767417
Physical measures,X4270.Volume level set by participant (left),ISM2,Isthmin-2,35931,-0.0561991103473048,0.0504795116029367,-0.155138953089061,0.042740732394451,0.26561704704717
Physical measures,X4270.Volume level set by participant (left),HMBS,Porphobilinogen deaminase,36888,-0.0490743857003002,0.044115937627064,-0.135541623449346,0.0373928520487452,0.26600275902555
Physical measures,X4270.Volume level set by participant (left),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35931,0.0390107377466984,0.0351177005629252,-0.0298199553566349,0.107841430850032,0.266669638999748
Physical measures,X4270.Volume level set by participant (left),RTN4R,Reticulon-4 receptor,36888,0.0613187421481288,0.055230852783159,-0.046933729306863,0.16957121360312,0.266936256748013
Physical measures,X4270.Volume level set by participant (left),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,36770,-0.0457551142032352,0.04129761681341,-0.126698443157519,0.0351882147510484,0.267924666411584
Physical measures,X4270.Volume level set by participant (left),PKD1,Polycystin-1,35916,-0.0915636984921234,0.0828683370378168,-0.253985639086244,0.0708582421019975,0.269229555391426
Physical measures,X4270.Volume level set by participant (left),GIPR,Gastric inhibitory polypeptide receptor,35725,0.0496730469663678,0.0450119427316472,-0.0385503607876606,0.137896454720396,0.269827934818656
Physical measures,X4270.Volume level set by participant (left),ATP2B4,Plasma membrane calcium-transporting ATPase 4,35706,0.0393875191775689,0.0357166517226114,-0.0306171181987494,0.109392156553887,0.270164581216786
Physical measures,X4270.Volume level set by participant (left),CLEC1B,C-type lectin domain family 1 member B,36894,0.0217245979806474,0.0197048286651663,-0.0168968662030786,0.0603460621643734,0.270278291804383
Physical measures,X4270.Volume level set by participant (left),DUSP13,Dual specificity protein phosphatase 13 isoform A,35874,0.0573879412786267,0.05214697245766,-0.0448201247383869,0.15959600729564,0.27115234837067
Physical measures,X4270.Volume level set by participant (left),TBCA,Tubulin-specific chaperone A,35779,-0.0300687503172741,0.0273332794717372,-0.0836419780818791,0.0235044774473308,0.271338196389957
Physical measures,X4270.Volume level set by participant (left),LGALS4,Galectin-4,36822,0.0366582115472204,0.0333297873472722,-0.0286681716534331,0.101984594747874,0.271426388381108
Physical measures,X4270.Volume level set by participant (left),NAGA,Alpha-N-acetylgalactosaminidase,35716,-0.0439778348735044,0.0400170555806321,-0.122411263811543,0.0344555940645344,0.271818560888669
Physical measures,X4270.Volume level set by participant (left),F2R,Proteinase-activated receptor 1,36853,0.036953164697004,0.0336409324776741,-0.0289830629592373,0.102889392353245,0.272038918475004
Physical measures,X4270.Volume level set by participant (left),DGKA,Diacylglycerol kinase alpha,35725,-0.0460886870448908,0.0419639324837749,-0.12833799471309,0.0361606206233081,0.272117138826543
Physical measures,X4270.Volume level set by participant (left),PLXDC2,Plexin domain-containing protein 2,35903,-0.0883572828657832,0.0804640417270878,-0.246066804650875,0.0693522389193088,0.272201776866868
Physical measures,X4270.Volume level set by participant (left),ERVV_1,,35706,-0.056500166131804,0.0514698423700351,-0.157381057177073,0.0443807249134649,0.272361517678111
Physical measures,X4270.Volume level set by participant (left),CRYBB2,Beta-crystallin B2,35903,-0.0279601551085477,0.0254901012596876,-0.0779207535775353,0.02200044336044,0.272723414321475
Physical measures,X4270.Volume level set by participant (left),RAB27B,Ras-related protein Rab-27B,35916,0.0301013546064449,0.0274535503605892,-0.02370760410031,0.0839103133131998,0.272922633931777
Physical measures,X4270.Volume level set by participant (left),TRIM58,E3 ubiquitin-protein ligase TRIM58,35874,-0.0281651840757437,0.0257496733304393,-0.0786345438034048,0.0223041756519174,0.274078901956236
Physical measures,X4270.Volume level set by participant (left),ASAH2,Neutral ceramidase,36763,-0.0388413544644575,0.0355146249474625,-0.108450019361484,0.030767310432569,0.2741336330141
Physical measures,X4270.Volume level set by participant (left),DCXR,L-xylulose reductase,36864,0.0401285854379795,0.0366971313557564,-0.031797792019303,0.112054962895262,0.274205427895024
Physical measures,X4270.Volume level set by participant (left),ICAM2,Intercellular adhesion molecule 2,36933,0.0633873796076264,0.0579686306932441,-0.050231136551132,0.177005895766385,0.274218354558498
Physical measures,X4270.Volume level set by participant (left),POLR2A,DNA-directed RNA polymerase II subunit RPB1,35725,0.0825269091072931,0.0755443476121681,-0.0655400122125564,0.230593830427143,0.274684471085543
Physical measures,X4270.Volume level set by participant (left),RNASE1,Ribonuclease pancreatic,35926,0.0871374071738358,0.079767051312536,-0.0692060133987348,0.243480827746406,0.274697090528752
Physical measures,X4270.Volume level set by participant (left),AGR3,Anterior gradient protein 3,36647,0.0347284557338986,0.0318874253955374,-0.0277708980413548,0.0972278095091519,0.276146943451921
Physical measures,X4270.Volume level set by participant (left),HSBP1,Heat shock factor-binding protein 1,35748,0.0260232283420087,0.0238949875955679,-0.0208109473453043,0.0728574040293218,0.276164662433443
Physical measures,X4270.Volume level set by participant (left),TMEM25,Transmembrane protein 25,35903,-0.0528202582796954,0.0485062451100077,-0.147892498695311,0.0422519821359196,0.276220678939375
Physical measures,X4270.Volume level set by participant (left),REST,RE1-silencing transcription factor,35678,0.0691205204525087,0.0635028326946159,-0.0553450316289384,0.193586072533956,0.276430980831649
Physical measures,X4270.Volume level set by participant (left),DIPK1C,Divergent protein kinase domain 1C,35741,-0.0577431168189008,0.0530737918508195,-0.161767748846507,0.0462815152087054,0.276644896676578
Physical measures,X4270.Volume level set by participant (left),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35850,0.02253575534871,0.0207194576742739,-0.0180743816928669,0.063145892390287,0.276783993654556
Physical measures,X4270.Volume level set by participant (left),ECSCR,Endothelial cell-specific chemotaxis regulator,35680,0.0451601768458376,0.0415688763091484,-0.0363148207200933,0.126635174411769,0.277345116905251
Physical measures,X4270.Volume level set by participant (left),BMPER,BMP-binding endothelial regulator protein,35779,0.105043120551149,0.0967267946021171,-0.0845413968690005,0.294627637971298,0.277528726599924
Physical measures,X4270.Volume level set by participant (left),CD84,SLAM family member 5,36820,0.0656205020858117,0.0604822653269149,-0.0529247379549415,0.184165742126565,0.277976146373352
Physical measures,X4270.Volume level set by participant (left),KIT,Mast/stem cell growth factor receptor Kit,36839,-0.0675046631824585,0.0626607536202763,-0.1903197402782,0.055310413913283,0.281378605003578
Physical measures,X4270.Volume level set by participant (left),CES1,Liver carboxylesterase 1,36889,0.0247641869780945,0.0229958799930211,-0.0203077378082269,0.0698361117644158,0.281560196229793
Physical measures,X4270.Volume level set by participant (left),GIPC3,PDZ domain-containing protein GIPC3,35894,0.0249761393573508,0.0232416952462451,-0.0205775833252897,0.0705298620399912,0.282580741623666
Physical measures,X4270.Volume level set by participant (left),MANSC1,MANSC domain-containing protein 1,36864,0.0715513041194247,0.0667091498513241,-0.0591986295891706,0.20230123782802,0.283490641200429
Physical measures,X4270.Volume level set by participant (left),ICAM1,Intercellular adhesion molecule 1,36764,-0.0706463303517507,0.0658829567529057,-0.199776925587446,0.0584842648839444,0.283619258961651
Physical measures,X4270.Volume level set by participant (left),ATXN3,Ataxin-3,35903,-0.0384460220405277,0.0359241163337605,-0.108857290054698,0.0319652459736429,0.284567401355442
Physical measures,X4270.Volume level set by participant (left),CASP2,Caspase-2,36820,0.0301123736884298,0.0281444539266538,-0.0250507560078116,0.0852755033846713,0.28468824324004
Physical measures,X4270.Volume level set by participant (left),DNLZ,DNL-type zinc finger protein,35680,0.0266085525294382,0.0248940528649098,-0.022183791085785,0.0754008961446614,0.285167210801824
Physical measures,X4270.Volume level set by participant (left),STK4,Serine/threonine-protein kinase 4,36828,0.0238005431913008,0.0222688664729871,-0.019846435095754,0.0674475214783556,0.285202132916053
Physical measures,X4270.Volume level set by participant (left),KLK11,Kallikrein-11,36787,0.0613676976124867,0.0574521367037155,-0.0512384903267957,0.173973885551769,0.285485273103951
Physical measures,X4270.Volume level set by participant (left),EXTL1,Exostosin-like 1,35706,-0.0501730549949511,0.0469828919300333,-0.142259523177816,0.0419134131879142,0.285604989356536
Physical measures,X4270.Volume level set by participant (left),CTSE,Cathepsin E,35779,-0.045351823016846,0.0424908992818921,-0.128633985609354,0.0379303395756625,0.28586186912783
Physical measures,X4270.Volume level set by participant (left),CXCL16,C-X-C motif chemokine 16,36914,0.0849272763878235,0.0795878898622646,-0.0710649877422152,0.240919540517862,0.285965514342926
Physical measures,X4270.Volume level set by participant (left),BLMH,Bleomycin hydrolase,36933,-0.0627850053435255,0.0588580532016165,-0.178146789618694,0.0525767789316429,0.286132020309447
Physical measures,X4270.Volume level set by participant (left),CDSN,Corneodesmosin,36893,0.0444764427426087,0.0417466577947006,-0.0373470065350044,0.126299892020222,0.286733217319947
Physical measures,X4270.Volume level set by participant (left),SHISA5,Protein shisa-5,35931,0.0813321548211532,0.0763742931409723,-0.0683614597351524,0.231025769377459,0.286952433214061
Physical measures,X4270.Volume level set by participant (left),MCAM,Cell surface glycoprotein MUC18,36863,-0.0593594301953683,0.0558425191558306,-0.168810767740796,0.0500919073500598,0.287824917066986
Physical measures,X4270.Volume level set by participant (left),PSMD5,26S proteasome non-ATPase regulatory subunit 5,35741,-0.0417302544669259,0.0392855301635562,-0.118729893587496,0.0352693846536443,0.288170646150675
Physical measures,X4270.Volume level set by participant (left),ALMS1,Alstrom syndrome protein 1,35798,0.0520451477345122,0.0490018743799076,-0.0439985260501068,0.148088821519131,0.288226765053329
Physical measures,X4270.Volume level set by participant (left),HAO1,Hydroxyacid oxidase 1,36888,0.0162645067785446,0.0153326219221433,-0.0137874321888563,0.0463164457459454,0.288824149058986
Physical measures,X4270.Volume level set by participant (left),RFC4,Replication factor C subunit 4,35874,0.111180157688269,0.104873762173554,-0.0943724161718961,0.316732731548435,0.289122349513573
Physical measures,X4270.Volume level set by participant (left),NLGN1,Neuroligin-1,35741,0.0352214058137295,0.0332489640142505,-0.0299465636542015,0.100389375281661,0.289491616569499
Physical measures,X4270.Volume level set by participant (left),MAP2,Microtubule-associated protein 2,35903,0.0478464927949029,0.0451676709950744,-0.040682142355443,0.136375127945249,0.28949750850331
Physical measures,X4270.Volume level set by participant (left),IL10RB,Interleukin-10 receptor subunit beta,36865,0.0658192283881473,0.0623065537723115,-0.0563016170055833,0.187940073781878,0.290829157424191
Physical measures,X4270.Volume level set by participant (left),LHB,Lutropin subunit beta,36654,0.0244707043444671,0.023165465917326,-0.0209336088534918,0.069875017542426,0.290845233830216
Physical measures,X4270.Volume level set by participant (left),CKB,Creatine kinase B-type,35931,-0.0386536716451956,0.0366332878031872,-0.110454915739443,0.0331475724490513,0.291393857615844
Physical measures,X4270.Volume level set by participant (left),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,35741,0.043128218614078,0.0408911811042206,-0.0370184963501944,0.12327493357835,0.291598246272562
Physical measures,X4270.Volume level set by participant (left),ART3,Ecto-ADP-ribosyltransferase 3,36863,-0.055719540031863,0.0529105555711322,-0.159424228951282,0.0479851488875561,0.292333256611132
Physical measures,X4270.Volume level set by participant (left),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,36822,0.0678282541734836,0.064479235467925,-0.0585510473436494,0.194207555690617,0.292860646956692
Physical measures,X4270.Volume level set by participant (left),IL11,Interleukin-11,36697,0.031853818007276,0.0302867109141879,-0.0275081353845323,0.0912157713990842,0.292951637308417
Physical measures,X4270.Volume level set by participant (left),ELOB,Elongin-B,35706,0.0594103678407506,0.0565218095250578,-0.0513723788283627,0.170193114509864,0.293249297857632
Physical measures,X4270.Volume level set by participant (left),IGFBP7,Insulin-like growth factor-binding protein 7,36933,0.0643522362398812,0.0612653493262663,-0.0557278484396007,0.184432320919363,0.293573708149293
Physical measures,X4270.Volume level set by participant (left),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,35680,0.0439986039211162,0.0418888029342289,-0.0381034498299725,0.126100657672205,0.293588698984284
Physical measures,X4270.Volume level set by participant (left),LPA,Apolipoprotein(a),35806,0.0128483163004824,0.0122364696926165,-0.011135164297046,0.0368317968980108,0.29375563663176
Physical measures,X4270.Volume level set by participant (left),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35916,-0.03053880512836,0.0290850351555015,-0.0875454740331429,0.0264678637764228,0.293763492221488
Physical measures,X4270.Volume level set by participant (left),CDCP1,CUB domain-containing protein 1,36763,0.0370382294410401,0.0352836673633103,-0.032117758591048,0.106194217473128,0.293877029435636
Physical measures,X4270.Volume level set by participant (left),WNT9A,Protein Wnt-9a,36697,0.0700503721867824,0.0667769553372117,-0.0608324602741526,0.200933204647717,0.294202643061836
Physical measures,X4270.Volume level set by participant (left),LRP2,Low-density lipoprotein receptor-related protein 2,35741,0.0617219038928627,0.0588613315035374,-0.0536463058540706,0.177090113639796,0.294401671702857
Physical measures,X4270.Volume level set by participant (left),SIGLEC1,Sialoadhesin,36865,0.0453118760567631,0.0432149810663253,-0.0393894868332345,0.130013238946761,0.294431029722888
Physical measures,X4270.Volume level set by participant (left),EPHA4,Ephrin type-A receptor 4,35779,-0.0795035833281488,0.075836578093366,-0.228143276391146,0.0691361097348486,0.294514011361648
Physical measures,X4270.Volume level set by participant (left),GPA33,Cell surface A33 antigen,36770,-0.0141656904587091,0.0135142469672521,-0.0406536145145233,0.012322233597105,0.2945779863065
Physical measures,X4270.Volume level set by participant (left),CA5A,"Carbonic anhydrase 5A, mitochondrial",36697,0.022268207315525,0.0212547495724237,-0.0193911018464254,0.0639275164774754,0.294819147770075
Physical measures,X4270.Volume level set by participant (left),NECTIN4,Nectin-4,36864,0.058816713268544,0.0562070087701089,-0.0513490239208695,0.168982450457957,0.295395428649749
Physical measures,X4270.Volume level set by participant (left),SCARF1,Scavenger receptor class F member 1,36933,0.0461415504876898,0.0441473566606507,-0.0403872685671856,0.132670369542565,0.295976458423585
Physical measures,X4270.Volume level set by participant (left),CPA2,Carboxypeptidase A2,36863,0.0287847203282526,0.0275753812287121,-0.0252630268800231,0.0828324675365282,0.296585047541678
Physical measures,X4270.Volume level set by participant (left),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,35706,-0.0584554198580983,0.0560869152653811,-0.168385773778245,0.0514749340620486,0.297344144297804
Physical measures,X4270.Volume level set by participant (left),HTRA2,"Serine protease HTRA2, mitochondrial",36864,0.0323597037811519,0.0310513202262815,-0.0285008838623599,0.0932202914246637,0.297381412685213
Physical measures,X4270.Volume level set by participant (left),COL9A1,Collagen alpha-1(IX) chain,36820,-0.0404015753176119,0.0388083165351036,-0.116465875726415,0.0356627250911912,0.297883238046618
Physical measures,X4270.Volume level set by participant (left),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35798,0.0331985440221788,0.0319083490506799,-0.0293418201171538,0.0957389081615115,0.298176232098895
Physical measures,X4270.Volume level set by participant (left),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",35678,0.0425853375153615,0.0409317738712668,-0.0376409392723214,0.122811614303044,0.298193819646011
Physical measures,X4270.Volume level set by participant (left),VTCN1,V-set domain-containing T-cell activation inhibitor 1,36654,0.0628710067382058,0.0604473437772079,-0.0556057870651217,0.181347800541533,0.298329282347043
Physical measures,X4270.Volume level set by participant (left),GSAP,Gamma-secretase-activating protein,36654,0.0224720876036558,0.0216618552742458,-0.0199851487338661,0.0649293239411776,0.299581418172375
Physical measures,X4270.Volume level set by participant (left),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35894,0.0260952699067381,0.0251845202382236,-0.0232663897601802,0.0754569295736565,0.300163482166277
Physical measures,X4270.Volume level set by participant (left),SPINK6,Serine protease inhibitor Kazal-type 6,36888,0.0362981106132695,0.0350725885989809,-0.032444163040733,0.105040384267272,0.300728330270902
Physical measures,X4270.Volume level set by participant (left),CD2,T-cell surface antigen CD2,35706,0.054765050670171,0.0529769130785191,-0.0490696989637265,0.158599800304068,0.301289985615194
Physical measures,X4270.Volume level set by participant (left),PSG1,Pregnancy-specific beta-1-glycoprotein 1,36763,0.0163116530017296,0.0158002493709135,-0.0146568357652609,0.04728014176872,0.301933313025329
Physical measures,X4270.Volume level set by participant (left),BABAM1,BRISC and BRCA1-A complex member 1,35725,-0.0778825443896243,0.0755085115857089,-0.225879227097614,0.0701141383183651,0.302372462053782
Physical measures,X4270.Volume level set by participant (left),NPPB,Natriuretic peptides B,36697,-0.0140155040430223,0.0135892594585011,-0.0406504525816845,0.01261944449564,0.302402342151848
Physical measures,X4270.Volume level set by participant (left),AP2B1,AP-2 complex subunit beta,35741,0.0465403573137246,0.0452296965444528,-0.042109847913403,0.135190562540852,0.303528098741601
Physical measures,X4270.Volume level set by participant (left),IL1RAP,Interleukin-1 receptor accessory protein,36836,-0.0437575141039374,0.0425494756114932,-0.127154486302464,0.0396394580945893,0.303798320591707
Physical measures,X4270.Volume level set by participant (left),FGF7,Fibroblast growth factor 7,35678,-0.0286278584758307,0.0278813681428179,-0.0832753400357538,0.0260196230840924,0.304565306068531
Physical measures,X4270.Volume level set by participant (left),FCRLB,Fc receptor-like B,36654,0.0303935266901895,0.0296256059149164,-0.0276726609030466,0.0884597142834256,0.304962173137927
Physical measures,X4270.Volume level set by participant (left),FYB1,FYN-binding protein 1,36813,0.0211904417274949,0.0207055853742945,-0.0193925056061224,0.0617733890611121,0.306143374936139
Physical measures,X4270.Volume level set by participant (left),EIF4B,Eukaryotic translation initiation factor 4B,36763,-0.0374255229825321,0.0366164938430942,-0.109193850914997,0.0343428049499324,0.306768777112091
Physical measures,X4270.Volume level set by participant (left),COL2A1,Collagen alpha-1(II) chain,35748,-0.0286097777107233,0.0279925554445574,-0.0834751863820558,0.0262556309606091,0.306795205997801
Physical measures,X4270.Volume level set by participant (left),MTSS1,Protein MTSS 1,35894,-0.0204999412425268,0.020061742451975,-0.0598209564483978,0.0188210739633442,0.306892356468701
Physical measures,X4270.Volume level set by participant (left),ITGA11,Integrin alpha-11,36820,-0.0559284993061124,0.0547467626099809,-0.163232154021675,0.0513751554094502,0.307009538109332
Physical measures,X4270.Volume level set by participant (left),CD300A,CMRF35-like molecule 8,35779,0.0724061310322808,0.0708894483100712,-0.0665371876554589,0.21134944972002,0.307104852333934
Physical measures,X4270.Volume level set by participant (left),SV2A,Synaptic vesicle glycoprotein 2A,35741,-0.0363279068641434,0.0355833380100483,-0.106071249363838,0.0334154356355514,0.307327879842922
Physical measures,X4270.Volume level set by participant (left),YES1,Tyrosine-protein kinase Yes,36770,0.0177048614137178,0.017342960836654,-0.0162873418261241,0.0516970646535597,0.307349929052168
Physical measures,X4270.Volume level set by participant (left),ACOT13,Acyl-coenzyme A thioesterase 13,35894,0.0203902219445461,0.0199942342570422,-0.0187984771992565,0.0595789210883488,0.307857744976097
Physical measures,X4270.Volume level set by participant (left),BRME1,Break repair meiotic recombinase recruitment factor 1,35680,-0.0524369577050578,0.0514187955418326,-0.15321779696705,0.0483438815569342,0.307860731264423
Physical measures,X4270.Volume level set by participant (left),LSP1,Lymphocyte-specific protein 1,36820,-0.0483045764138445,0.0473900774053341,-0.141189128128299,0.0445799753006103,0.30809420836422
Physical measures,X4270.Volume level set by participant (left),FABP3,"Fatty acid-binding protein, heart",35916,-0.0431177616865153,0.0423621912184761,-0.126147656474728,0.0399121331016977,0.30879256619403
Physical measures,X4270.Volume level set by participant (left),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,35748,0.043760473612684,0.0430049523932296,-0.040529233078046,0.128050180303414,0.308920766342068
Physical measures,X4270.Volume level set by participant (left),KIRREL2,Kin of IRRE-like protein 2,36639,-0.0484718571313401,0.0476776639447459,-0.141920078463042,0.0449763642003618,0.309349415388998
Physical measures,X4270.Volume level set by participant (left),C1S,Complement C1s subcomponent,35953,0.102598074003862,0.100916612521644,-0.0951984865385594,0.300394634546283,0.309350707205026
Physical measures,X4270.Volume level set by participant (left),NEK7,Serine/threonine-protein kinase Nek7,35798,-0.0312458607772115,0.0307457934357195,-0.0915076159112217,0.0290158943567987,0.309540658412903
Physical measures,X4270.Volume level set by participant (left),MZT1,Mitotic-spindle organizing protein 1,36654,0.0361281437583859,0.035587400696186,-0.0336231616061386,0.10587944912291,0.310045920788094
Physical measures,X4270.Volume level set by participant (left),NRP1,Neuropilin-1,36880,-0.0688992347594601,0.0679002133799559,-0.201983652984174,0.0641851834652536,0.310274569665798
Physical measures,X4270.Volume level set by participant (left),NECTIN2,Nectin-2,36807,0.0624597793507884,0.061583976122705,-0.0582448138497135,0.18316437255129,0.310509418930942
Physical measures,X4270.Volume level set by participant (left),ANGPTL3,Angiopoietin-related protein 3,36818,-0.0538970662312529,0.0531763914455709,-0.158122793464572,0.050328661002066,0.310828494005075
Physical measures,X4270.Volume level set by participant (left),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,35680,0.0302646455816909,0.0298921771549841,-0.028324021642078,0.0888533128054597,0.311355757072744
Physical measures,X4270.Volume level set by participant (left),MORN4,MORN repeat-containing protein 4,35678,0.0286689468138217,0.0283249022183358,-0.0268478615341164,0.0841857551617598,0.311505861174722
Physical measures,X4270.Volume level set by participant (left),RPS10,40S ribosomal protein S10,35706,0.0547586870294273,0.0541195370670106,-0.0513156056219135,0.160832979680768,0.311666533080269
Physical measures,X4270.Volume level set by participant (left),CDHR2,Cadherin-related family member 2,36770,0.027025097807469,0.0267284819098583,-0.0253627267358531,0.0794129223507912,0.312002131503713
Physical measures,X4270.Volume level set by participant (left),CASP10,Caspase-10,36639,0.028070334004227,0.0277664156379328,-0.0263518406461212,0.0824925086545752,0.312075363871906
Physical measures,X4270.Volume level set by participant (left),BANK1,B-cell scaffold protein with ankyrin repeats,36820,0.019660044799067,0.0194727342550874,-0.0185065143409044,0.0578266039390383,0.312709851143781
Physical measures,X4270.Volume level set by participant (left),SERPING1,Plasma protease C1 inhibitor,35940,0.118604535410567,0.117561080223239,-0.111815181826981,0.349024252648114,0.313070376237226
Physical measures,X4270.Volume level set by participant (left),EBI3_IL27,Interleukin-27,36880,0.0617422029515399,0.0613392318952417,-0.0584826915631339,0.181967097466214,0.314173373678263
Physical measures,X4270.Volume level set by participant (left),PRR5,Proline-rich protein 5,35725,-0.0481890550934891,0.0478781780429909,-0.142030284057751,0.0456521738707731,0.314215741690806
Physical measures,X4270.Volume level set by participant (left),CCL18,C-C motif chemokine 18,36715,0.0268942946416361,0.0267401221099686,-0.0255163446939023,0.0793049339771744,0.314560713784815
Physical measures,X4270.Volume level set by participant (left),TRIAP1,TP53-regulated inhibitor of apoptosis 1,36888,0.0310942958611286,0.0310153068858738,-0.029695705635184,0.0918842973574412,0.316111128366018
Physical measures,X4270.Volume level set by participant (left),CHL1,Neural cell adhesion molecule L1-like protein,36852,-0.0628904907087026,0.0627726349575739,-0.185924855225548,0.0601438738081423,0.316434427503292
Physical measures,X4270.Volume level set by participant (left),RANGAP1,Ran GTPase-activating protein 1,36654,-0.0417907862257976,0.0417772881403631,-0.123674270980909,0.0400926985293141,0.317186631648626
Physical measures,X4270.Volume level set by participant (left),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35874,0.0654230855845653,0.0654340614660169,-0.0628276748888278,0.193673846057958,0.3174279228043
Physical measures,X4270.Volume level set by participant (left),FOXO1,Forkhead box protein O1,36820,0.0232757518631782,0.0232839958904209,-0.0223608800820468,0.0689123838084031,0.317513614404489
Physical measures,X4270.Volume level set by participant (left),PPL,Periplakin,35725,-0.0689687379219397,0.0690566841741704,-0.204319838903314,0.0663823630594343,0.317964235666082
Physical measures,X4270.Volume level set by participant (left),EREG,Proepiregulin,36748,0.0237837398301739,0.023817656239243,-0.0228988663987423,0.0704663460590901,0.318032130638821
Physical measures,X4270.Volume level set by participant (left),MTUS1,Microtubule-associated tumor suppressor 1,35798,-0.039570087454658,0.03963800472668,-0.117260576718951,0.0381204018096348,0.318177014459302
Physical measures,X4270.Volume level set by participant (left),ADGRG1,Adhesion G-protein coupled receptor G1,36770,0.0236249968211418,0.0236777829450056,-0.0227834577510692,0.0700334513933528,0.318422465927861
Physical measures,X4270.Volume level set by participant (left),NELL1,Protein kinase C-binding protein NELL1,36864,-0.0434679584595116,0.0436152722670033,-0.128953892102838,0.0420179751838148,0.318979268521196
Physical measures,X4270.Volume level set by participant (left),ERMAP,Erythroid membrane-associated protein,35725,0.0501391403494841,0.0503189914825194,-0.0484860829562539,0.148764363655222,0.31908024459044
Physical measures,X4270.Volume level set by participant (left),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,35706,0.0395358370495856,0.0396920305925948,-0.0382605429119003,0.117332217011072,0.319255657114445
Physical measures,X4270.Volume level set by participant (left),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35798,0.0303474352494421,0.0304730746620788,-0.0293797910882322,0.0900746615871165,0.319346398461755
Physical measures,X4270.Volume level set by participant (left),MFAP5,Microfibrillar-associated protein 5,36933,-0.044862443104733,0.0451754280675302,-0.133406282117092,0.0436813959076261,0.320706031648759
Physical measures,X4270.Volume level set by participant (left),KIAA0319,Dyslexia-associated protein KIAA0319,35903,-0.0669333128372731,0.0674671403587155,-0.199168907940355,0.0653022822658093,0.32119059339742
Physical measures,X4270.Volume level set by participant (left),ALPI,Intestinal-type alkaline phosphatase,35725,-0.0178027239116418,0.0179525846645772,-0.0529897898542131,0.0173843420309296,0.32140386631426
Physical measures,X4270.Volume level set by participant (left),ICAM4,Intercellular adhesion molecule 4,36820,-0.0349948622422332,0.0353113483906257,-0.10420510508786,0.0342153806033932,0.32169883811569
Physical measures,X4270.Volume level set by participant (left),IL21R,Interleukin-21 receptor,35725,0.0389128249650574,0.0392650306378203,-0.0380466350850705,0.115872285015185,0.321707642273708
Physical measures,X4270.Volume level set by participant (left),AFP,Alpha-fetoprotein,36744,-0.0282038379350947,0.0284700988177997,-0.0840052316179822,0.0275975557477928,0.321889396436596
Physical measures,X4270.Volume level set by participant (left),CLSTN2,Calsyntenin-2,36908,0.0458658410033751,0.0463252461556988,-0.0449316414617944,0.136663323468545,0.322164593703611
Physical measures,X4270.Volume level set by participant (left),TIMP4,Metalloproteinase inhibitor 4,36836,0.0454867387818821,0.0459878989377349,-0.0446495431360783,0.135623020699843,0.322644396988917
Physical measures,X4270.Volume level set by participant (left),GLP1R,Glucagon-like peptide 1 receptor,35680,0.0567885259973622,0.0574165826516513,-0.0557479759998743,0.169325027994599,0.32267001052229
Physical measures,X4270.Volume level set by participant (left),CORO1A,Coronin-1A,36697,0.0203687765086913,0.0206357182819278,-0.0200772313238872,0.0608147843412699,0.323643061807185
Physical measures,X4270.Volume level set by participant (left),ALDH1A1,Retinal dehydrogenase 1,36836,-0.0341302348071953,0.0346054997113293,-0.101957014241401,0.03369654462701,0.324033736558278
Physical measures,X4270.Volume level set by participant (left),IPCEF1,Interactor protein for cytohesin exchange factors 1,36748,0.0216433939974644,0.0220038144428243,-0.0214840823104713,0.0647708703054001,0.325333856930865
Physical measures,X4270.Volume level set by participant (left),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35894,0.0216699779122239,0.0220463413631719,-0.021540851159593,0.0648808069840408,0.325678122963477
Physical measures,X4270.Volume level set by participant (left),NSFL1C,NSFL1 cofactor p47,36894,-0.0291799491823004,0.0296911137530604,-0.0873745321382988,0.029014633773698,0.325744687477015
Physical measures,X4270.Volume level set by participant (left),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",35741,0.0426935581123507,0.0434575902550839,-0.0424833187876138,0.127870435012315,0.325929836800567
Physical measures,X4270.Volume level set by participant (left),ACE2,Angiotensin-converting enzyme 2,36697,0.0361884169486767,0.0368531796447258,-0.0360438151549859,0.108420649052339,0.326150311352777
Physical measures,X4270.Volume level set by participant (left),CXCL10,C-X-C motif chemokine 10,36865,-0.0275332524705041,0.0280631147556806,-0.0825369573916381,0.0274704524506298,0.326565061460738
Physical measures,X4270.Volume level set by participant (left),AKR1B10,Aldo-keto reductase family 1 member B10,35741,0.0355925698429567,0.0363770951933223,-0.0357065367359551,0.106891676421868,0.327896117825803
Physical measures,X4270.Volume level set by participant (left),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,36822,0.0467529079973632,0.047816556620743,-0.0469675429792932,0.14047335897402,0.328226214226541
Physical measures,X4270.Volume level set by participant (left),IKBKG,NF-kappa-B essential modulator,36820,0.0219245864985938,0.022430600610388,-0.0220393906977667,0.0658885636949544,0.328381939128672
Physical measures,X4270.Volume level set by participant (left),STX16,Syntaxin-16,36654,0.0310208816725678,0.031742230268773,-0.0311938896542272,0.0932356529993628,0.328464828597511
Physical measures,X4270.Volume level set by participant (left),DTYMK,Thymidylate kinase,35916,-0.0324564488074171,0.0332653130756244,-0.097656462435641,0.0327435648208067,0.329255984347533
Physical measures,X4270.Volume level set by participant (left),CDHR5,Cadherin-related family member 5,36828,-0.0472241790111138,0.0484129707951355,-0.142113601769579,0.0476652437473518,0.329370606822263
Physical measures,X4270.Volume level set by participant (left),SKIV2L,Helicase SKI2W,35706,0.0543586888784733,0.0557308840524316,-0.0548738438642927,0.163591221621239,0.329408944788337
Physical measures,X4270.Volume level set by participant (left),IFNL2,Interferon lambda-2,35680,0.0349155967421091,0.0358136685249714,-0.0352791935668347,0.105110387051053,0.329634449433908
Physical measures,X4270.Volume level set by participant (left),CRYM,Ketimine reductase mu-crystallin,35680,0.028496453496477,0.0293445884858717,-0.0290189399358314,0.0860118469287855,0.331536008650602
Physical measures,X4270.Volume level set by participant (left),GSR,"Glutathione reductase, mitochondrial",35869,-0.0930456703701101,0.095843150656623,-0.280898245657091,0.0948069049168709,0.331677151795517
Physical measures,X4270.Volume level set by participant (left),RAB10,Ras-related protein Rab-10,35916,0.0397842282123736,0.0410279053787394,-0.0406304663299557,0.120198922754703,0.332237415408031
Physical measures,X4270.Volume level set by participant (left),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35798,-0.0577986540618753,0.0596349504551033,-0.174683156953878,0.059085848830127,0.332477072516118
Physical measures,X4270.Volume level set by participant (left),CST5,Cystatin-D,36686,-0.0328515285737955,0.0338978759229927,-0.0992913653828611,0.0335883082352701,0.332510449708175
Physical measures,X4270.Volume level set by participant (left),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,35680,0.0694740579332047,0.0716962846670031,-0.0710506600141214,0.209998775880531,0.332578845686632
Physical measures,X4270.Volume level set by participant (left),ITGA2,Integrin alpha-2,35779,0.0620896530517638,0.0641066283141858,-0.0635593384440403,0.187738644547568,0.332811746547457
Physical measures,X4270.Volume level set by participant (left),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,35741,0.0401063846795369,0.041441221807823,-0.0411184100637962,0.12133117942287,0.333185209611917
Physical measures,X4270.Volume level set by participant (left),ATP6V1F,V-type proton ATPase subunit F,36624,0.028042459494889,0.0289856646788836,-0.0287694432757229,0.0848543622655009,0.33334583130286
Physical measures,X4270.Volume level set by participant (left),ECHS1,"Enoyl-CoA hydratase, mitochondrial",35748,0.0230978822350123,0.0238852630216339,-0.0237172332873901,0.0699129977574146,0.333562300280101
Physical measures,X4270.Volume level set by participant (left),GRK5,G protein-coupled receptor kinase 5,36697,-0.0364823577458484,0.0377432248294756,-0.11045907841162,0.0374943629199237,0.333778426099743
Physical measures,X4270.Volume level set by participant (left),ECM1,Extracellular matrix protein 1,35756,-0.0575576871589548,0.0596452365578844,-0.174462350812408,0.0593469764944985,0.334580104636616
Physical measures,X4270.Volume level set by participant (left),FRZB,Secreted frizzled-related protein 3,36733,0.0727392115284231,0.0753858660577583,-0.0750170859447832,0.220495509001629,0.334629920458502
Physical measures,X4270.Volume level set by participant (left),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,36770,0.0546412012095609,0.0566615449525562,-0.0564154268974492,0.165697829316571,0.334904454459743
Physical measures,X4270.Volume level set by participant (left),SEZ6L,Seizure 6-like protein,36864,-0.064731945540849,0.0671730116655285,-0.196391048405285,0.0669271573235868,0.335246798749946
Physical measures,X4270.Volume level set by participant (left),TSLP,Thymic stromal lymphopoietin,36697,0.0302050020097187,0.0313793216690178,-0.0312984684615563,0.0917084724809937,0.335791058193607
Physical measures,X4270.Volume level set by participant (left),IL1RN,Interleukin-1 receptor antagonist protein,36813,0.0331199878204462,0.0344190296388139,-0.0343413102716292,0.100581285912521,0.335950553175208
Physical measures,X4270.Volume level set by participant (left),DXO,Decapping and exoribonuclease protein,35903,-0.0476826778233963,0.0495690950597637,-0.144838104140533,0.0494727484937405,0.336112577894399
Physical measures,X4270.Volume level set by participant (left),PI16,Peptidase inhibitor 16,35926,0.0833777441189041,0.0866795164063211,-0.0865141080374852,0.253269596275293,0.336130245021115
Physical measures,X4270.Volume level set by participant (left),TXN,Thioredoxin,35814,-0.0493157414285639,0.0512714724884262,-0.149807827505879,0.0511763446487515,0.33615740367189
Physical measures,X4270.Volume level set by participant (left),PPM1B,Protein phosphatase 1B,35725,-0.03611488996782,0.0375549240714969,-0.109722541147954,0.0374927612123139,0.336258425416455
Physical measures,X4270.Volume level set by participant (left),CASP8,Caspase-8,36873,-0.0304922665504391,0.0317139031330002,-0.0926515166911195,0.0316669835902412,0.336341432394827
Physical measures,X4270.Volume level set by participant (left),TNFSF14,Tumor necrosis factor ligand superfamily member 14,36763,0.031936215878073,0.0332233193109832,-0.033181489971454,0.0970539217276,0.336452658153559
Physical measures,X4270.Volume level set by participant (left),NMRK2,Nicotinamide riboside kinase 2,35678,-0.0522972050065654,0.0544507690606855,-0.159020712365509,0.0544263023523782,0.336864947585704
Physical measures,X4270.Volume level set by participant (left),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,36828,-0.0557074912704827,0.0580073405211581,-0.169401878691953,0.0579868961509872,0.336908290761714
Physical measures,X4270.Volume level set by participant (left),VSIG4,V-set and immunoglobulin domain-containing protein 4,36828,0.0418359598966316,0.0436049645195549,-0.043629770561696,0.127301690354959,0.337372001430705
Physical measures,X4270.Volume level set by participant (left),IGFBP3,Insulin-like growth factor-binding protein 3,36863,-0.0571682880383784,0.0596729110259697,-0.174127193649279,0.0597906175725223,0.338079118466669
Physical measures,X4270.Volume level set by participant (left),SEPTIN8,Septin-8,35888,-0.0631999624579985,0.0659740840588693,-0.192509167213382,0.0661092422973852,0.338121905983883
Physical measures,X4270.Volume level set by participant (left),PRELP,Prolargin,36822,-0.0727763640220744,0.0760264698223436,-0.221788244873868,0.076235516829719,0.338471263417323
Physical measures,X4270.Volume level set by participant (left),YY1,Transcriptional repressor protein YY1,35725,-0.0769334968091996,0.0803896410167369,-0.234497193202004,0.0806301995836047,0.338598862223219
Physical measures,X4270.Volume level set by participant (left),HRG,Histidine-rich glycoprotein,35905,-0.0638504566229764,0.0667421864847876,-0.19466514213316,0.0669642288872073,0.338766739122922
Physical measures,X4270.Volume level set by participant (left),FABP5,Fatty acid-binding protein 5,36861,0.0270428413697577,0.0282735945648884,-0.0283734039774234,0.0824590867169389,0.338865067603871
Physical measures,X4270.Volume level set by participant (left),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,35779,0.0337902443818149,0.0353345393293124,-0.0354654527036374,0.103045941467267,0.338958321118528
Physical measures,X4270.Volume level set by participant (left),MRI1,Methylthioribose-1-phosphate isomerase,35741,-0.030936353115174,0.0323525639121165,-0.0943473783829224,0.0324746721525744,0.338993540478108
Physical measures,X4270.Volume level set by participant (left),MPI,Mannose-6-phosphate isomerase,36770,0.0219766032710828,0.0229983209854723,-0.023100105860443,0.0670533124026086,0.339317878978748
Physical measures,X4270.Volume level set by participant (left),ITPA,Inosine triphosphate pyrophosphatase,35706,-0.0314155749648866,0.0328982420743116,-0.0958961294305373,0.033064979500764,0.339647688981406
Physical measures,X4270.Volume level set by participant (left),SNAP29,Synaptosomal-associated protein 29,36864,0.0202916619597785,0.0213211051854504,-0.0214977042037042,0.0620810281232613,0.341270438327493
Physical measures,X4270.Volume level set by participant (left),TCP11,T-complex protein 11 homolog,35798,-0.0366820967684676,0.0385429209548019,-0.112226221839879,0.038862028302944,0.341273480202224
Physical measures,X4270.Volume level set by participant (left),MSLNL,Mesothelin-like protein,35741,0.0553100561840329,0.0581647285227865,-0.0586928117206287,0.169312924088694,0.341679648008729
Physical measures,X4270.Volume level set by participant (left),TBC1D23,TBC1 domain family member 23,36770,0.0197271455638498,0.0207898240994755,-0.0210209096711223,0.0604752007988218,0.342709546415992
Physical measures,X4270.Volume level set by participant (left),POSTN,Periostin,35931,-0.0543669020341861,0.0573341328154209,-0.166741802352411,0.0580079982840388,0.343037906879778
Physical measures,X4270.Volume level set by participant (left),KLK6,Kallikrein-6,36851,0.0573927775191006,0.0605420762176862,-0.0612696918675644,0.176055246905766,0.343168722592168
Physical measures,X4270.Volume level set by participant (left),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",36639,0.0371875024789527,0.0392288511917771,-0.0397010458569304,0.114076050814836,0.343179031789415
Physical measures,X4270.Volume level set by participant (left),KIF22,Kinesin-like protein KIF22,35706,-0.0176742763898898,0.0186549120976329,-0.0542379041012502,0.0188893513214706,0.343453434030587
Physical measures,X4270.Volume level set by participant (left),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,36863,0.0402857676931026,0.0425223236894905,-0.0430579867382988,0.123629522124504,0.343463437302528
Physical measures,X4270.Volume level set by participant (left),BMP6,Bone morphogenetic protein 6,36679,-0.0430981003689276,0.0455284979691617,-0.132333956388484,0.0461377556506293,0.343863986207894
Physical measures,X4270.Volume level set by participant (left),PRKCQ,Protein kinase C theta type,36697,-0.0386884765104639,0.0408832585779687,-0.118819663323282,0.0414427103023547,0.344017986647019
Physical measures,X4270.Volume level set by participant (left),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,35779,-0.0303172165644117,0.0320500711913781,-0.0931353560995128,0.0325009229706895,0.344217538862765
Physical measures,X4270.Volume level set by participant (left),CDH15,Cadherin-15,36879,-0.0283075779148769,0.0299410841504728,-0.0869921028498036,0.0303769470200499,0.344462672765102
Physical measures,X4270.Volume level set by participant (left),CA12,Carbonic anhydrase 12,36770,-0.0546970696901875,0.0578989351722005,-0.1681789826277,0.0587848432473255,0.344842675182828
Physical measures,X4270.Volume level set by participant (left),TLR4,Toll-like receptor 4,35725,0.0729651875922414,0.077308157058904,-0.0785588002432105,0.224489175427693,0.345295226705098
Physical measures,X4270.Volume level set by participant (left),GPC5,Glypican-5,36763,-0.0321818384258355,0.034120289696567,-0.0990576062311069,0.0346939293794359,0.345615006470316
Physical measures,X4270.Volume level set by participant (left),GID8,Glucose-induced degradation protein 8 homolog,35903,0.059869501567652,0.0635094250667139,-0.0646089715631073,0.184347974698411,0.345875046531027
Physical measures,X4270.Volume level set by participant (left),HAVCR2,Hepatitis A virus cellular receptor 2,36836,0.0493030133733822,0.052352933257271,-0.0533087358108689,0.151914762557633,0.346353965702887
Physical measures,X4270.Volume level set by participant (left),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,36654,0.0405038700106036,0.0431473118642072,-0.0440648612432424,0.12507260126445,0.347897482140348
Physical measures,X4270.Volume level set by participant (left),SIRT1,NAD-dependent protein deacetylase sirtuin-1,35725,-0.0255109599101055,0.0271910638476654,-0.0788054450515296,0.0277835252313187,0.34817060769729
Physical measures,X4270.Volume level set by participant (left),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35916,-0.0680818174976573,0.0725927298571216,-0.210363568017616,0.0741999330223011,0.348350072809201
Physical measures,X4270.Volume level set by participant (left),VSTM2B,V-set and transmembrane domain-containing protein 2B,35798,0.0475713832687234,0.0507329982982459,-0.0518652933958385,0.147008059933285,0.348442527848572
Physical measures,X4270.Volume level set by participant (left),TREML2,Trem-like transcript 2 protein,36836,0.0512248510589625,0.0546822548040195,-0.0559523683569157,0.158402070474841,0.348905033661891
Physical measures,X4270.Volume level set by participant (left),CSNK1D,Casein kinase I isoform delta,35725,-0.0337486718257244,0.0360325550253679,-0.104372479675445,0.0368751360239967,0.348990705583376
Physical measures,X4270.Volume level set by participant (left),IDUA,Alpha-L-iduronidase,36888,0.0380263405006389,0.0406045323207278,-0.0415585428479877,0.117611223849265,0.349042733616293
Physical measures,X4270.Volume level set by participant (left),THOP1,Thimet oligopeptidase,36781,-0.0552556189717444,0.0590100874686269,-0.170915390410253,0.0604041524667643,0.349109539090109
Physical measures,X4270.Volume level set by participant (left),MET,Hepatocyte growth factor receptor,36873,-0.0878751910229595,0.093966008406956,-0.272048567500593,0.0962981854546741,0.34972463703018
Physical measures,X4270.Volume level set by participant (left),NOTCH2,Neurogenic locus notch homolog protein 2,35931,-0.0944738140988728,0.101172891910659,-0.292772682243764,0.103825054046018,0.350447854406458
Physical measures,X4270.Volume level set by participant (left),GP1BA,Platelet glycoprotein Ib alpha chain,36765,0.0523125285321065,0.0561098023938278,-0.0576626841597959,0.162287741224009,0.351198728920119
Physical measures,X4270.Volume level set by participant (left),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",35748,-0.0476941303040508,0.051179022135332,-0.148005013689302,0.0526167530811999,0.351418514734224
Physical measures,X4270.Volume level set by participant (left),CSF1,Macrophage colony-stimulating factor 1,36865,0.0631049142897434,0.0677626863458856,-0.0697099509481925,0.195919779527679,0.351746612548574
Physical measures,X4270.Volume level set by participant (left),ARHGAP5,Rho GTPase-activating protein 5,35678,0.0265527488149026,0.0285498185282827,-0.0294048955005315,0.0825103931303367,0.352380016443201
Physical measures,X4270.Volume level set by participant (left),CD80,T-lymphocyte activation antigen CD80,35916,-0.0589716825667849,0.0634342171698441,-0.183302748219679,0.0653593830861096,0.352585217009563
Physical measures,X4270.Volume level set by participant (left),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,35706,-0.080831141290227,0.0871752018675342,-0.251694536950594,0.09003225437014,0.353843421413837
Physical measures,X4270.Volume level set by participant (left),CDC123,Cell division cycle protein 123 homolog,35678,0.0312848433442388,0.0337434233414263,-0.0348522664049568,0.0974219530934343,0.353888900428787
Physical measures,X4270.Volume level set by participant (left),IL2RB,Interleukin-2 receptor subunit beta,36697,0.0484695339040557,0.0522942455975607,-0.0540271874671632,0.150966255275275,0.354028164087926
Physical measures,X4270.Volume level set by participant (left),ANKRD54,Ankyrin repeat domain-containing protein 54,36654,-0.0305327766705948,0.0329448967122835,-0.0951047742266704,0.0340392208854808,0.354069104956071
Physical measures,X4270.Volume level set by participant (left),SEZ6L2,Seizure 6-like protein 2,36770,-0.0729299932676903,0.0788473366082163,-0.227470773019794,0.0816107864844136,0.355020403636864
Physical measures,X4270.Volume level set by participant (left),MANSC4,MANSC domain-containing protein 4,35706,-0.0285730249781716,0.0309245091553391,-0.0891850629226362,0.0320390129662929,0.355541131484367
Physical measures,X4270.Volume level set by participant (left),IDS,Iduronate 2-sulfatase,36908,-0.192696115958637,0.208574524689942,-0.601502184350923,0.21610995243365,0.355581989443651
Physical measures,X4270.Volume level set by participant (left),CGA,Glycoprotein hormones alpha chain,36836,0.0275678534930815,0.0298407812231538,-0.0309200777043,0.086055784690463,0.355603234830208
Physical measures,X4270.Volume level set by participant (left),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,36697,0.0312850912938944,0.0338751958824434,-0.0351102926356947,0.0976804752234835,0.355755684922814
Physical measures,X4270.Volume level set by participant (left),ACP6,Lysophosphatidic acid phosphatase type 6,36880,-0.0253941555549118,0.0275011775229437,-0.0792964634998815,0.0285081523900579,0.355835968063044
Physical measures,X4270.Volume level set by participant (left),CCL5,C-C motif chemokine 5,36863,0.0167474308011972,0.0181407896205911,-0.0188085168551614,0.0523033784575558,0.355936242675266
Physical measures,X4270.Volume level set by participant (left),PPP1R2,Protein phosphatase inhibitor 2,36828,0.0226492242387479,0.0245515028708526,-0.0254717213881233,0.0707701698656191,0.356287167525646
Physical measures,X4270.Volume level set by participant (left),ACY1,Aminoacylase-1,36828,0.0292938165037629,0.0317673723435655,-0.0329702332896255,0.0915578662971513,0.356487141355469
Physical measures,X4270.Volume level set by participant (left),FGF3,Fibroblast growth factor 3,35725,0.0669573577056728,0.0726159942329261,-0.0753699909908623,0.209284706402208,0.356523785025784
Physical measures,X4270.Volume level set by participant (left),RGMB,RGM domain family member B,36894,-0.0615179792405169,0.0667514430958905,-0.192350807708462,0.0693148492274286,0.356767321622948
Physical measures,X4270.Volume level set by participant (left),FGF6,Fibroblast growth factor 6,35725,0.0493282154110115,0.0535419428235301,-0.0556139925231075,0.15427042334513,0.356927637739471
Physical measures,X4270.Volume level set by participant (left),NFX1,Transcriptional repressor NF-X1,35706,-0.0311022972068041,0.0337612207318426,-0.0972742898412156,0.0350696954276074,0.356957577448291
Physical measures,X4270.Volume level set by participant (left),STAMBP,STAM-binding protein,36748,-0.0292940983833669,0.0318140852252013,-0.0916497054247613,0.0330615086580276,0.357189380326724
Physical measures,X4270.Volume level set by participant (left),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,35741,-0.0190839907924939,0.0207642363086256,-0.0597818939574001,0.0216139123724122,0.358087692729775
Physical measures,X4270.Volume level set by participant (left),ELN,Elastin,35916,-0.05538112483561,0.0602612912701092,-0.173493255725024,0.0627310060538041,0.358119898551951
Physical measures,X4270.Volume level set by participant (left),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35798,-0.0310637435448033,0.0338150110535992,-0.0973411652098577,0.0352136781202511,0.358318677637541
Physical measures,X4270.Volume level set by participant (left),NEO1,Neogenin,35903,-0.0922236102075815,0.100455464291848,-0.289116320219604,0.104669099804441,0.358623251037164
Physical measures,X4270.Volume level set by participant (left),HHEX,Hematopoietically-expressed homeobox protein HHEX,35903,0.0269184252175921,0.0293226256211482,-0.0305539209998584,0.0843907714350427,0.358647330038889
Physical measures,X4270.Volume level set by participant (left),PBLD,Phenazine biosynthesis-like domain-containing protein,36639,0.0354557386768369,0.0386828977684049,-0.0403627409492367,0.111274218302911,0.359395609611478
Physical measures,X4270.Volume level set by participant (left),IL7,Interleukin-7,36820,0.0270038766868976,0.029474847840161,-0.030766825079818,0.0847745784536132,0.359608403126092
Physical measures,X4270.Volume level set by participant (left),CASC3,Protein CASC3,35741,0.0484206800126761,0.052853960886989,-0.0551730833258222,0.152014443351174,0.359636631675634
Physical measures,X4270.Volume level set by participant (left),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,35706,0.0281563221194628,0.0307563083542455,-0.0321260422548585,0.088438686493784,0.359981510889344
Physical measures,X4270.Volume level set by participant (left),LBP,Lipopolysaccharide-binding protein,36863,-0.0293889801253061,0.0321302763371825,-0.0923643217461837,0.0335863614955715,0.360387451696517
Physical measures,X4270.Volume level set by participant (left),FGF20,Fibroblast growth factor 20,35725,0.0449962918013572,0.0491970213539517,-0.0514298700523882,0.141422453655103,0.360428009156195
Physical measures,X4270.Volume level set by participant (left),CCN5,CCN family member 5,36836,-0.0449565196492181,0.0491701716582075,-0.141330056099305,0.0514170168008685,0.360585612647353
Physical measures,X4270.Volume level set by participant (left),IZUMO1,Izumo sperm-egg fusion protein 1,35678,0.0441330246442356,0.0483118001118496,-0.0505581035749896,0.138824152863461,0.36101149048382
Physical measures,X4270.Volume level set by participant (left),RNF43,E3 ubiquitin-protein ligase RNF43,35798,-0.0346766476663019,0.0380002854874757,-0.109157207221754,0.0398039118891504,0.361519688013115
Physical measures,X4270.Volume level set by participant (left),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,35706,0.0611485029263065,0.0671087165067944,-0.0703845814270105,0.192681587279624,0.362231279359258
Physical measures,X4270.Volume level set by participant (left),SEPTIN9,Septin-9,36770,-0.0609814832867794,0.0669631827672139,-0.192229321510519,0.0702663549369599,0.36249730265389
Physical measures,X4270.Volume level set by participant (left),CEND1,Cell cycle exit and neuronal differentiation protein 1,35680,0.0352090562412158,0.0386828641430387,-0.04060935747914,0.111027469961572,0.362752064541858
Physical measures,X4270.Volume level set by participant (left),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",36770,0.0423437182817307,0.0465580976408539,-0.0489101530943429,0.133597589657804,0.363125078022383
Physical measures,X4270.Volume level set by participant (left),SRPK2,SRSF protein kinase 2,36820,0.0202483468029784,0.0223173322744766,-0.0234936244549957,0.0639903180609525,0.364280851322587
Physical measures,X4270.Volume level set by participant (left),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35931,0.0503366356156922,0.0554796322649681,-0.0584034436236452,0.15907671485503,0.364280970641782
Physical measures,X4270.Volume level set by participant (left),EVI2B,Protein EVI2B,35678,0.0517303368496271,0.0570240656865871,-0.0600368318960836,0.163497505595338,0.364352346624092
Physical measures,X4270.Volume level set by participant (left),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,36770,0.0367429020042597,0.0405573639874096,-0.0427495314110632,0.116235335419583,0.364991686963988
Physical measures,X4270.Volume level set by participant (left),BCL7B,B-cell CLL/lymphoma 7 protein family member B,35874,-0.0433301872678111,0.0478306701039379,-0.137078300671529,0.0504179261359072,0.365017231567582
Physical measures,X4270.Volume level set by participant (left),ITGAL,Integrin alpha-L,35725,-0.044681490676305,0.0493918029040713,-0.141489424368285,0.0521264430156748,0.36569284572576
Physical measures,X4270.Volume level set by participant (left),SERPINB8,Serpin B8,36908,0.0283604321348047,0.0313664867663038,-0.0331178819271506,0.0898387461967601,0.365936962939085
Physical measures,X4270.Volume level set by participant (left),SCARF2,Scavenger receptor class F member 2,36894,-0.0571693962484292,0.0632383995730455,-0.181116659411598,0.0667778669147399,0.366007905409925
Physical measures,X4270.Volume level set by participant (left),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35903,0.0306925114208886,0.0339678532570847,-0.0358844809629975,0.0972695038047746,0.36625312750951
Physical measures,X4270.Volume level set by participant (left),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35916,-0.0603581220851259,0.0668198311616927,-0.191324991162044,0.0706087469917918,0.366400916743917
Physical measures,X4270.Volume level set by participant (left),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",35706,0.0409288664136407,0.0454007492102763,-0.048056602038501,0.129914334865782,0.367354824096601
Physical measures,X4270.Volume level set by participant (left),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",35748,0.0224914727028288,0.0249645488976563,-0.0264390431365775,0.0714219885422352,0.367655215076496
Physical measures,X4270.Volume level set by participant (left),NID1,Nidogen-1,36818,-0.0444091650160695,0.0492983294931305,-0.141033890822605,0.0522155607904662,0.367709867084432
Physical measures,X4270.Volume level set by participant (left),PRND,Prion-like protein doppel,35903,-0.0380622610810444,0.0423088309583031,-0.120987569759318,0.0448630475972296,0.368349898392746
Physical measures,X4270.Volume level set by participant (left),IL3,Interleukin-3,35678,-0.0331424840629536,0.0368471901009092,-0.105362976660736,0.0390780085348284,0.368442403704292
Physical measures,X4270.Volume level set by participant (left),CRIM1,Cysteine-rich motor neuron 1 protein,36865,-0.0790588938754479,0.0879073687694328,-0.251357336663536,0.0932395489126405,0.368498126863961
Physical measures,X4270.Volume level set by participant (left),OSMR,Oncostatin-M-specific receptor subunit beta,36880,0.0834547105101458,0.0931312663557559,-0.0990825715471358,0.265991992567428,0.370228677837161
Physical measures,X4270.Volume level set by participant (left),FCAR,Immunoglobulin alpha Fc receptor,36820,0.034038713377131,0.0380114533153409,-0.0404637351209371,0.108541161875199,0.370555774520203
Physical measures,X4270.Volume level set by participant (left),BRAP,BRCA1-associated protein,35828,0.0196716342488896,0.0219771197163082,-0.0234035203950744,0.0627467888928536,0.370768205324396
Physical measures,X4270.Volume level set by participant (left),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",36654,0.0214760219905096,0.0240068075539322,-0.0255773208151975,0.0685293647962167,0.371040250184099
Physical measures,X4270.Volume level set by participant (left),AGER,Advanced glycosylation end product-specific receptor,36816,-0.0400452444815839,0.0447646725988449,-0.12778400277532,0.0476935138121522,0.371043923190672
Physical measures,X4270.Volume level set by participant (left),FCER2,Low affinity immunoglobulin epsilon Fc receptor,36836,-0.0314629710876294,0.0352995760889446,-0.100650140221961,0.0377241980467019,0.372789348390388
Physical measures,X4270.Volume level set by participant (left),RNF168,E3 ubiquitin-protein ligase RNF168,35725,-0.0489871442213833,0.0549873517246387,-0.156762353601675,0.0587880651589084,0.373026263161133
Physical measures,X4270.Volume level set by participant (left),KLRF1,Killer cell lectin-like receptor subfamily F member 1,35725,-0.0418373911037574,0.0469644521998543,-0.133887717415472,0.0502129352079571,0.373052658563333
Physical measures,X4270.Volume level set by participant (left),CHM,Rab proteins geranylgeranyltransferase component A 1,35741,0.032828496375937,0.0369416224868666,-0.0395770836983215,0.105234076450196,0.374219164940819
Physical measures,X4270.Volume level set by participant (left),STX5,Syntaxin-5,35725,0.0472479962889067,0.0532377864313935,-0.0570980651166246,0.151594057694438,0.374847912333579
Physical measures,X4270.Volume level set by participant (left),SPRR3,Small proline-rich protein 3,35903,-0.0276652517296926,0.031192011054994,-0.0888015933974808,0.0334710899380957,0.375146300209838
Physical measures,X4270.Volume level set by participant (left),HEBP1,Heme-binding protein 1,36697,-0.0313284870739647,0.0353378498810875,-0.100590672840896,0.0379336986929668,0.37535397349373
Physical measures,X4270.Volume level set by participant (left),IRAK4,Interleukin-1 receptor-associated kinase 4,36820,0.0172421500420621,0.0194640895506715,-0.020907465477254,0.0553917655613781,0.375729452967254
Physical measures,X4270.Volume level set by participant (left),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,36770,0.0422745307161986,0.0477713913552988,-0.051357396340187,0.135906457772584,0.376220298870748
Physical measures,X4270.Volume level set by participant (left),HMMR,Hyaluronan mediated motility receptor,35660,0.0398324312804124,0.0450347463281596,-0.0484356715227803,0.128100534083605,0.376468872116305
Physical measures,X4270.Volume level set by participant (left),SIGLEC5,Sialic acid-binding Ig-like lectin 5,36836,0.0138021890450507,0.0156130835364897,-0.0167994546864691,0.0444038327765706,0.376716316940998
Physical measures,X4270.Volume level set by participant (left),VWA5A,von Willebrand factor A domain-containing protein 5A,35678,0.0258784119488011,0.0293035908728181,-0.0315566261619223,0.0833134500595245,0.377207425002503
Physical measures,X4270.Volume level set by participant (left),OSM,Oncostatin-M,36788,0.0238841836455868,0.0270511410785784,-0.0291360528684269,0.0769044201596004,0.377303657665125
Physical measures,X4270.Volume level set by participant (left),SERPINF1,Pigment epithelium-derived factor,35819,0.0722973027343981,0.0818989640844506,-0.0882246668711251,0.232819272339921,0.377396857614233
Physical measures,X4270.Volume level set by participant (left),BSG,Basigin,36891,0.0795492438995206,0.0902500109566039,-0.097340777575423,0.256439265374464,0.378111600287977
Physical measures,X4270.Volume level set by participant (left),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35894,0.0545907941037771,0.0619430617064918,-0.0668176068409468,0.175999195048501,0.378183828261127
Physical measures,X4270.Volume level set by participant (left),PGF,Placenta growth factor,36908,0.0627369402682717,0.0711893271901944,-0.0767941410245093,0.202268021561053,0.378199760740609
Physical measures,X4270.Volume level set by participant (left),GKN1,Gastrokine-1,36521,0.0619409450296616,0.0703203430711388,-0.0758869273897703,0.199768817449094,0.378433529498208
Physical measures,X4270.Volume level set by participant (left),SMC3,Structural maintenance of chromosomes protein 3,35678,0.0363479103160894,0.0412787458957257,-0.044558431639533,0.117254252271712,0.378595254639604
Physical measures,X4270.Volume level set by participant (left),GET3,ATPase GET3,35916,-0.0354980644694179,0.0403155279042782,-0.114516499161803,0.0435203702229674,0.378616745529296
Physical measures,X4270.Volume level set by participant (left),EPGN,Epigen,35874,0.037298019615322,0.042386600941724,-0.045779718230457,0.120375757461101,0.378918958517405
Physical measures,X4270.Volume level set by participant (left),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,35779,0.0451803688443013,0.0513684256480387,-0.0555017454258545,0.145862483114457,0.379142945629024
Physical measures,X4270.Volume level set by participant (left),SEMA3F,Semaphorin-3F,36828,-0.0627475166008395,0.071401336651173,-0.202694136437139,0.0771991032354595,0.379537229619631
Physical measures,X4270.Volume level set by participant (left),UNC5D,Netrin receptor UNC5D,35725,-0.0750469893615427,0.0854899816493054,-0.242607353394181,0.0925133746710959,0.380059915302169
Physical measures,X4270.Volume level set by participant (left),IL20RB,Interleukin-20 receptor subunit beta,35725,0.0472070303325572,0.0538221680216224,-0.0582844189898226,0.152698479654937,0.380468568856733
Physical measures,X4270.Volume level set by participant (left),SERPINA1,Alpha-1-antitrypsin,35768,-0.220417277556791,0.251870417470764,-0.714083295799488,0.273248740685907,0.381539655738087
Physical measures,X4270.Volume level set by participant (left),CLU,Clusterin,35953,0.0625596101206394,0.071542213265589,-0.0776631278799151,0.202782348121194,0.381907960534616
Physical measures,X4270.Volume level set by participant (left),OGN,Mimecan,36836,0.0387200515326251,0.0443264007599005,-0.0481596939567799,0.12559979702203,0.382406505207593
Physical measures,X4270.Volume level set by participant (left),SERPINA7,Thyroxine-binding globulin,35953,-0.103708527483703,0.119078346213422,-0.337102086062011,0.129685031094605,0.383825047324213
Physical measures,X4270.Volume level set by participant (left),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35931,-0.07364035409917,0.0846129241859902,-0.239481685503711,0.0922009773053707,0.384156355574788
Physical measures,X4270.Volume level set by participant (left),GAS6,Growth arrest-specific protein 6,36891,0.0632416749971143,0.0727502021031566,-0.0793487211250727,0.205832071119301,0.384710748456145
Physical measures,X4270.Volume level set by participant (left),CASP7,Caspase-7,35903,0.0234779661631572,0.0270077715995315,-0.0294572661719245,0.0764131984982389,0.384711941255026
Physical measures,X4270.Volume level set by participant (left),TGFBR2,TGF-beta receptor type-2,36864,0.0469670875370809,0.0540439826104631,-0.0589591183794268,0.152893293453589,0.384845322503206
Physical measures,X4270.Volume level set by participant (left),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,35725,-0.0358175701307375,0.0413387225303199,-0.116841466290164,0.0452063260286895,0.386280131772137
Physical measures,X4270.Volume level set by participant (left),GGH,Gamma-glutamyl hydrolase,36718,-0.0498066633469461,0.0575622621700957,-0.162628697200334,0.0630153705064415,0.386920453254059
Physical measures,X4270.Volume level set by participant (left),CETN3,Centrin-3,35894,0.0252804146622014,0.0292359567082158,-0.0320220604859015,0.0825828898103044,0.38723288402565
Physical measures,X4270.Volume level set by participant (left),CINP,Cyclin-dependent kinase 2-interacting protein,35798,-0.0421317982074027,0.0488465718002854,-0.137871078935962,0.0536074825211566,0.388425412184263
Physical measures,X4270.Volume level set by participant (left),CRYBB1,Beta-crystallin B1,35916,0.0301063432259558,0.034922979324748,-0.0383426962505503,0.098555382702462,0.388675188567373
Physical measures,X4270.Volume level set by participant (left),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,36894,-0.0342941653986445,0.0397884721897571,-0.112279570890569,0.0436912400932795,0.388762744186279
Physical measures,X4270.Volume level set by participant (left),LMNB2,Lamin-B2,35903,0.0642826872686273,0.0745843877279935,-0.08190271267824,0.210468087215495,0.388785146985812
Physical measures,X4270.Volume level set by participant (left),IGFBP2,Insulin-like growth factor-binding protein 2,36925,-0.0261948263839674,0.0304131869591785,-0.0858046728239572,0.0334150200560224,0.389100491167512
Physical measures,X4270.Volume level set by participant (left),PRSS27,Serine protease 27,36804,0.0404328523662673,0.0469834763686145,-0.0516547613162171,0.132520466048752,0.389498728557602
Physical measures,X4270.Volume level set by participant (left),NAGK,N-acetyl-D-glucosamine kinase,35736,-0.0354875196801419,0.0412486641521421,-0.11633490141834,0.0453598620580565,0.389637947831224
Physical measures,X4270.Volume level set by participant (left),SUSD1,Sushi domain-containing protein 1,36697,0.0340820883139633,0.0396249509651848,-0.0435828155777989,0.111746992205725,0.389752122152454
Physical measures,X4270.Volume level set by participant (left),CRELD1,Protein disulfide isomerase CRELD1,35779,0.0504463817317976,0.0586748630226006,-0.0645563497924995,0.165449113256095,0.389951899705667
Physical measures,X4270.Volume level set by participant (left),FBP1,"Fructose-1,6-bisphosphatase 1",36828,0.021517988745172,0.0250588644986232,-0.0275973856721295,0.0706333631624735,0.39053430337765
Physical measures,X4270.Volume level set by participant (left),CABP2,Calcium-binding protein 2,35741,0.0296172510511252,0.0344924819766174,-0.0379880136230449,0.0972225157252953,0.390560590851498
Physical measures,X4270.Volume level set by participant (left),CYB5A,Cytochrome b5,35678,0.0272717106992744,0.0317651842814175,-0.0349880504923038,0.0895314718908527,0.390625592792083
Physical measures,X4270.Volume level set by participant (left),CR2,Complement receptor type 2,36863,0.0334303234013102,0.038962993770172,-0.0429371443882268,0.109797791190847,0.390918228009693
Physical measures,X4270.Volume level set by participant (left),CDK1,Cyclin-dependent kinase 1,35678,0.0529973124114259,0.0618543977527465,-0.0682373071839573,0.174231932006809,0.391582954662073
Physical measures,X4270.Volume level set by participant (left),VPS37A,Vacuolar protein sorting-associated protein 37A,36770,0.0205796309896039,0.0240462682906765,-0.0265510548601221,0.0677103168393299,0.392116291405094
Physical measures,X4270.Volume level set by participant (left),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35874,0.0175460145408324,0.0205484285469714,-0.0227289054112314,0.0578209344928963,0.393198814654291
Physical measures,X4270.Volume level set by participant (left),GSTA3,Glutathione S-transferase A3,36654,0.0215597631658963,0.0252761068566304,-0.0279814062730993,0.071100932604892,0.39370328617614
Physical measures,X4270.Volume level set by participant (left),EPHX2,Bifunctional epoxide hydrolase 2,36697,0.025971782005559,0.0304492734103988,-0.0337087938788227,0.0856523578899407,0.393712918038213
Physical measures,X4270.Volume level set by participant (left),CCL24,C-C motif chemokine 24,36853,0.0193533174656838,0.0227007952808054,-0.0251402412846947,0.0638468762160623,0.393941569629085
Physical measures,X4270.Volume level set by participant (left),PTPRC,Receptor-type tyrosine-protein phosphatase C,35931,-0.0805694458487421,0.0945595121440062,-0.265906089650994,0.10476719795351,0.394216562508464
Physical measures,X4270.Volume level set by participant (left),CA9,Carbonic anhydrase 9,36888,0.0329176293890794,0.0386532069491055,-0.0428426562311673,0.108677915009326,0.394454634644926
Physical measures,X4270.Volume level set by participant (left),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,35779,-0.033412144707625,0.0392679245472592,-0.110377276820253,0.0435529874050031,0.394869047139107
Physical measures,X4270.Volume level set by participant (left),FABP2,"Fatty acid-binding protein, intestinal",36828,-0.0202070693084437,0.023761121388577,-0.0667788672300547,0.0263647286131674,0.395115110887261
Physical measures,X4270.Volume level set by participant (left),CMC1,COX assembly mitochondrial protein homolog,35916,0.0208413550895886,0.024530530051709,-0.0272384838117611,0.0689211939909383,0.395572868656555
Physical measures,X4270.Volume level set by participant (left),FOXO3,Forkhead box protein O3,36654,-0.0179370695994938,0.0211128293588964,-0.0593182151429307,0.023444075943943,0.395585065696925
Physical measures,X4270.Volume level set by participant (left),MVK,Mevalonate kinase,36697,0.020945916020884,0.0246596934164714,-0.0273870830754,0.069278915117168,0.395686486420663
Physical measures,X4270.Volume level set by participant (left),CDC27,Cell division cycle protein 27 homolog,36654,0.0259161584673206,0.0305192225790271,-0.0339015177875726,0.0857338347222138,0.395811224971625
Physical measures,X4270.Volume level set by participant (left),CRISP3,Cysteine-rich secretory protein 3,35864,-0.0680982977388501,0.0802808102270476,-0.225448685783863,0.0892520903061631,0.396328512743793
Physical measures,X4270.Volume level set by participant (left),C5,Complement C5,35953,-0.117825290828229,0.139026540465294,-0.390317310140206,0.154666728483748,0.396745315566769
Physical measures,X4270.Volume level set by participant (left),PRSS2,Trypsin-2,36863,0.0286621490162004,0.0338384466954529,-0.0376612065068873,0.094985504539288,0.397005343937182
Physical measures,X4270.Volume level set by participant (left),SMNDC1,Survival of motor neuron-related-splicing factor 30,35894,-0.0317078387824237,0.0374435145096848,-0.105097127221406,0.0416814496565585,0.397126881630818
Physical measures,X4270.Volume level set by participant (left),NUDT5,ADP-sugar pyrophosphatase,36836,-0.033159685289977,0.0391744434662769,-0.10994159448388,0.0436222239039257,0.397321472041547
Physical measures,X4270.Volume level set by participant (left),CWC15,Spliceosome-associated protein CWC15 homolog,35864,0.0308559381032312,0.0364610469801974,-0.0406077139779557,0.102319590184418,0.397431780496041
Physical measures,X4270.Volume level set by participant (left),GSN,Gelsolin,35902,-0.0925872124516394,0.109470231148204,-0.30714886550212,0.121974440598841,0.397708314557046
Physical measures,X4270.Volume level set by participant (left),DNAJB14,DnaJ homolog subfamily B member 14,35894,0.0304801672223727,0.0360610181626653,-0.0401994283764513,0.101159762821197,0.398007788632703
Physical measures,X4270.Volume level set by participant (left),TNPO1,Transportin-1,35798,-0.0522542119840468,0.0618227071544788,-0.173426718006825,0.0689182940387316,0.398014828808254
Physical measures,X4270.Volume level set by participant (left),TBC1D5,TBC1 domain family member 5,36820,0.0198008118727638,0.0234309728252676,-0.0261238948647606,0.0657255186102883,0.398098287032861
Physical measures,X4270.Volume level set by participant (left),GUSB,Beta-glucuronidase,36872,0.025932068070469,0.0307193894173049,-0.0342779351874485,0.0861420713283865,0.398606526663515
Physical measures,X4270.Volume level set by participant (left),KYNU,Kynureninase,36908,0.0355277040829878,0.0421707654819583,-0.0471269962616505,0.118182404427626,0.39954973700908
Physical measures,X4270.Volume level set by participant (left),CSH1,Chorionic somatomammotropin hormone 1,35926,-0.0639095979971635,0.0758728873758433,-0.212620457253816,0.0848012612594894,0.399636232420006
Physical measures,X4270.Volume level set by participant (left),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,36654,0.0250238462574246,0.0297134083840254,-0.0332144341752652,0.0832621266901144,0.399717832003431
Physical measures,X4270.Volume level set by participant (left),PXDNL,Peroxidasin-like protein,35874,-0.0327374891270275,0.0388908748830789,-0.108963603897862,0.0434886256438073,0.399942286084394
Physical measures,X4270.Volume level set by participant (left),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,36654,0.0381039133834894,0.0452702461515478,-0.0506257690735443,0.126833595840523,0.399983542642265
Physical measures,X4270.Volume level set by participant (left),DCTN2,Dynactin subunit 2,36770,-0.0168047450663017,0.0200119831786964,-0.0560282320965467,0.0224187419639433,0.401083987639352
Physical measures,X4270.Volume level set by participant (left),DTNB,Dystrobrevin beta,35856,-0.0428200663199487,0.0510486629156577,-0.142875445634638,0.0572353129947403,0.401606736126037
Physical measures,X4270.Volume level set by participant (left),LAMP2,Lysosome-associated membrane glycoprotein 2,36606,0.0824643808370001,0.0983222889922372,-0.110247305587785,0.275176067261785,0.401656304404818
Physical measures,X4270.Volume level set by participant (left),TP53INP1,Tumor protein p53-inducible nuclear protein 1,36697,-0.0479666157422957,0.0572246921210886,-0.160127012299629,0.064193780815038,0.401936475589226
Physical measures,X4270.Volume level set by participant (left),RELT,Tumor necrosis factor receptor superfamily member 19L,36836,0.0534151558684129,0.0637659100346416,-0.0715660277994847,0.17839633953631,0.402239049232955
Physical measures,X4270.Volume level set by participant (left),MEP1B,Meprin A subunit beta,36828,-0.0133984844197163,0.0160069703707242,-0.0447721463463356,0.0179751775069031,0.402595947530053
Physical measures,X4270.Volume level set by participant (left),AP1G2,AP-1 complex subunit gamma-like 2,35874,0.0228243194677792,0.0272838952231873,-0.030652115169668,0.0763007541052264,0.402875973723646
Physical measures,X4270.Volume level set by participant (left),FABP1,"Fatty acid-binding protein, liver",36822,0.0167806570218491,0.0200623467316003,-0.0225415425720875,0.0561028566157857,0.40294182167132
Physical measures,X4270.Volume level set by participant (left),CSF3R,Granulocyte colony-stimulating factor receptor,35725,-0.0594610433755074,0.071116525602641,-0.198849433556684,0.0799273468056691,0.403125166938515
Physical measures,X4270.Volume level set by participant (left),CRIP2,Cysteine-rich protein 2,36763,-0.0419648154103329,0.0502069930814507,-0.140370521849976,0.0564408910293106,0.40327353030125
Physical measures,X4270.Volume level set by participant (left),CD28,T-cell-specific surface glycoprotein CD28,36654,0.0445123814009485,0.0533437665666553,-0.0600414010696959,0.149066163871593,0.404057609815268
Physical measures,X4270.Volume level set by participant (left),RNF31,E3 ubiquitin-protein ligase RNF31,35725,-0.0505580985418357,0.0606122078137136,-0.169358025856714,0.068241828773043,0.404241620931287
Physical measures,X4270.Volume level set by participant (left),RNASET2,Ribonuclease T2,36903,0.0555551657263538,0.066623373522748,-0.0750266463782322,0.18613697783094,0.404380655375155
Physical measures,X4270.Volume level set by participant (left),CALB2,Calretinin,36639,-0.0536476480456893,0.0643630970215889,-0.179799318208004,0.072504022116625,0.404580731190964
Physical measures,X4270.Volume level set by participant (left),XRCC4,DNA repair protein XRCC4,36639,-0.0428097796158912,0.0513807750145105,-0.143516098644332,0.0578965394125493,0.404766167497884
Physical measures,X4270.Volume level set by participant (left),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,36820,0.0162548508663453,0.0195125808765275,-0.0219898076516486,0.0544995093843392,0.404845653853873
Physical measures,X4270.Volume level set by participant (left),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,35773,-0.037925284261442,0.0455690907106319,-0.127240702054281,0.0513901335313965,0.405293009526206
Physical measures,X4270.Volume level set by participant (left),REEP4,Receptor expression-enhancing protein 4,35903,-0.0274800630716816,0.0330370975165976,-0.092232774204213,0.0372726480608498,0.405554787488563
Physical measures,X4270.Volume level set by participant (left),PER3,Period circadian protein homolog 3,35725,-0.0148841453377053,0.0179063866917901,-0.049980663253614,0.0202123725782033,0.405879804211446
Physical measures,X4270.Volume level set by participant (left),GH2,Growth hormone variant,36654,0.00980800179499914,0.0118027564209166,-0.0133254007899975,0.0329414043799958,0.406004485057244
Physical measures,X4270.Volume level set by participant (left),LAG3,Lymphocyte activation gene 3 protein,36770,-0.0383192652848198,0.0461909864096735,-0.12885359864778,0.0522150680781403,0.406800639452595
Physical measures,X4270.Volume level set by participant (left),GNPDA2,Glucosamine-6-phosphate isomerase 2,35779,-0.0509228464222055,0.0614057461390398,-0.171278108854724,0.0694324160103125,0.406973393261963
Physical measures,X4270.Volume level set by participant (left),QSOX1,Sulfhydryl oxidase 1,35800,0.0439710828051522,0.053067096342735,-0.0600404260266084,0.147982591636913,0.407364078169935
Physical measures,X4270.Volume level set by participant (left),CST3,Cystatin-C,36854,0.0533672854353815,0.0644895302071455,-0.0730321937706236,0.179766764641387,0.407960191178507
Physical measures,X4270.Volume level set by participant (left),SEMA3G,Semaphorin-3G,35779,0.040537437464025,0.0489990825207423,-0.0555007642766299,0.13657563920468,0.408091294188995
Physical measures,X4270.Volume level set by participant (left),COL24A1,Collagen alpha-1(XXIV) chain,35894,0.032378802603173,0.0391486064271989,-0.0443524659941368,0.109110071200483,0.408224470390937
Physical measures,X4270.Volume level set by participant (left),KCNIP4,Kv channel-interacting protein 4,36639,-0.032330426372203,0.0390998794843261,-0.108966190161482,0.0443053374170762,0.408338578219397
Physical measures,X4270.Volume level set by participant (left),MIF,Macrophage migration inhibitory factor,36816,-0.0247743448049125,0.0299737658419004,-0.0835229258550373,0.0339742362452122,0.4085269663501
Physical measures,X4270.Volume level set by participant (left),LIPF,Gastric triacylglycerol lipase,35748,-0.0299917108275829,0.0362964220924151,-0.101132698128716,0.0411492764735506,0.408664381458458
Physical measures,X4270.Volume level set by participant (left),SERPINB5,Serpin B5,36697,0.0320254900450908,0.0388160025871144,-0.0440538750256535,0.108104855115835,0.409364368311399
Physical measures,X4270.Volume level set by participant (left),THAP12,52 kDa repressor of the inhibitor of the protein kinase,35662,0.0205313800773437,0.0249008756712931,-0.0282743362383908,0.0693370963930782,0.409672064885747
Physical measures,X4270.Volume level set by participant (left),PROCR,Endothelial protein C receptor,35706,-0.0549832679051542,0.0667178569111757,-0.185750267451059,0.0757837316407502,0.409903722297614
Physical measures,X4270.Volume level set by participant (left),NINJ1,Ninjurin-1,36654,-0.0295438381626867,0.035921035739564,-0.0999490682122321,0.0408613918868586,0.4108379075856
Physical measures,X4270.Volume level set by participant (left),ARG1,Arginase-1,36804,-0.0304261066222354,0.0370006546402859,-0.102947389717196,0.042095176472725,0.410924749079534
Physical measures,X4270.Volume level set by participant (left),CYTH3,Cytohesin-3,35678,0.0252795034115678,0.0307498999258772,-0.0349903004431515,0.0855493072662871,0.411050030781562
Physical measures,X4270.Volume level set by participant (left),TALDO1,Transaldolase,35892,-0.0417529853833663,0.0508005671284927,-0.141322096955212,0.0578161261884793,0.41116308952632
Physical measures,X4270.Volume level set by participant (left),ITGB2,Integrin beta-2,36801,-0.0551131594329707,0.0671325655478569,-0.18669298790677,0.0764666690408288,0.411694717575446
Physical measures,X4270.Volume level set by participant (left),COL15A1,Collagen alpha-1(XV) chain,35931,-0.065201827262609,0.0795214581859478,-0.221063885307067,0.0906602307818486,0.412286480974844
Physical measures,X4270.Volume level set by participant (left),NPHS2,Podocin,35725,0.0177549999719059,0.0216552803663472,-0.0246893495461345,0.0601993494899464,0.412307379013411
Physical measures,X4270.Volume level set by participant (left),IL7R,Interleukin-7 receptor subunit alpha,36836,-0.0301487404280672,0.036803686288116,-0.102283965552775,0.0419864846966402,0.412710880538544
Physical measures,X4270.Volume level set by participant (left),USP28,Ubiquitin carboxyl-terminal hydrolase 28,35903,-0.0470880037965543,0.0575099113460346,-0.159807430034782,0.0656314224416735,0.412940655649206
Physical measures,X4270.Volume level set by participant (left),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,36864,0.0162541880883991,0.019864305649543,-0.0226798509847052,0.0551882271615034,0.413233557458494
Physical measures,X4270.Volume level set by participant (left),TMPRSS5,Transmembrane protease serine 5,36727,-0.0411333181379094,0.0503516249477683,-0.139822503035535,0.0575558667597165,0.413999212305751
Physical measures,X4270.Volume level set by participant (left),EGFL7,Epidermal growth factor-like protein 7,36654,0.038849814621985,0.0475961120673796,-0.054438565030079,0.132138194274049,0.414389387250765
Physical measures,X4270.Volume level set by participant (left),MUC16,Mucin-16,36770,0.00817808644913455,0.0100535620712016,-0.0115268952104206,0.0278830681086897,0.415984742278212
Physical measures,X4270.Volume level set by participant (left),DCC,Netrin receptor DCC,35741,0.0841907241977014,0.103598102811505,-0.118861557312848,0.287243005708251,0.416438764056389
Physical measures,X4270.Volume level set by participant (left),LIFR,Leukemia inhibitory factor receptor,36820,0.0635560245370211,0.0783219315496284,-0.0899549613002505,0.217067010374293,0.417120221375729
Physical measures,X4270.Volume level set by participant (left),CASP1,Caspase-1,36639,-0.0217596452107711,0.0268166879761204,-0.0743203536439671,0.0308010632224249,0.417149434971553
Physical measures,X4270.Volume level set by participant (left),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",35748,0.026096600265863,0.0321751435295988,-0.0369666810521507,0.0891598815838767,0.417349466517333
Physical measures,X4270.Volume level set by participant (left),IGSF21,Immunoglobulin superfamily member 21,35748,-0.0472522085339262,0.0582914660644963,-0.161503482020339,0.0669990649524866,0.41761356853115
Physical measures,X4270.Volume level set by participant (left),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,36901,0.0433713784297966,0.0535178533495268,-0.061523614135276,0.148266370994869,0.417729874276668
Physical measures,X4270.Volume level set by participant (left),AKR7L,Aflatoxin B1 aldehyde reductase member 4,35725,0.0266709247174197,0.0329228964510702,-0.037857952326678,0.0911998017615173,0.417910726883071
Physical measures,X4270.Volume level set by participant (left),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,36654,0.0268146173946152,0.0331279231343319,-0.0381161119486754,0.0917453467379058,0.41829571600075
Physical measures,X4270.Volume level set by participant (left),TNC,Tenascin,36863,0.0310509285594872,0.0383924817970417,-0.0441983357627146,0.106300192881689,0.418668941983561
Physical measures,X4270.Volume level set by participant (left),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",35680,0.0315254667754127,0.0390191354704579,-0.0449520387466847,0.10800297229751,0.419149655494632
Physical measures,X4270.Volume level set by participant (left),MEGF9,Multiple epidermal growth factor-like domains protein 9,36909,0.0775188329128945,0.0959592946069813,-0.110561384516789,0.265599050342578,0.419213152801301
Physical measures,X4270.Volume level set by participant (left),PTS,6-pyruvoyl tetrahydrobiopterin synthase,36616,0.0282603076243373,0.0349850643059942,-0.0403104184154114,0.096831033664086,0.419241947494104
Physical measures,X4270.Volume level set by participant (left),MMP8,Neutrophil collagenase,36888,-0.0204553924781488,0.0253235458783277,-0.0700895423996711,0.0291787574433735,0.419252713072799
Physical measures,X4270.Volume level set by participant (left),AGXT,Serine--pyruvate aminotransferase,36828,0.0207154626588249,0.0256672751100637,-0.0295923965568999,0.0710233218745497,0.419647382280528
Physical measures,X4270.Volume level set by participant (left),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35903,-0.058396689026972,0.0724631754211607,-0.200424512852447,0.083631134798503,0.420340100249005
Physical measures,X4270.Volume level set by participant (left),BECN1,Beclin-1,35748,-0.0304059546746603,0.0377809127699665,-0.104456543703795,0.043644634354474,0.420966201059641
Physical measures,X4270.Volume level set by participant (left),CST7,Cystatin-F,36841,-0.0160833404934641,0.0199944108644233,-0.0552723857877337,0.0231057048008055,0.421195741271691
Physical measures,X4270.Volume level set by participant (left),DUSP29,Dual specificity phosphatase 29,35741,-0.027027520171743,0.0336117521434788,-0.0929065543729615,0.0388515140294755,0.42136310292532
Physical measures,X4270.Volume level set by participant (left),PCSK7,Proprotein convertase subtilisin/kexin type 7,35874,-0.0412098108768054,0.051309306012356,-0.141776050661023,0.0593564289074123,0.42190827534616
Physical measures,X4270.Volume level set by participant (left),SERPINA11,Serpin A11,36933,-0.0359515707985701,0.0448519552666308,-0.123861403121167,0.0519582615240263,0.422831658735643
Physical measures,X4270.Volume level set by participant (left),CD160,CD160 antigen,36908,-0.0304931708522774,0.038044361422013,-0.105060119239423,0.0440737775348681,0.422857584420398
Physical measures,X4270.Volume level set by participant (left),RBP7,Retinoid-binding protein 7,35894,-0.0277953249024614,0.0346884062742138,-0.0957846011999205,0.0401939513949976,0.422994678452302
Physical measures,X4270.Volume level set by participant (left),PEPD,Xaa-Pro dipeptidase,35926,-0.0648093080624389,0.0809076367464902,-0.22338827608556,0.0937696599606819,0.423143535110571
Physical measures,X4270.Volume level set by participant (left),HTR1B,5-hydroxytryptamine receptor 1B,35680,0.0416352585270486,0.0519802897440536,-0.0602461093712965,0.143516626425394,0.423171619270851
Physical measures,X4270.Volume level set by participant (left),AIF1,Allograft inflammatory factor 1,36654,0.0299003957603189,0.0373405919249776,-0.0432871644126373,0.103087955933275,0.423303191662065
Physical measures,X4270.Volume level set by participant (left),MFAP4,Microfibril-associated glycoprotein 4,35779,-0.0544958010991977,0.0680659842614086,-0.187905130251559,0.0789135280531632,0.423373651166333
Physical measures,X4270.Volume level set by participant (left),PNLIP,Pancreatic triacylglycerol lipase,35926,0.0263444849693916,0.0329637800212428,-0.0382645238722443,0.0909534938110274,0.424205615385261
Physical measures,X4270.Volume level set by participant (left),PPP3R1,Calcineurin subunit B type 1,36763,0.0378863500055014,0.0474244466112383,-0.0550655653525257,0.130838265363528,0.424386197141336
Physical measures,X4270.Volume level set by participant (left),STAT5B,Signal transducer and activator of transcription 5B,36770,0.0116835372333034,0.0146276520304834,-0.0169866607464441,0.0403537352130509,0.424472323755233
Physical measures,X4270.Volume level set by participant (left),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,35706,0.0257200344170171,0.0322040110359828,-0.0373998272135092,0.0888398960475435,0.42451710485192
Physical measures,X4270.Volume level set by participant (left),RBM25,RNA-binding protein 25,35678,0.0376166590374578,0.0471157697332886,-0.0547302496397879,0.129963567714704,0.424674694191256
Physical measures,X4270.Volume level set by participant (left),DPP10,Inactive dipeptidyl peptidase 10,36820,0.0416892957763743,0.0522702011233,-0.0607602984252936,0.144138889978042,0.42514322646856
Physical measures,X4270.Volume level set by participant (left),MDH1,"Malate dehydrogenase, cytoplasmic",35879,-0.0437996212667054,0.0549701881651538,-0.151541190070407,0.0639419475369959,0.425602105013211
Physical measures,X4270.Volume level set by participant (left),CCN1,CCN family member 1,36762,-0.0203515161048788,0.0255443407312824,-0.0704184239381923,0.0297153917284346,0.425642557703797
Physical measures,X4270.Volume level set by participant (left),REPS1,RalBP1-associated Eps domain-containing protein 1,35725,-0.0452148982871306,0.0567520628620177,-0.156448941496685,0.066019144922424,0.425648834537082
Physical measures,X4270.Volume level set by participant (left),MYH7B,Myosin-7B,35678,0.0424833676827532,0.0535047652645122,-0.0623859722356908,0.147352707601197,0.427218147309217
Physical measures,X4270.Volume level set by participant (left),ITGB7,Integrin beta-7,36888,0.0327137936486721,0.0412124746928245,-0.0480626567492639,0.113490244046608,0.427345810388435
Physical measures,X4270.Volume level set by participant (left),FLT3,Receptor-type tyrosine-protein kinase FLT3,36654,0.049442940215634,0.0623565635128326,-0.0727759242695178,0.171661804700786,0.427857379299712
Physical measures,X4270.Volume level set by participant (left),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,36894,-0.0217257126383692,0.0274194009930546,-0.0754677385847561,0.0320163133080177,0.42818210206199
Physical measures,X4270.Volume level set by participant (left),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35903,-0.0208306539993349,0.0263074078258661,-0.0723931733380326,0.0307318653393627,0.428495367302777
Physical measures,X4270.Volume level set by participant (left),VEGFC,Vascular endothelial growth factor C,36864,0.0269195995909431,0.0340009867333569,-0.0397223344064365,0.0935615335883226,0.428542647239077
Physical measures,X4270.Volume level set by participant (left),CRNN,Cornulin,36603,0.0221037869553205,0.0279244462262806,-0.0326281276481895,0.0768357015588304,0.428644460097959
Physical measures,X4270.Volume level set by participant (left),MFGE8,Lactadherin,36836,-0.0345920961759767,0.0437343422357441,-0.120311406958035,0.0511272146060818,0.428992145094656
Physical measures,X4270.Volume level set by participant (left),PLA2G2A,"Phospholipase A2, membrane associated",36817,-0.0264082743300784,0.0334542773762725,-0.0919786579875724,0.0391621093274157,0.429912112328416
Physical measures,X4270.Volume level set by participant (left),IGFBPL1,Insulin-like growth factor-binding protein-like 1,36828,-0.043359732232323,0.0549405433277488,-0.15104319715471,0.0643237326900646,0.43001266978857
Physical measures,X4270.Volume level set by participant (left),MUCL3,Mucin-like protein 3,35678,0.0401603076986514,0.0510516257088801,-0.0599008786907536,0.140221494088056,0.431509277896849
Physical measures,X4270.Volume level set by participant (left),CXCL17,C-X-C motif chemokine 17,36908,0.0345222329833807,0.0438914268601976,-0.0515049636626066,0.120549429629368,0.431577098539768
Physical measures,X4270.Volume level set by participant (left),VCAN,Versican core protein,36894,-0.0477117964526286,0.060733343182348,-0.166749149090031,0.0713255561847735,0.432129114029528
Physical measures,X4270.Volume level set by participant (left),NPTN,Neuroplastin,36654,0.0184333645416813,0.023470019893975,-0.0275678744505097,0.0644346035338722,0.432243760841935
Physical measures,X4270.Volume level set by participant (left),MELTF,Melanotransferrin,35916,-0.057614296292385,0.0734002124894555,-0.201478712771718,0.0862501201869479,0.432520149147024
Physical measures,X4270.Volume level set by participant (left),PKLR,Pyruvate kinase PKLR,36844,-0.0215975047595446,0.0275170649325431,-0.0755309520273291,0.03233594250824,0.432550143478233
Physical measures,X4270.Volume level set by participant (left),FXYD5,FXYD domain-containing ion transport regulator 5,36697,0.0233570244885976,0.0297693814039293,-0.0349909630631038,0.081705012040299,0.432713544301214
Physical measures,X4270.Volume level set by participant (left),CEBPB,CCAAT/enhancer-binding protein beta,36697,0.0366702499744718,0.0467421520800598,-0.0549443681024453,0.128284868051389,0.432758614055814
Physical measures,X4270.Volume level set by participant (left),RABEP1,Rab GTPase-binding effector protein 1,35779,-0.0235742673157065,0.0300547626766084,-0.082481602161859,0.035333067530446,0.432847104280266
Physical measures,X4270.Volume level set by participant (left),DAG1,Dystroglycan,36865,0.0319102639022976,0.0406892664236394,-0.0478406982880357,0.111661226092631,0.432921885512094
Physical measures,X4270.Volume level set by participant (left),NMI,N-myc-interactor,35842,-0.0244293988029819,0.0311565294144078,-0.0854961964552213,0.0366373988492575,0.433017592396044
Physical measures,X4270.Volume level set by participant (left),MYOC,Myocilin,36836,-0.0330980296657454,0.0422221321772255,-0.115853408733107,0.0496573494016166,0.433121701412213
Physical measures,X4270.Volume level set by participant (left),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,35706,0.0370955196857082,0.047353324002948,-0.0557169953600698,0.129908034731486,0.433434077449541
Physical measures,X4270.Volume level set by participant (left),MYO6,Unconventional myosin-VI,35903,-0.0485538947646918,0.0619806217073488,-0.170035913311095,0.0729281237817118,0.433436252734026
Physical measures,X4270.Volume level set by participant (left),PRSS53,Serine protease 53,35903,-0.0446490103172464,0.0570126390822728,-0.156393782918501,0.0670957622840083,0.433571198763427
Physical measures,X4270.Volume level set by participant (left),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,35680,0.0280416512506717,0.0358606738734682,-0.0422452695413261,0.0983285720426694,0.434266004598878
Physical measures,X4270.Volume level set by participant (left),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35894,0.0128536404450409,0.0164504144806141,-0.0193891719369627,0.0450964528270445,0.434620391157343
Physical measures,X4270.Volume level set by participant (left),TIMP3,Metalloproteinase inhibitor 3,36865,0.0112340581017033,0.0144012498100478,-0.0169923915259904,0.0394605077293969,0.43537067917726
Physical measures,X4270.Volume level set by participant (left),EFNA1,Ephrin-A1,36823,0.0500779454944408,0.0642200141749826,-0.0757932822885251,0.175949173277407,0.435540337397213
Physical measures,X4270.Volume level set by participant (left),SELE,E-selectin,36933,0.028469195668339,0.0365370388880299,-0.0431434005521996,0.100081791888878,0.435893241123605
Physical measures,X4270.Volume level set by participant (left),RAB37,Ras-related protein Rab-37,36697,-0.018884240323126,0.0242438234646028,-0.0664021343137474,0.0286336536674954,0.43604555243407
Physical measures,X4270.Volume level set by participant (left),SLITRK2,SLIT and NTRK-like protein 2,36888,0.0366284824414891,0.0470623016646829,-0.0556136288212894,0.128870593704268,0.436417457486284
Physical measures,X4270.Volume level set by participant (left),AHSG,Alpha-2-HS-glycoprotein,35926,-0.0591238751619579,0.0760947750366557,-0.208269634233803,0.0900218839098873,0.437199767480144
Physical measures,X4270.Volume level set by participant (left),PNLIPRP2,Pancreatic lipase-related protein 2,36822,0.00494214104189033,0.00637046946633145,-0.00754397911211932,0.0174282611959,0.43789755645062
Physical measures,X4270.Volume level set by participant (left),GIMAP8,GTPase IMAP family member 8,35678,0.0336322583815536,0.0434310525387824,-0.0514926045944599,0.118757121357567,0.438732723365024
Physical measures,X4270.Volume level set by participant (left),NBN,Nibrin,36697,-0.0270564079682942,0.0350355253571416,-0.0957260376682918,0.0416132217317033,0.439986928571645
Physical measures,X4270.Volume level set by participant (left),NXPH3,Neurexophilin-3,35725,-0.057822849025654,0.0749177166709006,-0.204661573700619,0.0890158756493111,0.44025011378407
Physical measures,X4270.Volume level set by participant (left),S100A12,Protein S100-A12,36699,0.0200590783350859,0.0260468210766814,-0.0309926909752096,0.0711108476453814,0.44125522862548
Physical measures,X4270.Volume level set by participant (left),TINAGL1,Tubulointerstitial nephritis antigen-like,36799,-0.0652894887243044,0.0848107901407477,-0.23151863740017,0.100939659951561,0.441427472438136
Physical measures,X4270.Volume level set by participant (left),OSTN,Osteocrin,35741,-0.0421224700290958,0.0547296396190181,-0.149392563682371,0.0651476236241796,0.441537453494502
Physical measures,X4270.Volume level set by participant (left),PPCDC,Phosphopantothenoylcysteine decarboxylase,36894,-0.0316615536757859,0.0411471727159259,-0.112310012199001,0.0489869048474289,0.441637401507124
Physical measures,X4270.Volume level set by participant (left),CPTP,Ceramide-1-phosphate transfer protein,35706,-0.0443919475473665,0.0577531534393354,-0.157588128288464,0.0688042331937309,0.44212914431295
Physical measures,X4270.Volume level set by participant (left),ERBIN,Erbin,36770,0.0146802016391533,0.0191074104749858,-0.0227703228918188,0.0521307261701254,0.442333609912613
Physical measures,X4270.Volume level set by participant (left),CNTN3,Contactin-3,36836,0.0465181197336111,0.0605888492302745,-0.0722360247577269,0.165272264224949,0.442649346810934
Physical measures,X4270.Volume level set by participant (left),NRGN,Neurogranin,35926,0.0189387370634347,0.0246695600530358,-0.0294136006405155,0.0672910747673848,0.442694401203202
Physical measures,X4270.Volume level set by participant (left),HPGDS,Hematopoietic prostaglandin D synthase,36654,0.038877239059937,0.0506527194495753,-0.0604020910612306,0.138156569181105,0.442793612230421
Physical measures,X4270.Volume level set by participant (left),HEXIM1,Protein HEXIM1,36820,0.0187096512104565,0.0243861536829746,-0.0290872100081738,0.0665065124290867,0.442971891607001
Physical measures,X4270.Volume level set by participant (left),BCAM,Basal cell adhesion molecule,36836,-0.0575648555948782,0.0751637758760194,-0.204885856311876,0.0897561451221199,0.443783855766598
Physical measures,X4270.Volume level set by participant (left),WFDC12,WAP four-disulfide core domain protein 12,36888,0.0219230126708395,0.028654375324333,-0.0342395629648532,0.0780855883065323,0.444244823854092
Physical measures,X4270.Volume level set by participant (left),TRAF2,TNF receptor-associated factor 2,36820,-0.0216150497835165,0.0283256958183994,-0.0771334135875793,0.0339033140205463,0.44543345154829
Physical measures,X4270.Volume level set by participant (left),SPESP1,Sperm equatorial segment protein 1,35916,0.0530531160294751,0.0695632001302598,-0.0832907562258342,0.189396988284784,0.445692571938956
Physical measures,X4270.Volume level set by participant (left),CCL25,C-C motif chemokine 25,36908,0.0293574852103777,0.0384991295340254,-0.046100808676312,0.104815779097067,0.445755541509821
Physical measures,X4270.Volume level set by participant (left),AP3B1,AP-3 complex subunit beta-1,35894,0.0221306633685595,0.0290421039802955,-0.0347918604328198,0.0790531871699387,0.446074917177856
Physical measures,X4270.Volume level set by participant (left),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,36863,0.014738295110075,0.0193425286845887,-0.0231730611117188,0.0526496513318689,0.446105407425053
Physical measures,X4270.Volume level set by participant (left),CCL2,C-C motif chemokine 2,36748,0.027951873903409,0.0366926156793882,-0.0439656528281919,0.0998694006350099,0.446212294175166
Physical measures,X4270.Volume level set by participant (left),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,35624,0.0339751796984961,0.0446615469368642,-0.0535614522977577,0.12151181169475,0.446848920462647
Physical measures,X4270.Volume level set by participant (left),EDF1,Endothelial differentiation-related factor 1,35903,0.0249176762768688,0.0327816783205864,-0.0393344132314806,0.0891697657852182,0.44721565265744
Physical measures,X4270.Volume level set by participant (left),CDKN1A,Cyclin-dependent kinase inhibitor 1,36770,0.0140503305208241,0.0184914007407151,-0.0221928149309775,0.0502934759726258,0.447379553438784
Physical measures,X4270.Volume level set by participant (left),CA7,Carbonic anhydrase 7,35798,0.0462180681215893,0.0608571448573174,-0.0730619357987528,0.165498072041931,0.447609457137706
Physical measures,X4270.Volume level set by participant (left),SPON1,Spondin-1,36837,0.0430824304616351,0.0567451935046185,-0.0681381488074171,0.154303009730687,0.447740754812469
Physical measures,X4270.Volume level set by participant (left),HGFAC,Hepatocyte growth factor activator,35849,0.0593400897360822,0.0781887742102612,-0.0939099077160298,0.212590087188194,0.447919154448528
Physical measures,X4270.Volume level set by participant (left),VPS28,Vacuolar protein sorting-associated protein 28 homolog,35798,-0.0259961454212359,0.0343291061498646,-0.0932811934749705,0.0412889026324987,0.448919630035493
Physical measures,X4270.Volume level set by participant (left),CHRM1,Muscarinic acetylcholine receptor M1,35741,0.0448443014707626,0.0592731878646348,-0.0713311467439216,0.161019749685447,0.44933490029684
Physical measures,X4270.Volume level set by participant (left),DLL1,Delta-like protein 1,36864,0.0458208344964264,0.0605712745258243,-0.0728988635741892,0.164540532567042,0.449385922139857
Physical measures,X4270.Volume level set by participant (left),ESR1,Estrogen receptor,35725,-0.0305162050736143,0.0403756642088476,-0.109652506922955,0.048620096775727,0.449792257754072
Physical measures,X4270.Volume level set by participant (left),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,35732,-0.0426140438316284,0.0563881642318679,-0.15313484572609,0.0679067580628326,0.449840283353065
Physical measures,X4270.Volume level set by participant (left),SPINK5,Serine protease inhibitor Kazal-type 5,36836,-0.0419582677587453,0.0555525659034853,-0.150841296929576,0.0669247614120859,0.450098604861861
Physical measures,X4270.Volume level set by participant (left),PON1,Serum paraoxonase/arylesterase 1,35926,-0.0610528338278807,0.0808764456215681,-0.219570667246154,0.0974649995903928,0.450341303143463
Physical measures,X4270.Volume level set by participant (left),MARCO,Macrophage receptor MARCO,36828,0.054513116796264,0.0723399437494989,-0.0872731729527538,0.196299406545282,0.451131498794544
Physical measures,X4270.Volume level set by participant (left),CTHRC1,Collagen triple helix repeat-containing protein 1,35931,-0.0565285356647311,0.0750216161825415,-0.203570903382512,0.0905138320530503,0.45117787320487
Physical measures,X4270.Volume level set by participant (left),LPL,Lipoprotein lipase,36828,-0.0302827385958812,0.0401960416068827,-0.109066980145371,0.0485015029536089,0.451247159969651
Physical measures,X4270.Volume level set by participant (left),DCTD,Deoxycytidylate deaminase,35779,0.0184290453544576,0.0244684078456916,-0.0295290340230979,0.0663871247320132,0.4513704147799
Physical measures,X4270.Volume level set by participant (left),SRPX,Sushi repeat-containing protein SRPX,35916,-0.0443600908034605,0.0589029423451297,-0.159809857799915,0.0710896761929936,0.451413303960421
Physical measures,X4270.Volume level set by participant (left),LRG1,Leucine-rich alpha-2-glycoprotein,35953,-0.0609079504378884,0.0808784620954612,-0.219429736144992,0.0976138352692155,0.451428095882862
Physical measures,X4270.Volume level set by participant (left),HBEGF,Proheparin-binding EGF-like growth factor,36873,-0.0192445053914242,0.0255758706417323,-0.0693732118492194,0.0308842010663711,0.451804935252615
Physical measures,X4270.Volume level set by participant (left),CEP164,Centrosomal protein of 164 kDa,36697,0.0216560057749154,0.0287838119110482,-0.0347602655707391,0.0780722771205699,0.451853672830975
Physical measures,X4270.Volume level set by participant (left),CFHR4,Complement factor H-related protein 4,35938,0.022338312219265,0.0297069442093252,-0.0358872984310123,0.0805639228695423,0.452103828156539
Physical measures,X4270.Volume level set by participant (left),SDC1,Syndecan-1,36828,0.0356612872200191,0.0474637390007834,-0.0573676412215163,0.128690215661555,0.452472733098041
Physical measures,X4270.Volume level set by participant (left),PRL,Prolactin,36894,0.0187187700858486,0.0249229741814583,-0.0301302593098097,0.0675677994815069,0.452636584480628
Physical measures,X4270.Volume level set by participant (left),SDHB,Succinate dehydrogenase,35894,0.0257619068452383,0.0343027487837659,-0.0414714807709429,0.0929952944614196,0.452669525618674
Physical measures,X4270.Volume level set by participant (left),PLAUR,Urokinase plasminogen activator surface receptor,36765,0.0500296521874018,0.0667569546434583,-0.0808139789137765,0.18087328328858,0.453621479936091
Physical measures,X4270.Volume level set by participant (left),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",35678,0.0297176614643096,0.039660961041295,-0.0480178221766286,0.107453145105248,0.453708109719349
Physical measures,X4270.Volume level set by participant (left),ERBB3,Receptor tyrosine-protein kinase erbB-3,36804,0.0722549650786901,0.0965779471601969,-0.117037811355296,0.261547741512676,0.454391728588795
Physical measures,X4270.Volume level set by participant (left),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",35706,-0.0391926296130924,0.052395489897227,-0.141887789811657,0.0635025305854726,0.454477935894584
Physical measures,X4270.Volume level set by participant (left),CPB1,Carboxypeptidase B,36933,0.0227629540905167,0.0304388102906967,-0.0368971140792488,0.0824230222602821,0.454587445626697
Physical measures,X4270.Volume level set by participant (left),SAP18,Histone deacetylase complex subunit SAP18,35798,-0.0233651981496576,0.0312468477113249,-0.0846090196638543,0.0378786233645391,0.454630502725546
Physical measures,X4270.Volume level set by participant (left),ADGRF5,Adhesion G protein-coupled receptor F5,35916,-0.0589905889598073,0.0789083467837135,-0.213650948655886,0.0956697707362711,0.454737499215469
Physical measures,X4270.Volume level set by participant (left),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35916,-0.0221700665065506,0.0296935835240482,-0.0803694902136851,0.0360293572005838,0.455314151090073
Physical measures,X4270.Volume level set by participant (left),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,36836,0.045175660517553,0.060550160663923,-0.0735026543837362,0.163853975418842,0.455638091343708
Physical measures,X4270.Volume level set by participant (left),SIGLEC6,Sialic acid-binding Ig-like lectin 6,36888,0.0418864883005789,0.0561818653668866,-0.0682299678185188,0.152002944419677,0.455961020205162
Physical measures,X4270.Volume level set by participant (left),SERPINB6,Serpin B6,36867,0.024392627801098,0.0327334112000186,-0.0397648581509385,0.0885501137531344,0.456179384930586
Physical measures,X4270.Volume level set by participant (left),CD200R1,Cell surface glycoprotein CD200 receptor 1,36793,0.0392653340307634,0.0527150864562305,-0.0640562354234484,0.142586903484975,0.456379692429254
Physical measures,X4270.Volume level set by participant (left),GRN,Progranulin,36796,0.0582365472617178,0.0781856086588918,-0.0950072457097101,0.211480340233146,0.456385465042102
Physical measures,X4270.Volume level set by participant (left),DYNLT3,Dynein light chain Tctex-type 3,35874,0.0360951922439869,0.0484913898650746,-0.0589479318915593,0.131138316379533,0.456683144668467
Physical measures,X4270.Volume level set by participant (left),B4GAT1,"Beta-1,4-glucuronyltransferase 1",36836,-0.057923431672852,0.0778291215897143,-0.210468509988692,0.0946216466429879,0.456755069341904
Physical measures,X4270.Volume level set by participant (left),GRAP2,GRB2-related adapter protein 2,36828,0.0113773864743944,0.0152916535157773,-0.0185942544165291,0.041349027365318,0.456883706853961
Physical measures,X4270.Volume level set by participant (left),PDCD5,Programmed cell death protein 5,36894,-0.0245970577769632,0.033064566630123,-0.0894036083720043,0.0402094928180779,0.45695370622665
Physical measures,X4270.Volume level set by participant (left),ARID4B,AT-rich interactive domain-containing protein 4B,36639,-0.0345151309435025,0.0464402362650001,-0.125537994022903,0.0565077321358977,0.457374322675372
Physical measures,X4270.Volume level set by participant (left),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,35779,0.0552923251322048,0.0744569281315885,-0.0906432540057087,0.201227904270118,0.457745425510546
Physical measures,X4270.Volume level set by participant (left),ADA,Adenosine deaminase,36908,0.0391345297199636,0.0527486734211581,-0.0642528701855063,0.142521929625434,0.458167203281732
Physical measures,X4270.Volume level set by participant (left),CREG1,Protein CREG1,36728,0.0364597911145016,0.0491934109436098,-0.0599592943349736,0.132878876563977,0.458624439130488
Physical measures,X4270.Volume level set by participant (left),FAM13A,Protein FAM13A,35894,0.0243844491105997,0.032905057367593,-0.0401094633298825,0.088878361551082,0.458686226291757
Physical measures,X4270.Volume level set by participant (left),STIP1,Stress-induced-phosphoprotein 1,36816,-0.0223025045910558,0.0301110436303752,-0.0813201501065912,0.0367151409244795,0.458913198067629
Physical measures,X4270.Volume level set by participant (left),CD1C,T-cell surface glycoprotein CD1c,36864,-0.0548549517602649,0.0741379641810545,-0.200165361555132,0.0904554580346019,0.459381102291538
Physical measures,X4270.Volume level set by participant (left),DOK2,Docking protein 2,36828,0.0117273776344052,0.0158584053808374,-0.0193550969120361,0.0428098521808466,0.459622862600535
Physical measures,X4270.Volume level set by participant (left),PAGR1,PAXIP1-associated glutamate-rich protein 1,35748,-0.0377783926725372,0.0510962515073506,-0.137927045626944,0.06237026028187,0.459716482191592
Physical measures,X4270.Volume level set by participant (left),TTN,Titin,35706,-0.0245437619159586,0.0332208271130412,-0.0896565830575193,0.0405690592256022,0.460051163327376
Physical measures,X4270.Volume level set by participant (left),KIAA1549L,UPF0606 protein KIAA1549L,35798,0.057426222539491,0.0778041257947001,-0.0950698640181211,0.209922309097103,0.460487752898937
Physical measures,X4270.Volume level set by participant (left),PLB1,"Phospholipase B1, membrane-associated",35903,0.0269885728430631,0.0365878332790788,-0.0447235803839314,0.0987007260700576,0.460760321538916
Physical measures,X4270.Volume level set by participant (left),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,36639,0.0303043481705045,0.0410883314080289,-0.0502287813892321,0.110837477730241,0.460816389758341
Physical measures,X4270.Volume level set by participant (left),EFNA4,Ephrin-A4,36748,0.0439749717310199,0.0596705568123251,-0.0729793196211372,0.160929263083177,0.46116795921192
Physical measures,X4270.Volume level set by participant (left),GRP,Gastrin-releasing peptide,35748,0.0299787103997052,0.0407565914822434,-0.0499042089054919,0.109861629704902,0.462027953484069
Physical measures,X4270.Volume level set by participant (left),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,36770,0.0156974052948834,0.0213422670220454,-0.0261334380683256,0.0575282486580925,0.46205302840903
Physical measures,X4270.Volume level set by participant (left),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,36697,0.0243637203630403,0.0331343980152575,-0.0405796997468644,0.0893071404729449,0.462179846080045
Physical measures,X4270.Volume level set by participant (left),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35874,-0.0290191461097386,0.0394954317030846,-0.106430192247784,0.0483919000283072,0.462519453205404
Physical measures,X4270.Volume level set by participant (left),KLK3,Prostate-specific antigen,35931,0.0160244144799658,0.0218340076648228,-0.0267702405430868,0.0588190695030184,0.463023060265453
Physical measures,X4270.Volume level set by participant (left),FOLH1,Glutamate carboxypeptidase 2,35725,-0.0159289815941422,0.0217563981926488,-0.0585715220517338,0.0267135588634494,0.464102330327888
Physical measures,X4270.Volume level set by participant (left),ARTN,Artemin,36697,0.0301525248576324,0.0412034601121553,-0.0506062569621921,0.110911306677457,0.464315991766985
Physical measures,X4270.Volume level set by participant (left),NEFL,Neurofilament light polypeptide,36624,-0.0311609653764284,0.0425877989974247,-0.114633051411381,0.052311120658524,0.464382338666718
Physical measures,X4270.Volume level set by participant (left),CELA3A,Chymotrypsin-like elastase family member 3A,36926,0.0229162063111643,0.0313648311077302,-0.0385588626599869,0.0843912752823154,0.465024996159726
Physical measures,X4270.Volume level set by participant (left),APOA2,Apolipoprotein A-II,35926,0.0321400361491224,0.0440050756892687,-0.0541099122018443,0.118389984500089,0.465188797001995
Physical measures,X4270.Volume level set by participant (left),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,36857,-0.0242009692073904,0.0331597491702017,-0.0891940775809856,0.0407921391662049,0.465516615773474
Physical measures,X4270.Volume level set by participant (left),DEFB104A_DEFB104B,Beta-defensin 104,35680,-0.0303964517044088,0.0416523330080782,-0.112035024400242,0.0512421209914245,0.465559666323367
Physical measures,X4270.Volume level set by participant (left),NPDC1,Neural proliferation differentiation and control protein 1,36828,0.0413301160565305,0.0567784891582391,-0.0699557226936181,0.152615954806679,0.466685775016731
Physical measures,X4270.Volume level set by participant (left),HSPB6,Heat shock protein beta-6,36888,-0.0350696869318316,0.0482011153208062,-0.129543872960612,0.0594044990969485,0.466898979380383
Physical measures,X4270.Volume level set by participant (left),CDH17,Cadherin-17,36828,0.0200678250729938,0.027600721646556,-0.0340295893542559,0.0741652395002435,0.467201642155013
Physical measures,X4270.Volume level set by participant (left),NRCAM,Neuronal cell adhesion molecule,36828,-0.0468589426646607,0.0645212688626203,-0.173320629635396,0.079602744306075,0.467704273901526
Physical measures,X4270.Volume level set by participant (left),PVALB,Parvalbumin alpha,36866,0.0124760644741902,0.0171846788229452,-0.0212059060187823,0.0461580349671628,0.467861366278901
Physical measures,X4270.Volume level set by participant (left),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35894,0.0159453407376072,0.0219846130938381,-0.0271445009263155,0.05903518240153,0.468296113639082
Physical measures,X4270.Volume level set by participant (left),CYTL1,Cytokine-like protein 1,35931,0.0612335673519383,0.0845711138987607,-0.104525815889633,0.226992950593509,0.469061263538839
Physical measures,X4270.Volume level set by participant (left),MASP1,Mannan-binding lectin serine protease 1,36748,-0.0583486844061891,0.0806443741455117,-0.216411657731392,0.0997142889190139,0.46937628233385
Physical measures,X4270.Volume level set by participant (left),BCL2L15,Bcl-2-like protein 15,35725,0.0268103157212792,0.0372199081307925,-0.0461407042150741,0.0997613356576325,0.471352601679582
Physical measures,X4270.Volume level set by participant (left),CD109,CD109 antigen,36836,-0.0398260179361989,0.0553395714749996,-0.148291578027198,0.0686395421548004,0.47175257131703
Physical measures,X4270.Volume level set by participant (left),FDX1,"Adrenodoxin, mitochondrial",35706,-0.0263113404707152,0.0365781197795831,-0.0980044552386981,0.0453817742972677,0.471970149613158
Physical measures,X4270.Volume level set by participant (left),CRADD,Death domain-containing protein CRADD,36748,-0.0194775038006973,0.0271307523203434,-0.0726537783485704,0.0336987707471759,0.472833504950862
Physical measures,X4270.Volume level set by participant (left),AMN,Protein amnionless,36697,0.0291800000216164,0.0406493276416107,-0.0504926821559406,0.108852682199173,0.472873956343064
Physical measures,X4270.Volume level set by participant (left),ARHGAP1,Rho GTPase-activating protein 1,36654,0.0315826596533639,0.0439997924998677,-0.0546569336463769,0.117822252953105,0.472908584460681
Physical measures,X4270.Volume level set by participant (left),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35903,-0.0393790063198684,0.0548694749645257,-0.146923177250339,0.068165164610602,0.472976452588368
Physical measures,X4270.Volume level set by participant (left),PEBP1,Phosphatidylethanolamine-binding protein 1,36836,-0.0240549359353763,0.033543959179773,-0.0898010959277314,0.0416912240569788,0.473323969542301
Physical measures,X4270.Volume level set by participant (left),HEG1,Protein HEG homolog 1,35779,0.0599200537853149,0.083566147292272,-0.103869594907538,0.223709702478168,0.473376457375951
Physical measures,X4270.Volume level set by participant (left),PHLDB1,Pleckstrin homology-like domain family B member 1,35894,0.0287909242432953,0.0402023412134365,-0.0500056645350403,0.107587513021631,0.473923433216347
Physical measures,X4270.Volume level set by participant (left),CCN3,CCN family member 3,36911,-0.0382572705317299,0.0535156397787075,-0.143147924497997,0.0666333834345367,0.474704714811727
Physical measures,X4270.Volume level set by participant (left),MORF4L2,Mortality factor 4-like protein 2,35678,0.0416549177083919,0.0582830837506871,-0.0725799264429548,0.155889761859739,0.474820203271007
Physical measures,X4270.Volume level set by participant (left),ARSA,Arylsulfatase A,36836,0.0301359341520915,0.0421992642919436,-0.0525746238601179,0.112846492164301,0.47516607347103
Physical measures,X4270.Volume level set by participant (left),COL9A2,Collagen alpha-2(IX) chain,35798,-0.0344812730538603,0.0482923956176544,-0.129134368464463,0.0601718223567423,0.475245989499707
Physical measures,X4270.Volume level set by participant (left),THRAP3,Thyroid hormone receptor-associated protein 3,35706,0.0144724301394709,0.0202718805365288,-0.0252604557121255,0.0542053159910673,0.475304407780742
Physical measures,X4270.Volume level set by participant (left),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,36654,0.0230199838564588,0.032253917144404,-0.040197693746573,0.0862376614594907,0.475428078561552
Physical measures,X4270.Volume level set by participant (left),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,35741,0.0312775687589012,0.0438294750235302,-0.0546282022872179,0.11718333980502,0.475487935211889
Physical measures,X4270.Volume level set by participant (left),DHODH,Dihydroorotate dehydrogenase,35706,-0.0327308200671963,0.0458812591512328,-0.122658088003612,0.05719644786922,0.475635582156022
Physical measures,X4270.Volume level set by participant (left),CCL15,C-C motif chemokine 15,36933,0.0294929165824884,0.0413842992404146,-0.0516203099287242,0.110606143093701,0.476077938987044
Physical measures,X4270.Volume level set by participant (left),COPB2,Coatomer subunit beta',35706,0.0368527592570102,0.0517614180695385,-0.0645996201592853,0.138305138673306,0.476506687846593
Physical measures,X4270.Volume level set by participant (left),EFNB2,Ephrin-B2,35741,-0.0296925066319507,0.0417062202914624,-0.111436698403217,0.0520516851393155,0.476524635474325
Physical measures,X4270.Volume level set by participant (left),FCRL6,Fc receptor-like protein 6,36820,-0.0189219678318451,0.0266021182516719,-0.071062119605122,0.0332181839414318,0.476922884200781
Physical measures,X4270.Volume level set by participant (left),NUCB2,Nucleobindin-2,36873,0.0365311028639635,0.0513665487651915,-0.0641473327158118,0.137209538443739,0.476991406707649
Physical measures,X4270.Volume level set by participant (left),SLMAP,Sarcolemmal membrane-associated protein,35894,0.0183829324906584,0.0258577560851439,-0.0322982694362237,0.0690641344175406,0.477155297539598
Physical measures,X4270.Volume level set by participant (left),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,36697,-0.0265776010715532,0.0374658667768926,-0.100010699954263,0.0468554978111563,0.478109679011955
Physical measures,X4270.Volume level set by participant (left),CYB5R2,NADH-cytochrome b5 reductase 2,35829,0.0279020169111903,0.0393409074453589,-0.0492061616817132,0.105010195504094,0.478202509721827
Physical measures,X4270.Volume level set by participant (left),PTX3,Pentraxin-related protein PTX3,36820,-0.027716333638024,0.0391052843480765,-0.104362690960254,0.048930023684206,0.478493950066513
Physical measures,X4270.Volume level set by participant (left),MANF,Mesencephalic astrocyte-derived neurotrophic factor,36865,0.0116901463182761,0.0164971538441098,-0.0206442752161791,0.0440245678527313,0.478584377773736
Physical measures,X4270.Volume level set by participant (left),ANGPTL2,Angiopoietin-related protein 2,36837,-0.0328199629155843,0.0463633514780909,-0.123692131812643,0.058052205981474,0.479037708959273
Physical measures,X4270.Volume level set by participant (left),SPINT2,Kunitz-type protease inhibitor 2,36865,0.0322967506275078,0.0456284578042939,-0.0571350266689083,0.121728527923924,0.479078345012551
Physical measures,X4270.Volume level set by participant (left),SF3B4,Splicing factor 3B subunit 4,36770,-0.0183525891301158,0.0259353502327843,-0.069185875586373,0.0324806973261414,0.479197857734222
Physical measures,X4270.Volume level set by participant (left),F7,Coagulation factor VII,36858,-0.0432432341941327,0.0611872786850737,-0.163170300416877,0.0766838320286119,0.479752234282598
Physical measures,X4270.Volume level set by participant (left),CD101,Immunoglobulin superfamily member 2,35894,-0.0355229917671938,0.0502827672681717,-0.13407721561281,0.0630312320784227,0.479923877560907
Physical measures,X4270.Volume level set by participant (left),NUP50,Nuclear pore complex protein Nup50,35706,-0.0505463558525672,0.0716199511927498,-0.190921460190357,0.0898287484852224,0.480363882150582
Physical measures,X4270.Volume level set by participant (left),MFAP3,Microfibril-associated glycoprotein 3,36697,0.0279849496846107,0.0396803473403774,-0.0497885311025289,0.10575843047175,0.480670539770154
Physical measures,X4270.Volume level set by participant (left),ATRN,"Attractin, Isoform 2",35953,-0.0922201785745912,0.130772558202315,-0.348534392651129,0.164094035501947,0.480713087751691
Physical measures,X4270.Volume level set by participant (left),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,36654,0.0159280395236132,0.022612810503746,-0.028393069063729,0.0602491481109554,0.481217381461259
Physical measures,X4270.Volume level set by participant (left),SCPEP1,Retinoid-inducible serine carboxypeptidase,35722,0.0317603598415267,0.0451238762827349,-0.0566824376726337,0.120203157355687,0.48155241877201
Physical measures,X4270.Volume level set by participant (left),AMIGO1,Amphoterin-induced protein 1,35741,0.0325904809509895,0.0463098184044271,-0.0581767631216877,0.123357725023667,0.481614238288676
Physical measures,X4270.Volume level set by participant (left),UPK3BL1,Uroplakin-3b-like protein 1,35780,-0.0275278856509267,0.0391219389568738,-0.104206886006399,0.049151114704546,0.481679897880031
Physical measures,X4270.Volume level set by participant (left),GCLM,Glutamate--cysteine ligase regulatory subunit,35706,-0.0342518854357684,0.0486892381751479,-0.129682792259058,0.0611790213875215,0.481782082408544
Physical measures,X4270.Volume level set by participant (left),PTK7,Inactive tyrosine-protein kinase 7,36639,0.0360883644471588,0.0513511136538745,-0.0645598183144352,0.136736547208753,0.482216923129504
Physical measures,X4270.Volume level set by participant (left),PPIB,Peptidyl-prolyl cis-trans isomerase B,36841,0.0144754953870539,0.0206025505468599,-0.0259055036847916,0.0548564944588993,0.482322119660702
Physical measures,X4270.Volume level set by participant (left),ADIPOQ,Adiponectin,35953,-0.0212077511998341,0.0301853934390685,-0.0803711223404083,0.03795561994074,0.482339723214897
Physical measures,X4270.Volume level set by participant (left),PTPRF,Receptor-type tyrosine-protein phosphatase F,36933,-0.0450364507699694,0.0641116952602067,-0.170695373479975,0.0806224719400357,0.482408132869159
Physical measures,X4270.Volume level set by participant (left),EDAR,Tumor necrosis factor receptor superfamily member EDAR,36820,-0.0146298806950538,0.0208389565463084,-0.0554742355258182,0.0262144741357106,0.482672670739567
Physical measures,X4270.Volume level set by participant (left),DDR1,Epithelial discoidin domain-containing receptor 1,36894,-0.056250010087855,0.0801595777198462,-0.213362782418754,0.100862762243044,0.482871659128262
Physical measures,X4270.Volume level set by participant (left),SLITRK6,SLIT and NTRK-like protein 6,36697,-0.0384271826063486,0.0547742831588434,-0.145784777597682,0.0689304123849845,0.482978373004516
Physical measures,X4270.Volume level set by participant (left),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35931,-0.0572889953785881,0.0816724228258384,-0.217366944117231,0.102788953360055,0.483047426861278
Physical measures,X4270.Volume level set by participant (left),RAC3,Ras-related C3 botulinum toxin substrate 3,35741,-0.0220452122802595,0.0314360301353023,-0.0836598313454519,0.039569406784933,0.483158129807285
Physical measures,X4270.Volume level set by participant (left),CNTN2,Contactin-2,36888,-0.0292757421846013,0.0417625868920146,-0.11113041249295,0.0525789281237473,0.483321700981317
Physical measures,X4270.Volume level set by participant (left),CDC42BPB,Serine/threonine-protein kinase MRCK beta,35894,0.0146517014404479,0.0209033316605298,-0.0263188286141905,0.0556222314950864,0.483373168000666
Physical measures,X4270.Volume level set by participant (left),HDAC9,Histone deacetylase 9,35680,-0.0247119187681696,0.035267616144185,-0.0938364464107722,0.044412608874433,0.483517170101451
Physical measures,X4270.Volume level set by participant (left),UMOD,Uromodulin,36912,-0.0239310142208869,0.0341606050757068,-0.0908858001692723,0.0430237717274985,0.483608629111981
Physical measures,X4270.Volume level set by participant (left),DAPK2,Death-associated protein kinase 2,35725,-0.0282388633953857,0.0403237527030778,-0.107273418693418,0.0507956919026469,0.483762770450427
Physical measures,X4270.Volume level set by participant (left),SAMD9L,Sterile alpha motif domain-containing protein 9-like,36820,0.0187529555278092,0.0267880164366335,-0.0337515566879925,0.0712574677436109,0.483917334847064
Physical measures,X4270.Volume level set by participant (left),C1GALT1C1,C1GALT1-specific chaperone 1,35706,0.0483273222951709,0.0692210654231944,-0.0873459659342902,0.184000610524632,0.485102591369028
Physical measures,X4270.Volume level set by participant (left),SMOC2,SPARC-related modular calcium-binding protein 2,36865,-0.033806208567237,0.048436156911173,-0.128741076113136,0.061128658978662,0.485227136982669
Physical measures,X4270.Volume level set by participant (left),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35894,-0.0251424507786937,0.0360264359089443,-0.0957542651602244,0.045469363602837,0.485270887523445
Physical measures,X4270.Volume level set by participant (left),CDH22,Cadherin-22,35798,0.0552908240328959,0.0792396318840423,-0.100018854459827,0.210600502525619,0.485347308332433
Physical measures,X4270.Volume level set by participant (left),CD48,CD48 antigen,36853,0.0424596073485339,0.0608517642043971,-0.0768098504920843,0.161729065189152,0.485351773243102
Physical measures,X4270.Volume level set by participant (left),APRT,Adenine phosphoribosyltransferase,36745,-0.0303539791960651,0.0435137048726519,-0.115640840746463,0.0549328823543326,0.48546585065205
Physical measures,X4270.Volume level set by participant (left),RNF4,E3 ubiquitin-protein ligase RNF4,35798,0.0223148921272429,0.0320493249222793,-0.0405017847204245,0.0851315689749104,0.486286056257934
Physical measures,X4270.Volume level set by participant (left),MTR,Methionine synthase,35706,0.0235574396426549,0.0338646235242399,-0.0428172224648552,0.089932101750165,0.486681864679557
Physical measures,X4270.Volume level set by participant (left),DNAJB1,DnaJ homolog subfamily B member 1,36770,-0.0161183607213385,0.023171353637448,-0.0615342138507366,0.0292974924080596,0.486690786011735
Physical measures,X4270.Volume level set by participant (left),TCL1B,T-cell leukemia/lymphoma protein 1B,36697,0.0165268037914702,0.0237656956685219,-0.0300539597188327,0.0631075673017731,0.486822540760179
Physical measures,X4270.Volume level set by participant (left),SBSN,Suprabasin,35918,0.0431852378816714,0.0621270992460724,-0.0785838766406304,0.164954352403973,0.487009693434039
Physical measures,X4270.Volume level set by participant (left),RASA1,Ras GTPase-activating protein 1,36639,0.0418075490193879,0.0601867136485581,-0.0761584097317859,0.159773507770562,0.487308348532901
Physical measures,X4270.Volume level set by participant (left),HIP1,Huntingtin-interacting protein 1,35706,-0.0456317477741235,0.0657883385492813,-0.174576891330715,0.0833133957824679,0.487948727370596
Physical measures,X4270.Volume level set by participant (left),TLR3,Toll-like receptor 3,36908,0.02114741841429,0.0305034935407898,-0.0386394289256581,0.0809342657542381,0.488155629048132
Physical measures,X4270.Volume level set by participant (left),NRTN,Neurturin,36697,-0.0262232974166008,0.0378337591914414,-0.100377465431826,0.0479308705986244,0.488256336016452
Physical measures,X4270.Volume level set by participant (left),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35894,-0.0686826369201158,0.0991097192974471,-0.262937686743112,0.12557241290288,0.488336105917749
Physical measures,X4270.Volume level set by participant (left),CNST,Consortin,36828,0.012790486597525,0.0184793627877415,-0.0234290644664483,0.0490100376614983,0.488864342175016
Physical measures,X4270.Volume level set by participant (left),COL4A1,Collagen alpha-1(IV) chain,36828,-0.0323641159000821,0.0468073409708873,-0.124106504203021,0.059378272402857,0.489314831907745
Physical measures,X4270.Volume level set by participant (left),MPRIP,Myosin phosphatase Rho-interacting protein,35861,0.034541311706183,0.0499624515088976,-0.0633850932512563,0.132467716663622,0.489372581477154
Physical measures,X4270.Volume level set by participant (left),SERPINI1,Neuroserpin,35762,-0.0501136360321219,0.0725167965454842,-0.192246557261271,0.0920192851970272,0.489550722325668
Physical measures,X4270.Volume level set by participant (left),IST1,IST1 homolog,35825,0.0165620807326853,0.0239792066393869,-0.0304371642805129,0.0635613257458836,0.489787641359011
Physical measures,X4270.Volume level set by participant (left),DLG4,Disks large homolog 4,35903,0.0211774029701128,0.0306745003319959,-0.0389446176805991,0.0812994236208247,0.489972145883374
Physical measures,X4270.Volume level set by participant (left),KRT5,"Keratin, type II cytoskeletal 5",36639,-0.0263328822584308,0.0381441224107737,-0.101095362183547,0.0484295976666856,0.489994200777401
Physical measures,X4270.Volume level set by participant (left),MIA,Melanoma-derived growth regulatory protein,36864,-0.0344735255472201,0.049957983984855,-0.132391174157536,0.0634441230630956,0.490183395689045
Physical measures,X4270.Volume level set by participant (left),CD200,OX-2 membrane glycoprotein,36820,0.0476776837423656,0.0691093986729395,-0.0877767376565958,0.183132105141327,0.49028617976105
Physical measures,X4270.Volume level set by participant (left),LGALS3BP,Galectin-3-binding protein,35953,-0.0487796646084363,0.070714981477112,-0.187381028303576,0.0898216990867031,0.490339477858914
Physical measures,X4270.Volume level set by participant (left),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35903,0.0361075507164801,0.0524497804183467,-0.0666940189034794,0.13890912033644,0.491211271464227
Physical measures,X4270.Volume level set by participant (left),MOCS2,Molybdopterin synthase catalytic subunit,35779,0.0232989277606559,0.0338887856040088,-0.0431230920232013,0.0897209475445132,0.491784719335701
Physical measures,X4270.Volume level set by participant (left),SPTLC1,Serine palmitoyltransferase 1,35903,-0.0380448624225314,0.0554643107494187,-0.146754911491392,0.0706651866463294,0.492778374593583
Physical measures,X4270.Volume level set by participant (left),MAGED1,Melanoma-associated antigen D1,36654,0.0270574201974138,0.0395049588227781,-0.0503722990952311,0.104487139490059,0.493420743381903
Physical measures,X4270.Volume level set by participant (left),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,36828,0.0257378157071855,0.0375970462552223,-0.0479523949530503,0.0994280263674212,0.493635996846194
Physical measures,X4270.Volume level set by participant (left),NECTIN1,Nectin-1,35725,0.0474080662680297,0.0694215242445188,-0.0886581212512271,0.183474253787287,0.494693290205699
Physical measures,X4270.Volume level set by participant (left),TPD52L2,Tumor protein D54,35779,0.0146930984787853,0.0215335578791812,-0.0275126749644099,0.0568988719219806,0.495051208919792
Physical measures,X4270.Volume level set by participant (left),FLI1,Friend leukemia integration 1 transcription factor,36654,0.0122746918632384,0.0180015964819005,-0.0230084372412866,0.0475578209677633,0.495344326490249
Physical measures,X4270.Volume level set by participant (left),CCAR2,Cell cycle and apoptosis regulator protein 2,35903,0.0255065339070105,0.0374727582048682,-0.0479400721745312,0.0989531399885523,0.496104640987277
Physical measures,X4270.Volume level set by participant (left),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35953,0.0554548753149888,0.0815904566872136,-0.10446241979195,0.215372170421927,0.496734473884728
Physical measures,X4270.Volume level set by participant (left),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",36697,0.0186120078262429,0.0274118130816866,-0.0351151458138628,0.0723391614663485,0.49717298853839
Physical measures,X4270.Volume level set by participant (left),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",35748,0.020759766228632,0.0306103937761771,-0.0392366055726751,0.0807561380299392,0.49767304712038
Physical measures,X4270.Volume level set by participant (left),MORF4L1,Mortality factor 4-like protein 1,35798,-0.0373036900798127,0.0550159732155658,-0.145134997582322,0.0705276174226963,0.497762496774055
Physical measures,X4270.Volume level set by participant (left),BTNL10,Butyrophilin-like protein 10,35678,0.0356366247847728,0.0525664422151064,-0.0673936019568357,0.138666851526381,0.497837183860541
Physical measures,X4270.Volume level set by participant (left),TRIM26,Tripartite motif-containing protein 26,35678,0.0270770431925407,0.0400210572669162,-0.051364229050615,0.105518315435696,0.498703019313925
Physical measures,X4270.Volume level set by participant (left),CXADR,Coxsackievirus and adenovirus receptor,36820,0.0245985596727869,0.0363893480879335,-0.0467245625795629,0.0959216819251366,0.49907231201257
Physical measures,X4270.Volume level set by participant (left),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35903,0.0158590790048554,0.0234685746233173,-0.0301393272568465,0.0618574852665574,0.499217553695069
Physical measures,X4270.Volume level set by participant (left),BAG3,BAG family molecular chaperone regulator 3,36748,0.0316102056425673,0.0467949004694925,-0.060107799277638,0.123328210562773,0.499375438436826
Physical measures,X4270.Volume level set by participant (left),CLEC2L,C-type lectin domain family 2 member L,35741,0.0289343816474261,0.0428659398340249,-0.0550828604272628,0.112951623722115,0.499701505467681
Physical measures,X4270.Volume level set by participant (left),BCHE,Cholinesterase,35772,-0.0522747608802388,0.0774590935487489,-0.204094584235787,0.099545062475309,0.499782563918586
Physical measures,X4270.Volume level set by participant (left),PTPRS,Receptor-type tyrosine-protein phosphatase S,36933,-0.0507504293520144,0.0753069354380653,-0.198352022810622,0.0968511641065936,0.500385861893799
Physical measures,X4270.Volume level set by participant (left),LECT2,Leukocyte cell-derived chemotaxin-2,35916,-0.0215084679069431,0.0319167369879976,-0.0840652724034184,0.0410483365895322,0.500402479276318
Physical measures,X4270.Volume level set by participant (left),MTPN,Myotrophin,36697,-0.0398582295702914,0.0591978369658734,-0.155885990023403,0.0761695308828204,0.50077369720075
Physical measures,X4270.Volume level set by participant (left),BEX3,Protein BEX3,35678,-0.0328199992125569,0.0487933966446586,-0.128455056636088,0.062815058210974,0.501205428551885
Physical measures,X4270.Volume level set by participant (left),CD6,T-cell differentiation antigen CD6,36891,0.0242307679447546,0.036032188576676,-0.0463923216655304,0.0948538575550396,0.501301157307325
Physical measures,X4270.Volume level set by participant (left),DTX3,Probable E3 ubiquitin-protein ligase DTX3,36770,-0.0522330743259212,0.0776974592744607,-0.204520094503864,0.100053945852022,0.501437221580441
Physical measures,X4270.Volume level set by participant (left),FGFBP2,Fibroblast growth factor-binding protein 2,35931,-0.0287312932865706,0.04273878584138,-0.112499313535675,0.0550367269625342,0.501445466908654
Physical measures,X4270.Volume level set by participant (left),MSRA,Mitochondrial peptide methionine sulfoxide reductase,36864,0.0182512644381549,0.0271523093117979,-0.034967261812969,0.0714697906892789,0.501488776815104
Physical measures,X4270.Volume level set by participant (left),APOF,Apolipoprotein F,35926,-0.0575961079027225,0.0858883821431737,-0.225937336903343,0.110745121097898,0.50250315397774
Physical measures,X4270.Volume level set by participant (left),CD164L2,CD164 sialomucin-like 2 protein,35741,0.0422684603931982,0.0630561555876099,-0.0813216045585173,0.165858525344914,0.50267082214466
Physical measures,X4270.Volume level set by participant (left),PDCD1,Programmed cell death protein 1,36874,0.0286395544583749,0.0427383714884981,-0.0551276536590813,0.112406762575831,0.502805673622523
Physical measures,X4270.Volume level set by participant (left),CASP3,Caspase-3,36933,0.0151300326327791,0.022580673858266,-0.0291280881294223,0.0593881533949804,0.502850091479588
Physical measures,X4270.Volume level set by participant (left),IL6ST,Interleukin-6 receptor subunit beta,36828,-0.073124000329323,0.109180338845659,-0.287117464466814,0.140869463808168,0.503034701439744
Physical measures,X4270.Volume level set by participant (left),HGF,Hepatocyte growth factor,36908,0.0360180583269221,0.0537869032107189,-0.069404271966087,0.141440388619931,0.503105030081017
Physical measures,X4270.Volume level set by participant (left),CCDC50,Coiled-coil domain-containing protein 50,35903,-0.0184565729643857,0.0275653661470525,-0.0724846906126086,0.0355715446838373,0.503163537024084
Physical measures,X4270.Volume level set by participant (left),EGFLAM,Pikachurin,35894,0.0479830974724657,0.0717564456013231,-0.0926595359061276,0.188625730851059,0.503713807305941
Physical measures,X4270.Volume level set by participant (left),MTIF3,"Translation initiation factor IF-3, mitochondrial",35894,0.017132663222226,0.0256414742031686,-0.0331246262159845,0.0673899526604365,0.504053102536835
Physical measures,X4270.Volume level set by participant (left),GGT5,Glutathione hydrolase 5 proenzyme,36763,0.0547621213049917,0.0819982839041864,-0.105954515147214,0.215478757757197,0.504253084895994
Physical measures,X4270.Volume level set by participant (left),ARHGAP30,Rho GTPase-activating protein 30,35798,-0.0366475309657784,0.0549642374838735,-0.14437743643417,0.0710823745026136,0.504953678708673
Physical measures,X4270.Volume level set by participant (left),AXIN1,Axin-1,36820,0.0138615754208039,0.02083579919312,-0.0269765909977114,0.0546997418393191,0.505893544382899
Physical measures,X4270.Volume level set by participant (left),CTLA4,Cytotoxic T-lymphocyte protein 4,35931,0.0502511536867369,0.0755764278345163,-0.097878644868915,0.198380952242389,0.506133951147239
Physical measures,X4270.Volume level set by participant (left),STOML2,"Stomatin-like protein 2, mitochondrial",35678,-0.0163064092206416,0.0245366148521164,-0.0643981743307897,0.0317853558895064,0.506346310440509
Physical measures,X4270.Volume level set by participant (left),YTHDF3,YTH domain-containing family protein 3,36697,0.0153125562566288,0.0230423837506626,-0.0298505158946698,0.0604756284079275,0.506366004667329
Physical measures,X4270.Volume level set by participant (left),TACC3,Transforming acidic coiled-coil-containing protein 3,36770,0.0111457103699675,0.0168168047749109,-0.0218152269888577,0.0441066477287928,0.507496644039499
Physical measures,X4270.Volume level set by participant (left),PDGFB,Platelet-derived growth factor subunit B,36865,0.0144927706892853,0.0218696619033036,-0.0283717666411897,0.0573573080197603,0.507550075048806
Physical measures,X4270.Volume level set by participant (left),HDGF,Hepatoma-derived growth factor,36866,0.0136312312095961,0.0205709612836552,-0.0266878529063681,0.0539503153255603,0.50757827446282
Physical measures,X4270.Volume level set by participant (left),SEMA4D,Semaphorin-4D,36894,0.0411647203237898,0.0622065581646591,-0.0807601336789421,0.163089574326522,0.508156102820456
Physical measures,X4270.Volume level set by participant (left),GABARAP,Gamma-aminobutyric acid receptor-associated protein,35874,-0.0296433424935274,0.044799630122965,-0.117450617534539,0.0581639325474839,0.508194533524807
Physical measures,X4270.Volume level set by participant (left),KIAA1549,UPF0606 protein KIAA1549,35798,-0.0211368962595656,0.0319559919434456,-0.083770640468719,0.0414968479495877,0.508354772856434
Physical measures,X4270.Volume level set by participant (left),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",36810,0.0181433642186558,0.0274323596146918,-0.0356240606261402,0.0719107890634517,0.508385153472107
Physical measures,X4270.Volume level set by participant (left),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",36805,0.0183878072742857,0.0278095178153811,-0.0361188476438613,0.0728944621924327,0.50850053059738
Physical measures,X4270.Volume level set by participant (left),SPRY2,Protein sprouty homolog 2,36697,0.0138240262518894,0.0209222254388549,-0.0271835356082661,0.0548315881120449,0.508803192294138
Physical measures,X4270.Volume level set by participant (left),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,36763,0.0207524495011163,0.0314214463209437,-0.0408335852879334,0.0823384842901659,0.508982031215922
Physical measures,X4270.Volume level set by participant (left),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",35680,0.0463496846343352,0.0703382681434102,-0.0915133209267487,0.184212690195419,0.509948697552122
Physical measures,X4270.Volume level set by participant (left),GART,Trifunctional purine biosynthetic protein adenosine-3,35903,-0.0510351217618255,0.0775039110651432,-0.202942787449506,0.100872543925855,0.510249479279351
Physical measures,X4270.Volume level set by participant (left),LGALS9,Galectin-9,36829,0.038760925470707,0.0589744604271451,-0.0768290169664975,0.154350867907911,0.511040421396991
Physical measures,X4270.Volume level set by participant (left),ARF6,ADP-ribosylation factor 6,35894,0.0139447199635065,0.0212836064274755,-0.0277711486343455,0.0556605885613584,0.512370540737716
Physical measures,X4270.Volume level set by participant (left),NT5E,5'-nucleotidase,36864,0.0211608191869336,0.0322976682245797,-0.0421426105332426,0.0844642489071097,0.51237086981719
Physical measures,X4270.Volume level set by participant (left),FKBPL,FK506-binding protein-like,35894,-0.0253575459745296,0.0387100991624169,-0.101229340332867,0.0505142483838074,0.512449819855006
Physical measures,X4270.Volume level set by participant (left),PRTN3,Myeloblastin,36657,0.0242226683913108,0.0369857053757546,-0.0482693141451682,0.0967146509277897,0.512539625210166
Physical measures,X4270.Volume level set by participant (left),A1BG,Alpha-1B-glycoprotein,35953,-0.0827427945902246,0.126362441223258,-0.330413179387809,0.16492759020736,0.512615418123962
Physical measures,X4270.Volume level set by participant (left),GAGE2A,G antigen 2A,35678,0.0230852338140994,0.0353051346642984,-0.0461128301279255,0.0922832977561244,0.513213918736793
Physical measures,X4270.Volume level set by participant (left),LPCAT2,Lysophosphatidylcholine acyltransferase 2,36770,0.0306206226757446,0.0468802159415127,-0.0612646005696204,0.122505845921109,0.513668276808126
Physical measures,X4270.Volume level set by participant (left),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,36852,0.0557506135361917,0.0854133625790289,-0.111659577118705,0.223160804191088,0.513959400011448
Physical measures,X4270.Volume level set by participant (left),PTPRM,Receptor-type tyrosine-protein phosphatase mu,36813,0.0493548921230479,0.0756332450192637,-0.0988862681147089,0.197596052360805,0.514062559154556
Physical measures,X4270.Volume level set by participant (left),EPHA1,Ephrin type-A receptor 1,36856,0.0366132898366495,0.0561736562918759,-0.0734870764954273,0.146713656168726,0.514557791587997
Physical measures,X4270.Volume level set by participant (left),NPR1,Atrial natriuretic peptide receptor 1,35706,0.0359020895464634,0.0551845388002086,-0.0722596065019456,0.144063785594872,0.515339059463536
Physical measures,X4270.Volume level set by participant (left),LARP1,La-related protein 1,35874,-0.0229264798327469,0.0352638259097448,-0.0920435786158468,0.0461906189503529,0.515623134325308
Physical measures,X4270.Volume level set by participant (left),SNU13,NHP2-like protein 1,35706,-0.0232618590302862,0.0358120544324698,-0.0934534857179271,0.0469297676573546,0.516003350598348
Physical measures,X4270.Volume level set by participant (left),MORC3,MORC family CW-type zinc finger protein 3,35903,-0.052293199958799,0.0805898674658023,-0.210249340191771,0.105662940274174,0.51643778814856
Physical measures,X4270.Volume level set by participant (left),VAMP8,Vesicle-associated membrane protein 8,35725,0.0169278159541524,0.0260899202325258,-0.0342084277015983,0.068064059609903,0.516473738992995
Physical measures,X4270.Volume level set by participant (left),WASF3,Wiskott-Aldrich syndrome protein family member 3,36639,0.0145900326333468,0.022537607825175,-0.0295836787039962,0.0587637439706899,0.517416452681756
Physical measures,X4270.Volume level set by participant (left),ITGA6,Integrin alpha-6,36820,0.0228784015121309,0.035343455796314,-0.0463947718486444,0.0921515748729063,0.517446627814339
Physical measures,X4270.Volume level set by participant (left),UHRF2,E3 ubiquitin-protein ligase UHRF2,35706,-0.0385953538130305,0.0596877564822362,-0.155583356518213,0.0783926488921525,0.517900094939886
Physical measures,X4270.Volume level set by participant (left),GFRA2,GDNF family receptor alpha-2,36770,-0.0588646912531962,0.0912261856911151,-0.237668015207782,0.119938632701389,0.518777670292967
Physical measures,X4270.Volume level set by participant (left),GPHA2,Glycoprotein hormone alpha-2,35894,0.0308246020213032,0.0478876149766488,-0.0630351233329284,0.124684327375535,0.51980091278068
Physical measures,X4270.Volume level set by participant (left),CACYBP,Calcyclin-binding protein,35762,0.0145892011770318,0.022667100789561,-0.0298383163705077,0.0590167187245713,0.519838586749075
Physical measures,X4270.Volume level set by participant (left),VWC2L,von Willebrand factor C domain-containing protein 2-like,35903,0.0326090920192519,0.0506883973023559,-0.0667401666933656,0.131958350731869,0.520035506210797
Physical measures,X4270.Volume level set by participant (left),ASPSCR1,Tether containing UBX domain for GLUT4,35903,0.02156546414896,0.0335947696622765,-0.044280284389102,0.087411212687022,0.52094108516431
Physical measures,X4270.Volume level set by participant (left),KLRD1,Natural killer cells antigen CD94,36908,-0.0249430572841727,0.0388983637393043,-0.101183850213209,0.0512977356448636,0.52138798516201
Physical measures,X4270.Volume level set by participant (left),MGMT,Methylated-DNA--protein-cysteine methyltransferase,36820,0.0104631276969282,0.016351433981727,-0.0215856829072567,0.0425119383011132,0.522263003837587
Physical measures,X4270.Volume level set by participant (left),PDAP1,28 kDa heat- and acid-stable phosphoprotein,35916,0.015048184423518,0.0235227089206613,-0.031056325060978,0.0611526939080141,0.522369908457892
Physical measures,X4270.Volume level set by participant (left),KLKB1,Plasma kallikrein,35768,-0.0575738541744273,0.0900188384973337,-0.234010777629201,0.118863069280347,0.522470834884523
Physical measures,X4270.Volume level set by participant (left),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,35680,0.0430514384212275,0.0673795589399674,-0.0890124971011086,0.175115373943564,0.522885087641238
Physical measures,X4270.Volume level set by participant (left),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35894,0.0122339228492818,0.0191508747635983,-0.0253017916873709,0.0497696373859345,0.522963206144357
Physical measures,X4270.Volume level set by participant (left),SCRIB,Protein scribble homolog,35748,0.0159953746874913,0.0250515798959455,-0.0331057219085618,0.0650964712835445,0.523172108791182
Physical measures,X4270.Volume level set by participant (left),SUGP1,SURP and G-patch domain-containing protein 1,35894,0.0346443008374367,0.0542787199854308,-0.0717419903340076,0.141030592008881,0.523321893027958
Physical measures,X4270.Volume level set by participant (left),CXCL5,C-X-C motif chemokine 5,36807,0.0105205345525806,0.0164835360399258,-0.0217871960856739,0.0428282651908351,0.523333409965021
Physical measures,X4270.Volume level set by participant (left),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35916,-0.0231433369682163,0.0362619417564884,-0.0942167428109335,0.047930068874501,0.523347914378367
Physical measures,X4270.Volume level set by participant (left),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,36763,-0.0300321141114874,0.047059707787217,-0.122269141374433,0.0622049131514579,0.523382055844246
Physical measures,X4270.Volume level set by participant (left),TJAP1,Tight junction-associated protein 1,36864,0.0149781102785954,0.0234868555880408,-0.0310561266739647,0.0610123472311554,0.523672992053355
Physical measures,X4270.Volume level set by participant (left),FUOM,Fucose mutarotase,35779,0.0226984175813038,0.0356024571336359,-0.0470823984006227,0.0924792335632302,0.52378752960354
Physical measures,X4270.Volume level set by participant (left),INHBC,Inhibin beta C chain,36836,0.0294368893342605,0.0462103780621605,-0.061135451667574,0.120009230336095,0.524131549732791
Physical measures,X4270.Volume level set by participant (left),CREBZF,CREB/ATF bZIP transcription factor,35678,0.0556889701525989,0.0874389939451546,-0.115691457979904,0.227069398285102,0.524219369312734
Physical measures,X4270.Volume level set by participant (left),PVR,Poliovirus receptor,36894,0.0325694513230028,0.0511484157653405,-0.0676814435770645,0.13282034622307,0.524297750843156
Physical measures,X4270.Volume level set by participant (left),CD22,B-cell receptor CD22,36908,-0.0277254037928807,0.0435510563151872,-0.113085474170648,0.0576346665848863,0.52439233409249
Physical measures,X4270.Volume level set by participant (left),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,35725,-0.0406656169682457,0.0639587208730733,-0.166024709879469,0.0846934759429781,0.524922326357797
Physical measures,X4270.Volume level set by participant (left),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,36894,0.0419877825446655,0.0660852513541046,-0.0875393101093795,0.171514875198711,0.525213945957195
Physical measures,X4270.Volume level set by participant (left),TET2,Methylcytosine dioxygenase TET2,35772,0.013708703329697,0.021576836916274,-0.0285818970262001,0.0559993036855941,0.525226511356633
Physical measures,X4270.Volume level set by participant (left),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",36760,0.0116743209993295,0.0183790837119131,-0.0243486830760202,0.0476973250746792,0.525319789024463
Physical measures,X4270.Volume level set by participant (left),DNER,Delta and Notch-like epidermal growth factor-related receptor,36807,0.0470023689635694,0.0741132072414138,-0.0982595172296017,0.19226425515674,0.525971369465151
Physical measures,X4270.Volume level set by participant (left),IL20,Interleukin-20,36697,0.0238749294927152,0.0376580422719891,-0.0499348333603835,0.0976846923458139,0.526104824168395
Physical measures,X4270.Volume level set by participant (left),TREH,Trehalase,35931,-0.0185986147276823,0.0293715658720557,-0.0761668838369116,0.0389696543815469,0.526612562158435
Physical measures,X4270.Volume level set by participant (left),STEAP4,Metalloreductase STEAP4,35680,-0.0193447575490908,0.0305915883261907,-0.0793042706684246,0.040614755570243,0.527176939228218
Physical measures,X4270.Volume level set by participant (left),ARHGAP45,Rho GTPase-activating protein 45,35779,0.0176580500906986,0.0279246922131098,-0.0370743466469967,0.0723904468283938,0.527183181390138
Physical measures,X4270.Volume level set by participant (left),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",35725,-0.0306713940038598,0.0485353364347141,-0.1258006534159,0.0644578654081799,0.52744857076094
Physical measures,X4270.Volume level set by participant (left),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,36908,0.012726866397741,0.0201414149128697,-0.0267503068314835,0.0522040396269655,0.527486973303246
Physical measures,X4270.Volume level set by participant (left),PLPBP,Pyridoxal phosphate homeostasis protein,36828,-0.0185765066303504,0.0294252922576768,-0.0762500794553969,0.0390970661946962,0.527856194805153
Physical measures,X4270.Volume level set by participant (left),ENO2,Gamma-enolase,36894,-0.0191345012475029,0.0303205846803845,-0.0785628472210564,0.0402938447260507,0.528011556181386
Physical measures,X4270.Volume level set by participant (left),GIGYF2,GRB10-interacting GYF protein 2,35903,0.0175190630519844,0.0277683371860165,-0.036906877832608,0.0719450039365767,0.528126962254843
Physical measures,X4270.Volume level set by participant (left),GC,Vitamin D-binding protein,35953,0.0534846493601869,0.0847802023188859,-0.11268454718483,0.219653845905203,0.528151781149079
Physical measures,X4270.Volume level set by participant (left),GGA1,ADP-ribosylation factor-binding protein GGA1,36639,-0.0183858754259514,0.0291821825187268,-0.0755829531626559,0.0388112023107532,0.528689255931298
Physical measures,X4270.Volume level set by participant (left),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,36853,0.0164495282772824,0.0261346076541767,-0.034774302724904,0.0676733592794688,0.529095825584434
Physical measures,X4270.Volume level set by participant (left),UGDH,UDP-glucose 6-dehydrogenase,35706,-0.0142529375087611,0.0226522494071196,-0.0586513463467154,0.0301454713291933,0.529236101875515
Physical measures,X4270.Volume level set by participant (left),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",36770,0.0176721133731441,0.0281241709693311,-0.0374512617267448,0.0727954884730331,0.529786867218889
Physical measures,X4270.Volume level set by participant (left),MAEA,E3 ubiquitin-protein transferase MAEA,36654,0.030804596445108,0.0491040267876735,-0.065439296058732,0.127048488948948,0.530459916542832
Physical measures,X4270.Volume level set by participant (left),JAM2,Junctional adhesion molecule B,36894,0.0430886416558945,0.068793395548071,-0.0917464136183247,0.177923696930114,0.531104940647649
Physical measures,X4270.Volume level set by participant (left),PSRC1,Proline/serine-rich coiled-coil protein 1,36654,-0.0202632289734385,0.0323578856392917,-0.0836846848264503,0.0431582268795733,0.531188321933494
Physical measures,X4270.Volume level set by participant (left),COMMD1,COMM domain-containing protein 1,35748,0.0234925801243537,0.0375769197799363,-0.0501581826443215,0.0971433428930289,0.531870486745366
Physical measures,X4270.Volume level set by participant (left),MAPRE3,Microtubule-associated protein RP/EB family member 3,35678,0.00949455586601319,0.015190516432386,-0.0202788563414633,0.0392679680734897,0.531972190538673
Physical measures,X4270.Volume level set by participant (left),CTSL,Cathepsin L1,36828,0.0478523515405423,0.076562289671545,-0.102209736215686,0.19791443929677,0.531981855384727
Physical measures,X4270.Volume level set by participant (left),MCEMP1,Mast cell-expressed membrane protein 1,35725,-0.0156113469494449,0.0250069345699542,-0.064624938706555,0.0334022448076653,0.532465063578872
Physical measures,X4270.Volume level set by participant (left),CXCL12,Stromal cell-derived factor 1,36697,0.0299424585081572,0.0479925149151105,-0.0641228707254594,0.124007787741774,0.532713214283076
Physical measures,X4270.Volume level set by participant (left),FCRL3,Fc receptor-like protein 3,36697,-0.0213515867602687,0.0342269688666227,-0.0884364457388493,0.0457332722183119,0.532762491258552
Physical measures,X4270.Volume level set by participant (left),MN1,Transcriptional activator MN1,35741,0.0236427239945449,0.037952981560495,-0.0507451198640252,0.0980305678531151,0.533340574229754
Physical measures,X4270.Volume level set by participant (left),TIMP2,Metalloproteinase inhibitor 2,35916,-0.0490621401016881,0.0788767998310568,-0.203660667770559,0.105536387567183,0.533956549239028
Physical measures,X4270.Volume level set by participant (left),CDH6,Cadherin-6,36828,0.0308762457591154,0.0496776845618171,-0.0664920159820462,0.128244507500277,0.534268542273939
Physical measures,X4270.Volume level set by participant (left),ERBB2,Receptor tyrosine-protein kinase erbB-2,36864,0.0488994828665326,0.0787522917673381,-0.10545500899745,0.203253974730515,0.534665623830296
Physical measures,X4270.Volume level set by participant (left),PTH,Parathyroid hormone,35741,-0.0167366317988072,0.0269583093687399,-0.0695749181615375,0.036101654563923,0.534730550908516
Physical measures,X4270.Volume level set by participant (left),IL22RA1,Interleukin-22 receptor subunit alpha-1,36697,-0.0267732498351573,0.0431690226664555,-0.11138453426141,0.0578380345910954,0.535147679246856
Physical measures,X4270.Volume level set by participant (left),CLTA,Clathrin light chain A,36697,-0.0246658809668604,0.0398193602148504,-0.102711826987967,0.0533800650542463,0.535642434458971
Physical measures,X4270.Volume level set by participant (left),VEGFD,Vascular endothelial growth factor D,36897,-0.0313634456949153,0.0506409809128599,-0.130619768284121,0.0678928768942901,0.53571773803444
Physical measures,X4270.Volume level set by participant (left),SHPK,Sedoheptulokinase,35798,-0.0327380539776313,0.0528823544739423,-0.136387468746558,0.0709113607912955,0.535889432079023
Physical measures,X4270.Volume level set by participant (left),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35900,-0.0179943932377501,0.0290849102055977,-0.0750008172407217,0.0390120307652214,0.536145017285532
Physical measures,X4270.Volume level set by participant (left),IMPA1,Inositol monophosphatase 1,36763,-0.019633995446367,0.0317411396123121,-0.0818466290864988,0.0425786381937648,0.536220809316973
Physical measures,X4270.Volume level set by participant (left),LCP1,Plastin-2,35931,0.0279393869327817,0.0451848848810526,-0.0606229874340815,0.116501761299645,0.536375576936599
Physical measures,X4270.Volume level set by participant (left),CTSO,Cathepsin O,36908,-0.0380706844478795,0.0615984919091493,-0.158803728589812,0.0826623596940531,0.536563452484686
Physical measures,X4270.Volume level set by participant (left),SMPD3,Sphingomyelin phosphodiesterase 3,35725,-0.0251457108390735,0.0406875979652797,-0.104893402851022,0.0546019811728747,0.536584337751129
Physical measures,X4270.Volume level set by participant (left),PDGFA,Platelet-derived growth factor subunit A,36933,0.0159341551803937,0.0258001081427265,-0.0346340567793503,0.0665023671401377,0.536857008885651
Physical measures,X4270.Volume level set by participant (left),SIL1,Nucleotide exchange factor SIL1,35748,0.0413429415940256,0.0670667333185256,-0.0901078557102845,0.172793738898336,0.53762238768038
Physical measures,X4270.Volume level set by participant (left),CDH3,Cadherin-3,36894,-0.0311992127127403,0.0506448880961391,-0.130463193381173,0.0680647679556923,0.537887172972537
Physical measures,X4270.Volume level set by participant (left),VIPR1,Vasoactive intestinal polypeptide receptor 1,35748,-0.058004020154913,0.0941557975212457,-0.242549383296555,0.126541342986729,0.537887542620548
Physical measures,X4270.Volume level set by participant (left),BTD,Biotinidase,35953,-0.0653714840030653,0.106119097099105,-0.273364914317311,0.14262194631118,0.537902086828551
Physical measures,X4270.Volume level set by participant (left),TOR1AIP1,Torsin-1A-interacting protein 1,35748,-0.0258177429382822,0.0419514523081714,-0.108042589462298,0.0564071035857338,0.538299077191864
Physical measures,X4270.Volume level set by participant (left),PRUNE2,Protein prune homolog 2,35798,0.0464670624583195,0.075528962227643,-0.101569703507861,0.1945038284245,0.538429475512186
Physical measures,X4270.Volume level set by participant (left),GCC1,GRIP and coiled-coil domain-containing protein 1,35903,0.012918465116078,0.0209986407367384,-0.0282388707279293,0.0540758009600853,0.538440336844283
Physical measures,X4270.Volume level set by participant (left),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35903,-0.0235533182110549,0.0382921732823236,-0.0986059778444092,0.0514993414222993,0.538512960587246
Physical measures,X4270.Volume level set by participant (left),TP53I3,Quinone oxidoreductase PIG3,35626,-0.0268502249672713,0.0436888023139883,-0.112480277502688,0.0587798275681457,0.538854467025895
Physical measures,X4270.Volume level set by participant (left),VCPKMT,Protein-lysine methyltransferase METTL21D,35678,-0.0159813073613924,0.026056427710977,-0.0670519056749073,0.0350892909521224,0.539676676416079
Physical measures,X4270.Volume level set by participant (left),IL5,Interleukin-5,36697,-0.00834669215103207,0.0136196929408752,-0.0350412903151475,0.0183479060130833,0.54000074388564
Physical measures,X4270.Volume level set by participant (left),CENPJ,Centromere protein J,35798,0.0193810033101892,0.0316392931581473,-0.0426320112797796,0.0813940179001579,0.540187622567996
Physical measures,X4270.Volume level set by participant (left),SCN4B,Sodium channel subunit beta-4,35748,-0.0312702266194436,0.0510530098688144,-0.13133412596232,0.0687936727234325,0.540224914318168
Physical measures,X4270.Volume level set by participant (left),UBQLN3,Ubiquilin-3,35706,0.0254618937201905,0.041581281218792,-0.0560374174686418,0.106961204909023,0.540334029728281
Physical measures,X4270.Volume level set by participant (left),NPTX1,Neuronal pentraxin-1,36836,0.0288987112029403,0.0472444833660541,-0.0637004761945258,0.121497898600406,0.540764820053787
Physical measures,X4270.Volume level set by participant (left),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35798,-0.0207671735236195,0.0339562092327697,-0.0873213436198481,0.0457869965726091,0.540832153976135
Physical measures,X4270.Volume level set by participant (left),SFTPA1,Pulmonary surfactant-associated protein A1,36654,-0.020640680093461,0.0337561297951363,-0.0868026944919281,0.0455213343050061,0.54091065372445
Physical measures,X4270.Volume level set by participant (left),SERPINC1,Antithrombin-III,35940,-0.0896165159431835,0.146617736027698,-0.376987278557472,0.197754246671105,0.541070831489095
Physical measures,X4270.Volume level set by participant (left),MMP10,Stromelysin-2,36796,-0.0199101988841442,0.0325805989353475,-0.0837681727974252,0.0439477750291368,0.541147699180877
Physical measures,X4270.Volume level set by participant (left),APOM,Apolipoprotein M,36839,-0.040882454063345,0.0669777897212197,-0.172158921916936,0.0903940137902457,0.54162281860814
Physical measures,X4270.Volume level set by participant (left),LRP1,Prolow-density lipoprotein receptor-related protein 1,36770,0.0433923776320411,0.0711094807561271,-0.0959822046499682,0.18276695991405,0.541734856442714
Physical measures,X4270.Volume level set by participant (left),MCTS1,Malignant T-cell-amplified sequence 1,35894,-0.0491212321757501,0.080568017209441,-0.207034545906254,0.108792081554754,0.542090185446486
Physical measures,X4270.Volume level set by participant (left),LUZP2,Leucine zipper protein 2,35874,-0.0297178773974622,0.0487819142146265,-0.12533042925813,0.0658946744632058,0.54241348682145
Physical measures,X4270.Volume level set by participant (left),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",36820,0.0143720883116883,0.0236439396863739,-0.0319700334736045,0.0607142100969811,0.543301717430809
Physical measures,X4270.Volume level set by participant (left),NRXN3,Neurexin-3,35741,0.0360420451570948,0.0593059726412687,-0.0801976612197919,0.152281751533982,0.543387355689587
Physical measures,X4270.Volume level set by participant (left),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,35725,0.0405014152929864,0.0666751078620375,-0.0901817961166071,0.17118462670258,0.543577214685996
Physical measures,X4270.Volume level set by participant (left),PPM1F,Protein phosphatase 1F,35916,0.026069749875819,0.0429226059728963,-0.0580585578310578,0.110198057582696,0.543628287801151
Physical measures,X4270.Volume level set by participant (left),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35903,0.0169934242704336,0.0279832809747513,-0.037853806440079,0.0718406549809462,0.543691896347916
Physical measures,X4270.Volume level set by participant (left),VIT,Vitrin,35916,0.034903502443666,0.0574814077860402,-0.0777600568169728,0.147567061704305,0.543729572572826
Physical measures,X4270.Volume level set by participant (left),DSG4,Desmoglein-4,36744,-0.022911266477224,0.0377505071655813,-0.0969022605217633,0.0510797275673152,0.54392703188753
Physical measures,X4270.Volume level set by participant (left),OPTC,Opticin,36770,0.0258421492457999,0.0425863686349755,-0.057627133278752,0.109311431770352,0.543990294385823
Physical measures,X4270.Volume level set by participant (left),PDIA5,Protein disulfide-isomerase A5,35678,-0.0225145597468983,0.0371027641562113,-0.0952359774930724,0.0502068579992758,0.543994127060759
Physical measures,X4270.Volume level set by participant (left),FUT8,"Alpha-(1,6)-fucosyltransferase",36763,0.0198820514890226,0.0328217959327355,-0.044448668539139,0.0842127715171841,0.544693916688322
Physical measures,X4270.Volume level set by participant (left),C2orf69,UPF0565 protein C2orf69,35741,-0.0231804042484126,0.0382680511217788,-0.0981857844470991,0.051824975950274,0.544709901315907
Physical measures,X4270.Volume level set by participant (left),CD40,Tumor necrosis factor receptor superfamily member 5,36829,0.0227591022474756,0.0376183876453332,-0.0509729375373775,0.0964911420323286,0.545197377413518
Physical measures,X4270.Volume level set by participant (left),ENO3,Beta-enolase,35748,-0.0228880448460871,0.0378368187819831,-0.0970482096587739,0.0512721199665998,0.545256680441759
Physical measures,X4270.Volume level set by participant (left),PROS1,Vitamin K-dependent protein S,35953,0.0504589558842393,0.0835596699640419,-0.113317997245283,0.214235909013761,0.54595211717888
Physical measures,X4270.Volume level set by participant (left),ANXA11,Annexin A11,36807,0.0182797740423038,0.0302851234074255,-0.0410790678362502,0.0776386159208578,0.54613477106957
Physical measures,X4270.Volume level set by participant (left),DNPEP,Aspartyl aminopeptidase,35903,-0.0236738089378148,0.0392425392848813,-0.100589185936182,0.0532415680605526,0.546350129033714
Physical measures,X4270.Volume level set by participant (left),IFNGR2,Interferon gamma receptor 2,36763,0.0217626358784998,0.0360968765037752,-0.0489872420688996,0.0925125138258992,0.546596437325066
Physical measures,X4270.Volume level set by participant (left),SCT,Secretin,35741,-0.0277811622852177,0.0460801031590832,-0.118098164477021,0.0625358399065853,0.546603787618671
Physical measures,X4270.Volume level set by participant (left),NIT2,Omega-amidase NIT2,35896,0.0189718938528543,0.031488385033278,-0.0427453408123706,0.0806891285180791,0.546858758533223
Physical measures,X4270.Volume level set by participant (left),STXBP3,Syntaxin-binding protein 3,36654,-0.0256751082930064,0.0426223894584477,-0.109214991631564,0.0578647750455512,0.546935893017616
Physical measures,X4270.Volume level set by participant (left),ICAM3,Intercellular adhesion molecule 3,36933,0.0417432964563365,0.0695895593950045,-0.0946522399578724,0.178138832870545,0.548623783416321
Physical measures,X4270.Volume level set by participant (left),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,36837,0.0310053180149488,0.0517194080178232,-0.0703647216999846,0.132375357729882,0.548863307970072
Physical measures,X4270.Volume level set by participant (left),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35798,-0.0339456973359909,0.0566343183670956,-0.144948961335498,0.0770575666635164,0.548937496764147
Physical measures,X4270.Volume level set by participant (left),DDC,Aromatic-L-amino-acid decarboxylase,36807,-0.0238845152790717,0.0399181983131461,-0.102124183972838,0.0543551534146947,0.549633230203595
Physical measures,X4270.Volume level set by participant (left),PSMA1,Proteasome subunit alpha type-1,36654,-0.0257028504466223,0.042965616672439,-0.109915459124603,0.0585097582313581,0.549711949326645
Physical measures,X4270.Volume level set by participant (left),IL1RL1,Interleukin-1 receptor-like 1,36909,0.0241300874621912,0.0403860234841863,-0.055026518566814,0.103286693491196,0.550200430302214
Physical measures,X4270.Volume level set by participant (left),AK2,"Adenylate kinase 2, mitochondrial",35903,0.01262159976399,0.0211737511501217,-0.0288789524902486,0.0541221520182286,0.551130855692884
Physical measures,X4270.Volume level set by participant (left),DDX25,ATP-dependent RNA helicase DDX25,35741,0.0345570246950777,0.0579821536954756,-0.0790879965480544,0.14820204593821,0.551199744466569
Physical measures,X4270.Volume level set by participant (left),SH2B3,SH2B adapter protein 3,36654,0.0124027820415793,0.0208367122481026,-0.0284371739647018,0.0532427380478605,0.551703125054911
Physical measures,X4270.Volume level set by participant (left),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35903,0.0173878042066633,0.0292169466579408,-0.0398774112429007,0.0746530196562272,0.551778425005636
Physical measures,X4270.Volume level set by participant (left),SSB,Lupus La protein,36639,-0.0193027411135641,0.0324423967582721,-0.0828898387597774,0.0442843565326491,0.551871552983063
Physical measures,X4270.Volume level set by participant (left),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35894,-0.0165316857271778,0.0278798322696067,-0.071176156975607,0.0381127855212514,0.553226494923515
Physical measures,X4270.Volume level set by participant (left),FURIN,Furin,36864,-0.0339144857628746,0.0572083452704758,-0.146042842493007,0.0782138709672579,0.553316362234375
Physical measures,X4270.Volume level set by participant (left),SLIT2,Slit homolog 2 protein,36639,-0.0220691694606047,0.0372339380376162,-0.0950476880143325,0.0509093490931231,0.553388905950492
Physical measures,X4270.Volume level set by participant (left),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,36697,-0.0364932584127803,0.0616035793888675,-0.157236274014961,0.0842497571893999,0.553608254007637
Physical measures,X4270.Volume level set by participant (left),PCDH9,Protocadherin-9,35894,-0.0380827731306974,0.0643702974401885,-0.164248556113467,0.0880830098520721,0.554124862732906
Physical measures,X4270.Volume level set by participant (left),SERPINA4,Kallistatin,35814,-0.0543437555168903,0.0919232733435735,-0.234513371270294,0.125825860236514,0.554415972001598
Physical measures,X4270.Volume level set by participant (left),IQGAP2,Ras GTPase-activating-like protein IQGAP2,36770,0.0204590304177284,0.0346166850408752,-0.0473896722623869,0.0883077330978438,0.554527035272525
Physical measures,X4270.Volume level set by participant (left),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",36864,0.0312876110790628,0.0529414151388391,-0.0724775625930618,0.135052784751188,0.554547527449876
Physical measures,X4270.Volume level set by participant (left),SEL1L,Protein sel-1 homolog 1,35748,0.0402023030081413,0.0681625503992739,-0.0933962957744355,0.173800901790718,0.555344781009999
Physical measures,X4270.Volume level set by participant (left),BTN2A1,Butyrophilin subfamily 2 member A1,36865,0.0405104060788275,0.0687135252021787,-0.0941681033174428,0.175188915475098,0.555506361665768
Physical measures,X4270.Volume level set by participant (left),HMOX1,Heme oxygenase 1,36730,-0.022893263405243,0.0389555736322849,-0.0992461877245214,0.0534596609140353,0.556767269873207
Physical measures,X4270.Volume level set by participant (left),HDAC8,Histone deacetylase 8,35725,-0.0222115662548232,0.0378053078315751,-0.0963099696047103,0.051886837095064,0.556871436846524
Physical measures,X4270.Volume level set by participant (left),ROBO1,Roundabout homolog 1,36837,-0.0449961052273656,0.0766199434788999,-0.195171194446009,0.105178983991278,0.5570440257378
Physical measures,X4270.Volume level set by participant (left),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",35748,-0.0357113680979292,0.0608200681020371,-0.154918701577922,0.0834959653820635,0.557113652247119
Physical measures,X4270.Volume level set by participant (left),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,36654,-0.0154028823960372,0.0262442412204879,-0.0668415951881935,0.036035830396119,0.557285125302091
Physical measures,X4270.Volume level set by participant (left),SERPINE2,Glia-derived nexin,35916,-0.0201716876746475,0.034396349309003,-0.0875885323202934,0.0472451569709984,0.557593856864529
Physical measures,X4270.Volume level set by participant (left),H2AP,Huntingtin-interacting protein M,35678,-0.0242914380357231,0.0414766514991157,-0.10558567497399,0.0570027989025436,0.558120809148116
Physical measures,X4270.Volume level set by participant (left),UNG,Uracil-DNA glycosylase,35874,-0.0385323466832051,0.0658843371435042,-0.167665647484473,0.0906009541180632,0.558669443936163
Physical measures,X4270.Volume level set by participant (left),FGFR4,Fibroblast growth factor receptor 4,35779,0.0243919212563838,0.0417144466058075,-0.0573683940909989,0.106152236603766,0.558745566544251
Physical measures,X4270.Volume level set by participant (left),C1QL2,Complement C1q-like protein 2,35725,-0.0296494662375834,0.0507198641867284,-0.129060400043571,0.0697614675684042,0.558855027770506
Physical measures,X4270.Volume level set by participant (left),F3,Tissue factor,36855,-0.0401107129866229,0.0688878381848012,-0.175130875828833,0.0949094498555874,0.560407920183273
Physical measures,X4270.Volume level set by participant (left),IFNAR1,Interferon alpha/beta receptor 1,35894,0.0478382546108434,0.0822318638837221,-0.113336198601252,0.209012707822939,0.560755751185521
Physical measures,X4270.Volume level set by participant (left),QPCT,Glutaminyl-peptide cyclotransferase,36860,0.0388781806021061,0.0668794734596264,-0.0922055873787617,0.169961948582974,0.561043865174582
Physical measures,X4270.Volume level set by participant (left),SCN2B,Sodium channel subunit beta-2,35741,0.0427859577407657,0.0738250900124058,-0.10191121868355,0.187483134165081,0.562232342693637
Physical measures,X4270.Volume level set by participant (left),APOA1,Apolipoprotein A-I,35953,-0.0461635543619535,0.0797240954199479,-0.202422781385051,0.110095672661144,0.562580521815295
Physical measures,X4270.Volume level set by participant (left),TCN2,Transcobalamin-2,36925,-0.0353867455146622,0.0612719393384987,-0.15547974661812,0.0847062555887952,0.563594309835809
Physical measures,X4270.Volume level set by participant (left),SIGLEC8,Sialic acid-binding Ig-like lectin 8,35748,-0.0281699415153851,0.0488413100152202,-0.123898909145217,0.0675590261144464,0.564118263755677
Physical measures,X4270.Volume level set by participant (left),HSPA1A,Heat shock 70 kDa protein 1A,36856,-0.0158025614893919,0.0274185381836649,-0.069542896329375,0.0379377733505913,0.564398354142847
Physical measures,X4270.Volume level set by participant (left),FSHB,Follitropin subunit beta,35748,-0.023522660312024,0.0408147842380809,-0.103519637418663,0.0564743167946146,0.564414006518106
Physical measures,X4270.Volume level set by participant (left),FES,Tyrosine-protein kinase Fes/Fps,36654,0.0236105197949569,0.0409938746022858,-0.0567374744255233,0.103958514015437,0.564664747832212
Physical measures,X4270.Volume level set by participant (left),PSMG3,Proteasome assembly chaperone 3,36820,-0.0208941173945313,0.0363087543996193,-0.0920592760177851,0.0502710412287226,0.564999426036682
Physical measures,X4270.Volume level set by participant (left),PCSK9,Proprotein convertase subtilisin/kexin type 9,36933,0.0260867557022964,0.0453944821557187,-0.0628864293229123,0.115059940727505,0.565532572354427
Physical measures,X4270.Volume level set by participant (left),CA11,Carbonic anhydrase-related protein 11,36654,0.0342748220694306,0.0596811190893919,-0.0827001713457775,0.151249815484639,0.565782637854679
Physical measures,X4270.Volume level set by participant (left),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",35779,0.0146031714239269,0.0254294234798177,-0.0352384985965158,0.0644448414443695,0.565809615907046
Physical measures,X4270.Volume level set by participant (left),YJU2,Splicing factor YJU2,35874,-0.0388950680829235,0.0678138746906334,-0.171810262476565,0.0940201263107181,0.566287477440233
Physical measures,X4270.Volume level set by participant (left),SCG2,Secretogranin-2,36858,0.0318222470778078,0.0555203912392672,-0.076997719751156,0.140642213906772,0.566550997197682
Physical measures,X4270.Volume level set by participant (left),IL12RB2,Interleukin-12 receptor subunit beta-2,35725,0.0313285463158746,0.0546955317855123,-0.0758746959837295,0.138531788615479,0.566812898866536
Physical measures,X4270.Volume level set by participant (left),NTF4,Neurotrophin-4,36654,0.0272486367059101,0.0476437767887075,-0.0661331657999565,0.120630439211777,0.567390456976138
Physical measures,X4270.Volume level set by participant (left),SKAP2,Src kinase-associated phosphoprotein 2,36865,0.0103397874492008,0.0180884755345151,-0.0251136245984487,0.0457931994968503,0.567594209705558
Physical measures,X4270.Volume level set by participant (left),CCDC80,Coiled-coil domain-containing protein 80,36828,-0.0290401902269593,0.0508268284716925,-0.128660774031477,0.070580393577558,0.567775484355838
Physical measures,X4270.Volume level set by participant (left),PRRT3,Proline-rich transmembrane protein 3,35748,-0.0318532956044439,0.055813822982485,-0.141248388650114,0.0775417974412266,0.568218380535349
Physical measures,X4270.Volume level set by participant (left),ICAM5,Intercellular adhesion molecule 5,36828,-0.0233189385677398,0.0409108497809824,-0.103504204138465,0.0568663270029857,0.568698553217374
Physical measures,X4270.Volume level set by participant (left),IGLC2,Immunoglobulin lambda constant 2,35935,0.0452727756636191,0.0794267224180333,-0.110403600275726,0.200949151602964,0.568700596784384
Physical measures,X4270.Volume level set by participant (left),FGFBP1,Fibroblast growth factor-binding protein 1,36864,-0.0323420995234001,0.0567813092283694,-0.143633465611004,0.078949266564204,0.568972098462403
Physical measures,X4270.Volume level set by participant (left),NACC1,Nucleus accumbens-associated protein 1,35874,0.0223221124176021,0.0391920222652316,-0.0544942512222518,0.099138476057456,0.568996983208151
Physical measures,X4270.Volume level set by participant (left),CD83,CD83 antigen,36820,-0.0307483312900089,0.0540431271734851,-0.13667286055004,0.0751761979700218,0.569400629676474
Physical measures,X4270.Volume level set by participant (left),CALCB,Calcitonin gene-related peptide 2,35903,0.0330954411754951,0.0581966402768596,-0.0809699737671497,0.14716085611814,0.56959031600767
Physical measures,X4270.Volume level set by participant (left),PFDN6,Prefoldin subunit 6,35741,0.0194564499025302,0.034266197680148,-0.0477052975505599,0.0866181973556203,0.570188220842485
Physical measures,X4270.Volume level set by participant (left),ACSL1,Long-chain-fatty-acid--CoA ligase 1,35706,-0.0337947509581952,0.0596936939229481,-0.150794391047174,0.0832048891307832,0.571320828608658
Physical measures,X4270.Volume level set by participant (left),ESAM,Endothelial cell-selective adhesion molecule,36933,0.0326206426851514,0.0576256602517469,-0.0803256514082725,0.145566936778575,0.571356892502843
Physical measures,X4270.Volume level set by participant (left),TUBB3,Tubulin beta-3 chain,35680,0.0456870541089211,0.0807194678175595,-0.112523102813495,0.203897211031338,0.571414757351379
Physical measures,X4270.Volume level set by participant (left),SIRPB1,Signal-regulatory protein beta-1,36813,0.022321921615983,0.0394985405546566,-0.055095217871144,0.09973906110311,0.57200007254501
Physical measures,X4270.Volume level set by participant (left),LEO1,RNA polymerase-associated protein LEO1,35903,0.03803437086566,0.0674375614673205,-0.0941432496102882,0.170211991341608,0.572777168600715
Physical measures,X4270.Volume level set by participant (left),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,35678,-0.0222217208280401,0.0394069997632333,-0.0994594403639773,0.0550159987078971,0.572839738588723
Physical measures,X4270.Volume level set by participant (left),SNAP23,Synaptosomal-associated protein 23,36828,0.0129502855892336,0.0229945571747528,-0.0321190464732819,0.058019617651749,0.573322622935834
Physical measures,X4270.Volume level set by participant (left),VASP,Vasodilator-stimulated phosphoprotein,35926,0.0172495969574575,0.0306402804799389,-0.0428053527832227,0.0773045466981378,0.573473218560146
Physical measures,X4270.Volume level set by participant (left),WFDC1,WAP four-disulfide core domain protein 1,35721,0.022502636003804,0.0399852928518598,-0.0558685379858413,0.100873809993449,0.573608928568363
Physical measures,X4270.Volume level set by participant (left),DBI,Acyl-CoA-binding protein,36798,0.0142681423556464,0.0253745775515833,-0.0354660296454569,0.0640023143567497,0.573927752852985
Physical measures,X4270.Volume level set by participant (left),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35916,-0.0441216295880511,0.0785627036562174,-0.198104528754237,0.109861269578135,0.574400240386061
Physical measures,X4270.Volume level set by participant (left),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35903,-0.0179460192990398,0.0319594440032154,-0.080586529545342,0.0446944909472624,0.574458616683055
Physical measures,X4270.Volume level set by participant (left),ERBB4,Receptor tyrosine-protein kinase erbB-4,36864,-0.0429783876590133,0.0766141843721199,-0.193142189028368,0.107185413710342,0.574833237524044
Physical measures,X4270.Volume level set by participant (left),KLK4,Kallikrein-4,36888,-0.0164434953137877,0.0293555372333622,-0.0739803482911776,0.0410933576636022,0.575393648899947
Physical measures,X4270.Volume level set by participant (left),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,35713,0.0325126654212829,0.0580454960103991,-0.0812565067590993,0.146281837601665,0.575414234064752
Physical measures,X4270.Volume level set by participant (left),PGR,Progesterone receptor,35725,-0.0127480760342387,0.0228563693164385,-0.0575465598944581,0.0320504078259806,0.577036145800871
Physical measures,X4270.Volume level set by participant (left),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35849,-0.0403744423146658,0.072419862184232,-0.182317372195761,0.101568487566429,0.577201136594061
Physical measures,X4270.Volume level set by participant (left),BRD2,Bromodomain-containing protein 2,35680,-0.0349775527523857,0.0627683234384159,-0.158003466691681,0.0880483611869095,0.577376909342174
Physical measures,X4270.Volume level set by participant (left),PLXNB2,Plexin-B2,36892,-0.0432474153416577,0.0776129268949513,-0.195368752055762,0.108873921372447,0.577393859742322
Physical measures,X4270.Volume level set by participant (left),TREM2,Triggering receptor expressed on myeloid cells 2,36822,0.0199499526627484,0.0358327515991212,-0.0502822404715292,0.090182145797026,0.577713288904506
Physical measures,X4270.Volume level set by participant (left),C8B,Complement component C8 beta chain,35953,0.0392274299122189,0.0704705447204764,-0.0988948377399149,0.177349697564353,0.577785010791219
Physical measures,X4270.Volume level set by participant (left),TNFSF8,Tumor necrosis factor ligand superfamily member 8,35931,-0.0330630458904127,0.0594229074639836,-0.149531944519821,0.0834058527389953,0.577954314773694
Physical measures,X4270.Volume level set by participant (left),EGF,Pro-epidermal growth factor,36822,0.0103570738825893,0.0186198074077,-0.0261377486365028,0.0468518964016814,0.57806340616525
Physical measures,X4270.Volume level set by participant (left),ANGPT1,Angiopoietin-1,36794,0.0123834006058787,0.022265466068041,-0.0312569128874817,0.056023714099239,0.578110523920379
Physical measures,X4270.Volume level set by participant (left),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],36770,0.0191151998112211,0.0343754376143261,-0.048260657912858,0.0864910575353002,0.578178432539065
Physical measures,X4270.Volume level set by participant (left),ENPEP,Glutamyl aminopeptidase,35706,-0.0286872112619257,0.0515995645672626,-0.12982235781376,0.072447935289909,0.578258404251065
Physical measures,X4270.Volume level set by participant (left),GYS1,"Glycogen [starch] synthase, muscle",36697,-0.0118270465780895,0.021283190980301,-0.0535421008994796,0.0298880077433005,0.578433259739545
Physical measures,X4270.Volume level set by participant (left),TGFBI,Transforming growth factor-beta-induced protein ig-h3,36753,-0.0392882058270887,0.0708673498222568,-0.178188211478712,0.0996117998245346,0.57932783763785
Physical measures,X4270.Volume level set by participant (left),FN1,Fibronectin,35953,0.044540363681905,0.0803495377998778,-0.112944730405855,0.202025457769665,0.579369630299285
Physical measures,X4270.Volume level set by participant (left),HS1BP3,HCLS1-binding protein 3,35748,0.0143169905965405,0.0258364726534435,-0.0363224958042087,0.0649564769972897,0.57950280876428
Physical measures,X4270.Volume level set by participant (left),COCH,Cochlin,35916,-0.0256525628540226,0.0463075947162285,-0.11641544849783,0.0651103227897852,0.579624542326537
Physical measures,X4270.Volume level set by participant (left),CDH1,Cadherin-1,36616,0.0266882573026578,0.048179264359212,-0.0677431008413977,0.121119615446713,0.579638938914565
Physical measures,X4270.Volume level set by participant (left),MSR1,Macrophage scavenger receptor types I and II,36894,0.0224724866375477,0.0405811306763711,-0.0570665294881397,0.102011502763235,0.579754474829199
Physical measures,X4270.Volume level set by participant (left),TXNDC5,Thioredoxin domain-containing protein 5,36894,0.0155185475510586,0.0281601606775551,-0.0396753673769494,0.0707124624790666,0.581593705601057
Physical measures,X4270.Volume level set by participant (left),HLA_DRA,,36796,-0.0286967828424884,0.0520770833065804,-0.130767866123386,0.0733743004384091,0.581619468698405
Physical measures,X4270.Volume level set by participant (left),ARHGEF1,Rho guanine nucleotide exchange factor 1,35903,0.0139991253872855,0.0254550564718853,-0.0358927852976097,0.0638910360721807,0.582368829065524
Physical measures,X4270.Volume level set by participant (left),VEGFA,Vascular endothelial growth factor A,36892,0.0175842203926771,0.0319904794051816,-0.0451171192414789,0.0802855600268331,0.582561397816479
Physical measures,X4270.Volume level set by participant (left),CD59,CD59 glycoprotein,36597,0.0439260347413708,0.0799235689950585,-0.112724160488944,0.200576229971685,0.582609990385644
Physical measures,X4270.Volume level set by participant (left),GAD1,Glutamate decarboxylase 1,35678,0.0477719545703696,0.0869340782146522,-0.122618838730349,0.218162747871088,0.582668051215348
Physical measures,X4270.Volume level set by participant (left),TMSB10,Thymosin beta-10,36836,0.0142825167699015,0.0261024460728666,-0.036878277532917,0.06544331107272,0.584276840365697
Physical measures,X4270.Volume level set by participant (left),WARS,"Tryptophan--tRNA ligase, cytoplasmic",36836,-0.0269516428440091,0.0492851593876665,-0.123550555243835,0.0696472695558173,0.584497017209367
Physical measures,X4270.Volume level set by participant (left),GUK1,Guanylate kinase,35706,-0.0322011140790404,0.0588953098157944,-0.147635921317998,0.0832336931599167,0.584568033591166
Physical measures,X4270.Volume level set by participant (left),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35874,-0.0132049808495242,0.0241528407816672,-0.060544548781592,0.0341345870825435,0.584585405921664
Physical measures,X4270.Volume level set by participant (left),DAAM1,Disheveled-associated activator of morphogenesis 1,35779,0.0147534084730791,0.0269880954708834,-0.0381432586498523,0.0676500755960106,0.584628421128099
Physical measures,X4270.Volume level set by participant (left),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,36864,0.0285389423714487,0.0522316002212297,-0.0738349940621614,0.130912878805059,0.584812224979335
Physical measures,X4270.Volume level set by participant (left),DLL4,Delta-like protein 4,35748,-0.0140406084891852,0.0257236774518699,-0.0644590162948501,0.0363777993164798,0.585205296565357
Physical measures,X4270.Volume level set by participant (left),CLEC1A,C-type lectin domain family 1 member A,36697,0.0303104814256461,0.0555332500950416,-0.0785346887606353,0.139155651611928,0.585214289687236
Physical measures,X4270.Volume level set by participant (left),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35874,-0.0260645018303992,0.0477961462865303,-0.119744948551999,0.0676159448912002,0.585547244710928
Physical measures,X4270.Volume level set by participant (left),IL17RB,Interleukin-17 receptor B,36718,0.0195211544607907,0.0358053220547029,-0.050657276766427,0.0896995856880083,0.58563035469451
Physical measures,X4270.Volume level set by participant (left),EDN1,Endothelin-1,35748,0.0393321970998185,0.072249166956317,-0.102276170134563,0.1809405643342,0.586187149545452
Physical measures,X4270.Volume level set by participant (left),FHIT,Bis(5'-adenosyl)-triphosphatase,36639,-0.0153460706936377,0.0281899004235662,-0.0705982755238274,0.0399061341365521,0.586195029575328
Physical measures,X4270.Volume level set by participant (left),KEL,Kell blood group glycoprotein,36639,-0.029715192666448,0.0547339887373116,-0.136993810591579,0.0775634252586826,0.587213528493456
Physical measures,X4270.Volume level set by participant (left),NAA80,N-alpha-acetyltransferase 80,35741,0.0103351634825601,0.0190730607273618,-0.0270480355430691,0.0477183625081892,0.587924922000693
Physical measures,X4270.Volume level set by participant (left),ATG4A,Cysteine protease ATG4A,36654,-0.017437486964666,0.032188144554958,-0.0805262502923836,0.0456512763630516,0.588016351220523
Physical measures,X4270.Volume level set by participant (left),ADGRE1,Adhesion G protein-coupled receptor E1,35894,0.021196235433964,0.0391970305686739,-0.0556299444806368,0.0980224153485648,0.588690136266311
Physical measures,X4270.Volume level set by participant (left),HMCN2,Hemicentin-2,35769,0.0209863525994859,0.0388670398805418,-0.0551930455663761,0.0971657507653479,0.589248134249892
Physical measures,X4270.Volume level set by participant (left),CXCL13,C-X-C motif chemokine 13,36894,0.0159301233958345,0.0295145052556158,-0.0419183069051725,0.0737785536968415,0.589392797738363
Physical measures,X4270.Volume level set by participant (left),LAT2,Linker for activation of T-cells family member 2,36770,0.00845900902933886,0.0156778428167859,-0.0222695628915615,0.0391875809502392,0.589521996156706
Physical measures,X4270.Volume level set by participant (left),IL5RA,Interleukin-5 receptor subunit alpha,36820,0.0177120719027739,0.0328378990234651,-0.0466502101832177,0.0820743539887655,0.589641147249291
Physical measures,X4270.Volume level set by participant (left),SHBG,Sex hormone-binding globulin,35926,-0.0231260693862267,0.0428868181054245,-0.107184232872859,0.0609320941004053,0.589742617335311
Physical measures,X4270.Volume level set by participant (left),NXPE4,NXPE family member 4,35706,0.036036810560456,0.0669223583626294,-0.0951310118302975,0.16720463295121,0.59025938869429
Physical measures,X4270.Volume level set by participant (left),IL24,Interleukin-24,36697,-0.0212924007984907,0.0395616912294132,-0.0988333156081405,0.0562485140111592,0.590449741375131
Physical measures,X4270.Volume level set by participant (left),SPINT3,Kunitz-type protease inhibitor 3,35894,0.00798102432130648,0.0148307134290219,-0.0210871739995764,0.0370492226421893,0.590497156362858
Physical measures,X4270.Volume level set by participant (left),SMTN,Smoothelin,35891,0.011981194965762,0.0222854907845304,-0.0316983669719177,0.0556607569034416,0.590855140670489
Physical measures,X4270.Volume level set by participant (left),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,36816,0.0165692298011556,0.0308779187670465,-0.0439514909822555,0.0770899505845668,0.591556510576599
Physical measures,X4270.Volume level set by participant (left),ATOX1,Copper transport protein ATOX1,36864,0.0149869025303434,0.0279613558137723,-0.0398173548646504,0.0697911599253371,0.591983594981913
Physical measures,X4270.Volume level set by participant (left),GFRA1,GDNF family receptor alpha-1,36880,0.0346190627822181,0.0646217618153113,-0.092039590375792,0.161277715940228,0.592168735657264
Physical measures,X4270.Volume level set by participant (left),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,36820,0.0259137850703246,0.0483915508954114,-0.0689336546846818,0.120761224825331,0.592318214313538
Physical measures,X4270.Volume level set by participant (left),DKK4,Dickkopf-related protein 4,36754,-0.0219860094051227,0.0410819214317144,-0.102506575411283,0.0585345566010375,0.592544731991103
Physical measures,X4270.Volume level set by participant (left),IL18RAP,Interleukin-18 receptor accessory protein,36708,0.00586886139322301,0.010982953448028,-0.0156577273649118,0.0273954501513578,0.593107649270139
Physical measures,X4270.Volume level set by participant (left),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,36697,-0.0271528096896181,0.0508701441422469,-0.126858292208422,0.0725526728291857,0.593518492100324
Physical measures,X4270.Volume level set by participant (left),DENR,Density-regulated protein,35725,0.0213469167442933,0.0400475369929963,-0.0571462557619795,0.0998400892505661,0.594024423224588
Physical measures,X4270.Volume level set by participant (left),GP1BB,Platelet glycoprotein Ib beta chain,35706,0.0175763033126098,0.0329825311089218,-0.047069457660877,0.0822220642860965,0.59412283454609
Physical measures,X4270.Volume level set by participant (left),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,35678,0.0268607497851934,0.0504280191870932,-0.0719781678215093,0.125699667391896,0.594290501753879
Physical measures,X4270.Volume level set by participant (left),FIS1,Mitochondrial fission 1 protein,36832,0.0133469610371974,0.0250903291072541,-0.0358300840130206,0.0625240060874154,0.594771674017351
Physical measures,X4270.Volume level set by participant (left),DCDC2C,Doublecortin domain-containing protein 2C,35678,0.0186386091996704,0.0351572990130684,-0.0502696968659437,0.0875469152652845,0.596026744806395
Physical measures,X4270.Volume level set by participant (left),LYZL2,Lysozyme-like protein 2,35678,-0.0329867990564444,0.0622668243522921,-0.155029774786937,0.0890561766740481,0.596292856111147
Physical measures,X4270.Volume level set by participant (left),BCL2L1,Bcl-2-like protein 1,35903,0.0123424429422767,0.0233041095992868,-0.0333336118723253,0.0580184977568788,0.596389374030786
Physical measures,X4270.Volume level set by participant (left),NFKB2,Nuclear factor NF-kappa-B p100 subunit,35798,0.020392496546942,0.0385177669156047,-0.0551023266076432,0.0958873197015272,0.596524361568501
Physical measures,X4270.Volume level set by participant (left),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35903,0.0139944505483419,0.0264505746256373,-0.0378486757179072,0.0658375768145909,0.596767977199353
Physical measures,X4270.Volume level set by participant (left),CNTN5,Contactin-5,36846,-0.0262917676572995,0.0497534939492614,-0.123808615797852,0.0712250804832529,0.59720887547648
Physical measures,X4270.Volume level set by participant (left),NOP56,Nucleolar protein 56,35706,0.01039432974615,0.0196726870245365,-0.0281641368219415,0.0489527963142415,0.597265080178979
Physical measures,X4270.Volume level set by participant (left),NCF2,Neutrophil cytosol factor 2,36804,0.0118332817494062,0.0224068979272986,-0.0320842381880991,0.0557508016869115,0.597439173207584
Physical measures,X4270.Volume level set by participant (left),PILRA,Paired immunoglobulin-like type 2 receptor alpha,36836,0.0233798316473799,0.0442752895977643,-0.0633997359642382,0.110159399258998,0.597475817698596
Physical measures,X4270.Volume level set by participant (left),PNLIPRP1,Inactive pancreatic lipase-related protein 1,35903,0.0140976749925967,0.0267126099703738,-0.0382590405493359,0.0664543905345293,0.597687854807145
Physical measures,X4270.Volume level set by participant (left),SLC34A3,Sodium-dependent phosphate transport protein 2C,35678,-0.0235055765032232,0.044541349597517,-0.110806621714357,0.0637954687079102,0.597708397186084
Physical measures,X4270.Volume level set by participant (left),SLAMF6,SLAM family member 6,36654,-0.0264282964754253,0.0500867980376139,-0.124598420629149,0.071741827678298,0.597758016278381
Physical measures,X4270.Volume level set by participant (left),CD302,CD302 antigen,36770,0.0318914335775465,0.0604980118898747,-0.0866846697266079,0.150467536881701,0.598105940532671
Physical measures,X4270.Volume level set by participant (left),CEP43,Centrosomal protein 43,36648,-0.0150911271253236,0.0286481421074309,-0.0712414856558882,0.0410592314052411,0.598365476980639
Physical measures,X4270.Volume level set by participant (left),DNAJC21,DnaJ homolog subfamily C member 21,35903,0.0289084476352476,0.0549006569998074,-0.0786968400843748,0.13651373535487,0.598517126062325
Physical measures,X4270.Volume level set by participant (left),MINK1,Misshapen-like kinase 1,35903,0.0127670092657792,0.0242863087703153,-0.0348341559240388,0.0603681744555972,0.599122722753584
Physical measures,X4270.Volume level set by participant (left),MPHOSPH8,M-phase phosphoprotein 8,36697,-0.0133945932553786,0.0254940668928556,-0.0633629643653755,0.0365737778546184,0.599320398875903
Physical measures,X4270.Volume level set by participant (left),EPCAM,Epithelial cell adhesion molecule,36819,-0.00999648479086498,0.0190674040341693,-0.0473685966978369,0.0273756271161069,0.600105389414088
Physical measures,X4270.Volume level set by participant (left),GBP4,Guanylate-binding protein 4,36639,0.0207654955449924,0.0396608434709065,-0.0569697576579844,0.0985007487479691,0.600588545882865
Physical measures,X4270.Volume level set by participant (left),CTSC,Dipeptidyl peptidase 1,36801,-0.022588719090765,0.043187127382191,-0.107235488759859,0.0620580505783295,0.600959659921439
Physical measures,X4270.Volume level set by participant (left),PAM,Peptidyl-glycine alpha-amidating monooxygenase,36905,-0.0336199475240646,0.0642898621747658,-0.159628077386606,0.0923881823384764,0.601028797992515
Physical measures,X4270.Volume level set by participant (left),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,36853,0.0116946546949456,0.0223634101276001,-0.0321376291551506,0.0555269385450417,0.601033225421985
Physical measures,X4270.Volume level set by participant (left),TDGF1,Teratocarcinoma-derived growth factor 1,36639,0.00680883698036198,0.0130212605592113,-0.0187128337156922,0.0323305076764161,0.601058351433282
Physical measures,X4270.Volume level set by participant (left),ASRGL1,Isoaspartyl peptidase/L-asparaginase,35748,-0.0119785723356077,0.0229826531178032,-0.0570245724465019,0.0330674277752866,0.602244661668802
Physical measures,X4270.Volume level set by participant (left),RTBDN,Retbindin,36770,-0.0326843698748615,0.0628259158871574,-0.15582316501369,0.090454425263967,0.602913564418613
Physical measures,X4270.Volume level set by participant (left),KIAA2013,Uncharacterized protein KIAA2013,35874,-0.0202696089635835,0.0389661088469271,-0.0966431823035606,0.0561039643763935,0.602951462635927
Physical measures,X4270.Volume level set by participant (left),OLR1,Oxidized low-density lipoprotein receptor 1,36769,-0.0160043913557019,0.0308204317268223,-0.0764124375402735,0.0444036548288698,0.60358163532566
Physical measures,X4270.Volume level set by participant (left),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",35725,-0.0248328541323241,0.0478282694047167,-0.118576262165569,0.0689105539009205,0.603632806352988
Physical measures,X4270.Volume level set by participant (left),MYL6B,Myosin light chain 6B,35741,0.0123273285438756,0.023748921336862,-0.034220557276374,0.0588752143641253,0.6037301872541
Physical measures,X4270.Volume level set by participant (left),CCL8,C-C motif chemokine 8,36881,-0.0162267231723872,0.0312678889624171,-0.0775117855387247,0.0450583391939503,0.603804929687391
Physical measures,X4270.Volume level set by participant (left),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,35725,-0.0201466635456068,0.038835955762817,-0.0962651368407281,0.0559718097495146,0.603943487880368
Physical measures,X4270.Volume level set by participant (left),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35903,0.0160007151072268,0.0308646015873753,-0.0444939040040289,0.0764953342184824,0.604184891017551
Physical measures,X4270.Volume level set by participant (left),HSPB1,Heat shock protein beta-1,36712,0.0152389784487037,0.0294037222370585,-0.0423923171359309,0.0728702740333384,0.604287262846326
Physical measures,X4270.Volume level set by participant (left),CTBS,Di-N-acetylchitobiase,35802,0.0415907700937541,0.0803244911666534,-0.115845232592886,0.199026772780395,0.604626030930815
Physical measures,X4270.Volume level set by participant (left),SCGB2A2,Mammaglobin-A,35706,0.0389486889045148,0.0752304197159483,-0.108502933738744,0.186400311547773,0.604667563510241
Physical measures,X4270.Volume level set by participant (left),ITGB6,Integrin beta-6,36697,-0.0320085695331294,0.0618576810538252,-0.153249624398627,0.0892324853323681,0.604853799163821
Physical measures,X4270.Volume level set by participant (left),COPE,Coatomer subunit epsilon,36639,0.021263736909081,0.0411005736079256,-0.0592933873624531,0.101820861180615,0.60492120183369
Physical measures,X4270.Volume level set by participant (left),CCN2,CCN family member 2,36812,0.0176176480858228,0.0340589368538026,-0.0491378681476304,0.0843731643192759,0.604983089718464
Physical measures,X4270.Volume level set by participant (left),RNF41,E3 ubiquitin-protein ligase NRDP1,36654,-0.01560493792166,0.0301706142098586,-0.0747393417729829,0.0435294659296629,0.605015785127152
Physical measures,X4270.Volume level set by participant (left),TANK,TRAF family member-associated NF-kappa-B activator,36697,-0.0145619365116317,0.0281549665836622,-0.0697456710156096,0.0406217979923462,0.605027148672663
Physical measures,X4270.Volume level set by participant (left),CRLF1,Cytokine receptor-like factor 1,36865,0.0388334261795531,0.0751059769971325,-0.108374288734827,0.186041141093933,0.6051372767623
Physical measures,X4270.Volume level set by participant (left),RP2,Protein XRP2,36770,-0.023611165488274,0.0457185619728514,-0.113219546955063,0.0659972159785146,0.605558069953413
Physical measures,X4270.Volume level set by participant (left),MAVS,Mitochondrial antiviral-signaling protein,36654,0.0107353415228736,0.0207935474837732,-0.0300200115453218,0.051490694591069,0.60567253152396
Physical measures,X4270.Volume level set by participant (left),ATG16L1,Autophagy-related protein 16-1,35894,0.0138147330880619,0.0267994830593894,-0.0387122537083414,0.0663417198844652,0.606231123502654
Physical measures,X4270.Volume level set by participant (left),DDA1,DET1- and DDB1-associated protein 1,35706,-0.0276638695683058,0.0537045807664102,-0.13292484787047,0.0775971087338582,0.606492307729772
Physical measures,X4270.Volume level set by participant (left),PARK7,Parkinson disease protein 7,36836,-0.0194811931068452,0.037848901474026,-0.0936650399959362,0.0547026537822458,0.606770852262999
Physical measures,X4270.Volume level set by participant (left),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,36863,-0.0230815049183893,0.0448481073540294,-0.110983795332287,0.0648207854955083,0.606805809955944
Physical measures,X4270.Volume level set by participant (left),DDX1,ATP-dependent RNA helicase DDX1,35894,-0.0230755783438803,0.0448777307885952,-0.111035930689527,0.0648847740017663,0.6071377143078
Physical measures,X4270.Volume level set by participant (left),CLEC5A,C-type lectin domain family 5 member A,36804,-0.0317013711133474,0.061721428079768,-0.152675370149693,0.0892726279229978,0.607532484096203
Physical measures,X4270.Volume level set by participant (left),BMP4,Bone morphogenetic protein 4,36748,-0.0180583755278492,0.0351716929485714,-0.0869948937070492,0.0508781426513507,0.607662142375283
Physical measures,X4270.Volume level set by participant (left),FAM3B,Protein FAM3B,36770,-0.0276965688223344,0.0539685562735229,-0.133474939118439,0.0780818014737704,0.607827617798322
Physical measures,X4270.Volume level set by participant (left),ERP44,Endoplasmic reticulum resident protein 44,36762,0.0377296738123893,0.0736914101016809,-0.106705489986905,0.182164837611684,0.608669071776921
Physical measures,X4270.Volume level set by participant (left),IL12RB1,Interleukin-12 receptor subunit beta-1,36697,-0.0260002604829799,0.050836569928075,-0.125639937542007,0.0736394165760471,0.60905246898618
Physical measures,X4270.Volume level set by participant (left),AIDA,"Axin interactor, dorsalization-associated protein",35741,0.012997542787246,0.0254874815540059,-0.0369579210586056,0.0629530066330976,0.610098148797217
Physical measures,X4270.Volume level set by participant (left),HPCAL1,Hippocalcin-like protein 1,36908,0.0136474683141124,0.0267632712531385,-0.038808543342039,0.0661034799702638,0.610113176482684
Physical measures,X4270.Volume level set by participant (left),ESPL1,Separin,35678,0.0188225964411818,0.036929398647612,-0.0535590249081377,0.0912042177905013,0.610285042424255
Physical measures,X4270.Volume level set by participant (left),CDH23,Cadherin-23,35903,-0.0426606801134935,0.0838686121770162,-0.207043159980445,0.121721799753458,0.611006697512861
Physical measures,X4270.Volume level set by participant (left),OXT,Oxytocin-neurophysin 1,36894,0.00688710139029147,0.0135414067782873,-0.0196540558951517,0.0334282586757346,0.611050213742945
Physical measures,X4270.Volume level set by participant (left),IL15RA,Interleukin-15 receptor subunit alpha,36697,-0.0266668082523852,0.0524930666789505,-0.129553218943128,0.0762196024383577,0.611463869205289
Physical measures,X4270.Volume level set by participant (left),TTF2,Transcription termination factor 2,35741,0.0223514235525999,0.044023128634978,-0.063933908571957,0.108636755677157,0.611666820705675
Physical measures,X4270.Volume level set by participant (left),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35874,0.0235981654001593,0.0465882292832036,-0.0677147639949198,0.114911094795238,0.612503926458798
Physical measures,X4270.Volume level set by participant (left),ANK2,Ankyrin-2,35706,-0.0157617157209312,0.031160423582382,-0.0768361459423999,0.0453127145005375,0.612996760620458
Physical measures,X4270.Volume level set by participant (left),PYY,Peptide YY,35706,0.0112928927875845,0.0223388305591763,-0.032491215108401,0.05507700068357,0.613205517956984
Physical measures,X4270.Volume level set by participant (left),STX4,Syntaxin-4,36770,0.014068340878213,0.0278315896005601,-0.0404815747388848,0.0686182564953108,0.613235722510389
Physical measures,X4270.Volume level set by participant (left),POF1B,Protein POF1B,35725,0.0243347289319313,0.0482554075038503,-0.0702458697756153,0.118915327639478,0.61407448525617
Physical measures,X4270.Volume level set by participant (left),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,36654,-0.0151219099810378,0.0300341009852653,-0.0739887479121577,0.0437449279500821,0.614633734285558
Physical measures,X4270.Volume level set by participant (left),F9,Coagulation factor IX,36839,0.0525258852382739,0.104327027662642,-0.151955088980504,0.257006859457052,0.614645976244204
Physical measures,X4270.Volume level set by participant (left),GIT1,ARF GTPase-activating protein GIT1,35725,-0.0123064226376798,0.024443496370855,-0.0602156755245557,0.0356028302491961,0.614655009695361
Physical measures,X4270.Volume level set by participant (left),BHLHE40,Class E basic helix-loop-helix protein 40,35680,0.0158155929890238,0.0315049113268064,-0.0459340332115168,0.0775652191895644,0.615681722621206
Physical measures,X4270.Volume level set by participant (left),WAS,Wiskott-Aldrich syndrome protein,36697,0.014092864554697,0.0280806915945316,-0.040945290970585,0.0691310200799789,0.615773504481339
Physical measures,X4270.Volume level set by participant (left),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,35779,0.0134209977563434,0.0268023139022739,-0.0391115374921134,0.0659535330048002,0.616570674347256
Physical measures,X4270.Volume level set by participant (left),COL4A4,Collagen alpha-4(IV) chain,35790,-0.0210474047675899,0.0420332541880062,-0.103432582976082,0.0613377734409021,0.616576307083777
Physical measures,X4270.Volume level set by participant (left),CXCL11,C-X-C motif chemokine 11,36894,0.011769747152081,0.0235317894353669,-0.0343525601412381,0.0578920544454001,0.616974106619643
Physical measures,X4270.Volume level set by participant (left),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,35748,-0.0334318854318526,0.066851709675043,-0.164461236394937,0.0975974655312317,0.617028357828359
Physical measures,X4270.Volume level set by participant (left),IL17D,Interleukin-17D,36697,-0.0285179215394764,0.0570658455981599,-0.14036697891187,0.0833311358329171,0.617274849108922
Physical measures,X4270.Volume level set by participant (left),PAPPA,Pappalysin-1,36697,0.0203055544743802,0.0407268437500026,-0.0595190592756249,0.100130168224385,0.618090529282076
Physical measures,X4270.Volume level set by participant (left),SAT2,Thialysine N-epsilon-acetyltransferase,35798,-0.0169974043289109,0.0341713579687364,-0.0839732659476342,0.0499784572898125,0.618911794873616
Physical measures,X4270.Volume level set by participant (left),CD207,C-type lectin domain family 4 member K,36629,0.0242100787443658,0.0488287301353159,-0.0714942323208533,0.119914389809585,0.620038707202805
Physical measures,X4270.Volume level set by participant (left),FUCA1,Tissue alpha-L-fucosidase,36889,-0.011150671217484,0.0224947775919136,-0.0552404352976347,0.0329390928626667,0.620119936160222
Physical measures,X4270.Volume level set by participant (left),TBCC,Tubulin-specific chaperone C,36763,0.0122441539976565,0.0247667657070333,-0.0362987067881287,0.0607870147834417,0.621053319277921
Physical measures,X4270.Volume level set by participant (left),ZCCHC8,Zinc finger CCHC domain-containing protein 8,35706,-0.0175774207380853,0.0355816537439701,-0.0873174620762667,0.052162620600096,0.621321186063929
Physical measures,X4270.Volume level set by participant (left),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,36820,0.00965006535199255,0.0195663194382493,-0.028699920746976,0.0480000514509611,0.621887051841176
Physical measures,X4270.Volume level set by participant (left),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35903,0.014969405379618,0.0303556017854069,-0.0445275741197796,0.0744663848790156,0.621933449500606
Physical measures,X4270.Volume level set by participant (left),FZD8,Frizzled-8,35680,0.0250793378693191,0.0508771254520674,-0.0746398280167331,0.124798503755371,0.622072127343844
Physical measures,X4270.Volume level set by participant (left),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35903,0.0119895140839706,0.024353271114007,-0.0357428972994832,0.0597219254674244,0.622511824517308
Physical measures,X4270.Volume level set by participant (left),ATP1B4,Protein ATP1B4,35678,-0.0261293882395515,0.0530771651271931,-0.13016063188885,0.0779018554097469,0.622530615725606
Physical measures,X4270.Volume level set by participant (left),KLK10,Kallikrein-10,36844,0.0224652446196994,0.0457106780294299,-0.0671276843179831,0.112058173557382,0.623110990995745
Physical measures,X4270.Volume level set by participant (left),LTO1,Protein LTO1 homolog,36697,0.0214794830211333,0.043813790109783,-0.0643955455940413,0.107354511636308,0.623975019464372
Physical measures,X4270.Volume level set by participant (left),WIF1,Wnt inhibitory factor 1,36888,0.0266044591459102,0.0543403470389699,-0.0799026210504707,0.133111539342291,0.624438425839497
Physical measures,X4270.Volume level set by participant (left),CNTNAP2,Contactin-associated protein-like 2,36820,-0.0224382247456847,0.0458746462059655,-0.112352531309377,0.0674760818180077,0.624770540551131
Physical measures,X4270.Volume level set by participant (left),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,36894,-0.0187118980044036,0.0382573205408002,-0.093696246264372,0.0562724502555648,0.624780350173015
Physical measures,X4270.Volume level set by participant (left),LEPR,Leptin receptor,36828,-0.0294095037011042,0.0602018418938402,-0.147405113813031,0.0885861064108226,0.625199130543684
Physical measures,X4270.Volume level set by participant (left),NFASC,Neurofascin,36908,-0.031783900068236,0.0650943109845951,-0.159368749598042,0.0958009494615703,0.625369219037824
Physical measures,X4270.Volume level set by participant (left),DGKZ,Diacylglycerol kinase zeta,36697,-0.0264055181120536,0.0542291244825055,-0.132694602097764,0.0798835658736572,0.626325689273667
Physical measures,X4270.Volume level set by participant (left),B2M,Beta-2-microglobulin,35953,-0.0315201718107809,0.0647807221734743,-0.158490387270791,0.0954500436492287,0.626580886155692
Physical measures,X4270.Volume level set by participant (left),S100A3,Protein S100-A3,35874,0.0248894176029663,0.0511976156477372,-0.0754579090665985,0.125236744272531,0.626880971908906
Physical measures,X4270.Volume level set by participant (left),IFT20,Intraflagellar transport protein 20 homolog,35741,0.0248822372399612,0.0511995197018247,-0.0754688213756153,0.125233295855538,0.626993537961429
Physical measures,X4270.Volume level set by participant (left),CLEC3B,Tetranectin,35775,-0.0509403028658998,0.104891634859129,-0.256527907189793,0.154647301457994,0.627233675496043
Physical measures,X4270.Volume level set by participant (left),M6PR,Cation-dependent mannose-6-phosphate receptor,35748,0.0264510356316888,0.0545019547445792,-0.0803727956676864,0.133274866931064,0.627463687655211
Physical measures,X4270.Volume level set by participant (left),FRMD4B,FERM domain-containing protein 4B,35706,0.0142698780658753,0.029418826087211,-0.0433910210650582,0.0719307771968088,0.627650536164859
Physical measures,X4270.Volume level set by participant (left),SULT1A1,Sulfotransferase 1A1,36894,0.00745365946258178,0.0153690728082976,-0.0226697232416814,0.037577042166845,0.627705879156543
Physical measures,X4270.Volume level set by participant (left),IL9,Interleukin-9,35798,0.0183536182919308,0.037976157139458,-0.0560796497014068,0.0927868862852684,0.628903601014351
Physical measures,X4270.Volume level set by participant (left),MTSS2,Protein MTSS 2,35874,0.011084456402379,0.0229543154178409,-0.0339060018165892,0.0560749146213471,0.629188219546335
Physical measures,X4270.Volume level set by participant (left),BTN1A1,Butyrophilin subfamily 1 member A1,35867,0.0273268318892925,0.0566171078500628,-0.0836426994968307,0.138296363275416,0.629352775457509
Physical measures,X4270.Volume level set by participant (left),LGALS8,Galectin-8,36894,0.0150973459958213,0.0312807558052644,-0.0462129353824968,0.0764076273741395,0.629365052296121
Physical measures,X4270.Volume level set by participant (left),TAX1BP1,Tax1-binding protein 1,35903,0.0161221654263707,0.0334242911830469,-0.0493894452924012,0.0816337761451426,0.6295739571484
Physical measures,X4270.Volume level set by participant (left),CILP,Cartilage intermediate layer protein 1,35931,0.0194397570047789,0.0403260053513372,-0.0595992134838421,0.0984787274933998,0.629775417514289
Physical measures,X4270.Volume level set by participant (left),LSM8,U6 snRNA-associated Sm-like protein LSm8,35798,-0.0119100130420253,0.0247150829141442,-0.0603515755537478,0.0365315494696973,0.629898291890417
Physical measures,X4270.Volume level set by participant (left),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",36770,0.0210118048159146,0.0436504996042933,-0.0645431744085004,0.106566784040329,0.630271307459629
Physical measures,X4270.Volume level set by participant (left),MENT,Protein MENT,35779,0.0480150704663759,0.0997915724472922,-0.147576411530317,0.243606552463069,0.630423357340132
Physical measures,X4270.Volume level set by participant (left),EDA2R,Tumor necrosis factor receptor superfamily member 27,36888,0.0225396500798874,0.0468611427009792,-0.0693081896140319,0.114387489773807,0.630538667910856
Physical measures,X4270.Volume level set by participant (left),VPS53,Vacuolar protein sorting-associated protein 53 homolog,36770,0.0116770547372571,0.0242829597496115,-0.0359175463719814,0.0592716558464957,0.630619629918462
Physical measures,X4270.Volume level set by participant (left),NAA10,N-alpha-acetyltransferase 10,35706,-0.0214230237860997,0.0446142464389362,-0.108866946806415,0.0660208992342152,0.631113074006759
Physical measures,X4270.Volume level set by participant (left),IL32,Interleukin-32,36820,-0.0209765456762428,0.0437087818297931,-0.106645758062637,0.0646926667101517,0.631300861623592
Physical measures,X4270.Volume level set by participant (left),SELENOP,Selenoprotein P,35953,-0.0444442909682249,0.0926997132381167,-0.226135728914934,0.137247146978484,0.631638549689151
Physical measures,X4270.Volume level set by participant (left),VWF,von Willebrand factor,36933,0.0119959304784295,0.0250234155925407,-0.0370499640829503,0.0610418250398093,0.631676028619145
Physical measures,X4270.Volume level set by participant (left),AMY2A,Pancreatic alpha-amylase,36545,-0.0193763041396782,0.0404634342862505,-0.0986846353407291,0.0599320270613728,0.632052758974414
Physical measures,X4270.Volume level set by participant (left),NUDT16,U8 snoRNA-decapping enzyme,35886,0.0124201293618189,0.0259780815073081,-0.038496910392505,0.0633371691161427,0.632594420792206
Physical measures,X4270.Volume level set by participant (left),MLLT1,Protein ENL,35678,0.0154247401647534,0.0322975066364223,-0.0478783728426343,0.0787278531721411,0.632963137384651
Physical measures,X4270.Volume level set by participant (left),IL17RA,Interleukin-17 receptor A,36836,0.0203126471236532,0.042550526874207,-0.0630863855497926,0.103711679797099,0.633107275416365
Physical measures,X4270.Volume level set by participant (left),ITGBL1,Integrin beta-like protein 1,35931,0.027373355850331,0.0574038807095889,-0.0851382503404632,0.139884962041125,0.633480500029724
Physical measures,X4270.Volume level set by participant (left),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35894,0.00771146380173881,0.0161763765389265,-0.023994234214557,0.0394171618180347,0.633583167008392
Physical measures,X4270.Volume level set by participant (left),HSD17B3,Testosterone 17-beta-dehydrogenase 3,35706,0.0211135873615839,0.0443244967843362,-0.065762426335715,0.107989601058883,0.633847252379991
Physical measures,X4270.Volume level set by participant (left),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35953,-0.0543794500040219,0.114401449219792,-0.278606290474814,0.16984739046677,0.634560860083244
Physical measures,X4270.Volume level set by participant (left),PLXNB3,Plexin-B3,36814,-0.0190807898356313,0.0401477871826474,-0.0977704527136202,0.0596088730423575,0.634612586461255
Physical measures,X4270.Volume level set by participant (left),DNAJB8,DnaJ homolog subfamily B member 8,36697,-0.0156900113304498,0.0330227612552144,-0.0804146233906701,0.0490346007297705,0.634710164441728
Physical measures,X4270.Volume level set by participant (left),DKK1,Dickkopf-related protein 1,36894,0.0151406494093608,0.0319490143150888,-0.0474794186482133,0.0777607174669348,0.63558440376226
Physical measures,X4270.Volume level set by participant (left),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",35736,-0.0141365606455865,0.0298317704174241,-0.0726068306637376,0.0443337093725647,0.635604141330409
Physical measures,X4270.Volume level set by participant (left),KLB,Beta-klotho,36639,-0.0122584855282753,0.0258996016572996,-0.0630217047765826,0.038504733720032,0.636007424245635
Physical measures,X4270.Volume level set by participant (left),PDLIM7,PDZ and LIM domain protein 7,36865,0.00710644017502286,0.0150159028511964,-0.022324729413322,0.0365376097633677,0.636040503138236
Physical measures,X4270.Volume level set by participant (left),SH3GLB2,Endophilin-B2,35903,-0.0157368489299738,0.0333225242958643,-0.0810489965498679,0.0495752986899202,0.636757578504147
Physical measures,X4270.Volume level set by participant (left),PDGFC,Platelet-derived growth factor C,36654,0.0310295027388015,0.0657433328373738,-0.0978274296224512,0.159886435100054,0.636955259789948
Physical measures,X4270.Volume level set by participant (left),FEN1,Flap endonuclease 1,36654,-0.0143763233621236,0.0305055708867833,-0.0741672423002188,0.0454145955759716,0.637462589437202
Physical measures,X4270.Volume level set by participant (left),NADK,NAD kinase,36828,-0.0158300251887231,0.0335948402826146,-0.0816759121426477,0.0500158617652016,0.637508488587709
Physical measures,X4270.Volume level set by participant (left),HCLS1,Hematopoietic lineage cell-specific protein,36908,-0.0169270242156309,0.0359296434231088,-0.0873491253249241,0.0534950768936624,0.637571340091095
Physical measures,X4270.Volume level set by participant (left),ELOA,Elongin-A,36770,-0.0170721404526413,0.0362949618402132,-0.088210265659459,0.0540659847541765,0.638102679884782
Physical measures,X4270.Volume level set by participant (left),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,35748,-0.0221471431028172,0.0471109496020506,-0.114484604322836,0.070190318117202,0.638294890668226
Physical measures,X4270.Volume level set by participant (left),DSCAM,Down syndrome cell adhesion molecule,35903,0.0288752428770438,0.0614529608298803,-0.0915725603495215,0.149323046103609,0.638459222593664
Physical measures,X4270.Volume level set by participant (left),SGSH,N-sulphoglucosamine sulphohydrolase,35789,-0.0182819400052761,0.0389274933371864,-0.0945798269461615,0.0580159469356093,0.638627187550579
Physical measures,X4270.Volume level set by participant (left),STC2,Stanniocalcin-2,36828,-0.0349620383470886,0.0744913396125936,-0.180965063987772,0.111040987293595,0.638837418159441
Physical measures,X4270.Volume level set by participant (left),ABRAXAS2,BRISC complex subunit Abraxas 2,35706,0.0164800106341597,0.0351340793361097,-0.0523827848646153,0.0853428061329348,0.639042065112688
Physical measures,X4270.Volume level set by participant (left),PTGES2,Prostaglandin E synthase 2,35688,0.0197097248416333,0.0422436166698637,-0.0630877638312996,0.102507213514566,0.640821169955459
Physical measures,X4270.Volume level set by participant (left),FUS,RNA-binding protein FUS,36652,0.0233055396637624,0.0499627828320904,-0.0746215146871347,0.12123259401466,0.640901335049484
Physical measures,X4270.Volume level set by participant (left),MMP15,Matrix metalloproteinase-15,35916,0.0210032153237023,0.0450348172604691,-0.0672650265068171,0.109271457154222,0.640960595067277
Physical measures,X4270.Volume level set by participant (left),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35903,-0.024819479338488,0.0532867201079167,-0.129261450750005,0.0796224920730287,0.641393605560655
Physical measures,X4270.Volume level set by participant (left),PTPRR,Receptor-type tyrosine-protein phosphatase R,35903,0.0273741795102402,0.058802822489397,-0.087879352568978,0.142627711589458,0.641570709520713
Physical measures,X4270.Volume level set by participant (left),C2,Complement C2,36839,0.0359758407615253,0.077286420175359,-0.115505542782178,0.187457224305229,0.64159585256104
Physical measures,X4270.Volume level set by participant (left),SNRPB2,U2 small nuclear ribonucleoprotein B'',35903,-0.0240850814476254,0.0517421953354138,-0.125499784305036,0.0773296214097857,0.641601151183336
Physical measures,X4270.Volume level set by participant (left),CES3,Carboxylesterase 3,36770,0.0105013305015504,0.0225976183149853,-0.0337900013958208,0.0547926623989216,0.642152782144574
Physical measures,X4270.Volume level set by participant (left),ARHGAP25,Rho GTPase-activating protein 25,36654,-0.0155825371201737,0.0335616764078606,-0.0813634228795806,0.0501983486392331,0.642449563472413
Physical measures,X4270.Volume level set by participant (left),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35894,0.0184331238070539,0.039719479456848,-0.0594170559283683,0.096283303542476,0.642603570580379
Physical measures,X4270.Volume level set by participant (left),MRPL52,"39S ribosomal protein L52, mitochondrial",35660,-0.0402720261974376,0.0868282481085192,-0.210455392490135,0.12991134009526,0.642797712181503
Physical measures,X4270.Volume level set by participant (left),AARSD1,Alanyl-tRNA editing protein Aarsd1,36770,-0.0158367029464654,0.034212528259748,-0.0828932583355714,0.0512198524426406,0.643455138905764
Physical measures,X4270.Volume level set by participant (left),TXLNA,Alpha-taxilin,36763,0.0105845665204863,0.022975249064598,-0.0344469216461257,0.0556160546870983,0.645031178656682
Physical measures,X4270.Volume level set by participant (left),CCL7,C-C motif chemokine 7,36820,0.0145245449368446,0.0315761181886463,-0.0473646467129021,0.0764137365865914,0.64554001043331
Physical measures,X4270.Volume level set by participant (left),L1CAM,Neural cell adhesion molecule L1,36864,0.0290156873858807,0.0632263563451146,-0.0949079710505439,0.152939345822305,0.646306352403723
Physical measures,X4270.Volume level set by participant (left),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,36697,0.020665317648295,0.0450688198217983,-0.0676695692024296,0.10900020449902,0.646586407759716
Physical measures,X4270.Volume level set by participant (left),TMPRSS11B,Transmembrane protease serine 11B,35680,0.0135842192157176,0.0296557145322772,-0.0445409812675457,0.0717094196989809,0.64692171755293
Physical measures,X4270.Volume level set by participant (left),CKAP4,Cytoskeleton-associated protein 4,36868,-0.0295728787956113,0.0645625708616483,-0.156115517684442,0.0969697600932192,0.6469295696959
Physical measures,X4270.Volume level set by participant (left),CHRDL2,Chordin-like protein 2,36828,-0.0179452930290628,0.039251237753135,-0.0948777190252074,0.0589871329670818,0.647547140445077
Physical measures,X4270.Volume level set by participant (left),TYMP,Thymidine phosphorylase,36783,0.01356577974551,0.0296741332911978,-0.0445955215052377,0.0717270809962578,0.647570276641421
Physical measures,X4270.Volume level set by participant (left),LONP1,"Lon protease homolog, mitochondrial",35748,0.0119716678914198,0.0262867838861375,-0.0395504285254097,0.0634937643082493,0.648818351193609
Physical measures,X4270.Volume level set by participant (left),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",35678,-0.0203504351756378,0.0446983376159706,-0.10795917690294,0.0672583065516646,0.648920231413313
Physical measures,X4270.Volume level set by participant (left),CRYGD,Gamma-crystallin D,35903,-0.0104459321835448,0.0229661285955201,-0.0554595442307642,0.0345676798636746,0.649238502458936
Physical measures,X4270.Volume level set by participant (left),PDIA4,Protein disulfide-isomerase A4,35931,0.0164772675331273,0.0362711717748605,-0.0546142291455992,0.0875687642118538,0.649641958369242
Physical measures,X4270.Volume level set by participant (left),CES2,Cocaine esterase,36770,0.0150803500756418,0.0332388195137939,-0.0500677361713941,0.0802284363226778,0.650059983794457
Physical measures,X4270.Volume level set by participant (left),ZNRD2,Protein ZNRD2,35894,0.0139686203808208,0.0308112434798931,-0.0464214168397697,0.0743586576014112,0.650303404604198
Physical measures,X4270.Volume level set by participant (left),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,36836,-0.023151784546638,0.0511095770102455,-0.123326555486719,0.0770229863934431,0.650573636432658
Physical measures,X4270.Volume level set by participant (left),CAPS,Calcyphosin,35903,0.00971656226973038,0.0215053070045412,-0.0324338394591704,0.0518669639986311,0.651412118418123
Physical measures,X4270.Volume level set by participant (left),ARHGEF12,Rho guanine nucleotide exchange factor 12,36820,0.00882891558938657,0.0195491185629409,-0.0294873567939776,0.0471451879727507,0.651550349617541
Physical measures,X4270.Volume level set by participant (left),MEP1A,Meprin A subunit alpha,35894,0.013535697793735,0.0300484121603887,-0.045359190040627,0.0724305856280969,0.652391211801349
Physical measures,X4270.Volume level set by participant (left),CLEC14A,C-type lectin domain family 14 member A,36836,0.0259722201925225,0.0576748886364133,-0.0870705615348477,0.139015001919893,0.652491695089019
Physical measures,X4270.Volume level set by participant (left),THBD,Thrombomodulin,36828,0.0284008352726485,0.0630861729937416,-0.095248063795085,0.152049734340382,0.652585422798364
Physical measures,X4270.Volume level set by participant (left),DDHD2,Phospholipase DDHD2,35903,-0.0156500037462276,0.0347692956407598,-0.0837978232021168,0.0524978157096616,0.652645757434062
Physical measures,X4270.Volume level set by participant (left),TRAF3,"TNF receptor-associated factor 3, Isoform 2",35725,-0.0279246649604853,0.0621628360627579,-0.149763823643491,0.0939144937225201,0.653289315879862
Physical measures,X4270.Volume level set by participant (left),GH1,Somatotropin,36807,0.00497080773405864,0.0110714133819097,-0.0167291624944843,0.0266707779626016,0.653461178564647
Physical measures,X4270.Volume level set by participant (left),CPA1,Carboxypeptidase A1,36933,0.0133281668325569,0.0297037782101587,-0.0448912384593542,0.0715475721244679,0.653658671673052
Physical measures,X4270.Volume level set by participant (left),CD33,Myeloid cell surface antigen CD33,36864,0.0105059925524083,0.02345238340779,-0.0354606789268601,0.0564726640316767,0.654186632604575
Physical measures,X4270.Volume level set by participant (left),EHBP1,EH domain-binding protein 1,35916,0.0129714727282217,0.0289825382375131,-0.0438343022173039,0.0697772476737473,0.654484011599318
Physical measures,X4270.Volume level set by participant (left),CD226,CD226 antigen,35725,-0.0240341728344698,0.0537485005633055,-0.129381233938549,0.0813128882696089,0.65477446510739
Physical measures,X4270.Volume level set by participant (left),CSTB,Cystatin-B,36739,0.0192523443487915,0.0431407939199165,-0.0653036117342448,0.103808300431828,0.655416672304762
Physical measures,X4270.Volume level set by participant (left),CLSTN3,Calsyntenin-3,35903,-0.0318344943136744,0.0713590299281812,-0.17169819297291,0.108029204345561,0.65552695514858
Physical measures,X4270.Volume level set by participant (left),ZFYVE19,Abscission/NoCut checkpoint regulator,35894,-0.0114697861347618,0.025808670647719,-0.062054780604291,0.0391152083347674,0.656756209311814
Physical measures,X4270.Volume level set by participant (left),PROC,Vitamin K-dependent protein C,36839,0.0329699744348168,0.0744072427196125,-0.112868221295624,0.178808170165257,0.657704730932863
Physical measures,X4270.Volume level set by participant (left),AP3S2,AP-3 complex subunit sigma-2,35903,-0.020001345779479,0.0451723366895131,-0.108539125690925,0.0685364341319666,0.657940136540204
Physical measures,X4270.Volume level set by participant (left),CD177,CD177 antigen,36825,-0.00635971156252452,0.0144003226072468,-0.0345843438727283,0.0218649207476793,0.658764610362941
Physical measures,X4270.Volume level set by participant (left),CDNF,Cerebral dopamine neurotrophic factor,36770,-0.0257919263098193,0.0584484180841707,-0.140350825754794,0.0887669731351552,0.659025274374445
Physical measures,X4270.Volume level set by participant (left),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35798,-0.0210765812463777,0.047767273447157,-0.114700437202805,0.07254727471005,0.659057505333583
Physical measures,X4270.Volume level set by participant (left),PRKG1,cGMP-dependent protein kinase 1,35779,0.00787282434770651,0.0178640289900186,-0.02714067247273,0.042886321168143,0.659438721322342
Physical measures,X4270.Volume level set by participant (left),PMCH,Pro-MCH,35706,0.0114001507474913,0.025936905358166,-0.039436183754514,0.0622364852494966,0.660289271644118
Physical measures,X4270.Volume level set by participant (left),TRIM21,E3 ubiquitin-protein ligase TRIM21,36820,-0.0104619868098677,0.0238294440965506,-0.0571676972391069,0.0362437236193716,0.660647803846943
Physical measures,X4270.Volume level set by participant (left),PLTP,Phospholipid transfer protein,36910,-0.0230655248200768,0.0525455080624431,-0.126054720622465,0.0799236709823117,0.660700766838938
Physical measures,X4270.Volume level set by participant (left),USP8,Ubiquitin carboxyl-terminal hydrolase 8,36697,-0.00914056041834885,0.0209071060542045,-0.0501184882845896,0.0318373674478919,0.661979811354896
Physical measures,X4270.Volume level set by participant (left),CCDC134,Coiled-coil domain-containing protein 134,35874,0.0196236552004562,0.0449366883580643,-0.0684522539813498,0.107699564382262,0.662346223489005
Physical measures,X4270.Volume level set by participant (left),CALB1,Calbindin,36770,-0.0182623511194133,0.0418525619386919,-0.100293372519249,0.0637686702804228,0.66259549661198
Physical measures,X4270.Volume level set by participant (left),CD63,CD63 antigen,36748,0.0164338246735366,0.0376624758816289,-0.0573846280544561,0.0902522774015292,0.662599073407458
Physical measures,X4270.Volume level set by participant (left),S100A11,Protein S100-A11,36780,-0.0164307058904428,0.0376764190058218,-0.0902764871418534,0.0574150753609678,0.662776215098887
Physical measures,X4270.Volume level set by participant (left),CTSB,Cathepsin B,36839,-0.0150654859370246,0.0345530037461843,-0.082789373279546,0.0526584014054967,0.662841143923462
Physical measures,X4270.Volume level set by participant (left),NCLN,Nicalin,36697,-0.0170455031686898,0.0391320227629243,-0.0937442677840214,0.0596532614466418,0.663147034105587
Physical measures,X4270.Volume level set by participant (left),HYAL1,Hyaluronidase-1,36796,-0.0360936951970176,0.0828782483319114,-0.198535061927564,0.126347671533529,0.66320999902613
Physical measures,X4270.Volume level set by participant (left),SOST,Sclerostin,36807,0.0214229835994591,0.0492133932252086,-0.0750352671219497,0.117881234320868,0.663351226641492
Physical measures,X4270.Volume level set by participant (left),FOLR3,Folate receptor gamma,36847,-0.00428150715695214,0.00985670528079356,-0.0236006495073075,0.0150376351934032,0.664028340940719
Physical measures,X4270.Volume level set by participant (left),OTOA,Otoancorin,35680,0.0179906551311148,0.0414186249194119,-0.0631898497109325,0.0991711599731621,0.66404042245105
Physical measures,X4270.Volume level set by participant (left),SMAD5,Mothers against decapentaplegic homolog 5,36770,0.0404681315165332,0.0932033699860034,-0.142210473656033,0.2231467366891,0.664161594939827
Physical measures,X4270.Volume level set by participant (left),STXBP1,Syntaxin-binding protein 1,35903,0.0127034080489114,0.0292716713682231,-0.0446690678328058,0.0700758839306286,0.664314739942055
Physical measures,X4270.Volume level set by participant (left),CDH2,Cadherin-2,36828,-0.022187955175234,0.0512441027255406,-0.122626396517293,0.0782504861668255,0.665037516422251
Physical measures,X4270.Volume level set by participant (left),GPI,Glucose-6-phosphate isomerase,35926,-0.0203728980920365,0.0470887669481857,-0.11266688131048,0.0719210851264074,0.665283802900822
Physical measures,X4270.Volume level set by participant (left),OMP,Olfactory marker protein,35680,-0.0200463965655798,0.0464327020270531,-0.111054492538604,0.0709616994074443,0.665951921810972
Physical measures,X4270.Volume level set by participant (left),PSIP1,PC4 and SFRS1-interacting protein,36820,0.0128053120293022,0.0296760765654664,-0.0453597980390119,0.0709704220976164,0.666114973276516
Physical measures,X4270.Volume level set by participant (left),ABHD14B,Protein ABHD14B,36739,0.014667071515726,0.0340518993184687,-0.0520746511484726,0.0814087941799246,0.66667921269342
Physical measures,X4270.Volume level set by participant (left),SCRN1,Secernin-1,36820,0.0144684396329784,0.0336327423321868,-0.0514517353381078,0.0803886146040645,0.667070240711091
Physical measures,X4270.Volume level set by participant (left),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35903,0.0210088735031181,0.048893275560688,-0.0748219465958304,0.116839693602067,0.667436125848714
Physical measures,X4270.Volume level set by participant (left),TPR,Nucleoprotein TPR,35706,-0.0196873401044015,0.0458371732332275,-0.109528199641527,0.0701535194327244,0.667569257945868
Physical measures,X4270.Volume level set by participant (left),DPT,Dermatopontin,36933,0.031399428246911,0.0732196663150287,-0.112111117730545,0.174909974224367,0.668052536714774
Physical measures,X4270.Volume level set by participant (left),TEF,Thyrotroph embryonic factor,35706,-0.0235898102464779,0.0550104949993945,-0.131410380445291,0.0842307599523353,0.668065638535953
Physical measures,X4270.Volume level set by participant (left),KLRB1,Killer cell lectin-like receptor subfamily B member 1,36908,-0.0203342584263225,0.0474611049997257,-0.113358024225785,0.0726895073731399,0.668342428159812
Physical measures,X4270.Volume level set by participant (left),LELP1,Late cornified envelope-like proline-rich protein 1,35680,0.0131315718833673,0.0306498201825503,-0.0469420756744312,0.0732052194411658,0.66834592194813
Physical measures,X4270.Volume level set by participant (left),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35874,0.0114080833988515,0.0266877794833728,-0.0408999643885593,0.0637161311862622,0.66905468253987
Physical measures,X4270.Volume level set by participant (left),RHOC,Rho-related GTP-binding protein RhoC,36719,0.00729321678874398,0.0171245486753093,-0.0262708986148622,0.0408573321923502,0.670198368158395
Physical measures,X4270.Volume level set by participant (left),LTBP3,Latent-transforming growth factor beta-binding protein 3,36654,0.0155596777042603,0.0365798887502752,-0.0561369042462792,0.0872562596547998,0.670585414797918
Physical measures,X4270.Volume level set by participant (left),FLT3LG,Fms-related tyrosine kinase 3 ligand,36908,-0.023180613505949,0.0545213176976874,-0.130042396193416,0.0836811691815183,0.670727492316463
Physical measures,X4270.Volume level set by participant (left),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,36836,-0.0204399125455347,0.0481107336350288,-0.114736950470191,0.0738571253791218,0.670956970895454
Physical measures,X4270.Volume level set by participant (left),CORO6,Coronin-6,35680,-0.026073188689643,0.0615080980572573,-0.146629060881867,0.0944826835025813,0.671653923536044
Physical measures,X4270.Volume level set by participant (left),TPT1,Translationally-controlled tumor protein,36697,0.0121124331851453,0.0285747128368011,-0.0438940039749848,0.0681188703452754,0.671660793175088
Physical measures,X4270.Volume level set by participant (left),CD4,T-cell surface glycoprotein CD4,36811,0.0257569471006863,0.0608553251690934,-0.0935194902307367,0.145033384432109,0.67212565483737
Physical measures,X4270.Volume level set by participant (left),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35798,0.0195743502195338,0.0463558855210521,-0.0712831854017282,0.110431885840796,0.67284720884879
Physical measures,X4270.Volume level set by participant (left),MESD,LRP chaperone MESD,36836,0.0067894973041447,0.0160936090275736,-0.0247539763898995,0.0383329709981889,0.673127858330288
Physical measures,X4270.Volume level set by participant (left),STX8,Syntaxin-8,36820,0.015984436783703,0.0379630952682639,-0.0584232299420944,0.0903921035095003,0.673728989148094
Physical measures,X4270.Volume level set by participant (left),ZP4,Zona pellucida sperm-binding protein 4,35678,0.0273567435874033,0.0650230590243097,-0.100088452100244,0.15480193927505,0.673970784615701
Physical measures,X4270.Volume level set by participant (left),SOD3,Extracellular superoxide dismutase,35926,0.015477149657836,0.0368287003362554,-0.0567071030012245,0.0876614023168966,0.674318465130186
Physical measures,X4270.Volume level set by participant (left),YWHAQ,14-3-3 protein theta,35779,-0.0130131162807509,0.0311103432119498,-0.0739893889761725,0.0479631564146708,0.675749432336133
Physical measures,X4270.Volume level set by participant (left),SCGB3A1,Secretoglobin family 3A member 1,35779,-0.0350101619984501,0.083709792488597,-0.1990813552761,0.1290610312792,0.67579072612913
Physical measures,X4270.Volume level set by participant (left),EVI5,Ecotropic viral integration site 5 protein homolog,35725,0.0108516569305381,0.0259773619577119,-0.0400639725065772,0.0617672863676535,0.676154516119109
Physical measures,X4270.Volume level set by participant (left),UNC79,Protein unc-79 homolog,35678,0.01654466436901,0.0396083440475801,-0.0610876899642469,0.094177018702267,0.67617552716149
Physical measures,X4270.Volume level set by participant (left),AOC3,Membrane primary amine oxidase,36863,-0.0258136658018499,0.0618393635604677,-0.147018818380367,0.0953914867766669,0.676374892511872
Physical measures,X4270.Volume level set by participant (left),SRC,Proto-oncogene tyrosine-protein kinase Src,36842,0.00671571958526407,0.0161009296721486,-0.0248421025721473,0.0382735417426754,0.676615985369283
Physical measures,X4270.Volume level set by participant (left),IL36A,Interleukin-36 alpha,35725,-0.016272990816061,0.0390204273001217,-0.0927530283242995,0.0602070466921775,0.676664516425747
Physical measures,X4270.Volume level set by participant (left),MED18,Mediator of RNA polymerase II transcription subunit 18,36654,0.0109801333806667,0.0263514672640561,-0.0406687424568832,0.0626290092182166,0.676924367300846
Physical measures,X4270.Volume level set by participant (left),BATF,Basic leucine zipper transcriptional factor ATF-like,35741,0.0109169295513802,0.0262078437563596,-0.0404504442110847,0.0622843033138451,0.677019791640431
Physical measures,X4270.Volume level set by participant (left),ANGPTL7,Angiopoietin-related protein 7,36888,-0.0217920219933881,0.0523795423751361,-0.124455925048655,0.0808718810618787,0.67739182243961
Physical measures,X4270.Volume level set by participant (left),TCTN3,Tectonic-3,35916,0.0303229897531336,0.072925105394521,-0.112610216820128,0.173256196326395,0.677562303298365
Physical measures,X4270.Volume level set by participant (left),CR1,Complement receptor type 1,35887,0.0255983699129893,0.0616494745055248,-0.0952346001178394,0.146431339943818,0.677990908449729
Physical measures,X4270.Volume level set by participant (left),IGFBP6,Insulin-like growth factor-binding protein 6,36778,-0.0252223740187003,0.0607707332892375,-0.144333011265606,0.0938882632282052,0.67812329576714
Physical measures,X4270.Volume level set by participant (left),TP53BP1,TP53-binding protein 1,35725,-0.0107056426015397,0.0257949763575346,-0.0612637962623075,0.0398525110592281,0.678134898583854
Physical measures,X4270.Volume level set by participant (left),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",36836,-0.0175392012707052,0.042512254395071,-0.100863219885044,0.0657848173436341,0.679934633583887
Physical measures,X4270.Volume level set by participant (left),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,35556,0.00922900984099743,0.0223819737617609,-0.0346396587320539,0.0530976784140488,0.680103257162628
Physical measures,X4270.Volume level set by participant (left),ARL13B,ADP-ribosylation factor-like protein 13B,35706,0.0135127583053253,0.0327745141966689,-0.0507252895201458,0.0777508061307963,0.680137015083158
Physical measures,X4270.Volume level set by participant (left),S100A14,Protein S100-A14,35903,-0.01684105784762,0.0408647481119121,-0.0969359641469677,0.0632538484517278,0.680266833513672
Physical measures,X4270.Volume level set by participant (left),NGRN,Neugrin,35903,-0.0416760157709461,0.101129415075946,-0.239889669319801,0.156537637777908,0.680275069766829
Physical measures,X4270.Volume level set by participant (left),LRP2BP,LRP2-binding protein,35741,0.0110535556113569,0.0268240601540729,-0.041521602290626,0.0636287135133398,0.680297101621513
Physical measures,X4270.Volume level set by participant (left),TMPRSS15,Enteropeptidase,36770,0.0085863396856352,0.0208541409434821,-0.0322877765635896,0.04946045593486,0.680546728122634
Physical measures,X4270.Volume level set by participant (left),GPRC5C,G-protein coupled receptor family C group 5 member C,35874,0.0162253550459736,0.039462895415884,-0.061121919969159,0.0935726300611062,0.68097229568717
Physical measures,X4270.Volume level set by participant (left),HCG22,Protein PBMUCL2,35706,-0.0163391601873478,0.0398268109137699,-0.0943997095783367,0.0617213892036412,0.681632182651489
Physical measures,X4270.Volume level set by participant (left),CPPED1,Serine/threonine-protein phosphatase CPPED1,36894,-0.0117622213464784,0.0286881670869145,-0.0679910288368308,0.044466586143874,0.681815495757031
Physical measures,X4270.Volume level set by participant (left),RWDD1,RWD domain-containing protein 1,36894,-0.0129769630908242,0.0316568932467164,-0.0750244738543883,0.0490705476727398,0.681872116165416
Physical measures,X4270.Volume level set by participant (left),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35903,0.016289348901218,0.0397375198985224,-0.061596190099886,0.094174887902322,0.681875055646954
Physical measures,X4270.Volume level set by participant (left),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,36763,-0.0267455785195995,0.0653500776182331,-0.154831730651336,0.101340573612137,0.682355895696504
Physical measures,X4270.Volume level set by participant (left),CTRL,Chymotrypsin-like protease CTRL-1,35903,0.0127757107910632,0.0312797970832845,-0.0485326914921745,0.0740841130743009,0.68296862976935
Physical measures,X4270.Volume level set by participant (left),MPO,Myeloperoxidase,36836,0.01599831564897,0.0392800721431324,-0.0609906257515694,0.0929872570495095,0.6838076327965
Physical measures,X4270.Volume level set by participant (left),CD55,Complement decay-accelerating factor,36594,0.029222390301518,0.0717692169524963,-0.111445274925375,0.169890055528411,0.683893705767546
Physical measures,X4270.Volume level set by participant (left),SDC4,Syndecan-4,36828,0.0161519980833235,0.0397395855972857,-0.0617375896873566,0.0940415858540035,0.684426278504412
Physical measures,X4270.Volume level set by participant (left),PTGDS,Prostaglandin-H2 D-isomerase,36739,0.0242771348129672,0.0597328502733491,-0.0927992517227971,0.141353521348731,0.684439288725865
Physical measures,X4270.Volume level set by participant (left),CXCL1,Growth-regulated alpha protein,36810,0.00814943613311027,0.0200664179108516,-0.0311807429721588,0.0474796152383793,0.684663557684769
Physical measures,X4270.Volume level set by participant (left),DNMBP,Dynamin-binding protein,36763,0.0126089050299815,0.031072760550118,-0.0482937056482498,0.0735115157082128,0.684910994292144
Physical measures,X4270.Volume level set by participant (left),RRP15,RRP15-like protein,35680,-0.00972106206565288,0.0240197246474657,-0.0567997223746856,0.0373575982433798,0.685702839855636
Physical measures,X4270.Volume level set by participant (left),CPE,Carboxypeptidase E,36837,0.0197213315519527,0.0487381042145926,-0.0758053527086488,0.115248015812554,0.685754308116427
Physical measures,X4270.Volume level set by participant (left),CNDP1,Beta-Ala-His dipeptidase,36863,-0.0157322381667649,0.0389038918712807,-0.0919838662344751,0.0605193899009452,0.68593925001509
Physical measures,X4270.Volume level set by participant (left),NCS1,Neuronal calcium sensor 1,36888,0.0261545115309449,0.0648331272355418,-0.100918417850717,0.153227440912607,0.686655807616035
Physical measures,X4270.Volume level set by participant (left),PRSS22,Brain-specific serine protease 4,35725,-0.0249177889941685,0.0617804153576145,-0.146007403095093,0.0961718251067559,0.686719945547767
Physical measures,X4270.Volume level set by participant (left),IL36G,Interleukin-36 gamma,35681,0.0136562663499978,0.0338829656916632,-0.0527543464056621,0.0800668791056577,0.686930440110196
Physical measures,X4270.Volume level set by participant (left),PECR,Peroxisomal trans-2-enoyl-CoA reductase,35748,-0.0319342183579759,0.0792718106436976,-0.187306967219623,0.123438530503671,0.687075717158359
Physical measures,X4270.Volume level set by participant (left),ABL1,Tyrosine-protein kinase ABL1,36770,0.0112015783060497,0.0278526163575669,-0.0433895497547814,0.0657927063668807,0.687567849529107
Physical measures,X4270.Volume level set by participant (left),DBH,Dopamine beta-hydroxylase,35903,-0.0077183872772538,0.0192030028392271,-0.0453562728421389,0.0299194982876313,0.687743587056223
Physical measures,X4270.Volume level set by participant (left),PDIA3,Protein disulfide-isomerase A3,35779,-0.035212424919094,0.0876592384598378,-0.207024532300376,0.136599682462188,0.687920311212148
Physical measures,X4270.Volume level set by participant (left),CHCHD6,MICOS complex subunit MIC25,35874,0.0311630228668373,0.0778228175575561,-0.121369699545973,0.183695745279647,0.688848554762763
Physical measures,X4270.Volume level set by participant (left),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,35779,-0.0216433870444249,0.0540595778198096,-0.127600159571252,0.0843133854824019,0.688903087939268
Physical measures,X4270.Volume level set by participant (left),KAZN,Kazrin,35894,0.0087800351164178,0.0220555329589956,-0.0344488094832135,0.0520088797160491,0.690578272684644
Physical measures,X4270.Volume level set by participant (left),CTRB1,Chymotrypsinogen B,36836,0.012928672771783,0.0324804783937428,-0.0507330648799528,0.0765904104235189,0.690608575494399
Physical measures,X4270.Volume level set by participant (left),CLEC7A,C-type lectin domain family 7 member A,36908,-0.0120413047447209,0.0302559847156294,-0.0713430347873546,0.0472604252979128,0.69065526500804
Physical measures,X4270.Volume level set by participant (left),FETUB,Fetuin-B,36839,0.0227065155923672,0.057086928094716,-0.0891838634732761,0.13459689465801,0.690823134045234
Physical measures,X4270.Volume level set by participant (left),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",35706,-0.0129298095903406,0.0325128474929872,-0.0766549906765956,0.0507953714959144,0.690876846454011
Physical measures,X4270.Volume level set by participant (left),AKT1S1,Proline-rich AKT1 substrate 1,36639,0.0123897503610387,0.0311782770896211,-0.0487196727346187,0.0734991734566961,0.691095664194395
Physical measures,X4270.Volume level set by participant (left),STAM,Signal transducing adapter molecule 1,35874,-0.0224548929790102,0.0565521367787118,-0.133297081065285,0.0883872951072649,0.691331974880422
Physical measures,X4270.Volume level set by participant (left),DCTN1,Dynactin subunit 1,36888,-0.0119563705586168,0.0301203472486643,-0.0709922511659987,0.0470795100487652,0.691412929509785
Physical measures,X4270.Volume level set by participant (left),IL2RA,Interleukin-2 receptor subunit alpha,36768,0.017943449872571,0.045206367153722,-0.0706610297487241,0.106547929493866,0.691435381944506
Physical measures,X4270.Volume level set by participant (left),UXS1,UDP-glucuronic acid decarboxylase 1,36654,0.0138757674175648,0.0349710823393934,-0.0546675539676462,0.0824190888027758,0.691542291295083
Physical measures,X4270.Volume level set by participant (left),LYPD1,Ly6/PLAUR domain-containing protein 1,36639,-0.0125604621311104,0.0317231830111868,-0.0747379008330366,0.0496169765708157,0.692160989763386
Physical measures,X4270.Volume level set by participant (left),CTAG1A_CTAG1B,Cancer/testis antigen 1,35781,0.0181357592397826,0.0459301605348759,-0.0718873554085741,0.108158873888139,0.692962600723565
Physical measures,X4270.Volume level set by participant (left),CDKL5,Cyclin-dependent kinase-like 5,35680,0.0173669877464403,0.0440828973472063,-0.069035491054084,0.103769466546965,0.693622029292222
Physical measures,X4270.Volume level set by participant (left),ORM1,Alpha-1-acid glycoprotein 1,35926,0.0416525068590202,0.10593516991258,-0.165980426169636,0.249285439887677,0.694192605242072
Physical measures,X4270.Volume level set by participant (left),SPP1,Osteopontin,36925,0.0150168495335062,0.0382507530521689,-0.0599546264487448,0.0899883255157573,0.694633416913755
Physical measures,X4270.Volume level set by participant (left),SMAD2,Mothers against decapentaplegic homolog 2,35874,-0.0126124715487003,0.0321704741154621,-0.0756666008150059,0.0504416577176054,0.695032929247047
Physical measures,X4270.Volume level set by participant (left),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,36888,0.0255821228291023,0.065426825463365,-0.102654455079093,0.153818700737298,0.695805422113285
Physical measures,X4270.Volume level set by participant (left),TXNDC9,Thioredoxin domain-containing protein 9,35903,0.016233986432252,0.0415586382394175,-0.0652209445170064,0.0976889173815103,0.696084301589653
Physical measures,X4270.Volume level set by participant (left),KDM3A,Lysine-specific demethylase 3A,35725,-0.00994716222821926,0.0254658349941863,-0.0598601988168244,0.0399658743603859,0.696099659934134
Physical measures,X4270.Volume level set by participant (left),CLEC10A,C-type lectin domain family 10 member A,36763,0.0204777640637028,0.0525551750938033,-0.0825303791201516,0.123485907247557,0.69681140570906
Physical measures,X4270.Volume level set by participant (left),GDNF,Glial cell line-derived neurotrophic factor,36639,0.0197458537029745,0.0506791399017364,-0.0795852605044289,0.119076967910378,0.696825102377638
Physical measures,X4270.Volume level set by participant (left),CD7,T-cell antigen CD7,35716,-0.0198717680041635,0.0510511411635767,-0.119932004684774,0.0801884686764468,0.697102321039171
Physical measures,X4270.Volume level set by participant (left),SDK2,Protein sidekick-2,35779,0.0217124855212642,0.0558003630874769,-0.0876562261301905,0.131081197172719,0.697207281039984
Physical measures,X4270.Volume level set by participant (left),PRDX5,"Peroxiredoxin-5, mitochondrial",36908,0.01202463807315,0.0309349228453574,-0.0486078107037506,0.0726570868500505,0.697503228669189
Physical measures,X4270.Volume level set by participant (left),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,36933,0.0267294271285088,0.0687887069183445,-0.108096438431446,0.161555292688464,0.697602812581224
Physical measures,X4270.Volume level set by participant (left),REG3G,Regenerating islet-derived protein 3-gamma,35874,0.0217009383347091,0.0558602948089725,-0.0877852394908771,0.131187116160295,0.69766885374578
Physical measures,X4270.Volume level set by participant (left),IMPG1,Interphotoreceptor matrix proteoglycan 1,35680,-0.0301246562082853,0.077581689060116,-0.182184766766113,0.121935454349542,0.697809778688407
Physical measures,X4270.Volume level set by participant (left),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,36820,0.0187084382460232,0.0481829369616363,-0.075730118198784,0.11314699469083,0.697820178303517
Physical measures,X4270.Volume level set by participant (left),IGSF3,Immunoglobulin superfamily member 3,36770,-0.0211930641740623,0.0546409698368433,-0.128289365054275,0.0859032367061507,0.698130303401813
Physical measures,X4270.Volume level set by participant (left),CEP170,Centrosomal protein of 170 kDa,35748,0.0109337393839101,0.0282009601875449,-0.0443401425836779,0.0662076213514982,0.698244691539609
Physical measures,X4270.Volume level set by participant (left),LRRC37A2,Leucine-rich repeat-containing protein 37A2,35894,-0.019654637545004,0.0508600892553348,-0.11934041248546,0.0800311373954523,0.699179254830432
Physical measures,X4270.Volume level set by participant (left),RELB,Transcription factor RelB,35725,-0.0168309969929399,0.0436735985418106,-0.102431250134889,0.0687692561490089,0.699967342184315
Physical measures,X4270.Volume level set by participant (left),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,36856,-0.0139924739822953,0.0363247065957076,-0.0851888989098823,0.0572039509452916,0.700095922463287
Physical measures,X4270.Volume level set by participant (left),NT5C3A,Cytosolic 5'-nucleotidase 3A,36807,-0.00897011896828493,0.0233461276556946,-0.0547285291734463,0.0367882912368765,0.700823915557466
Physical measures,X4270.Volume level set by participant (left),RPE,Ribulose-phosphate 3-epimerase,35798,0.0122463054014944,0.0319313243373421,-0.0503390902996961,0.0748317011026848,0.701346504742958
Physical measures,X4270.Volume level set by participant (left),MYO9B,Unconventional myosin-IXb,36697,0.0103088361657149,0.0269160273623362,-0.0424465774644641,0.0630642497958939,0.701730682123574
Physical measures,X4270.Volume level set by participant (left),SMAD1,Mothers against decapentaplegic homolog 1,36654,0.00908015365225786,0.0237101688901243,-0.0373917773723857,0.0555520846769014,0.70175698059702
Physical measures,X4270.Volume level set by participant (left),MTDH,Protein LYRIC,35725,0.00945141242210782,0.0246886453596556,-0.0389383324828172,0.0578411573270328,0.701862535547397
Physical measures,X4270.Volume level set by participant (left),AKT2,RAC-beta serine/threonine-protein kinase,35903,0.00684122430746612,0.0178804821714141,-0.0282045207485055,0.0418869693634377,0.702022199029827
Physical measures,X4270.Volume level set by participant (left),CADPS,Calcium-dependent secretion activator 1,35741,0.0209770953796017,0.0548278239078136,-0.086485439479713,0.128439630238916,0.702029202190052
Physical measures,X4270.Volume level set by participant (left),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,35706,0.0409999731951349,0.107398648111059,-0.169501377102541,0.251501323492811,0.702655545992082
Physical measures,X4270.Volume level set by participant (left),SLC51B,Organic solute transporter subunit beta,35706,0.0111189063126059,0.0292132788476022,-0.0461391202286945,0.0683769328539062,0.703504057795618
Physical measures,X4270.Volume level set by participant (left),SOD2,"Superoxide dismutase [Mn], mitochondrial",36836,0.019003339074586,0.0499592691798242,-0.0789168285178694,0.116923506667041,0.703676426390486
Physical measures,X4270.Volume level set by participant (left),TSPAN8,Tetraspanin-8,35894,0.00816254763898265,0.0215002265175449,-0.0339778963354053,0.0503029916133706,0.70421773933995
Physical measures,X4270.Volume level set by participant (left),GUCA2A,Guanylin,36779,-0.020349453649713,0.0537237991167655,-0.125648099918573,0.0849491926191474,0.704862495622921
Physical measures,X4270.Volume level set by participant (left),RALB,Ras-related protein Ral-B,35725,-0.0277870528433897,0.0734817771238237,-0.171811336006084,0.116237230319305,0.705332282672445
Physical measures,X4270.Volume level set by participant (left),CXCL3,C-X-C motif chemokine 3,36829,-0.00740531510302013,0.0196005289991099,-0.0458223519412756,0.0310117217352353,0.705580763657074
Physical measures,X4270.Volume level set by participant (left),MAPT,Microtubule-associated protein tau,36639,-0.013970345722593,0.0369930295748582,-0.0864766836893151,0.0585359922441291,0.70570282950964
Physical measures,X4270.Volume level set by participant (left),TMOD4,Tropomodulin-4,35678,0.0210171383943999,0.0558208459153797,-0.0883917195997443,0.130425996388544,0.70654968581013
Physical measures,X4270.Volume level set by participant (left),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35903,-0.0258128914043579,0.0685856591155295,-0.160240783270796,0.10861500046208,0.706661264179248
Physical measures,X4270.Volume level set by participant (left),GSTT2B,Glutathione S-transferase theta-2B,35903,-0.00339608033729091,0.0090252230670389,-0.0210855175486872,0.0142933568741053,0.706714934102513
Physical measures,X4270.Volume level set by participant (left),LCAT,Phosphatidylcholine-sterol acyltransferase,35926,-0.0363680914352034,0.0967291509206805,-0.225957227239737,0.15322104436933,0.706944652690779
Physical measures,X4270.Volume level set by participant (left),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,35680,-0.0136892806645504,0.0365203063187387,-0.0852690810492783,0.0578905197201774,0.707791540722517
Physical measures,X4270.Volume level set by participant (left),ARAF,Serine/threonine-protein kinase A-Raf,35798,0.0126189577312323,0.0337007793818093,-0.053434569857114,0.0786724853195785,0.708088179230161
Physical measures,X4270.Volume level set by participant (left),AGRP,Agouti-related protein,36908,0.0133537871903619,0.0357831809941591,-0.0567812475581899,0.0834888219389138,0.709020169206189
Physical measures,X4270.Volume level set by participant (left),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,36820,0.00606805785981814,0.0162636715891163,-0.0258087384548499,0.0379448541744862,0.709080640884434
Physical measures,X4270.Volume level set by participant (left),THSD1,Thrombospondin type-1 domain-containing protein 1,35686,-0.0251006628768003,0.0672760869211401,-0.156961793242235,0.106760467488634,0.7090867050243
Physical measures,X4270.Volume level set by participant (left),ELAC1,Zinc phosphodiesterase ELAC protein 1,35903,0.0101343571168335,0.0271984561323874,-0.0431746169026458,0.0634433311363128,0.70945213616902
Physical measures,X4270.Volume level set by participant (left),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35894,0.00467816013485767,0.0125695908935671,-0.0199582380165338,0.0293145582862492,0.709770031918497
Physical measures,X4270.Volume level set by participant (left),MXRA8,Matrix remodeling-associated protein 8,35779,-0.0269474940494113,0.0725878611930961,-0.16921970198788,0.115324713889057,0.710470972742172
Physical measures,X4270.Volume level set by participant (left),RPA2,Replication protein A 32 kDa subunit,35725,0.0269200748012983,0.0727384242990856,-0.11564723682491,0.169487386427506,0.711324249889062
Physical measures,X4270.Volume level set by participant (left),MAGEA3,Melanoma-associated antigen 3,35798,0.0100062187105408,0.0270374309817483,-0.0429871460136859,0.0629995834347675,0.711329073111965
Physical measures,X4270.Volume level set by participant (left),SELP,P-selectin,36863,0.0123227839733793,0.0333473720921934,-0.0530380653273196,0.0776836332740783,0.711744497071842
Physical measures,X4270.Volume level set by participant (left),DRG2,Developmentally-regulated GTP-binding protein 2,36770,0.0126586056480351,0.0342857606060947,-0.0545414851399105,0.0798586964359808,0.711982395055362
Physical measures,X4270.Volume level set by participant (left),SEZ6,Seizure protein 6 homolog,35741,-0.0258668632387758,0.0702909666514505,-0.163637157875619,0.111903431398067,0.712887390345306
Physical measures,X4270.Volume level set by participant (left),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,35678,0.0141047878049562,0.0383689258958426,-0.0610983069508953,0.0893078825608077,0.713176314608215
Physical measures,X4270.Volume level set by participant (left),GRPEL1,"GrpE protein homolog 1, mitochondrial",36770,0.0118965216909395,0.0324943823091366,-0.0517924676349683,0.0755855110168472,0.714293144899138
Physical measures,X4270.Volume level set by participant (left),CDAN1,Codanin-1,35903,-0.0323300676302414,0.088488659422603,-0.205767840098543,0.141107704838061,0.714855475106873
Physical measures,X4270.Volume level set by participant (left),SMARCA2,Probable global transcription activator SNF2L2,36639,0.0101193166000405,0.0277542046229385,-0.0442789244609189,0.0645175576609998,0.715416780822092
Physical measures,X4270.Volume level set by participant (left),RNASE10,Inactive ribonuclease-like protein 10,35748,0.0166706863798926,0.0457616220759051,-0.0730220928888813,0.106363465648667,0.715650204281942
Physical measures,X4270.Volume level set by participant (left),PSMC3,26S proteasome regulatory subunit 6A,35678,-0.0256052471361967,0.0703141970183211,-0.163421073292106,0.112210579019713,0.715754352332154
Physical measures,X4270.Volume level set by participant (left),BID,BH3-interacting domain death agonist,36820,0.010089782781876,0.0277471148794114,-0.0442945623817704,0.0644741279455224,0.716141730036345
Physical measures,X4270.Volume level set by participant (left),NFIC,Nuclear factor 1 C-type,35903,0.0179192227839786,0.0493063601815893,-0.0787212431719365,0.114559688739894,0.716297993722229
Physical measures,X4270.Volume level set by participant (left),DSC2,Desmocollin-2,36762,0.0199707276713109,0.0549770029704827,-0.0877841981508353,0.127725653493457,0.716423788040615
Physical measures,X4270.Volume level set by participant (left),USP25,Ubiquitin carboxyl-terminal hydrolase 25,35874,-0.0118186227693042,0.0325471461333195,-0.0756110291906104,0.0519737836520019,0.71652437443144
Physical measures,X4270.Volume level set by participant (left),SLC13A1,Solute carrier family 13 member 1,35874,0.0125301057929267,0.0345378397897618,-0.0551640601950064,0.0802242717808597,0.716770587615293
Physical measures,X4270.Volume level set by participant (left),SLA2,Src-like-adapter 2,35903,0.00780972731701049,0.0215578372505368,-0.0344436336940416,0.0500630883280626,0.717162742908056
Physical measures,X4270.Volume level set by participant (left),TST,Thiosulfate sulfurtransferase,36614,0.00946002172583198,0.0261494162605645,-0.0417928341448744,0.0607128775965384,0.717535720989027
Physical measures,X4270.Volume level set by participant (left),HJV,Hemojuvelin,35903,0.0176790868496775,0.0488857686697502,-0.0781370197430328,0.113495193442388,0.717631890188551
Physical measures,X4270.Volume level set by participant (left),PMS1,PMS1 protein homolog 1,35741,0.0161425392332592,0.0447476180885087,-0.0715627922202178,0.103847870686736,0.718300727304195
Physical measures,X4270.Volume level set by participant (left),CMIP,C-Maf-inducing protein,35874,0.00972502266082388,0.0269932918805586,-0.0431818294250709,0.0626318747467187,0.718652488899188
Physical measures,X4270.Volume level set by participant (left),IL16,Pro-interleukin-16,36908,-0.0167451236762169,0.0465031401537623,-0.107891278377591,0.0744010310251571,0.718792781105282
Physical measures,X4270.Volume level set by participant (left),IL10RA,Interleukin-10 receptor subunit alpha,36697,0.0115325730252871,0.032177076575567,-0.0515344970628241,0.0745996431133985,0.720046898679749
Physical measures,X4270.Volume level set by participant (left),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35798,0.00949519804211895,0.0265259693167904,-0.0424957018187903,0.0614860979030282,0.720385763726664
Physical measures,X4270.Volume level set by participant (left),SNX2,Sorting nexin-2,35874,0.00927396080351369,0.0260223416218444,-0.0417298287753012,0.0602777503823286,0.721563850140967
Physical measures,X4270.Volume level set by participant (left),TFF3,Trefoil factor 3,36824,0.0168661735761579,0.0473421012599776,-0.0759243448933982,0.109656692045714,0.721654504926719
Physical measures,X4270.Volume level set by participant (left),RSPO3,R-spondin-3,36888,-0.0238228221952972,0.0669231039942703,-0.154992106024067,0.107346461633473,0.72187050302778
Physical measures,X4270.Volume level set by participant (left),EFHD1,EF-hand domain-containing protein D1,35903,0.0217207013382898,0.0610264540664293,-0.0978911486319116,0.141332551308491,0.72190963850463
Physical measures,X4270.Volume level set by participant (left),SCN3B,Sodium channel subunit beta-3,35680,0.016985420028778,0.0477314721367181,-0.0765682653591896,0.110539105416746,0.721961724221312
Physical measures,X4270.Volume level set by participant (left),AFAP1,Actin filament-associated protein 1,35779,0.00918862539690319,0.0258666199860262,-0.0415099497757082,0.0598872005695146,0.722427921701341
Physical measures,X4270.Volume level set by participant (left),IFNGR1,Interferon gamma receptor 1,36865,0.0308760314135598,0.0869489452083602,-0.139543901194826,0.201295964021946,0.722520471605484
Physical measures,X4270.Volume level set by participant (left),TREML1,Trem-like transcript 1 protein,35926,-0.0146706070401791,0.041354787647853,-0.095725990829971,0.0663847767496128,0.7227880767723
Physical measures,X4270.Volume level set by participant (left),CD8A,T-cell surface glycoprotein CD8 alpha chain,36894,-0.0126629016695348,0.0357080218141416,-0.0826506244252524,0.0573248210861828,0.722881425824847
Physical measures,X4270.Volume level set by participant (left),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35894,0.0075791669981845,0.0213850562447013,-0.0343355432414301,0.0494938772377991,0.723039674091259
Physical measures,X4270.Volume level set by participant (left),SHH,Sonic hedgehog protein,35725,0.0180284649976452,0.0508764913259898,-0.0816894580012947,0.117746387996585,0.723082445228976
Physical measures,X4270.Volume level set by participant (left),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,35680,-0.0132669356915855,0.0374745216363483,-0.0867169980988281,0.0601831267156571,0.723331297517051
Physical measures,X4270.Volume level set by participant (left),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",35680,0.0145405774711302,0.041171703134379,-0.0661559606722527,0.0952371156145131,0.723973079210451
Physical measures,X4270.Volume level set by participant (left),CCL27,C-C motif chemokine 27,36828,0.0111602300758335,0.0316368717466987,-0.0508480385476959,0.0731684986993628,0.724277945919103
Physical measures,X4270.Volume level set by participant (left),IL2,Interleukin-2,36697,0.0214407692420538,0.0608378874402058,-0.0978014901407497,0.140683028624857,0.72452974493513
Physical measures,X4270.Volume level set by participant (left),SH3BP1,SH3 domain-binding protein 1,35894,0.0160897822930373,0.0458681602333715,-0.0738118117643708,0.105991376350445,0.725761998061212
Physical measures,X4270.Volume level set by participant (left),SNX9,Sorting nexin-9,36828,-0.0100593751060295,0.028895358357606,-0.0666942774869373,0.0465755272748783,0.727751274224774
Physical measures,X4270.Volume level set by participant (left),MYH4,Myosin-4,35706,0.016543287276135,0.0475364192426874,-0.0766280944395322,0.109714668991802,0.727841746902147
Physical measures,X4270.Volume level set by participant (left),CTNNA1,Catenin alpha-1,35680,0.0219885922034967,0.0632447310774228,-0.101971080708252,0.145948265115245,0.728095794452728
Physical measures,X4270.Volume level set by participant (left),SCN2A,Sodium channel protein type 2 subunit alpha,35680,0.0160659936304098,0.0463204642513391,-0.0747221163022148,0.106854103563034,0.728719476364773
Physical measures,X4270.Volume level set by participant (left),HPSE,Heparanase,35810,0.00821774828474486,0.0236945307663726,-0.0382235320173453,0.0546590285868351,0.728737233441478
Physical measures,X4270.Volume level set by participant (left),CSDE1,Cold shock domain-containing protein E1,35706,0.00655547061408372,0.0189716192426831,-0.0306289031015751,0.0437398443297426,0.729698925199371
Physical measures,X4270.Volume level set by participant (left),IL31RA,Interleukin-31 receptor subunit alpha,35708,-0.0203943752588512,0.0590748190248316,-0.136181020547521,0.0953922700298187,0.729932930774836
Physical measures,X4270.Volume level set by participant (left),CNPY4,Protein canopy homolog 4,36770,0.00898980772109386,0.0260914516178643,-0.0421494374499202,0.0601290528921079,0.730442323787321
Physical measures,X4270.Volume level set by participant (left),LACTB2,Endoribonuclease LACTB2,36828,0.0103732625864487,0.0301172118729424,-0.0486564726845185,0.0694029978574159,0.730532639061709
Physical measures,X4270.Volume level set by participant (left),BPIFB2,BPI fold-containing family B member 2,35900,-0.0110412544900078,0.0321061045675021,-0.0739692194423119,0.0518867104622963,0.730933095603165
Physical measures,X4270.Volume level set by participant (left),ANXA1,Annexin A1,35724,-0.0172352201623939,0.0502181047523303,-0.115662705476961,0.0811922651521735,0.731453566376168
Physical measures,X4270.Volume level set by participant (left),CLINT1,Clathrin interactor 1,35678,-0.0170800583798236,0.0498486628859152,-0.114783437636217,0.0806233208765702,0.731881737978493
Physical measures,X4270.Volume level set by participant (left),SCIN,Adseverin,35680,0.0105284002260226,0.0307638356104943,-0.0497687175705463,0.0708255180225915,0.732186634889854
Physical measures,X4270.Volume level set by participant (left),NCK2,Cytoplasmic protein NCK2,36865,0.00631487171093531,0.0184552354871657,-0.0298573898439095,0.0424871332657802,0.732230553005487
Physical measures,X4270.Volume level set by participant (left),ICOSLG,ICOS ligand,36770,-0.0330463155250214,0.0965932992809574,-0.222369182115698,0.156276551065655,0.732271514176137
Physical measures,X4270.Volume level set by participant (left),ANXA3,Annexin A3,36888,0.00975354927406846,0.0285433946605634,-0.0461915042606359,0.0656986028087728,0.73257885377311
Physical measures,X4270.Volume level set by participant (left),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,36891,0.0159539379138776,0.0467016820082912,-0.0755813588223731,0.107489234650128,0.732650898234105
Physical measures,X4270.Volume level set by participant (left),DDX39A,ATP-dependent RNA helicase DDX39A,35725,-0.0317808134251432,0.0932269999950977,-0.214505733415535,0.150944106565248,0.733192022697472
Physical measures,X4270.Volume level set by participant (left),AKR1B1,Aldo-keto reductase family 1 member B1,36654,0.00922235637961776,0.0270758838091198,-0.0438463758862571,0.0622910886454926,0.733405694199134
Physical measures,X4270.Volume level set by participant (left),FMNL1,Formin-like protein 1,36639,0.0108350331986951,0.031865475444199,-0.0516212986719349,0.0732913650693251,0.733847890322493
Physical measures,X4270.Volume level set by participant (left),CHIT1,Chitotriosidase-1,36874,-0.00393451173667014,0.0116029638209715,-0.0266763208257743,0.018807297352434,0.734547133306491
Physical measures,X4270.Volume level set by participant (left),ADAMTSL2,ADAMTS-like protein 2,35931,0.0218652272789331,0.0644994102563141,-0.104553616823442,0.148284071381309,0.734621150674971
Physical measures,X4270.Volume level set by participant (left),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,35725,-0.0210502441183129,0.0622796607141512,-0.143118379118049,0.101017890881423,0.73537745894549
Physical measures,X4270.Volume level set by participant (left),ECI2,Enoyl-CoA delta isomerase 2,35706,-0.0122486179595857,0.0362413772147331,-0.0832817173004624,0.0587844813812911,0.735394205938183
Physical measures,X4270.Volume level set by participant (left),EFCAB14,EF-hand calcium-binding domain-containing protein 14,35894,-0.0255833447093718,0.0757616198667252,-0.174076119648153,0.12290943022941,0.735613330926961
Physical measures,X4270.Volume level set by participant (left),PTP4A3,Protein tyrosine phosphatase type IVA 3,35725,0.0149423398203157,0.0442522723697111,-0.071792114024318,0.101676793664949,0.735628276637219
Physical measures,X4270.Volume level set by participant (left),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,36837,-0.0243729402282291,0.0724106286621893,-0.16629777240612,0.117551891949662,0.736432671400391
Physical measures,X4270.Volume level set by participant (left),KRT14,"Keratin, type I cytoskeletal 14",36417,-0.0224934749092444,0.0668941911587937,-0.15360608958048,0.108619139761991,0.736688705945443
Physical measures,X4270.Volume level set by participant (left),SHD,SH2 domain-containing adapter protein D,35697,-0.00844307321307327,0.025113233012993,-0.0576650099185395,0.0407788634923929,0.736730776787729
Physical measures,X4270.Volume level set by participant (left),DDX4,Probable ATP-dependent RNA helicase DDX4,35725,0.0139779820115635,0.0416674488801847,-0.0676902177935984,0.0956461818167255,0.737284918433794
Physical measures,X4270.Volume level set by participant (left),ANPEP,Aminopeptidase N,36847,-0.0226261179204237,0.0675968488693246,-0.1551159417043,0.109863705863453,0.737844366240931
Physical measures,X4270.Volume level set by participant (left),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,36836,0.0217352493953295,0.0649770675919339,-0.105619803084861,0.14909030187552,0.738006594269363
Physical measures,X4270.Volume level set by participant (left),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,36820,0.00728873902602198,0.0218034325155173,-0.0354459887043918,0.0500234667564358,0.738167524484968
Physical measures,X4270.Volume level set by participant (left),FCRL2,Fc receptor-like protein 2,36865,-0.0116950572171426,0.0350146907566643,-0.0803238511002047,0.0569337366659195,0.738385448932724
Physical measures,X4270.Volume level set by participant (left),DLGAP5,Disks large-associated protein 5,35903,0.0151526349867616,0.0454829433503569,-0.0739939339799379,0.104299203953461,0.739031599330637
Physical measures,X4270.Volume level set by participant (left),CNGB3,Cyclic nucleotide-gated cation channel beta-3,35680,0.0137943204754294,0.041415365354868,-0.0673797956201119,0.0949684365709707,0.739090305773229
Physical measures,X4270.Volume level set by participant (left),STX3,Syntaxin-3,35903,-0.0185295697645018,0.0558476997393395,-0.127991061253607,0.0909319217246036,0.74006007756545
Physical measures,X4270.Volume level set by participant (left),IL20RA,Interleukin-20 receptor subunit alpha,36697,0.0138242962753847,0.0417048387781199,-0.0679171877297304,0.0955657802804997,0.74029163597579
Physical measures,X4270.Volume level set by participant (left),GHR,Growth hormone receptor,35779,0.0257414217524235,0.0779123163662886,-0.126966718325502,0.178449561830349,0.741116087944794
Physical measures,X4270.Volume level set by participant (left),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",35706,0.0086085161869849,0.026066399971145,-0.0424816277564594,0.0596986601304292,0.741219159228079
Physical measures,X4270.Volume level set by participant (left),SRP14,Signal recognition particle 14 kDa protein,36770,0.0109356629242804,0.0332095959829677,-0.0541551452023364,0.0760264710508972,0.741943900072802
Physical measures,X4270.Volume level set by participant (left),FCN2,Ficolin-2,36763,0.0153438906358583,0.0466009958544475,-0.0759940612388588,0.106681842510575,0.741967531233713
Physical measures,X4270.Volume level set by participant (left),TXK,Tyrosine-protein kinase TXK,35798,-0.00938730085519494,0.0285273960363028,-0.0653009970863485,0.0465263953759586,0.742118765513182
Physical measures,X4270.Volume level set by participant (left),RLN1,Prorelaxin H1,35903,0.0150401627996826,0.0457877986036371,-0.0747039224634461,0.104784248062811,0.742562541335197
Physical measures,X4270.Volume level set by participant (left),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,35609,-0.0279357669268169,0.0850770400911531,-0.194686765505477,0.138815231651843,0.742651360140441
Physical measures,X4270.Volume level set by participant (left),LAMB1,Laminin subunit beta-1,35748,-0.0244022725087226,0.0743377718450466,-0.170104305325014,0.121299760307569,0.742723994940091
Physical measures,X4270.Volume level set by participant (left),FMR1,Synaptic functional regulator FMR1,36654,-0.0177881681544285,0.0542259719767519,-0.124071073228862,0.0884947369200052,0.742892297610836
Physical measures,X4270.Volume level set by participant (left),GLA,Alpha-galactosidase A,35762,-0.0196711137180365,0.0600067301857674,-0.137284304882141,0.0979420774460676,0.743061904535274
Physical measures,X4270.Volume level set by participant (left),CCDC28A,Coiled-coil domain-containing protein 28A,35741,-0.0248865582563354,0.076016315702364,-0.173878537032969,0.124105420520298,0.743387612587088
Physical measures,X4270.Volume level set by participant (left),CETN2,Centrin-2,36639,0.00937780578479641,0.0286736877580218,-0.0468226222209263,0.0655782337905191,0.743637256442822
Physical measures,X4270.Volume level set by participant (left),PQBP1,Polyglutamine-binding protein 1,36654,0.0110897866521234,0.0342490230548743,-0.0560382985354302,0.078217871839677,0.746099576166532
Physical measures,X4270.Volume level set by participant (left),S100G,Protein S100-G,35903,-0.0145633980209476,0.0452919383900008,-0.103335597265349,0.0742088012234539,0.747807409263002
Physical measures,X4270.Volume level set by participant (left),ERCC1,DNA excision repair protein ERCC-1,35678,0.0222301724002221,0.0692330413549968,-0.113466588655572,0.157926933456016,0.748151062402478
Physical measures,X4270.Volume level set by participant (left),EGFR,Epidermal growth factor receptor,36933,-0.0359027694230786,0.111828013733822,-0.255085676341371,0.183280137495213,0.748178559912329
Physical measures,X4270.Volume level set by participant (left),APOD,Apolipoprotein D,35672,-0.0173086595707322,0.0542886837322423,-0.123714479685927,0.0890971605444627,0.749868525886992
Physical measures,X4270.Volume level set by participant (left),IGF2R,Cation-independent mannose-6-phosphate receptor,36836,-0.025789674680685,0.0810759553887098,-0.184698547242556,0.133119197881186,0.75042326804027
Physical measures,X4270.Volume level set by participant (left),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,36894,0.0104727322459559,0.0329347962242201,-0.0540794683535154,0.0750249328454272,0.750505838210074
Physical measures,X4270.Volume level set by participant (left),TF,Serotransferrin,35953,-0.0316720491272876,0.0996628769740449,-0.227011287996416,0.16366718974184,0.750652661780999
Physical measures,X4270.Volume level set by participant (left),ENDOU,Poly(U)-specific endoribonuclease,35394,0.0135813584417037,0.0427561181430925,-0.0702206331187576,0.097383350002165,0.750763317842162
Physical measures,X4270.Volume level set by participant (left),ALDH2,"Aldehyde dehydrogenase, mitochondrial",35874,0.0121806124934735,0.0383572503577157,-0.0629995982076493,0.0873608231945964,0.750830942681617
Physical measures,X4270.Volume level set by participant (left),OTUD7B,OTU domain-containing protein 7B,35903,0.0112167519540037,0.0353385309362355,-0.0580467686810178,0.0804802725890252,0.75094350031211
Physical measures,X4270.Volume level set by participant (left),ZBTB17,Zinc finger and BTB domain-containing protein 17,36697,-0.013861454626674,0.0436871714191171,-0.0994883106081435,0.0717654013547956,0.751033230088021
Physical measures,X4270.Volume level set by participant (left),IFNL1,Interferon lambda-1,36639,-0.013609268477483,0.0429076256648005,-0.0977082147804919,0.070489677825526,0.75111896779682
Physical measures,X4270.Volume level set by participant (left),DMD,Dystrophin,35748,0.013060601366268,0.0412360952754034,-0.0677621453735227,0.0938833481060588,0.751460546044464
Physical measures,X4270.Volume level set by participant (left),GLOD4,Glyoxalase domain-containing protein 4,36820,-0.0180170509680423,0.0569080598909404,-0.129556848354285,0.0935227464182008,0.751556348911043
Physical measures,X4270.Volume level set by participant (left),CLMP,CXADR-like membrane protein,36888,0.0277489914567429,0.0877990275217204,-0.144337102485829,0.199835085399315,0.751972192903169
Physical measures,X4270.Volume level set by participant (left),GBP2,Guanylate-binding protein 2,36697,0.0102686665575903,0.0325240491134122,-0.0534784697046977,0.0740158028198783,0.752219774068562
Physical measures,X4270.Volume level set by participant (left),SAFB2,Scaffold attachment factor B2,35903,-0.023907568782535,0.0758760331211471,-0.172624593699983,0.124809456134913,0.752705230889752
Physical measures,X4270.Volume level set by participant (left),CLEC4C,C-type lectin domain family 4 member C,36820,-0.0122988258991144,0.039034482993541,-0.0888064125664547,0.0642087607682259,0.752712630132678
Physical measures,X4270.Volume level set by participant (left),HMOX2,Heme oxygenase 2,36639,0.0133429979970712,0.0425048770631705,-0.0699665610467429,0.0966525570408854,0.753592975298156
Physical measures,X4270.Volume level set by participant (left),IL18R1,Interleukin-18 receptor 1,36908,0.0177094435488974,0.056437392073413,-0.0929078449149921,0.128326732012787,0.753689643075223
Physical measures,X4270.Volume level set by participant (left),GSTM4,Glutathione S-transferase Mu 4,35706,0.00978127835584964,0.0312198100166669,-0.0514095492768175,0.0709721059885168,0.754060066403652
Physical measures,X4270.Volume level set by participant (left),TBR1,T-box brain protein 1,35741,0.0141910826253218,0.0454287673571396,-0.0748493013946717,0.103231466645315,0.754760960599499
Physical measures,X4270.Volume level set by participant (left),PF4,Platelet factor 4,35875,0.0069627174168316,0.0223644756157946,-0.0368716547901259,0.0507970896237891,0.755559983219051
Physical measures,X4270.Volume level set by participant (left),CLIC5,Chloride intracellular channel protein 5,35741,0.0220756407813554,0.0711085461179874,-0.1172971096099,0.161448391172611,0.756228741931814
Physical measures,X4270.Volume level set by participant (left),PXN,Paxillin,36639,0.0118279453167086,0.0380999362746473,-0.0628479297816001,0.0865038204150174,0.756231060307058
Physical measures,X4270.Volume level set by participant (left),PPT1,Palmitoyl-protein thioesterase 1,35741,0.00888465110179205,0.0286531482885406,-0.0472755195437476,0.0650448217473317,0.756513103015311
Physical measures,X4270.Volume level set by participant (left),PODXL,Podocalyxin,36770,0.0382012464601178,0.1232669807226,-0.203402035756178,0.279804528676414,0.756640538197468
Physical measures,X4270.Volume level set by participant (left),CD70,CD70 antigen,36820,0.0133666278270551,0.043141405742104,-0.0711905274274688,0.0979237830815789,0.756696483202265
Physical measures,X4270.Volume level set by participant (left),MMP9,Matrix metalloproteinase-9,36813,-0.00987588631454478,0.031894322319627,-0.0723887580610137,0.0526369854319241,0.756840145310314
Physical measures,X4270.Volume level set by participant (left),ITGB1,Integrin beta-1,36830,-0.0268426763128853,0.0868433899593214,-0.197055720633155,0.143370368007385,0.757259286806279
Physical measures,X4270.Volume level set by participant (left),WASF1,Wiskott-Aldrich syndrome protein family member 1,36697,0.00621105427523174,0.0201286471010565,-0.0332410940428391,0.0456632025933026,0.757658815598002
Physical measures,X4270.Volume level set by participant (left),ING1,Inhibitor of growth protein 1,36624,0.0129207581320348,0.0419562725536535,-0.069313536073126,0.0951550523371956,0.758123138477299
Physical measures,X4270.Volume level set by participant (left),SFTPA2,Pulmonary surfactant-associated protein A2,36654,0.0111687379442225,0.0364918317024028,-0.0603552521924869,0.082692728080932,0.759566506731389
Physical measures,X4270.Volume level set by participant (left),APOH,Beta-2-glycoprotein 1,36836,0.0166455307290317,0.0545134418817579,-0.0902008153592138,0.123491876817277,0.760109996089503
Physical measures,X4270.Volume level set by participant (left),SERPINA3,Alpha-1-antichymotrypsin,35912,-0.0433777164693122,0.142166440715581,-0.322023940271852,0.235268507333228,0.760284794065955
Physical measures,X4270.Volume level set by participant (left),LY9,T-lymphocyte surface antigen Ly-9,36730,0.0191178666481416,0.0627395443464035,-0.103851640270809,0.142087373567092,0.760589379207571
Physical measures,X4270.Volume level set by participant (left),RGCC,Regulator of cell cycle RGCC,35903,0.00888585332022588,0.029165086016885,-0.0482777152728686,0.0660494219133204,0.76062364954142
Physical measures,X4270.Volume level set by participant (left),BIN2,Bridging integrator 2,36836,0.00634555144210718,0.0208568600506902,-0.0345338942572455,0.0472249971414599,0.76095113586452
Physical measures,X4270.Volume level set by participant (left),CD82,CD82 antigen,35798,-0.0155541976848201,0.0511538377838348,-0.115815719741136,0.084707324371496,0.761086376688179
Physical measures,X4270.Volume level set by participant (left),IGLON5,IgLON family member 5,35678,-0.00753047491837915,0.0247973215415376,-0.0561332251397929,0.0410722753030346,0.761380697862364
Physical measures,X4270.Volume level set by participant (left),TSC22D1,TSC22 domain family protein 1,35903,0.0102290269224176,0.0336871584128268,-0.0557978035667229,0.0762558574115581,0.761405755390662
Physical measures,X4270.Volume level set by participant (left),XCL1,Lymphotactin,36888,0.0103988912124266,0.0342592519820355,-0.056749242672363,0.0775470250972162,0.761490185342034
Physical measures,X4270.Volume level set by participant (left),SLAMF8,SLAM family member 8,36654,0.0108016951792558,0.0355984309371704,-0.0589712294575981,0.0805746198161097,0.76156929645943
Physical measures,X4270.Volume level set by participant (left),CEMIP2,Cell surface hyaluronidase,35725,0.0198504213222359,0.0655716638577893,-0.108670039839031,0.148370882483503,0.762106307136108
Physical measures,X4270.Volume level set by participant (left),CGREF1,Cell growth regulator with EF hand domain protein 1,36828,0.0131641980199203,0.0434884919658688,-0.0720732462331826,0.0984016422730233,0.762122691292562
Physical measures,X4270.Volume level set by participant (left),HRAS,GTPase Hras,35772,0.00673271002094522,0.0222486599764742,-0.0368746635329443,0.0503400835748347,0.762195191360568
Physical measures,X4270.Volume level set by participant (left),TIA1,Nucleolysin TIA-1 isoform p40,36653,0.00494706430192842,0.0163764969765,-0.0271508697720115,0.0370449983758684,0.762597079062702
Physical measures,X4270.Volume level set by participant (left),SLC16A1,Monocarboxylate transporter 1,36639,0.00997589278095742,0.0330773336849338,-0.0548556812415129,0.0748074668034277,0.762970760488054
Physical measures,X4270.Volume level set by participant (left),LYPLA2,Acyl-protein thioesterase 2,35680,0.00599541043381573,0.0198896851255847,-0.0329883724123303,0.0449791932799617,0.763093887053513
Physical measures,X4270.Volume level set by participant (left),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,36763,0.00626336834565445,0.0207982472742034,-0.0345011963117843,0.0470279330030932,0.763309263996481
Physical measures,X4270.Volume level set by participant (left),DIPK2B,Divergent protein kinase domain 2B,35779,-0.0235023402714393,0.0781029986487571,-0.176584217623003,0.129579537080125,0.763489046624437
Physical measures,X4270.Volume level set by participant (left),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35903,-0.0136593330215336,0.045462036646121,-0.102764924847931,0.0754462588048635,0.7638388127135
Physical measures,X4270.Volume level set by participant (left),DOK1,Docking protein 1,35903,0.00522048683788004,0.0173781809421629,-0.0288407478087593,0.0392817214845194,0.76387780836437
Physical measures,X4270.Volume level set by participant (left),PHACTR2,Phosphatase and actin regulator 2,35903,0.00593807861859707,0.0197775237547123,-0.032825867940639,0.0447020251778331,0.764000514677976
Physical measures,X4270.Volume level set by participant (left),IMMT,MICOS complex subunit MIC60,35874,0.0152062030897909,0.0506484783450169,-0.0840648144664421,0.114477220646024,0.76401091269816
Physical measures,X4270.Volume level set by participant (left),PADI2,Protein-arginine deiminase type-2,36697,-0.0104149816478891,0.0347240672972188,-0.0784741535504379,0.0576441902546598,0.76423464180598
Physical measures,X4270.Volume level set by participant (left),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,36763,-0.0111422968178142,0.0371684087898001,-0.0839923780458224,0.061707784410194,0.764354207757284
Physical measures,X4270.Volume level set by participant (left),SLC27A4,Long-chain fatty acid transport protein 4,36639,0.0073230502548017,0.0244436185140789,-0.040586442032793,0.0552325425423964,0.764498698130661
Physical measures,X4270.Volume level set by participant (left),AHCY,Adenosylhomocysteinase,36828,0.00857806926740608,0.028650458232659,-0.0475768288686056,0.0647329674034178,0.764639765522978
Physical measures,X4270.Volume level set by participant (left),CA8,Carbonic anhydrase-related protein,35725,-0.0263953483663621,0.0882048106810118,-0.199276777301145,0.146486080568421,0.764758319691913
Physical measures,X4270.Volume level set by participant (left),RAB39B,Ras-related protein Rab-39B,35706,0.00735393963020473,0.0245795178637131,-0.040821915382673,0.0555297946430824,0.76480482714644
Physical measures,X4270.Volume level set by participant (left),IFNG,Interferon gamma,36697,0.00516715091802064,0.0172912191338394,-0.0287236385843047,0.0390579404203459,0.765077336996738
Physical measures,X4270.Volume level set by participant (left),IGFL4,Insulin growth factor-like family member 4,35725,-0.0091276842062625,0.0305469746287752,-0.0689997544786618,0.0507443860661368,0.765095962582677
Physical measures,X4270.Volume level set by participant (left),LTBR,Tumor necrosis factor receptor superfamily member 3,36789,-0.0188843959430202,0.0632369914337033,-0.142828899153079,0.105060107267038,0.765231351895001
Physical measures,X4270.Volume level set by participant (left),IL25,Interleukin-25,35649,-0.0196709288973363,0.0659107890956154,-0.148856075524742,0.10951421773007,0.765371034782565
Physical measures,X4270.Volume level set by participant (left),TAP1,Antigen peptide transporter 1,35798,0.0110213029821907,0.036984971128077,-0.0614692404288401,0.0835118463932216,0.765717049406186
Physical measures,X4270.Volume level set by participant (left),SH2D1A,SH2 domain-containing protein 1A,36820,-0.00944966643850393,0.0318588922366637,-0.0718930952223647,0.0529937623453568,0.766772346190707
Physical measures,X4270.Volume level set by participant (left),CHMP6,Charged multivesicular body protein 6,35916,0.0117980661286596,0.0398276939337438,-0.0662642139814782,0.0898603462387974,0.767065352072949
Physical measures,X4270.Volume level set by participant (left),IL12B,Interleukin-12 subunit beta,36908,-0.00973195818853171,0.0329865004270889,-0.074385499025626,0.0549215826485626,0.767980040729494
Physical measures,X4270.Volume level set by participant (left),PLAT,Tissue-type plasminogen activator,36909,0.0110457090917388,0.0374640142426107,-0.0623837588237782,0.0844751770072557,0.768127732670667
Physical measures,X4270.Volume level set by participant (left),WASHC3,WASH complex subunit 3,35903,0.00824886957047979,0.0281653515310754,-0.0469552194304279,0.0634529585713875,0.769628327559648
Physical measures,X4270.Volume level set by participant (left),EPHB4,Ephrin type-B receptor 4,36933,0.0206462241651584,0.0706390808990372,-0.117806374396955,0.159098822727271,0.770082188073786
Physical measures,X4270.Volume level set by participant (left),DPEP1,Dipeptidase 1,36748,0.0112478420924554,0.0384892782977289,-0.0641911433710932,0.086686827556004,0.770116414715831
Physical measures,X4270.Volume level set by participant (left),LYAR,Cell growth-regulating nucleolar protein,36654,0.0109060914274501,0.0373616439730696,-0.0623227307597664,0.0841349136146665,0.770366546753868
Physical measures,X4270.Volume level set by participant (left),SCGB1A1,Uteroglobin,36824,-0.00983894129301516,0.0337098913741984,-0.075910328386444,0.0562324458004136,0.770393159252566
Physical measures,X4270.Volume level set by participant (left),CD34,Hematopoietic progenitor cell antigen CD34,36871,-0.0227300305530809,0.0778921848465199,-0.17539871285226,0.129938651746098,0.770436723143266
Physical measures,X4270.Volume level set by participant (left),SCARB2,Lysosome membrane protein 2,36595,0.0171404672989855,0.0587493449106676,-0.0980082487259229,0.132289183323894,0.77048145504115
Physical measures,X4270.Volume level set by participant (left),THTPA,Thiamine-triphosphatase,35859,-0.00756269980244978,0.0259342588181137,-0.0583938470859526,0.043268447481053,0.770593595733128
Physical measures,X4270.Volume level set by participant (left),TP73,Tumor protein p73,35741,-0.0188752917624604,0.0649516843782714,-0.146180593143872,0.108430009618952,0.771362555795009
Physical measures,X4270.Volume level set by participant (left),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,36654,0.00550794932855945,0.0189657500410805,-0.0316649207519583,0.0426808194090772,0.771506400427319
Physical measures,X4270.Volume level set by participant (left),ISM1,Isthmin-1,36820,0.0138930258247292,0.0478871820069765,-0.0799658509089448,0.107751902558403,0.771732381543696
Physical measures,X4270.Volume level set by participant (left),CEP350,Centrosome-associated protein 350,35678,0.0174280022942836,0.0600772946473283,-0.10032349521448,0.135179499803047,0.771754375963945
Physical measures,X4270.Volume level set by participant (left),DLK1,Protein delta homolog 1,36933,-0.0099419638111177,0.03428044675127,-0.0771316394436068,0.0572477118213714,0.77180985619367
Physical measures,X4270.Volume level set by participant (left),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,36540,0.00660340931765963,0.0227891614950264,-0.0380633472125921,0.0512701658479114,0.772007297591497
Physical measures,X4270.Volume level set by participant (left),CFH,Complement factor H,35504,0.0284593060082967,0.0982335169767804,-0.164078387266193,0.220996999282786,0.772047053885729
Physical measures,X4270.Volume level set by participant (left),HK2,Hexokinase-2,36697,-0.0191582807336783,0.0661821749579,-0.148875343651162,0.110558782183806,0.772223648280419
Physical measures,X4270.Volume level set by participant (left),PPY,Pancreatic prohormone,36817,0.00532866353885192,0.0184277061829679,-0.0307896405797652,0.041446967657469,0.772462321299332
Physical measures,X4270.Volume level set by participant (left),MSLN,Mesothelin,36756,0.0092193823765517,0.0319163834739401,-0.053336729232371,0.0717754939854744,0.772696055900192
Physical measures,X4270.Volume level set by participant (left),TNFSF10,Tumor necrosis factor ligand superfamily member 10,36908,-0.0212772565379802,0.0737095764112651,-0.16574802630406,0.123193513228099,0.77284673685066
Physical measures,X4270.Volume level set by participant (left),AGT,Angiotensinogen,35926,-0.0223757508447266,0.0776280190615101,-0.174526668205286,0.129775166515833,0.773169438339414
Physical measures,X4270.Volume level set by participant (left),CD300E,CMRF35-like molecule 2,36863,0.0126791530838244,0.0440947617036548,-0.0737465798553391,0.0991048860229878,0.773704128463544
Physical measures,X4270.Volume level set by participant (left),ZHX2,Zinc fingers and homeoboxes protein 2,35903,-0.0193535300239388,0.0676178711115068,-0.151884557402492,0.113177497354615,0.774719113804978
Physical measures,X4270.Volume level set by participant (left),TRIM24,Transcription intermediary factor 1-alpha,35781,-0.00996035929340061,0.0348561966043724,-0.0782785046379705,0.0583577860511692,0.775074176139086
Physical measures,X4270.Volume level set by participant (left),APOB,Apolipoprotein B-100,35926,-0.0266747597257327,0.0934355655440902,-0.20980846819215,0.156458948740684,0.77527886235613
Physical measures,X4270.Volume level set by participant (left),TXNL1,Thioredoxin-like protein 1,35661,0.00636869450503691,0.0223227119990296,-0.037383821013061,0.0501212100231349,0.775422603526489
Physical measures,X4270.Volume level set by participant (left),DHPS,Deoxyhypusine synthase,35874,-0.0156825932568388,0.0550869757155599,-0.123653065659336,0.0922878791456587,0.775892120758991
Physical measures,X4270.Volume level set by participant (left),ITGB1BP2,Integrin beta-1-binding protein 2,36697,0.00510127052846685,0.017969725363086,-0.0301193911831817,0.0403219322401154,0.776509118576102
Physical measures,X4270.Volume level set by participant (left),MYBPC2,"Myosin-binding protein C, fast-type",35748,-0.00722781077702612,0.0254797181119514,-0.0571680582764509,0.0427124367223986,0.776672878927914
Physical measures,X4270.Volume level set by participant (left),DNAJC6,Putative tyrosine-protein phosphatase auxilin,35748,-0.00783326196551015,0.0276249006115413,-0.0619780671641311,0.0463115432331108,0.776758077021517
Physical measures,X4270.Volume level set by participant (left),EFCAB2,Dynein regulatory complex protein 8,35798,0.0178647358799932,0.0632348598614644,-0.106075589448477,0.141805061208463,0.777558238332229
Physical measures,X4270.Volume level set by participant (left),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,36634,-0.00971053750893754,0.0345993468886002,-0.077525257410594,0.0581041823927189,0.778981551964344
Physical measures,X4270.Volume level set by participant (left),LGALS3,Galectin-3,36860,0.0174627537276031,0.0623077358993106,-0.104660408635046,0.139585916090252,0.779280829137094
Physical measures,X4270.Volume level set by participant (left),CCND2,G1/S-specific cyclin-D2,35798,-0.0172079872071505,0.0616374474095087,-0.138017384129788,0.103601409715487,0.780114881765275
Physical measures,X4270.Volume level set by participant (left),NAMPT,Nicotinamide phosphoribosyltransferase,36654,-0.0100919303831915,0.0362537513908045,-0.0811492831091683,0.0609654223427853,0.780736623223388
Physical measures,X4270.Volume level set by participant (left),PLA2G4A,Cytosolic phospholipase A2,36865,0.00617548686030882,0.0222495466486127,-0.037433624570972,0.0497845982915896,0.781360981445901
Physical measures,X4270.Volume level set by participant (left),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,35725,0.0137603450488979,0.0496510917138741,-0.0835557947102954,0.111076484808091,0.781680742131799
Physical measures,X4270.Volume level set by participant (left),GAD2,Glutamate decarboxylase 2,35725,0.0135339733699862,0.0488349131276571,-0.0821824563602219,0.109250403100194,0.781683497653062
Physical measures,X4270.Volume level set by participant (left),RAD23B,UV excision repair protein RAD23 homolog B,36654,0.0120923231903535,0.0438671253404484,-0.0738872424769253,0.0980718888576324,0.782818410195749
Physical measures,X4270.Volume level set by participant (left),CLPS,Colipase,36813,0.0072004561478102,0.0261219615110393,-0.0439985884138268,0.0583995007094472,0.782826219852865
Physical measures,X4270.Volume level set by participant (left),TARBP2,RISC-loading complex subunit TARBP2,36639,0.00692064502371045,0.0251502867418364,-0.042373916990289,0.0562152070377099,0.783192032435132
Physical measures,X4270.Volume level set by participant (left),POMC,Pro-opiomelanocortin,35748,0.00855920057217897,0.0311292596697663,-0.052454148380563,0.069572549524921,0.783358124967391
Physical measures,X4270.Volume level set by participant (left),AMY2B,Alpha-amylase 2B,36335,-0.0112081049048858,0.0407724798533798,-0.0911221654175103,0.0687059556077387,0.783405730291813
Physical measures,X4270.Volume level set by participant (left),STK24,Serine/threonine-protein kinase 24,36639,0.00871511363202993,0.0318181584763997,-0.0536484769817134,0.0710787042457733,0.78416617423587
Physical measures,X4270.Volume level set by participant (left),PTTG1,Securin,35798,-0.0144334737118369,0.0527414787294842,-0.117806772021626,0.0889398245979522,0.784350975446603
Physical measures,X4270.Volume level set by participant (left),DTD1,D-aminoacyl-tRNA deacylase 1,35779,0.00723574102283054,0.0264453213776619,-0.0445970888773867,0.0590685709230478,0.784391868485172
Physical measures,X4270.Volume level set by participant (left),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,36770,0.0186943510996066,0.0685044843690276,-0.115574438263687,0.152963140462901,0.78494339260237
Physical measures,X4270.Volume level set by participant (left),LGALS1,Galectin-1,36828,-0.0144935972239863,0.0531393317143717,-0.118646687384155,0.0896594929361823,0.785055026518728
Physical measures,X4270.Volume level set by participant (left),XPNPEP2,Xaa-Pro aminopeptidase 2,36864,0.00522668925653705,0.01918514614805,-0.0323761971936409,0.042829575706715,0.78529554295293
Physical measures,X4270.Volume level set by participant (left),MAPKAPK2,MAP kinase-activated protein kinase 2,35798,-0.00847892088529333,0.0311346762684477,-0.0695028863714507,0.0525450446008641,0.785376450684661
Physical measures,X4270.Volume level set by participant (left),ERP29,Endoplasmic reticulum resident protein 29,35779,0.00530145154243679,0.0195080206518088,-0.0329342689351085,0.0435371720199821,0.785816984551276
Physical measures,X4270.Volume level set by participant (left),APPL2,DCC-interacting protein 13-beta,35779,0.00553228583001643,0.0203800128389948,-0.0344125393344134,0.0454771109944463,0.786048507581155
Physical measures,X4270.Volume level set by participant (left),VWA1,von Willebrand factor A domain-containing protein 1,36880,0.0124235303403589,0.0458150581519174,-0.0773739836373993,0.102221044318117,0.786269903271822
Physical measures,X4270.Volume level set by participant (left),KYAT1,Kynurenine--oxoglutarate transaminase 1,36809,0.00910790185847113,0.0337470957828285,-0.0570364058758728,0.075252209592815,0.787254517934215
Physical measures,X4270.Volume level set by participant (left),CFD,Complement factor D,35953,-0.0276586995593506,0.102541058886477,-0.228639174976845,0.173321775858144,0.787373967900408
Physical measures,X4270.Volume level set by participant (left),TSPAN15,Tetraspanin-15,35706,0.0118670868741752,0.044017598132405,-0.0744074054653386,0.098141579213689,0.787477552865579
Physical measures,X4270.Volume level set by participant (left),RBPMS,RNA-binding protein with multiple splicing,35725,0.00889001634378919,0.0329989868823482,-0.0557879979456132,0.0735680306331916,0.787628318992871
Physical measures,X4270.Volume level set by participant (left),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,36828,-0.00782871381856232,0.0290762141686033,-0.0648180935890247,0.0491606659519001,0.787746089783362
Physical measures,X4270.Volume level set by participant (left),TMED8,Protein TMED8,35894,0.00600636073452882,0.0223947904255918,-0.037887428499631,0.0499001499686887,0.788550956594264
Physical measures,X4270.Volume level set by participant (left),GUCY2C,Heat-stable enterotoxin receptor,35798,-0.0074132712827187,0.027640654327971,-0.0615889537655419,0.0467624112001045,0.788552424665151
Physical measures,X4270.Volume level set by participant (left),APOA4,Apolipoprotein A-IV,35953,0.0165764415459087,0.0618513399928536,-0.104652184840084,0.137805067931902,0.788703985777399
Physical measures,X4270.Volume level set by participant (left),HTR1A,5-hydroxytryptamine receptor 1A,35680,0.00769535341983162,0.0287614542745947,-0.048677096958374,0.0640678037980372,0.789048175670181
Physical measures,X4270.Volume level set by participant (left),FH,"Fumarate hydratase, mitochondrial",35680,-0.00721177973685243,0.0269679660959398,-0.0600689932848944,0.0456454338111896,0.789154130628964
Physical measures,X4270.Volume level set by participant (left),CD36,Platelet glycoprotein 4,35725,-0.0135729253202817,0.0507576994745543,-0.113058016290408,0.0859121656498447,0.789164846782232
Physical measures,X4270.Volume level set by participant (left),VSIG10,V-set and immunoglobulin domain-containing protein 10,35874,-0.0177966987198231,0.0667251335993561,-0.148577960574561,0.112984563134915,0.789695631880655
Physical measures,X4270.Volume level set by participant (left),IGHMBP2,DNA-binding protein SMUBP-2,35706,-0.0107195935265944,0.0402273099447569,-0.0895651210183178,0.0681259339651291,0.789881447473042
Physical measures,X4270.Volume level set by participant (left),ENAH,Protein enabled homolog,36697,0.0107956784276018,0.0405374762532063,-0.0686577750286826,0.0902491318838862,0.79000507411436
Physical measures,X4270.Volume level set by participant (left),TPSD1,Tryptase delta,35903,0.0150573383274872,0.05659593055299,-0.0958706855563731,0.125985362211348,0.790209003205625
Physical measures,X4270.Volume level set by participant (left),B4GALT1,"Beta-1,4-galactosyltransferase 1",36865,-0.0172674644139331,0.0649621563560759,-0.144593290871842,0.110058362043976,0.790394185555724
Physical measures,X4270.Volume level set by participant (left),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",35725,0.0139559233602516,0.0527290591768398,-0.0893930326263544,0.117304879346858,0.791270244901878
Physical measures,X4270.Volume level set by participant (left),MGLL,Monoglyceride lipase,36853,0.00595605725685071,0.0225426009946807,-0.0382274406927235,0.0501395552064249,0.791622597724393
Physical measures,X4270.Volume level set by participant (left),HNF1A,Hepatocyte nuclear factor 1-alpha,35741,-0.00833191607875754,0.0315511738175789,-0.0701722167612121,0.053508384603697,0.791729469679858
Physical measures,X4270.Volume level set by participant (left),SDCCAG8,Serologically defined colon cancer antigen 8,35874,0.00535596883375123,0.0202820158981645,-0.0343967823266513,0.0451087199941537,0.791730448798419
Physical measures,X4270.Volume level set by participant (left),TNIP1,TNFAIP3-interacting protein 1,35903,0.00680070161696898,0.0258139177942066,-0.043794577259676,0.057395980493614,0.792211105523041
Physical measures,X4270.Volume level set by participant (left),MSTN,Growth/differentiation factor 8,36697,-0.00951683957402998,0.0361319556445037,-0.0803354726372573,0.0613017934891973,0.792256299331576
Physical measures,X4270.Volume level set by participant (left),IGFBP1,Insulin-like growth factor-binding protein 1,36932,-0.00406215090376652,0.0154559447627907,-0.0343558026388363,0.0262315008313032,0.792695346725632
Physical measures,X4270.Volume level set by participant (left),PDCL2,Phosducin-like protein 2,35678,0.0107180239286653,0.040949334694924,-0.0695426720733856,0.0909787199307163,0.79353125164563
Physical measures,X4270.Volume level set by participant (left),GAL,Galanin peptides,36865,-0.00772496949910628,0.029533868911371,-0.0656113525653933,0.0501614135671808,0.793665341888685
Physical measures,X4270.Volume level set by participant (left),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,35678,0.0223099717908219,0.0853935909222897,-0.145061466416866,0.18968140999851,0.793899931143613
Physical measures,X4270.Volume level set by participant (left),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,35706,-0.0107786172782794,0.0413654771525026,-0.0918549524971845,0.0702977179406256,0.79443209207917
Physical measures,X4270.Volume level set by participant (left),CD5L,CD5 antigen-like,35905,0.0117037807868016,0.0450918126920178,-0.0766761720895533,0.100083733663157,0.795215438601791
Physical measures,X4270.Volume level set by participant (left),NT5C1A,Cytosolic 5'-nucleotidase 1A,35903,0.0172753227057322,0.0666206824727352,-0.113301214940829,0.147851860352293,0.795405025188262
Physical measures,X4270.Volume level set by participant (left),OPHN1,Oligophrenin-1,35903,0.00550043420011333,0.0212386293028511,-0.0361272792334749,0.0471281476337015,0.795656659644869
Physical measures,X4270.Volume level set by participant (left),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,36763,0.0068930808311964,0.0266542573426115,-0.0453492635603222,0.059135425222715,0.795942525797228
Physical measures,X4270.Volume level set by participant (left),IL18BP,Interleukin-18-binding protein,36863,0.0151870789313489,0.0587388657329782,-0.0999410979052883,0.130315255767986,0.795987499662621
Physical measures,X4270.Volume level set by participant (left),CCL22,C-C motif chemokine 22,36756,0.00911691661533242,0.0353133661936425,-0.0600972811242068,0.0783311143548717,0.796281320825675
Physical measures,X4270.Volume level set by participant (left),IL33,Interleukin-33,36697,-0.0126195160901434,0.0489807128831878,-0.108621713341191,0.0833826811609047,0.796689851254755
Physical measures,X4270.Volume level set by participant (left),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,36864,-0.0106147831566881,0.0412528790821697,-0.0914704261577406,0.0702408598443644,0.796946287930049
Physical measures,X4270.Volume level set by participant (left),CD163,Scavenger receptor cysteine-rich type 1 protein M130,36863,0.0112147240132637,0.0435866910018425,-0.0742151903503476,0.096644638376875,0.796956428333842
Physical measures,X4270.Volume level set by participant (left),SSNA1,Sjoegren syndrome nuclear autoantigen 1,35894,0.0109414353363088,0.042837770162973,-0.0730205941831183,0.0949034648557359,0.798409956652712
Physical measures,X4270.Volume level set by participant (left),LAMP3,Lysosome-associated membrane glycoprotein 3,36891,0.00906523739416277,0.0355066865830939,-0.0605278683087013,0.0786583430970268,0.798489952214056
Physical measures,X4270.Volume level set by participant (left),DAB2,Disabled homolog 2,36888,0.00449876340345744,0.0176542822731596,-0.0301036298519353,0.0391011566588502,0.798864600706723
Physical measures,X4270.Volume level set by participant (left),ATP6V1G1,V-type proton ATPase subunit G 1,35748,0.00803076117149998,0.0317061742592509,-0.0541133403766318,0.0701748627196317,0.800054403343473
Physical measures,X4270.Volume level set by participant (left),FAM172A,Cotranscriptional regulator FAM172A,35748,-0.00951827680702707,0.0376828793926127,-0.083376720416548,0.0643401668024939,0.800593838259443
Physical measures,X4270.Volume level set by participant (left),SHMT1,"Serine hydroxymethyltransferase, cytosolic",36853,0.00570579692254354,0.0225989138065445,-0.0385880741382837,0.0499996679833708,0.800676056856895
Physical measures,X4270.Volume level set by participant (left),TFPI,Tissue factor pathway inhibitor,36794,-0.0148207659685482,0.0587666167236595,-0.130003334746921,0.100361802809824,0.800895599096779
Physical measures,X4270.Volume level set by participant (left),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,35725,0.00720035938358174,0.0286956898713919,-0.0490431927643464,0.0634439115315099,0.801882864734964
Physical measures,X4270.Volume level set by participant (left),ATXN2L,Ataxin-2-like protein,35903,-0.0118382566164913,0.0471890663661995,-0.104328826694242,0.0806523134612598,0.801923361450673
Physical measures,X4270.Volume level set by participant (left),MRPL46,"39S ribosomal protein L46, mitochondrial",36639,-0.0170984298703724,0.0682444184225902,-0.150857489978649,0.116660630237904,0.802171329298185
Physical measures,X4270.Volume level set by participant (left),STK11,Serine/threonine-protein kinase STK11,36697,0.00689094922609363,0.0276282797503905,-0.0472604790846717,0.061042377536859,0.803045442573599
Physical measures,X4270.Volume level set by participant (left),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35798,-0.0111298811498203,0.0446289385039272,-0.0986026006175176,0.076342838317877,0.803069129133987
Physical measures,X4270.Volume level set by participant (left),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,35748,0.00747138263214142,0.0299828982718548,-0.051295097980694,0.0662378632449768,0.803223065708214
Physical measures,X4270.Volume level set by participant (left),SOX9,Transcription factor SOX-9,35741,0.0201817441687985,0.0811171109748725,-0.138807793341952,0.179171281679549,0.803525139618253
Physical measures,X4270.Volume level set by participant (left),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,36844,0.0144859117100403,0.0582774326962607,-0.0997378563746307,0.128709679794711,0.803701548405114
Physical measures,X4270.Volume level set by participant (left),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,35779,-0.0111410971566555,0.0448232131740825,-0.0989945949778572,0.0767124006645463,0.803711681198613
Physical measures,X4270.Volume level set by participant (left),PALM3,Paralemmin-3,35706,-0.00737789880540167,0.0297102709984684,-0.0656100299623998,0.0508542323515965,0.803888297822473
Physical measures,X4270.Volume level set by participant (left),LRP11,Low-density lipoprotein receptor-related protein 11,36828,0.0126102254770068,0.0508937964221021,-0.0871416155103132,0.112362066464327,0.804314936330393
Physical measures,X4270.Volume level set by participant (left),PRG2,Bone marrow proteoglycan,35931,0.0102117489904601,0.041268989036329,-0.0706754695207447,0.0910989675016649,0.804572445580832
Physical measures,X4270.Volume level set by participant (left),SOD1,Superoxide dismutase [Cu-Zn],36691,-0.0100198935244017,0.0405205158663748,-0.0894401046224963,0.0694003175736928,0.80469868499471
Physical measures,X4270.Volume level set by participant (left),SIGLEC7,Sialic acid-binding Ig-like lectin 7,36828,-0.0169252368036975,0.0686434167042565,-0.15146633354404,0.117615859936645,0.805249578466429
Physical measures,X4270.Volume level set by participant (left),BRK1,Protein BRICK1,36639,-0.0106847260699788,0.0433841844362811,-0.0957177275650898,0.0743482754251322,0.805471049881301
Physical measures,X4270.Volume level set by participant (left),AMIGO2,Amphoterin-induced protein 2,36770,-0.0198312045544085,0.0807173656019835,-0.178037241134296,0.138374832025479,0.805931221463353
Physical measures,X4270.Volume level set by participant (left),ALPP,"Alkaline phosphatase, placental type",36770,0.00462761372948817,0.0188375015687456,-0.0322938893452533,0.0415491168042296,0.805952379657479
Physical measures,X4270.Volume level set by participant (left),C1QA,Complement C1q subcomponent subunit A,36882,-0.0205036248431313,0.0836511399304823,-0.184459859106877,0.143452609420614,0.806378786471593
Physical measures,X4270.Volume level set by participant (left),NTF3,Neurotrophin-3,36820,-0.0122725250708064,0.0502224992978308,-0.110708623694555,0.086163573552942,0.806956202624089
Physical measures,X4270.Volume level set by participant (left),ATRAID,All-trans retinoic acid-induced differentiation factor,35894,0.0178671726223579,0.0734907433925744,-0.126174684427088,0.161909029671804,0.807918797499994
Physical measures,X4270.Volume level set by participant (left),C7,Complement component C7,35759,-0.0161215603084552,0.0663113074650458,-0.146091722939945,0.113848602323035,0.807920560164083
Physical measures,X4270.Volume level set by participant (left),ADA2,Adenosine deaminase 2,36748,-0.0104787206588536,0.0432458651934549,-0.0952406164380253,0.0742831751203181,0.808549859628039
Physical measures,X4270.Volume level set by participant (left),RILP,Rab-interacting lysosomal protein,36873,-0.00793009343199636,0.0328707230183683,-0.0723567105479982,0.0564965236840055,0.809367061612707
Physical measures,X4270.Volume level set by participant (left),MCFD2,Multiple coagulation factor deficiency protein 2,36793,0.010578614482679,0.0439405981274687,-0.0755449578471596,0.0967021868125176,0.809756872210197
Physical measures,X4270.Volume level set by participant (left),METAP2,Methionine aminopeptidase 2,36880,-0.00851951450607381,0.0353879926914671,-0.0778799801813494,0.0608409511692018,0.809758477820659
Physical measures,X4270.Volume level set by participant (left),MAN2B2,Epididymis-specific alpha-mannosidase,35916,0.00871143579333192,0.0361991432578821,-0.062238884992117,0.0796617565787808,0.809831339141439
Physical measures,X4270.Volume level set by participant (left),MYOM1,Myomesin-1,35680,-0.0109341529317234,0.0456178521428876,-0.100345143131783,0.0784768372683363,0.810577996293076
Physical measures,X4270.Volume level set by participant (left),MEPE,Matrix extracellular phosphoglycoprotein,36822,-0.0166692638160812,0.0695689256293137,-0.153024358049536,0.119685830417374,0.810640684229131
Physical measures,X4270.Volume level set by participant (left),PLA2G7,Platelet-activating factor acetylhydrolase,36836,-0.0137122760067046,0.0573228787203149,-0.126065118298522,0.0986405662851126,0.810948216842359
Physical measures,X4270.Volume level set by participant (left),GOLGA3,Golgin subfamily A member 3,35903,0.00690213528124728,0.0288650342438907,-0.0496733318367785,0.0634776023992731,0.81102176726942
Physical measures,X4270.Volume level set by participant (left),LDLR,Low-density lipoprotein receptor,36876,0.00894846903835224,0.0374739338260023,-0.0645004412606123,0.0823973793373168,0.811273381991734
Physical measures,X4270.Volume level set by participant (left),ARSB,Arylsulfatase B,36770,0.00825039411434104,0.034582406748116,-0.0595311231119663,0.0760319113406484,0.811443930293324
Physical measures,X4270.Volume level set by participant (left),PCBP2,Poly(rC)-binding protein 2,35903,-0.00756505803427942,0.0318133437268672,-0.0699192117389391,0.0547890956703802,0.812047265010652
Physical measures,X4270.Volume level set by participant (left),PGA4,Pepsin A-4,35926,0.0065252679787503,0.0274506890231037,-0.047278082506533,0.0603286184640336,0.81211426194653
Physical measures,X4270.Volume level set by participant (left),CD74,HLA class II histocompatibility antigen gamma chain,36894,-0.0125215508678559,0.052693452607732,-0.115800717979011,0.0907576162432988,0.812174320803075
Physical measures,X4270.Volume level set by participant (left),FGR,Tyrosine-protein kinase Fgr,36639,0.00789393885873147,0.0332250727123111,-0.0572272036573982,0.0730150813748611,0.812205791631849
Physical measures,X4270.Volume level set by participant (left),SULT2A1,Bile salt sulfotransferase,36820,0.00808998451654189,0.0341266944184878,-0.0587983365436942,0.0749783055767779,0.812618651566869
Physical measures,X4270.Volume level set by participant (left),PLIN3,Perilipin-3,36828,-0.0105515134062304,0.0446202185503011,-0.0980071417648205,0.0769041149523598,0.813071368938747
Physical measures,X4270.Volume level set by participant (left),CGN,Cingulin,35741,0.0136388202924459,0.0577201913494638,-0.0994927547525032,0.126770395337395,0.813213478187691
Physical measures,X4270.Volume level set by participant (left),MLN,Promotilin,36820,-0.00500240449648672,0.021178380305746,-0.0465120298957489,0.0365072209027755,0.813281221656024
Physical measures,X4270.Volume level set by participant (left),LYPD3,Ly6/PLAUR domain-containing protein 3,36807,0.0132077665338501,0.0559405396310837,-0.0964356911430739,0.122851224210774,0.813358582573289
Physical measures,X4270.Volume level set by participant (left),ASPN,Asporin,35916,-0.0189748692838409,0.0803751016790314,-0.176510068574742,0.138560330007061,0.813378606692495
Physical measures,X4270.Volume level set by participant (left),ATF2,Cyclic AMP-dependent transcription factor ATF-2,36639,-0.00693506087196097,0.0294122994024416,-0.0645831677007465,0.0507130459568246,0.8136038368614
Physical measures,X4270.Volume level set by participant (left),IL13RA2,Interleukin-13 receptor subunit alpha-2,35680,0.0185300766388789,0.0786466204788183,-0.135617299499605,0.172677452777363,0.813741310746298
Physical measures,X4270.Volume level set by participant (left),TPSAB1,Tryptase alpha/beta-1,36895,0.00837973596833541,0.0355762671713434,-0.0613497476874977,0.0781092196241686,0.813793677158844
Physical measures,X4270.Volume level set by participant (left),DEFB118,Beta-defensin 118,35680,-0.0100943449407142,0.0428759320940673,-0.0941311718450861,0.0739424819636578,0.813881277022054
Physical measures,X4270.Volume level set by participant (left),SERPINA9,Serpin A9,36722,-0.00631251225554016,0.0268338791164926,-0.0589069153238657,0.0462818908127854,0.814025665713627
Physical measures,X4270.Volume level set by participant (left),BRD1,Bromodomain-containing protein 1,35798,0.0170148623562043,0.0724018728342049,-0.124892808398837,0.158922533111246,0.814211496210782
Physical measures,X4270.Volume level set by participant (left),TPSG1,Tryptase gamma,35725,0.0190002792437426,0.081102984740997,-0.139961570848611,0.177962129336097,0.814780012461323
Physical measures,X4270.Volume level set by participant (left),SERPINH1,Serpin H1,35798,0.0040455364197489,0.0173347065723588,-0.0299304884620743,0.0380215613015721,0.815475253794108
Physical measures,X4270.Volume level set by participant (left),PROK1,Prokineticin-1,36820,-0.00781898250251832,0.033536120294887,-0.0735497782804968,0.0579118132754602,0.815650355241306
Physical measures,X4270.Volume level set by participant (left),CXCL9,C-X-C motif chemokine 9,36865,0.00657736876554895,0.0282684019059721,-0.0488286989701564,0.0619834365012543,0.816019489287569
Physical measures,X4270.Volume level set by participant (left),PLA2G1B,Phospholipase A2,36924,0.00954912312808086,0.0410993272462051,-0.0710055582744811,0.0901038045306429,0.816278107655377
Physical measures,X4270.Volume level set by participant (left),RILPL2,RILP-like protein 2,35916,0.00535833655598605,0.0230968462690326,-0.0399114821313179,0.05062815524329,0.816549510430829
Physical measures,X4270.Volume level set by participant (left),CCL19,C-C motif chemokine 19,36894,-0.00329440513094456,0.0142375311881808,-0.0311999662597789,0.0246111559978898,0.817018922875963
Physical measures,X4270.Volume level set by participant (left),NFKBIE,NF-kappa-B inhibitor epsilon,36654,0.00927265020219644,0.0402442827093759,-0.0696061439081803,0.0881514443125732,0.817780186998166
Physical measures,X4270.Volume level set by participant (left),ENO1,Alpha-enolase,36830,-0.00582528090376701,0.0253481399139001,-0.0555076351350112,0.0438570733274772,0.818244809246382
Physical measures,X4270.Volume level set by participant (left),GPC1,Glypican-1,36888,-0.0144215527455165,0.0631529282589189,-0.138201292132998,0.109358186641965,0.819373069154277
Physical measures,X4270.Volume level set by participant (left),ID4,DNA-binding protein inhibitor ID-4,35798,0.0118669754298475,0.0520250820949314,-0.090102185476218,0.113836136335913,0.819574755251408
Physical measures,X4270.Volume level set by participant (left),RAB44,Ras-related protein Rab-44,35874,0.0116785253717134,0.0512753349298677,-0.0888211310908274,0.112178181834254,0.8198389633122
Physical measures,X4270.Volume level set by participant (left),CLEC4A,C-type lectin domain family 4 member A,36820,0.0121874489979866,0.0536026383863834,-0.0928737222393249,0.117248620235298,0.820144796163208
Physical measures,X4270.Volume level set by participant (left),DSG3,Desmoglein-3,36855,0.0122536811465477,0.0541298265970732,-0.0938407789837157,0.118348141276811,0.820915213735583
Physical measures,X4270.Volume level set by participant (left),ESYT2,Extended synaptotagmin-2,35903,0.00595151919395349,0.026307069466145,-0.0456103369596906,0.0575133753475976,0.821027338532561
Physical measures,X4270.Volume level set by participant (left),TFPI2,Tissue factor pathway inhibitor 2,36836,-0.0110429246204316,0.048887692949343,-0.106862802801144,0.0847769535602807,0.821298051539964
Physical measures,X4270.Volume level set by participant (left),SERPINB1,Leukocyte elastase inhibitor,36793,0.00505385076946834,0.0224907083691368,-0.0390279376340398,0.0491356391729765,0.822212184798048
Physical measures,X4270.Volume level set by participant (left),HIF1A,Hypoxia-inducible factor 1-alpha,35725,0.00801805550590383,0.0357020520488411,-0.0619579665098248,0.0779940775216324,0.822311122017394
Physical measures,X4270.Volume level set by participant (left),FABP9,Fatty acid-binding protein 9,36820,-0.00757785306708303,0.0337577378057068,-0.0737430191662684,0.0585873130321024,0.822391777858056
Physical measures,X4270.Volume level set by participant (left),CPVL,Probable serine carboxypeptidase CPVL,36888,-0.0103450286174542,0.046182031466871,-0.100861810292521,0.080171753057613,0.822758980862129
Physical measures,X4270.Volume level set by participant (left),GIPC2,PDZ domain-containing protein GIPC2,35903,-0.0148788105390631,0.06671246334787,-0.145635238700888,0.115877617622762,0.823519769225051
Physical measures,X4270.Volume level set by participant (left),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35903,0.00408412800685043,0.018359589334714,-0.031900667089189,0.0400689231028898,0.823968782884617
Physical measures,X4270.Volume level set by participant (left),DBNL,Drebrin-like protein,36865,0.00474069641840903,0.0213470653328402,-0.0370995516339577,0.0465809444707758,0.824259703505334
Physical measures,X4270.Volume level set by participant (left),GSTP1,Glutathione S-transferase P,36601,-0.00611993790842285,0.0275859709548925,-0.0601884409800122,0.0479485651631665,0.824437048340249
Physical measures,X4270.Volume level set by participant (left),SORT1,Sortilin,36807,-0.0113324880388892,0.051183963551836,-0.111653056600488,0.0889880805227092,0.824781479548725
Physical measures,X4270.Volume level set by participant (left),CDHR1,Cadherin-related family member 1,36639,-0.00952314377125626,0.0430524824281789,-0.0939060093304869,0.0748597217879744,0.824943959530549
Physical measures,X4270.Volume level set by participant (left),RAB11FIP3,Rab11 family-interacting protein 3,35916,-0.0045437372038836,0.0207040704402843,-0.0451237152668408,0.0360362408590736,0.826297578097462
Physical measures,X4270.Volume level set by participant (left),DIABLO,"Diablo homolog, mitochondrial",36804,0.00389161192352067,0.017737084965578,-0.0308730746090123,0.0386562984560536,0.82634016371321
Physical measures,X4270.Volume level set by participant (left),DARS1,"Aspartate--tRNA ligase, cytoplasmic",36748,-0.00618881437994227,0.0283112070417539,-0.06167878018178,0.0493011514218954,0.826967986378711
Physical measures,X4270.Volume level set by participant (left),S100A13,Protein S100-A13,35725,0.0136049855900757,0.0624355524487506,-0.108768697209475,0.135978668389627,0.827510359689436
Physical measures,X4270.Volume level set by participant (left),FADD,FAS-associated death domain protein,36828,0.00563865625852713,0.0258941539435209,-0.0451138854707739,0.0563911979878282,0.827623580348717
Physical measures,X4270.Volume level set by participant (left),DNAJB6,DnaJ homolog subfamily B member 6,35692,0.00601064849181955,0.0276546424429266,-0.0481924506963166,0.0602137476799557,0.827944901895395
Physical measures,X4270.Volume level set by participant (left),OPLAH,5-oxoprolinase,35748,-0.00719197427647395,0.0331345460797284,-0.0721356845927416,0.0577517360397937,0.828173291382253
Physical measures,X4270.Volume level set by participant (left),LMOD2,Leiomodin-2,35680,0.00783646677053058,0.0361058323184203,-0.0629309645735733,0.0786038981146344,0.828182773369556
Physical measures,X4270.Volume level set by participant (left),TWF2,Twinfilin-2,35931,0.00577065861952417,0.0267674829821252,-0.0466936080254412,0.0582349252644896,0.829318046148981
Physical measures,X4270.Volume level set by participant (left),SYAP1,Synapse-associated protein 1,35779,0.00839008661261107,0.0389630618151967,-0.0679775145451745,0.0847576877703966,0.829513301645191
Physical measures,X4270.Volume level set by participant (left),NXPH1,Neurexophilin-1,36639,-0.0110107927514126,0.0512515927224316,-0.111463914487378,0.0894423289845533,0.829899464735519
Physical measures,X4270.Volume level set by participant (left),VAV3,Guanine nucleotide exchange factor VAV3,35680,0.005062217367729,0.0237216755056799,-0.0414322666234035,0.0515567013588615,0.831021302364705
Physical measures,X4270.Volume level set by participant (left),MRPS16,"28S ribosomal protein S16, mitochondrial",35725,0.0165667673103155,0.0777707790016885,-0.135863959532994,0.168997494153625,0.831317653908474
Physical measures,X4270.Volume level set by participant (left),FRMD7,FERM domain-containing protein 7,35741,-0.0138631012570988,0.0651421048176263,-0.141541626699646,0.113815424185449,0.831479278501544
Physical measures,X4270.Volume level set by participant (left),ARHGEF10,Rho guanine nucleotide exchange factor 10,35903,0.0051017194341038,0.0239948055989385,-0.0419280995398156,0.0521315384080232,0.831631657581395
Physical measures,X4270.Volume level set by participant (left),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,36820,-0.00653695299823595,0.0308227754305478,-0.0669495928421097,0.0538756868456378,0.832048804718566
Physical measures,X4270.Volume level set by participant (left),STAT2,Signal transducer and activator of transcription 2,35725,0.00622988890407819,0.0294561160684309,-0.0515040985900463,0.0639638763982027,0.832505844023184
Physical measures,X4270.Volume level set by participant (left),GPR101,Probable G-protein coupled receptor 101,35680,0.00803021321834594,0.0380422884092309,-0.0665326720637465,0.0825930985004384,0.83282641493352
Physical measures,X4270.Volume level set by participant (left),BRSK2,Serine/threonine-protein kinase BRSK2,35903,-0.0113930649494444,0.0540554748868558,-0.117341795727682,0.094555665828793,0.833076148417879
Physical measures,X4270.Volume level set by participant (left),PRR4,Proline-rich protein 4,35721,0.00680960727375993,0.0323733173847844,-0.0566420948004174,0.0702613093479373,0.833403976353636
Physical measures,X4270.Volume level set by participant (left),SLC39A5,Zinc transporter ZIP5,36820,0.00706503586878829,0.0336299164629601,-0.0588496003986135,0.0729796721361901,0.833609386816994
Physical measures,X4270.Volume level set by participant (left),EEF1D,Elongation factor 1-delta,35916,0.00506585464915258,0.0242066525490365,-0.0423791843469589,0.052510893645264,0.834239671362929
Physical measures,X4270.Volume level set by participant (left),PPBP,Platelet basic protein,35880,0.00538989642740537,0.0257637849284222,-0.0451071220323021,0.0558869148871128,0.834295076477279
Physical measures,X4270.Volume level set by participant (left),SERPINB9,Serpin B9,36763,0.0129322913892729,0.0618191438426537,-0.108233230542328,0.134097813320874,0.83430119798604
Physical measures,X4270.Volume level set by participant (left),JUN,Transcription factor AP-1,36697,-0.00827956105117955,0.0396445709167747,-0.085982920048058,0.0694237979456989,0.8345750968452
Physical measures,X4270.Volume level set by participant (left),APP,Amyloid-beta precursor protein,36828,-0.00597758709556572,0.0286744324804896,-0.0621794747573254,0.0502243005661939,0.834872247110143
Physical measures,X4270.Volume level set by participant (left),NUB1,NEDD8 ultimate buster 1,36820,0.00484786472597576,0.0232598087897285,-0.0407413605018921,0.0504370899538437,0.834904750974078
Physical measures,X4270.Volume level set by participant (left),AMBN,Ameloblastin,36697,-0.0138074516243182,0.0666074916390416,-0.14435813523684,0.116743231988203,0.835784501124134
Physical measures,X4270.Volume level set by participant (left),ATXN2,Ataxin-2,35680,-0.004304716259901,0.0208525817255234,-0.0451757764419269,0.0365663439221249,0.836457108548211
Physical measures,X4270.Volume level set by participant (left),PDCD6,Programmed cell death protein 6,36828,0.00536754799941572,0.0260096924488028,-0.0456114492002377,0.0563465451990691,0.836509577584692
Physical measures,X4270.Volume level set by participant (left),CSF1R,Macrophage colony-stimulating factor 1 receptor,35926,-0.0111688407111683,0.0542398705448694,-0.117478986979112,0.0951413055567756,0.836862993587924
Physical measures,X4270.Volume level set by participant (left),RBP1,Retinol-binding protein 1,35741,0.00648312158741384,0.0315262415914955,-0.0553083119319172,0.0682745551067449,0.837076909044994
Physical measures,X4270.Volume level set by participant (left),PZP,Pregnancy zone protein,35953,-0.00901241144543739,0.0438459430006048,-0.0949504597266228,0.076925636835748,0.837150806615103
Physical measures,X4270.Volume level set by participant (left),CALCA,Calcitonin,36748,0.00633328526715114,0.030953463876323,-0.0543355039304419,0.0670020744647442,0.837884955790106
Physical measures,X4270.Volume level set by participant (left),SLAMF7,SLAM family member 7,36820,0.00649449448210927,0.0317774748567054,-0.0557893562370334,0.0687783452012519,0.838066583463853
Physical measures,X4270.Volume level set by participant (left),PNMA1,Paraneoplastic antigen Ma1,35748,0.00815950405526229,0.0400135660364147,-0.0702670853761104,0.086586093486635,0.838423567138298
Physical measures,X4270.Volume level set by participant (left),ANG,Angiogenin,36794,0.0115706873353762,0.0569837037549389,-0.100117372024304,0.123258746695057,0.839099383165563
Physical measures,X4270.Volume level set by participant (left),EPHB6,Ephrin type-B receptor 6,36748,0.0117235747930656,0.0578580223064988,-0.101678148927672,0.125125298513803,0.839432350522094
Physical measures,X4270.Volume level set by participant (left),DAND5,DAN domain family member 5,35725,0.0080688756071464,0.0399643082096408,-0.0702611684837497,0.0863989196980424,0.839999593480278
Physical measures,X4270.Volume level set by participant (left),FST,Follistatin,36853,0.00757209518071256,0.0375486693949175,-0.0660232968333258,0.0811674871947509,0.840187257821116
Physical measures,X4270.Volume level set by participant (left),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,36654,-0.00591043117893556,0.0293866791197196,-0.0635083222535859,0.0516874598957148,0.840605379367794
Physical measures,X4270.Volume level set by participant (left),EIF4E,Eukaryotic translation initiation factor 4E,35725,-0.005313531848172,0.0265278080107726,-0.0573080355492863,0.0466809718529423,0.841251851058523
Physical measures,X4270.Volume level set by participant (left),OSCAR,Osteoclast-associated immunoglobulin-like receptor,36837,0.0108453864929851,0.0543008039553721,-0.0955841892595442,0.117274962245514,0.841698694147017
Physical measures,X4270.Volume level set by participant (left),FCN1,Ficolin-1,35903,0.00779429457156196,0.0392434490477688,-0.0691228655620649,0.0847114547051888,0.84257079828083
Physical measures,X4270.Volume level set by participant (left),RSPO1,R-spondin-1,36763,-0.0111637372865585,0.0565214382208841,-0.121945756199491,0.0996182816263743,0.843431159555087
Physical measures,X4270.Volume level set by participant (left),GFRA3,GDNF family receptor alpha-3,36755,-0.0131511133654559,0.0668361828786296,-0.14415003180757,0.117847805076658,0.844015656830299
Physical measures,X4270.Volume level set by participant (left),LPP,Lipoma-preferred partner,35706,-0.00694507435094242,0.0353099695744508,-0.0761526147168659,0.0622624660149811,0.844077242367985
Physical measures,X4270.Volume level set by participant (left),PALM,Paralemmin-1,35846,0.0138308952453898,0.0703344360390961,-0.124024599391238,0.151686389882018,0.844111584990119
Physical measures,X4270.Volume level set by participant (left),TDO2,"Tryptophan 2,3-dioxygenase",35741,0.0114829169961156,0.0587297370429553,-0.103627367608077,0.126593201600308,0.844990902022427
Physical measures,X4270.Volume level set by participant (left),BCL2,Apoptosis regulator Bcl-2,35894,-0.0076144602056354,0.0390509902258595,-0.0841544010483201,0.0689254806370493,0.845408543045028
Physical measures,X4270.Volume level set by participant (left),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,36770,-0.00967039547601547,0.049619417907692,-0.106924454575092,0.0875836636230609,0.845483231990031
Physical measures,X4270.Volume level set by participant (left),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,36894,0.00796195995404988,0.0408638969657537,-0.0721312780988274,0.0880551980069272,0.845522616141472
Physical measures,X4270.Volume level set by participant (left),OGA,Protein O-GlcNAcase,35894,0.00634006891065233,0.032609072963482,-0.0575737140977725,0.0702538519190771,0.845847815428055
Physical measures,X4270.Volume level set by participant (left),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35874,0.00428466837369349,0.0220919523556062,-0.0390155582432947,0.0475848949906816,0.846223264152964
Physical measures,X4270.Volume level set by participant (left),BMP10,Bone morphogenetic protein 10,35779,-0.0148382208743341,0.0765610236549174,-0.164897827237972,0.135221385489304,0.84633136461378
Physical measures,X4270.Volume level set by participant (left),SERPINF2,Alpha-2-antiplasmin,35795,-0.0312327091735482,0.161370016453715,-0.347517941422829,0.285052523075732,0.846536429856999
Physical measures,X4270.Volume level set by participant (left),DCTN6,Dynactin subunit 6,36639,-0.00509239044048906,0.0263590682383981,-0.0567561641877493,0.0465713833067712,0.846813004517935
Physical measures,X4270.Volume level set by participant (left),ITM2A,Integral membrane protein 2A,36820,-0.0057449218502064,0.0298076255932549,-0.0641678680129859,0.0526780243125731,0.847172982129335
Physical measures,X4270.Volume level set by participant (left),SEC31A,Protein transport protein Sec31A,35748,0.00574303871350569,0.0298992318059616,-0.052859455626179,0.0643455330531903,0.847685644505307
Physical measures,X4270.Volume level set by participant (left),NFAT5,Nuclear factor of activated T-cells 5,35725,-0.00475868428308674,0.0248157680171978,-0.0533975895967943,0.0438802210306209,0.847935770952935
Physical measures,X4270.Volume level set by participant (left),VAMP5,Vesicle-associated membrane protein 5,36697,0.00654676574636776,0.0342670578187815,-0.060616667578444,0.0737101990711796,0.84849057758625
Physical measures,X4270.Volume level set by participant (left),PPP1R9B,Neurabin-2,36908,0.00376262609560012,0.0198038740932144,-0.0350529671271002,0.0425782193183004,0.849318483469929
Physical measures,X4270.Volume level set by participant (left),RETN,Resistin,36847,-0.00804495779224471,0.0426161091514726,-0.091572531729131,0.0754826161446416,0.850272302183134
Physical measures,X4270.Volume level set by participant (left),LMOD1,Leiomodin-1,35903,-0.0117185980292492,0.0623336092138157,-0.133892472088328,0.11045527602983,0.850883854780099
Physical measures,X4270.Volume level set by participant (left),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,36858,-0.00712007003907189,0.0379070213968104,-0.0814178319768203,0.0671776918986765,0.851015011934265
Physical measures,X4270.Volume level set by participant (left),CD3D,T-cell surface glycoprotein CD3 delta chain,35680,-0.0119031370996989,0.0634910596774847,-0.136345614067569,0.112539339868171,0.851292229583216
Physical measures,X4270.Volume level set by participant (left),CRKL,Crk-like protein,36844,0.00357291263734464,0.0191233913539679,-0.0339089344164325,0.0410547596911218,0.851795214026697
Physical measures,X4270.Volume level set by participant (left),CFP,Properdin,35953,-0.0187081573828395,0.100927453816089,-0.216525966862373,0.179109652096694,0.852950344120985
Physical measures,X4270.Volume level set by participant (left),CLEC11A,C-type lectin domain family 11 member A,36821,0.00699417946721916,0.0379236763026385,-0.0673362260859523,0.0813245850203906,0.853682782728565
Physical measures,X4270.Volume level set by participant (left),PTPRB,Receptor-type tyrosine-protein phosphatase beta,35916,0.0138835984994376,0.0756846959674049,-0.134458405596676,0.162225602595551,0.854458350052726
Physical measures,X4270.Volume level set by participant (left),MILR1,Allergin-1,36697,-0.0067919054651888,0.0371498099023845,-0.0796055328738624,0.0660217219434848,0.854940453815209
Physical measures,X4270.Volume level set by participant (left),RAP1A,Ras-related protein Rap-1A,35725,0.00571134542432044,0.0312475176934165,-0.0555337892547759,0.0669564801034167,0.854978222724461
Physical measures,X4270.Volume level set by participant (left),ANGPTL4,Angiopoietin-related protein 4,36853,-0.00754695154301723,0.0413398333602464,-0.0885730249291001,0.0734791218430657,0.855149025203486
Physical measures,X4270.Volume level set by participant (left),TOP2B,DNA topoisomerase 2-beta,35725,0.00532812252442684,0.029344195795734,-0.0521865012352118,0.0628427462840655,0.855923239773517
Physical measures,X4270.Volume level set by participant (left),OSBPL2,Oxysterol-binding protein-related protein 2,35903,-0.00994289180388392,0.0549063510023887,-0.117559339768566,0.0976735561607979,0.856303825758959
Physical measures,X4270.Volume level set by participant (left),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,36697,-0.00642661981941292,0.0355259252596366,-0.0760574333283006,0.0632041936894748,0.856451400026951
Physical measures,X4270.Volume level set by participant (left),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,36639,-0.00326731135825725,0.018158954707252,-0.0388588625844712,0.0323242398679567,0.857213691180899
Physical measures,X4270.Volume level set by participant (left),ZNF75D,Zinc finger protein 75D,35798,0.00598146442952085,0.0332660846168662,-0.0592200614195369,0.0711829902785786,0.857309853610083
Physical measures,X4270.Volume level set by participant (left),PBK,Lymphokine-activated killer T-cell-originated protein kinase,35678,0.0129668533742101,0.0721920951973486,-0.128529653212593,0.154463359961013,0.857459679620344
Physical measures,X4270.Volume level set by participant (left),LATS1,Serine/threonine-protein kinase LATS1,35725,0.00482939330010153,0.0268998978604835,-0.0478944065064461,0.0575531931066492,0.857525540692575
Physical measures,X4270.Volume level set by participant (left),VIM,Vimentin,36697,0.00294549939601743,0.0164191720476333,-0.0292360778173438,0.0351270766093786,0.857633262641682
Physical measures,X4270.Volume level set by participant (left),LCN2,Neutrophil gelatinase-associated lipocalin,36635,0.00839613392481212,0.0468567891970309,-0.0834431729013684,0.100235440750993,0.857795643759487
Physical measures,X4270.Volume level set by participant (left),TDRKH,Tudor and KH domain-containing protein,36639,0.00388519284927437,0.0216890104282636,-0.0386252675901223,0.046395653288671,0.857839039867231
Physical measures,X4270.Volume level set by participant (left),CST1,Cystatin-SN,35028,-0.00408145840111597,0.0227894656347584,-0.0487488110452425,0.0405858942430105,0.857870052015844
Physical measures,X4270.Volume level set by participant (left),CPA4,Carboxypeptidase A4,35654,0.00898699789062811,0.0506149887318903,-0.0902183800238768,0.108192375805133,0.859077205906072
Physical measures,X4270.Volume level set by participant (left),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35894,0.00849441246066109,0.047854342083039,-0.0853000980220954,0.102288922943418,0.859116655593386
Physical measures,X4270.Volume level set by participant (left),JAM3,Junctional adhesion molecule C,35779,0.00779540132855469,0.0441848415178012,-0.0788068880463356,0.094397690703445,0.859963881525729
Physical measures,X4270.Volume level set by participant (left),SNCA,Alpha-synuclein,35779,-0.00354900517833792,0.0201338097004481,-0.0430112721912163,0.0359132618345404,0.86008652897803
Physical measures,X4270.Volume level set by participant (left),CRYZL1,Quinone oxidoreductase-like protein 1,35748,-0.00455789216519643,0.0259109668958433,-0.0553433872810493,0.0462276029506564,0.860373300634092
Physical measures,X4270.Volume level set by participant (left),SELPLG,P-selectin glycoprotein ligand 1,36820,0.0122608111927802,0.0697314744594723,-0.124412878747786,0.148934501133346,0.860433003835079
Physical measures,X4270.Volume level set by participant (left),PCDH1,Protocadherin-1,36875,-0.0149987537897707,0.0854409467791995,-0.182463009477002,0.15246550189746,0.860655834444672
Physical measures,X4270.Volume level set by participant (left),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,36820,0.00214327323937718,0.0122872767319527,-0.0219397891552502,0.0262263356340045,0.861531943598881
Physical measures,X4270.Volume level set by participant (left),RAB2B,Ras-related protein Rab-2B,35874,0.00649066683300167,0.0372715877709699,-0.0665616451980994,0.0795429788641027,0.86175665774557
Physical measures,X4270.Volume level set by participant (left),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,36933,-0.00455329197860698,0.026171922332341,-0.0558502597499954,0.0467436757927815,0.861888707300986
Physical measures,X4270.Volume level set by participant (left),MERTK,Tyrosine-protein kinase Mer,36908,0.0125190267962504,0.0725183646235432,-0.129616967865894,0.154655021458395,0.862944832497822
Physical measures,X4270.Volume level set by participant (left),NOS2,"Nitric oxide synthase, inducible",35706,0.00979047549760911,0.056995649661926,-0.101920997839766,0.121501948834984,0.863619101434324
Physical measures,X4270.Volume level set by participant (left),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,36888,0.00954565113088092,0.0556002768167613,-0.0994308914299713,0.118522193691733,0.8636908608996
Physical measures,X4270.Volume level set by participant (left),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,36863,-0.00727194575622834,0.0425785134499556,-0.0907258321181413,0.0761819406056846,0.864394111736286
Physical measures,X4270.Volume level set by participant (left),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35953,-0.0186561593539733,0.109349566020202,-0.23298130875357,0.195668990045623,0.864535328273947
Physical measures,X4270.Volume level set by participant (left),GPR15L,Protein GPR15L,35894,0.00612688779923874,0.0360785222978952,-0.0645870159046359,0.0768407915031133,0.865156104611926
Physical measures,X4270.Volume level set by participant (left),EPHA2,Ephrin type-A receptor 2,36551,-0.0100400201253556,0.0591278930189642,-0.125930690442525,0.105850650191814,0.865170715693885
Physical measures,X4270.Volume level set by participant (left),LY75,Lymphocyte antigen 75,36820,0.00804911195365104,0.0474233805284458,-0.0849007138821027,0.100998937789405,0.865227952509226
Physical measures,X4270.Volume level set by participant (left),TBCB,Tubulin-folding cofactor B,36763,0.00345813534374232,0.0203803250493246,-0.0364873017529339,0.0434035724404186,0.865266271021455
Physical measures,X4270.Volume level set by participant (left),MAX,Protein max,36639,0.00317029672741905,0.0186944103901965,-0.0334707476373662,0.0398113410922043,0.865340912983415
Physical measures,X4270.Volume level set by participant (left),TDP1,Tyrosyl-DNA phosphodiesterase 1,35874,-0.00537854816036163,0.0317305389388069,-0.0675704044804231,0.0568133081596999,0.865403009364252
Physical measures,X4270.Volume level set by participant (left),GDF2,Growth/differentiation factor 2,36828,0.00881385568284129,0.0523147545312995,-0.0937230631985058,0.111350774564188,0.866212158818587
Physical measures,X4270.Volume level set by participant (left),CDC37,Hsp90 co-chaperone Cdc37,36864,-0.00391020645930899,0.0234172391418455,-0.0498079951773263,0.0419875822587083,0.867390328045412
Physical measures,X4270.Volume level set by participant (left),SUSD5,Sushi domain-containing protein 5,35726,-0.0105086354891021,0.0630972262512298,-0.134179198941513,0.113161927963308,0.867731883844279
Physical measures,X4270.Volume level set by participant (left),ELAVL4,ELAV-like protein 4,35680,0.00453049694647905,0.0272121761902756,-0.0488053683864611,0.0578663622794192,0.867778229109839
Physical measures,X4270.Volume level set by participant (left),SUOX,"Sulfite oxidase, mitochondrial",35903,0.00570387907807057,0.034901566657492,-0.0627031915706138,0.0741109497267549,0.870186702508163
Physical measures,X4270.Volume level set by participant (left),CIAPIN1,Anamorsin,36864,0.00520847576418916,0.0319134188044533,-0.0573418250925393,0.0677587766209176,0.870360190056793
Physical measures,X4270.Volume level set by participant (left),ARNT,Aryl hydrocarbon receptor nuclear translocator,36697,0.00831618275477651,0.0509877628834686,-0.091619832496822,0.108252198006375,0.870442879987086
Physical measures,X4270.Volume level set by participant (left),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",35748,0.00750309890658499,0.0460068258490249,-0.0826702797575038,0.0976764775706737,0.870455244673469
Physical measures,X4270.Volume level set by participant (left),BDNF,Brain-derived neurotrophic factor,35931,-0.00419024862539725,0.0257436207414197,-0.0546477452785798,0.0462672480277853,0.870705653122146
Physical measures,X4270.Volume level set by participant (left),FOS,Proto-oncogene c-Fos,35662,0.0104773559070378,0.064512975740832,-0.115968076544993,0.136922788359069,0.870990470343763
Physical measures,X4270.Volume level set by participant (left),COLEC12,Collectin-12,36822,0.0113664207030268,0.0700117987913854,-0.125856704928089,0.148589546334142,0.871034486363506
Physical measures,X4270.Volume level set by participant (left),GGACT,Gamma-glutamylaminecyclotransferase,35916,0.00518299352705671,0.0319978376150124,-0.0575327681983677,0.0678987552524811,0.87132687303727
Physical measures,X4270.Volume level set by participant (left),SAT1,Diamine acetyltransferase 1,35706,0.00719309130142389,0.0446276374175746,-0.0802770780370222,0.09466326063987,0.871956481520013
Physical measures,X4270.Volume level set by participant (left),MATN2,Matrilin-2,36837,0.0102092728101188,0.0636863542349573,-0.114615981490398,0.135034527110635,0.872644665195929
Physical measures,X4270.Volume level set by participant (left),THBS2,Thrombospondin-2,36836,-0.00788771170895285,0.0492491548782849,-0.104416055270391,0.0886406318524855,0.872759799412399
Physical measures,X4270.Volume level set by participant (left),TGFB1,Transforming growth factor beta-1 proprotein,36891,-0.00766082359700966,0.0478593365181368,-0.101465123172558,0.0861434759785385,0.872830470686361
Physical measures,X4270.Volume level set by participant (left),ARFIP1,Arfaptin-1,35903,0.00515646266468306,0.0323188942647933,-0.0581885700943117,0.0685014954236779,0.873240785808113
Physical measures,X4270.Volume level set by participant (left),CRTAP,Cartilage-associated protein,35741,-0.00710748486255923,0.0445558910421854,-0.0944370313052426,0.0802220615801242,0.873265378485524
Physical measures,X4270.Volume level set by participant (left),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35903,0.00806452609358357,0.050561158507784,-0.091035344581673,0.10716439676884,0.873279429741508
Physical measures,X4270.Volume level set by participant (left),CDC26,Anaphase-promoting complex subunit CDC26,35876,0.00499309345893119,0.0314998211790235,-0.0567465560519548,0.0667327429698172,0.874058312842544
Physical measures,X4270.Volume level set by participant (left),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",35706,0.00820970094001773,0.0518845618865037,-0.0934840403575296,0.109903442237565,0.874280371500523
Physical measures,X4270.Volume level set by participant (left),HIP1R,Huntingtin-interacting protein 1-related protein,35879,0.00814091588758625,0.0516084985951993,-0.0930117413590044,0.109293573134177,0.874663524700288
Physical measures,X4270.Volume level set by participant (left),TSPAN1,Tetraspanin-1,36697,-0.00427867356710028,0.0273412102011742,-0.0578674455614017,0.0493100984272011,0.875649641338375
Physical measures,X4270.Volume level set by participant (left),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,35517,-0.00712811650236097,0.0459278390620775,-0.0971466810640328,0.0828904480593108,0.876666615579869
Physical measures,X4270.Volume level set by participant (left),GMFG,Glia maturation factor gamma,35916,-0.00491046194571187,0.0316853494320384,-0.0670137468325071,0.0571928229410833,0.87684506134347
Physical measures,X4270.Volume level set by participant (left),FGF2,Fibroblast growth factor 2,36820,0.00427028691014741,0.0275970045324078,-0.0498198419733719,0.0583604157936667,0.877032492665569
Physical measures,X4270.Volume level set by participant (left),CEP290,Centrosomal protein of 290 kDa,35798,-0.0063878427357036,0.0412864799144204,-0.0873093433679676,0.0745336578965604,0.877046819822161
Physical measures,X4270.Volume level set by participant (left),S100A4,Protein S100-A4,36864,0.00541269993654992,0.0351932568926607,-0.0635660835730651,0.0743914834461649,0.877771996355043
Physical measures,X4270.Volume level set by participant (left),TNF,Tumor necrosis factor,36687,0.00720911052174527,0.0468746360206394,-0.084665176078708,0.0990833971221985,0.877775084444925
Physical measures,X4270.Volume level set by participant (left),GGCT,Gamma-glutamylcyclotransferase,35900,-0.0072466515934978,0.0472708733306721,-0.0998975633216151,0.0854042601346195,0.878165869644432
Physical measures,X4270.Volume level set by participant (left),EVPL,Envoplakin,35798,0.00992159070063359,0.0647242540142062,-0.116937947167211,0.136781128568478,0.878174152439372
Physical measures,X4270.Volume level set by participant (left),CNTNAP4,Contactin-associated protein-like 4,35741,0.00318195568863192,0.0208075446531779,-0.0376008318315968,0.0439647432088607,0.878463578578385
Physical measures,X4270.Volume level set by participant (left),RBM17,Splicing factor 45,35903,0.0044630966900517,0.0293252494750858,-0.0530143922811164,0.0619405856612198,0.879039320269124
Physical measures,X4270.Volume level set by participant (left),PSAPL1,Proactivator polypeptide-like 1,35894,-0.00644359508688539,0.0424225159742193,-0.0895917263963552,0.0767045362225844,0.879277543299812
Physical measures,X4270.Volume level set by participant (left),FGF5,Fibroblast growth factor 5,36697,0.00884353954409709,0.0585487833758196,-0.105912075872509,0.123599154960703,0.879943760922085
Physical measures,X4270.Volume level set by participant (left),CEP152,Centrosomal protein of 152 kDa,35678,0.00811348853471597,0.0537412935012749,-0.0972194467277829,0.113446423797215,0.880001651103248
Physical measures,X4270.Volume level set by participant (left),IL1B,Interleukin-1 beta,36662,-0.00473566956154481,0.0315781829020074,-0.0666289080494793,0.0571575689263897,0.880795097025952
Physical measures,X4270.Volume level set by participant (left),PCDH12,Protocadherin-12,35903,-0.012935018399664,0.0863455457818071,-0.182172288132006,0.156302251332678,0.880922750997503
Physical measures,X4270.Volume level set by participant (left),SIGLEC15,Sialic acid-binding Ig-like lectin 15,36639,0.00368640893220751,0.0246161995520112,-0.0445613421897345,0.0519341600541495,0.880961652329185
Physical measures,X4270.Volume level set by participant (left),THPO,Thrombopoietin,36697,-0.00735272302498727,0.0491044626521318,-0.103597469823166,0.0888920237731911,0.880976654261519
Physical measures,X4270.Volume level set by participant (left),INSR,Insulin receptor,35725,-0.0195080127162711,0.130518252871283,-0.275323788343986,0.236307762911444,0.881190725320258
Physical measures,X4270.Volume level set by participant (left),SCAMP3,Secretory carrier-associated membrane protein 3,36770,0.00340485150400333,0.0227866176869178,-0.0412569191623555,0.0480666221703622,0.881223609982595
Physical measures,X4270.Volume level set by participant (left),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,36654,0.0023860773845135,0.0159893611968293,-0.0289530705612719,0.0337252253302989,0.881376923478731
Physical measures,X4270.Volume level set by participant (left),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35894,-0.0103421785518434,0.0696815559465978,-0.146918028207175,0.126233671103488,0.882015309834412
Physical measures,X4270.Volume level set by participant (left),NOTCH1,Neurogenic locus notch homolog protein 1,36933,-0.0171736844201429,0.11587279343385,-0.244284359550489,0.209936990710204,0.882179692657209
Physical measures,X4270.Volume level set by participant (left),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35903,0.0134153180698939,0.0914450076656364,-0.165816896954753,0.192647533094541,0.883370332918947
Physical measures,X4270.Volume level set by participant (left),FXN,"Frataxin, mitochondrial",36888,0.00392708160827199,0.0268531638454353,-0.0487051195287812,0.0565592827453252,0.883733559661565
Physical measures,X4270.Volume level set by participant (left),COL28A1,Collagen alpha-1(XXVIII) chain,35741,-0.0042201436294749,0.0291109021437831,-0.0612775118312898,0.05283722457234,0.884740754375755
Physical measures,X4270.Volume level set by participant (left),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35874,0.00641915651066008,0.0443409755537113,-0.0804891555746141,0.0933274685959343,0.884898379208977
Physical measures,X4270.Volume level set by participant (left),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,36725,-0.00588410293953493,0.0406699901769534,-0.0855972836863635,0.0738290778072937,0.884968010198968
Physical measures,X4270.Volume level set by participant (left),MITD1,MIT domain-containing protein 1,36763,0.00298264388124549,0.0206589776562493,-0.0375089523250032,0.0434742400874942,0.885208050193089
Physical measures,X4270.Volume level set by participant (left),PECAM1,Platelet endothelial cell adhesion molecule,36836,0.00877560551215617,0.0608932518165342,-0.110575168048251,0.128126379072563,0.885413791972479
Physical measures,X4270.Volume level set by participant (left),SFRP4,Secreted frizzled-related protein 4,35779,-0.00798818867902847,0.0556688420216891,-0.117099119041539,0.101122741683482,0.885903819987662
Physical measures,X4270.Volume level set by participant (left),PEAR1,Platelet endothelial aggregation receptor 1,36933,0.0116033072819768,0.0816181177083806,-0.148368203426449,0.171574817990403,0.886952725050768
Physical measures,X4270.Volume level set by participant (left),PKD2,Polycystin-2,35706,-0.00543154170547177,0.0382664558431221,-0.0804337951579912,0.0695707117470476,0.887131771738169
Physical measures,X4270.Volume level set by participant (left),REG1B,Lithostathine-1-beta,36933,-0.00456441301373682,0.0321710624950541,-0.0676196955040429,0.0584908694765693,0.887178912295444
Physical measures,X4270.Volume level set by participant (left),NFKB1,Nuclear factor NF-kappa-B p105 subunit,35706,-0.00452837060995677,0.032139636848613,-0.0675220588332383,0.0584653176133247,0.887955863943752
Physical measures,X4270.Volume level set by participant (left),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,35779,-0.00835966851882347,0.0593939310038163,-0.124771773286303,0.108052436248657,0.888072113705285
Physical measures,X4270.Volume level set by participant (left),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35903,-0.00658580546651519,0.0468208292804331,-0.098354630856164,0.0851830199231336,0.888142979761863
Physical measures,X4270.Volume level set by participant (left),MARS1,"Methionine--tRNA ligase, cytoplasmic",35762,0.00380808296777494,0.0272429742606918,-0.0495881465831811,0.057204312518731,0.888836362858804
Physical measures,X4270.Volume level set by participant (left),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",35725,0.00487180741568873,0.0349350084422882,-0.0636008091311961,0.0733444239625735,0.889096140714066
Physical measures,X4270.Volume level set by participant (left),IFNLR1,Interferon lambda receptor 1,36820,-0.00725179983412562,0.0520831885467961,-0.109334849385846,0.0948312497175947,0.889268174317126
Physical measures,X4270.Volume level set by participant (left),SCG3,Secretogranin-3,36837,0.00752222951690188,0.0541165589701232,-0.0985462260645396,0.113590685098343,0.889453406446033
Physical measures,X4270.Volume level set by participant (left),CALY,Neuron-specific vesicular protein calcyon,35706,-0.0086793776323719,0.0625039843429625,-0.131187186944578,0.113828431679835,0.889564135653742
Physical measures,X4270.Volume level set by participant (left),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35903,0.00438069666838149,0.0316042701236548,-0.057563672773982,0.066325066110745,0.889761782907198
Physical measures,X4270.Volume level set by participant (left),SPART,Spartin,35779,-0.00410205732533182,0.0296524320800168,-0.0622208242021648,0.0540167095515012,0.889977548378661
Physical measures,X4270.Volume level set by participant (left),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,36770,0.00583375848493805,0.0423613062953982,-0.0771944018540424,0.0888619188239185,0.890469862838277
Physical measures,X4270.Volume level set by participant (left),SEMA6C,Semaphorin-6C,35725,-0.0120077100663061,0.0876904357393637,-0.183880964115459,0.159865543982847,0.891088016439117
Physical measures,X4270.Volume level set by participant (left),PRG3,Proteoglycan 3,35931,0.0059592614908066,0.0437697656326367,-0.0798294791491614,0.0917480021307746,0.891706628291186
Physical measures,X4270.Volume level set by participant (left),DEFA1_DEFA1B,Neutrophil defensin 1,36682,-0.00457108095348956,0.0336785114998843,-0.0705809634932627,0.0614388015862836,0.892040807956264
Physical measures,X4270.Volume level set by participant (left),ANKRA2,Ankyrin repeat family A protein 2,35678,0.00541451477543537,0.0400514381969594,-0.073086304090605,0.0839153336414757,0.892466624519999
Physical measures,X4270.Volume level set by participant (left),SARG,Specifically androgen-regulated gene protein,35877,0.00282033642349432,0.0208951768897101,-0.0381342102803376,0.0437748831273262,0.89263533170276
Physical measures,X4270.Volume level set by participant (left),KCNH2,Potassium voltage-gated channel subfamily H member 2,35741,0.00380666909024543,0.0283338333590636,-0.0517276442935191,0.05934098247401,0.893129430429969
Physical measures,X4270.Volume level set by participant (left),SNX5,Sorting nexin-5,35748,-0.0101024229810177,0.0752798081266914,-0.157650846909333,0.137446000947297,0.89324988515988
Physical measures,X4270.Volume level set by participant (left),TTR,Transthyretin,35868,0.0118057202046795,0.08829639680844,-0.161255217539863,0.184866657949222,0.89363943237995
Physical measures,X4270.Volume level set by participant (left),ENOPH1,Enolase-phosphatase E1,35874,-0.00529190178688333,0.0395908522674309,-0.0828899722310478,0.0723061686572812,0.893671700354441
Physical measures,X4270.Volume level set by participant (left),ANGPT2,Angiopoietin-2,36888,-0.00648872548978324,0.0486553343487256,-0.101853180813285,0.0888757298337189,0.893911352938172
Physical measures,X4270.Volume level set by participant (left),SUGT1,Protein SGT1 homolog,36654,-0.00341567763557231,0.02561915348657,-0.0536292184692496,0.0467978631981049,0.893939831172311
Physical measures,X4270.Volume level set by participant (left),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35894,0.00960428949224217,0.0722207342639158,-0.131948349665033,0.151156928649517,0.894209073005566
Physical measures,X4270.Volume level set by participant (left),VASN,Vasorin,36690,-0.00926995458554151,0.0699017450150229,-0.146277374814986,0.127737465643903,0.894502168983131
Physical measures,X4270.Volume level set by participant (left),MYH9,Myosin-9,35931,-0.00251870604309693,0.0191332100897472,-0.0400197978190015,0.0349823857328077,0.89527255361178
Physical measures,X4270.Volume level set by participant (left),CSPG5,Chondroitin sulfate proteoglycan 5,35680,0.00583868476140815,0.0445536611280833,-0.0814864910496352,0.0931638605724514,0.895741108175226
Physical measures,X4270.Volume level set by participant (left),CLEC12A,C-type lectin domain family 12 member A,35725,-0.0140657469659468,0.107494840182418,-0.224755633723486,0.196624139791592,0.89589765389337
Physical measures,X4270.Volume level set by participant (left),PRC1,Protein regulator of cytokinesis 1,35874,0.00627644239132137,0.0481349140854511,-0.0880679892161629,0.100620873998806,0.896259653762251
Physical measures,X4270.Volume level set by participant (left),RCOR1,REST corepressor 1,36697,0.00556168764379236,0.0427986070887727,-0.0783235822502022,0.0894469575377869,0.89660931034024
Physical measures,X4270.Volume level set by participant (left),CD86,T-lymphocyte activation antigen CD86,35894,-0.00948702830675773,0.0730132760682279,-0.152593049400484,0.133618992786969,0.896621232175952
Physical measures,X4270.Volume level set by participant (left),LACRT,Extracellular glycoprotein lacritin,35860,-0.00590303773435211,0.0454647335489294,-0.0950139154902538,0.0832078400215496,0.896698731708826
Physical measures,X4270.Volume level set by participant (left),ART5,Ecto-ADP-ribosyltransferase 5,35680,0.00464843019414056,0.0358914381249447,-0.0656987885307511,0.0749956489190323,0.896955263811018
Physical measures,X4270.Volume level set by participant (left),NEDD9,Enhancer of filamentation 1,35725,-0.00825454272522238,0.0637820809746513,-0.133267421435539,0.116758335985094,0.897030974915646
Physical measures,X4270.Volume level set by participant (left),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",35725,0.00998592439168817,0.0776215080193473,-0.142152231326233,0.162124080109609,0.897639406026684
Physical measures,X4270.Volume level set by participant (left),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",35748,0.00382483320262993,0.0297567065553522,-0.0544983116458605,0.0621479780511203,0.897728086972378
Physical measures,X4270.Volume level set by participant (left),ECE1,Endothelin-converting enzyme 1,36639,-0.00677336067753418,0.0527425703758738,-0.110148798614247,0.0966020772591785,0.897817677209233
Physical measures,X4270.Volume level set by participant (left),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35931,0.00194649837434949,0.0151729003808161,-0.02779238637205,0.031685383120749,0.897925031378516
Physical measures,X4270.Volume level set by participant (left),FAM3C,Protein FAM3C,36807,0.00802547064288401,0.0626220812788069,-0.114713808663577,0.130764749949345,0.898027955949881
Physical measures,X4270.Volume level set by participant (left),ANXA4,Annexin A4,36798,0.00348103913055072,0.0271771860199564,-0.0497862454685638,0.0567483237296652,0.898083660695852
Physical measures,X4270.Volume level set by participant (left),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,36748,0.00230410832695436,0.0180406696457365,-0.0330556041786893,0.037663820832598,0.898375980906624
Physical measures,X4270.Volume level set by participant (left),RGS10,Regulator of G-protein signaling 10,35903,-0.00478299764797209,0.0378260421126525,-0.078922040188771,0.0693560448928268,0.899381721383934
Physical measures,X4270.Volume level set by participant (left),ADAMTSL5,ADAMTS-like protein 5,35916,-0.00697277766652214,0.0554644425428841,-0.115683085050575,0.101737529717531,0.899960357494754
Physical measures,X4270.Volume level set by participant (left),ACE,Angiotensin-converting enzyme,35926,0.00970257983724382,0.0773494978661866,-0.141902435980482,0.16130759565497,0.900180414886359
Physical measures,X4270.Volume level set by participant (left),CEBPA,CCAAT/enhancer-binding protein alpha,35725,-0.00739981335050889,0.0596058156824442,-0.124227212088099,0.109427585387082,0.901203635429571
Physical measures,X4270.Volume level set by participant (left),FDX2,"Ferredoxin-2, mitochondrial",35706,-0.0050222085930893,0.0405225279808298,-0.0844463634355158,0.0744019462493372,0.901369608278004
Physical measures,X4270.Volume level set by participant (left),DNAJA1,DnaJ homolog subfamily A member 1,35678,-0.00589161179292276,0.047568883350392,-0.099126623159691,0.0873433995738455,0.901434460990471
Physical measures,X4270.Volume level set by participant (left),AZI2,5-azacytidine-induced protein 2,35903,0.00477965576116849,0.0386447387203922,-0.0709640321308003,0.0805233436531372,0.901570828467098
Physical measures,X4270.Volume level set by participant (left),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,36828,0.00286654481932751,0.0231865128530296,-0.0425790203726106,0.0483121100112656,0.901611622692188
Physical measures,X4270.Volume level set by participant (left),CELA2A,Chymotrypsin-like elastase family member 2A,35931,-0.00425081416421474,0.0344099829127148,-0.0716943806731357,0.0631927523447063,0.901687678338602
Physical measures,X4270.Volume level set by participant (left),TNNI3,"Troponin I, cardiac muscle",36697,-0.0028040020606935,0.0227739687516774,-0.0474409808139812,0.0418329766925942,0.902012903474366
Physical measures,X4270.Volume level set by participant (left),OGFR,Opioid growth factor receptor,36770,0.00716324157604225,0.0582343589727097,-0.106976102010469,0.121302585162553,0.902104713210104
Physical measures,X4270.Volume level set by participant (left),SORD,Sorbitol dehydrogenase,36865,-0.00361200676788701,0.0294640808827113,-0.0613616052980012,0.0541375917622272,0.902434849318262
Physical measures,X4270.Volume level set by participant (left),VSNL1,Visinin-like protein 1,35903,0.00704943760536361,0.0576876064048799,-0.106018270948201,0.120117146158928,0.902744121941442
Physical measures,X4270.Volume level set by participant (left),UROS,Uroporphyrinogen-III synthase,35741,0.00393903299789829,0.032278027316105,-0.0593259005416675,0.0672039665374641,0.902875440722576
Physical measures,X4270.Volume level set by participant (left),EPN1,Epsin-1,35798,0.00631530305472455,0.0518407478168375,-0.095292562666277,0.107923168775726,0.903044317536371
Physical measures,X4270.Volume level set by participant (left),RRAS,Ras-related protein R-Ras,35741,0.00214627430365712,0.0176304088992358,-0.0324093271388451,0.0367018757461593,0.903110992639611
Physical measures,X4270.Volume level set by participant (left),SPINT1,Kunitz-type protease inhibitor 1,36803,-0.00897639095031458,0.0739388652957435,-0.153896566929972,0.135943785029343,0.903375145423427
Physical measures,X4270.Volume level set by participant (left),GFER,FAD-linked sulfhydryl oxidase ALR,36654,0.00375938405758939,0.0309709132343986,-0.0569436058818319,0.0644623739970107,0.90338988560551
Physical measures,X4270.Volume level set by participant (left),TYRO3,Tyrosine-protein kinase receptor TYRO3,36828,-0.00807937011889894,0.0670856144928825,-0.139567174524949,0.123408434287151,0.904142751625895
Physical measures,X4270.Volume level set by participant (left),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,36780,0.00389836971072308,0.0324429094459274,-0.0596897328032946,0.0674864722247408,0.904358861408022
Physical measures,X4270.Volume level set by participant (left),PTGR1,Prostaglandin reductase 1,35916,-0.00316749111695819,0.0264215886416511,-0.0549538048545943,0.0486188226206779,0.904579661321377
Physical measures,X4270.Volume level set by participant (left),TGFBR3,Transforming growth factor beta receptor type 3,36933,-0.00662545393912915,0.0553266278129109,-0.115065644452435,0.101814736574176,0.904683008306014
Physical measures,X4270.Volume level set by participant (left),CCT5,T-complex protein 1 subunit epsilon,36654,0.00457813352900447,0.03828700480511,-0.0704643958890111,0.0796206629470201,0.904823771479466
Physical measures,X4270.Volume level set by participant (left),CRX,Cone-rod homeobox protein,36697,-0.00214411274584135,0.0179477368438354,-0.0373216769597588,0.0330334514680761,0.904910768936619
Physical measures,X4270.Volume level set by participant (left),NGFR,Tumor necrosis factor receptor superfamily member 16,35916,-0.00904921789344956,0.0760295868429018,-0.158067208105537,0.139968772318638,0.905261230037312
Physical measures,X4270.Volume level set by participant (left),GCG,Pro-glucagon,36654,-0.00183021627163654,0.0153955032675772,-0.0320054026760878,0.0283449701328148,0.905373688761642
Physical measures,X4270.Volume level set by participant (left),RNF5,E3 ubiquitin-protein ligase RNF5,35748,-0.00388148081026426,0.0327132199145032,-0.0679993918426905,0.060236430222162,0.905554901778479
Physical measures,X4270.Volume level set by participant (left),F10,Coagulation factor X,35926,0.0093806458804991,0.0794249159643566,-0.14629218940964,0.165053481170638,0.905986329153615
Physical measures,X4270.Volume level set by participant (left),GTPBP2,GTP-binding protein 2,35741,0.00329412763242791,0.0282197897718494,-0.0520166603203969,0.0586049155852527,0.907076711677681
Physical measures,X4270.Volume level set by participant (left),REXO2,"Oligoribonuclease, mitochondrial",35706,0.00513189403788517,0.0442148060357635,-0.0815291257922112,0.0917929138679816,0.907602769223622
Physical measures,X4270.Volume level set by participant (left),F12,Coagulation factor XII,35953,-0.00578274386043019,0.0505688881577418,-0.104897764649604,0.0933322769287438,0.908960744408385
Physical measures,X4270.Volume level set by participant (left),CD93,Complement component C1q receptor,36548,-0.00692616353318387,0.0606610010627364,-0.125821725616147,0.111969398549779,0.909099655903472
Physical measures,X4270.Volume level set by participant (left),OLFM4,Olfactomedin-4,35458,0.0020964664815123,0.0184104874651621,-0.0339880889502053,0.0381810219132299,0.909341730995395
Physical measures,X4270.Volume level set by participant (left),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,35748,-0.00597893402978628,0.0525751339693583,-0.109026196609729,0.097068328550156,0.909461888529936
Physical measures,X4270.Volume level set by participant (left),TGFB2,Transforming growth factor beta-2 proprotein,35874,0.00458445972306301,0.0403515421817268,-0.0745045629531215,0.0836734823992475,0.909547998081967
Physical measures,X4270.Volume level set by participant (left),FBN2,Fibrillin-2,35741,-0.00424988384644878,0.0374147292225888,-0.0775827531227228,0.0690829854298252,0.909567469856892
Physical measures,X4270.Volume level set by participant (left),SIGLEC10,Sialic acid-binding Ig-like lectin 10,36820,0.00610514903426057,0.054149989241336,-0.100028829878758,0.112239127947279,0.910235568148152
Physical measures,X4270.Volume level set by participant (left),TSPAN7,Tetraspanin-7,35680,0.00265777889908875,0.0239794041711191,-0.0443418532763046,0.0496574110744821,0.911749905703169
Physical measures,X4270.Volume level set by participant (left),AKT3,RAC-gamma serine/threonine-protein kinase,36627,0.00378605523151913,0.0342132197655841,-0.0632718555090258,0.070843965972064,0.911888484052304
Physical measures,X4270.Volume level set by participant (left),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",36762,-0.00292487672629616,0.0265439142911011,-0.0549509487368543,0.0491011952842619,0.912261531734644
Physical measures,X4270.Volume level set by participant (left),METAP1,Methionine aminopeptidase 1,36639,-0.00725427577957849,0.0658573248841731,-0.136334632552558,0.121826080993401,0.9122922840709
Physical measures,X4270.Volume level set by participant (left),SEPTIN7,Septin-7,35798,-0.00431412716888714,0.039392535897942,-0.0815234975288534,0.0728952431910791,0.91279627489093
Physical measures,X4270.Volume level set by participant (left),TOP1MT,"DNA topoisomerase I, mitochondrial",35678,0.0050164232741494,0.0460170415058912,-0.0851769780773973,0.0952098246256961,0.91319611381933
Physical measures,X4270.Volume level set by participant (left),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,36763,0.00265185720207732,0.0243408245409759,-0.0450561588982354,0.05035987330239,0.91324750203357
Physical measures,X4270.Volume level set by participant (left),CA4,Carbonic anhydrase 4,36933,-0.00841232552240531,0.0772735633597647,-0.159868509707544,0.143043858662733,0.913313016686001
Physical measures,X4270.Volume level set by participant (left),TACSTD2,Tumor-associated calcium signal transducer 2,35975,-0.00761088226653565,0.0699673609447473,-0.14474690971824,0.129525145185169,0.91338210340064
Physical measures,X4270.Volume level set by participant (left),SMS,Spermine synthase,35680,0.00383861410951839,0.0353529809150645,-0.065453228484008,0.0731304567030448,0.913539266670192
Physical measures,X4270.Volume level set by participant (left),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,35680,0.00486509107011278,0.04537465914287,-0.0840692408499124,0.093799422990138,0.914617415201736
Physical measures,X4270.Volume level set by participant (left),SCN3A,Sodium channel protein type 3 subunit alpha,35741,0.00681647561783013,0.0637361052583814,-0.118106290688597,0.131739241924258,0.914833179907893
Physical measures,X4270.Volume level set by participant (left),NPHS1,Nephrin,35725,0.00690489695747867,0.0645687139004512,-0.119649782287406,0.133459576202363,0.914840864816312
Physical measures,X4270.Volume level set by participant (left),ARHGEF5,Rho guanine nucleotide exchange factor 5,35680,0.00336541059630093,0.031556874256258,-0.0584860629459647,0.0652168841385665,0.915073219611823
Physical measures,X4270.Volume level set by participant (left),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,36864,0.00362778253939755,0.0341960763021669,-0.0633965270128495,0.0706520920916446,0.915515558105124
Physical measures,X4270.Volume level set by participant (left),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,36654,-0.00254652348411231,0.0240197635709313,-0.0496252600831377,0.0445322131149131,0.915571048274877
Physical measures,X4270.Volume level set by participant (left),CPLX2,Complexin-2,35678,0.00711736960705283,0.0671481257742918,-0.124492956910559,0.138727696124665,0.915589552219837
Physical measures,X4270.Volume level set by participant (left),PMVK,Phosphomevalonate kinase,36619,0.00199586412809038,0.0188473168500623,-0.0349448768980318,0.0389366051542125,0.915667364886984
Physical measures,X4270.Volume level set by participant (left),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,36754,0.00731218337389748,0.06941091002108,-0.128733200267419,0.143357567015214,0.91610381176687
Physical measures,X4270.Volume level set by participant (left),FCRL5,Fc receptor-like protein 5,36836,-0.00334013161261428,0.0317797747868111,-0.0656284901947641,0.0589482269695355,0.916297289128706
Physical measures,X4270.Volume level set by participant (left),NARS1,"Asparagine--tRNA ligase, cytoplasmic",35903,0.00513767336291549,0.0490266873552247,-0.0909546338533249,0.101229980579156,0.916542879578239
Physical measures,X4270.Volume level set by participant (left),IL1RL2,Interleukin-1 receptor-like 2,36697,-0.00521684013964703,0.0500308802977827,-0.103277365523301,0.0928436852440071,0.91695596545012
Physical measures,X4270.Volume level set by participant (left),PSAP,Prosaposin,35848,0.00745687589626422,0.0730871768485056,-0.135793990726807,0.150707742519335,0.918738205586561
Physical measures,X4270.Volume level set by participant (left),CD99,CD99 antigen,36836,0.00959265806569157,0.0946390221182989,-0.175899825286174,0.195085141417557,0.919266956055986
Physical measures,X4270.Volume level set by participant (left),DCLRE1C,Protein artemis,35678,-0.00743833092348164,0.0734528489750209,-0.151405914914523,0.136529253067559,0.919341846702705
Physical measures,X4270.Volume level set by participant (left),FGL1,Fibrinogen-like protein 1,35926,0.00331074634154049,0.032714571331073,-0.0608098134673627,0.0674313061504437,0.919393942113945
Physical measures,X4270.Volume level set by participant (left),ITGA5,Integrin alpha-5,36836,0.00755836739735479,0.0755146993589383,-0.140450443346164,0.155567178140874,0.920274437580081
Physical measures,X4270.Volume level set by participant (left),LAMA4,Laminin subunit alpha-4,36865,0.00563888397602618,0.0570618754061442,-0.106202391820016,0.117480159772069,0.921283361829676
Physical measures,X4270.Volume level set by participant (left),RABGAP1L,Rab GTPase-activating protein 1-like,36697,0.00311917691001446,0.032153412162379,-0.0599015109282484,0.0661398647482774,0.922721677515092
Physical measures,X4270.Volume level set by participant (left),FGF23,Fibroblast growth factor 23,36886,-0.00334221293705794,0.0346033069106759,-0.0711646944819827,0.0644802686078668,0.923057280502103
Physical measures,X4270.Volume level set by participant (left),LZTFL1,Leucine zipper transcription factor-like protein 1,35779,-0.00312181276170695,0.0323297948329303,-0.0664882106342502,0.0602445851108363,0.923077589693627
Physical measures,X4270.Volume level set by participant (left),BAG4,BAG family molecular chaperone regulator 4,35725,0.00436259512371727,0.0452391953962147,-0.0843062278528635,0.093031418100298,0.923178875429638
Physical measures,X4270.Volume level set by participant (left),LTA,Lymphotoxin-alpha,36820,0.00449112988336948,0.046641462457038,-0.086926136532425,0.0959083962991639,0.923292384693424
Physical measures,X4270.Volume level set by participant (left),CD40LG,CD40 ligand,36908,0.00230343580803513,0.0240928272395465,-0.0449185055814759,0.0495253771975462,0.923835424764209
Physical measures,X4270.Volume level set by participant (left),OBP2B,Odorant-binding protein 2b,36736,-0.00293652136387836,0.0307715493180549,-0.063248758027266,0.0573757152995092,0.923976020411263
Physical measures,X4270.Volume level set by participant (left),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",36820,0.00194175574019718,0.0203800118773457,-0.0380030675394005,0.0418865790197948,0.924096950857437
Physical measures,X4270.Volume level set by participant (left),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35916,-0.0034618846700799,0.0365214939790907,-0.0750440128690977,0.0681202435289379,0.924484190002454
Physical measures,X4270.Volume level set by participant (left),P4HB,Protein disulfide-isomerase,36802,0.0046965550166506,0.0498367230216809,-0.0929834221058439,0.102376532139145,0.924921914042793
Physical measures,X4270.Volume level set by participant (left),BAX,Apoptosis regulator BAX,36628,-0.00209496179991614,0.0222456961023172,-0.0456965261604579,0.0415066025606257,0.924973633545544
Physical measures,X4270.Volume level set by participant (left),CD276,CD276 antigen,36822,-0.00481681504060612,0.0512506462423651,-0.105268081675642,0.0956344515944295,0.925123184352967
Physical measures,X4270.Volume level set by participant (left),PILRB,Paired immunoglobulin-like type 2 receptor beta,36828,0.00304672745033651,0.0326718612519228,-0.0609901206034323,0.0670835755041053,0.925705543806784
Physical measures,X4270.Volume level set by participant (left),THY1,Thy-1 membrane glycoprotein,36894,-0.00587722992848668,0.0634004714036641,-0.130142153879668,0.118387694022695,0.926144231533232
Physical measures,X4270.Volume level set by participant (left),PYDC1,Pyrin domain-containing protein 1,35748,0.00504061792562418,0.0545759569331245,-0.1019282576633,0.112009493514548,0.926415097164361
Physical measures,X4270.Volume level set by participant (left),ACRBP,Acrosin-binding protein,35874,0.00530334090455805,0.0575668177747456,-0.107527621933943,0.118134303743059,0.926601519638404
Physical measures,X4270.Volume level set by participant (left),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35798,0.00195314817584991,0.021207089775786,-0.0396127477846906,0.0435190441363904,0.926622312033387
Physical measures,X4270.Volume level set by participant (left),PFDN2,Prefoldin subunit 2,36639,0.00302125402757598,0.0335231597212673,-0.062684139026108,0.0687266470812599,0.928190799969839
Physical measures,X4270.Volume level set by participant (left),CNTF,Ciliary neurotrophic factor,35680,0.00580250383388945,0.0646626858964598,-0.120936360523172,0.132541368190951,0.928500602222598
Physical measures,X4270.Volume level set by participant (left),RTKN2,Rhotekin-2,35706,-0.0041002035202697,0.0459569052376507,-0.0941757377860651,0.0859753307455257,0.928911053509626
Physical measures,X4270.Volume level set by participant (left),NAAA,N-acylethanolamine-hydrolyzing acid amidase,36727,0.00290166922255797,0.0326219759772736,-0.0610374036928983,0.0668407421380142,0.929125365309651
Physical measures,X4270.Volume level set by participant (left),DNM3,Dynamin-3,35903,-0.00347016635786715,0.0390474418802326,-0.080003152443123,0.0730628197273887,0.929187468424501
Physical measures,X4270.Volume level set by participant (left),RAB33A,Ras-related protein Rab-33A,35706,-0.003075987923047,0.0347115915681927,-0.0711107073967046,0.0649587315506106,0.929390149590166
Physical measures,X4270.Volume level set by participant (left),EIF5,Eukaryotic translation initiation factor 5,35706,-0.00468044333709316,0.052831959438793,-0.108231083837127,0.0988701971629411,0.929409577784853
Physical measures,X4270.Volume level set by participant (left),NUDC,Nuclear migration protein nudC,36908,0.00275108068450861,0.0312806445763171,-0.0585589826850729,0.0640611440540901,0.929920021490845
Physical measures,X4270.Volume level set by participant (left),PKN3,Serine/threonine-protein kinase N3,35798,-0.00255521233688438,0.0291619540955413,-0.0597126423641453,0.0546022176903766,0.930180220911832
Physical measures,X4270.Volume level set by participant (left),DBN1,Drebrin,35725,-0.00380630756382818,0.0437838138329368,-0.0896225826763844,0.0820099675487281,0.930726540327274
Physical measures,X4270.Volume level set by participant (left),FAS,Tumor necrosis factor receptor superfamily member 6,36909,0.00493995373777024,0.05693275516256,-0.106648246380847,0.116528153856388,0.930858002935937
Physical measures,X4270.Volume level set by participant (left),SLC1A4,Neutral amino acid transporter A,35741,-0.00404873104102197,0.0468659170774971,-0.0959059285129162,0.0878084664308723,0.931159302566458
Physical measures,X4270.Volume level set by participant (left),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,35748,0.00738767397874695,0.0857408849323361,-0.160664460488632,0.175439808446126,0.931339642070368
Physical measures,X4270.Volume level set by participant (left),YAP1,Transcriptional coactivator YAP1,35903,-0.00660078589741806,0.0768694079279036,-0.157264825436109,0.144063253641273,0.931572221723028
Physical measures,X4270.Volume level set by participant (left),RNASE3,Eosinophil cationic protein,36792,0.00137812868533049,0.0160527950898966,-0.0300853496908668,0.0328416070615278,0.931588108699407
Physical measures,X4270.Volume level set by participant (left),CRH,Corticoliberin,36631,0.00191583139492319,0.0223441549420259,-0.0418787122914475,0.0457103750812939,0.931673863388576
Physical measures,X4270.Volume level set by participant (left),CD2AP,CD2-associated protein,36828,-0.00259133530009932,0.0303072787737172,-0.0619936016965851,0.0568109310963864,0.931864486950464
Physical measures,X4270.Volume level set by participant (left),XG,Glycoprotein Xg,36891,0.00461790627506154,0.0559923630755989,-0.105127125353112,0.114362937903235,0.934272050126974
Physical measures,X4270.Volume level set by participant (left),TP53,Cellular tumor antigen p53,36654,-0.00367632581992614,0.0445949041377943,-0.0910823379300029,0.0837296862901506,0.934300433692818
Physical measures,X4270.Volume level set by participant (left),FGFBP3,Fibroblast growth factor-binding protein 3,35903,-0.00489536680972661,0.0594041808322544,-0.121327561240945,0.111536827621492,0.934324907082346
Physical measures,X4270.Volume level set by participant (left),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,36697,0.00336353696543833,0.0422340473371946,-0.0794151958154631,0.0861422697463398,0.936525377266973
Physical measures,X4270.Volume level set by participant (left),SERPINA6,Corticosteroid-binding globulin,35953,0.0108845376690564,0.136777110968847,-0.257198599829883,0.278967675167996,0.936574734113108
Physical measures,X4270.Volume level set by participant (left),APOL1,Apolipoprotein L1,35926,0.00287191339328293,0.0361319807989169,-0.0679467689725941,0.07369059575916,0.936650042363847
Physical measures,X4270.Volume level set by participant (left),PCDHB15,Protocadherin beta-15,35874,-0.00442541526470216,0.0559391952109796,-0.114066237878222,0.105215407348818,0.936946568522754
Physical measures,X4270.Volume level set by participant (left),TMEM132A,Transmembrane protein 132A,35748,-0.00273610475333653,0.0346835078364605,-0.0707157801127992,0.0652435706061261,0.93712429672515
Physical measures,X4270.Volume level set by participant (left),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,35779,0.00294139172570627,0.0374522010919267,-0.07046492241447,0.0763477058658825,0.937403112395955
Physical measures,X4270.Volume level set by participant (left),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",35779,0.00178666597199025,0.0227889128991225,-0.0428796033102899,0.0464529352542704,0.937511726157856
Physical measures,X4270.Volume level set by participant (left),PMM2,Phosphomannomutase 2,35706,-0.00290800229997052,0.0373577212120773,-0.076129135875642,0.070313131275701,0.93795607464614
Physical measures,X4270.Volume level set by participant (left),SKAP1,Src kinase-associated phosphoprotein 1,36748,0.0020337268587546,0.0264992601092135,-0.0499048229553038,0.053972276672813,0.938827203422769
Physical measures,X4270.Volume level set by participant (left),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,36697,-0.00339686343345311,0.0444567879893081,-0.090532167892497,0.0837384410255908,0.939096378951654
Physical measures,X4270.Volume level set by participant (left),AKR1C4,Aldo-keto reductase family 1 member C4,36697,-0.00273007750148077,0.0360821679043197,-0.0734511265939473,0.0679909715909858,0.939689398227359
Physical measures,X4270.Volume level set by participant (left),IL12A_IL12B,Interleukin-12,36770,-0.00176394369580354,0.0233630649012389,-0.0475555509022318,0.0440276635106247,0.939817792028188
Physical measures,X4270.Volume level set by participant (left),COL6A3,Collagen alpha-3(VI) chain,36933,0.00382941907629369,0.0510247937599742,-0.0961791766932557,0.103838014845843,0.940176740838275
Physical measures,X4270.Volume level set by participant (left),F11,Coagulation factor XI,35839,0.00540521274104594,0.0725663750259015,-0.136824882309721,0.147635307791813,0.940625553849638
Physical measures,X4270.Volume level set by participant (left),APOC1,Apolipoprotein C-I,35940,0.00449459210858387,0.0606113554717483,-0.114303664616043,0.123292848833211,0.940889815532119
Physical measures,X4270.Volume level set by participant (left),PDZD2,PDZ domain-containing protein 2,35706,-0.00265486452420442,0.0358733746059514,-0.0729666787518691,0.0676569497034603,0.941007451222997
Physical measures,X4270.Volume level set by participant (left),SWAP70,Switch-associated protein 70,35894,-0.00473477456637388,0.064108548123574,-0.130387528888579,0.120917979755831,0.941127500055589
Physical measures,X4270.Volume level set by participant (left),OTUD6B,Deubiquitinase OTUD6B,35894,-0.00285334677313357,0.0386824095349728,-0.0786708694616803,0.0729641759154132,0.941200838263426
Physical measures,X4270.Volume level set by participant (left),IDI2,Isopentenyl-diphosphate delta-isomerase 2,36639,0.00297454196611491,0.0404108942039964,-0.076230810673718,0.0821798946059478,0.941324739090134
Physical measures,X4270.Volume level set by participant (left),CERT,Ceramide transfer protein,36639,0.00240554591601807,0.0327790149818776,-0.061841323448462,0.0666524152804982,0.941500320324073
Physical measures,X4270.Volume level set by participant (left),STX6,Syntaxin-6,36654,-0.00209076216101329,0.0284975591857703,-0.0579459781651232,0.0537644538430966,0.941516554709904
Physical measures,X4270.Volume level set by participant (left),MNDA,Myeloid cell nuclear differentiation antigen,36816,0.00139310933942737,0.0190068789568011,-0.0358603734159027,0.0386465920947575,0.941573288317948
Physical measures,X4270.Volume level set by participant (left),SCARB1,Scavenger receptor class B member 1,36639,-0.00244903505014055,0.0335104657298282,-0.0681295478806038,0.0632314777803227,0.941742278545864
Physical measures,X4270.Volume level set by participant (left),CHRDL1,Chordin-like protein 1,36853,0.00423505080706917,0.0581627218767208,-0.109763884071304,0.118233985685442,0.941956163896834
Physical measures,X4270.Volume level set by participant (left),ATP5IF1,"ATPase inhibitor, mitochondrial",36865,0.00127239353792391,0.0175217326485552,-0.0330702024532442,0.035614989529092,0.942111980394956
Physical measures,X4270.Volume level set by participant (left),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35874,-0.00431095662603941,0.0602540111989007,-0.122408818575885,0.113786905323806,0.942965052791471
Physical measures,X4270.Volume level set by participant (left),CTSZ,Cathepsin Z,36837,0.00417733501240886,0.0587273672835942,-0.110928304863436,0.119282974888253,0.943295376304497
Physical measures,X4270.Volume level set by participant (left),EPB41L5,Band 4.1-like protein 5,35741,0.00254907717789723,0.0360267949060673,-0.0680634408379948,0.0731615951937892,0.943594880056618
Physical measures,X4270.Volume level set by participant (left),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35916,0.00453787785826558,0.0647696980816624,-0.122410730381793,0.131486486098324,0.944146602540064
Physical measures,X4270.Volume level set by participant (left),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,35706,-0.00508908659972087,0.0729782825694777,-0.148126520435897,0.137948347236455,0.944407314033357
Physical measures,X4270.Volume level set by participant (left),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35916,-0.00214012996896974,0.0307794343035084,-0.0624678212038461,0.0581875612659066,0.944568894607128
Physical measures,X4270.Volume level set by participant (left),CFB,Complement factor B,35824,0.00464904861123246,0.0671048320400055,-0.126876422187178,0.136174519409643,0.944768528846263
Physical measures,X4270.Volume level set by participant (left),GIP,Gastric inhibitory polypeptide,35748,-0.00261512716023949,0.0385481807950335,-0.0781695615185052,0.0729393071980262,0.945914688474385
Physical measures,X4270.Volume level set by participant (left),TBL1X,F-box-like/WD repeat-containing protein TBL1X,36654,0.00159530537990257,0.0235181120732249,-0.0445001942836182,0.0476908050434234,0.945920349233032
Physical measures,X4270.Volume level set by participant (left),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,36763,0.00144548693114512,0.0213421665218524,-0.0403851594516856,0.0432761333139759,0.946003028935001
Physical measures,X4270.Volume level set by participant (left),SSH3,Protein phosphatase Slingshot homolog 3,35678,0.00519813192305905,0.077107395971791,-0.145932364181651,0.156328628027769,0.94625405984939
Physical measures,X4270.Volume level set by participant (left),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35874,0.00393478318133251,0.0585805988200932,-0.11088319050605,0.118752756868715,0.946449406733648
Physical measures,X4270.Volume level set by participant (left),CLIP2,CAP-Gly domain-containing linker protein 2,36820,-0.00115312592764601,0.0172454913233148,-0.034954288921343,0.032648037066051,0.946690646228843
Physical measures,X4270.Volume level set by participant (left),CD3E,T-cell surface glycoprotein CD3 epsilon chain,35798,0.00398288587578281,0.059685155274573,-0.11300001846238,0.120965790213946,0.946797398590447
Physical measures,X4270.Volume level set by participant (left),BAG6,Large proline-rich protein BAG6,36697,-0.00349003353268409,0.0533030212250293,-0.107963955133742,0.100983888068373,0.947797283690217
Physical measures,X4270.Volume level set by participant (left),GPNMB,Transmembrane glycoprotein NMB,36599,-0.00440473588269895,0.0674411260293596,-0.136589342900244,0.127779871134846,0.947927103272954
Physical measures,X4270.Volume level set by participant (left),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",36770,0.00374370315591568,0.057330481960155,-0.108624041485988,0.116111447797819,0.947936550944787
Physical measures,X4270.Volume level set by participant (left),SFRP1,Secreted frizzled-related protein 1,36739,-0.00278620917990019,0.0427341686891412,-0.086545179810617,0.0809727614508166,0.948017581269082
Physical measures,X4270.Volume level set by participant (left),INPP1,Inositol polyphosphate 1-phosphatase,36770,-0.00233967974787496,0.0359670449255719,-0.0728350878019959,0.068155728306246,0.948135387611994
Physical measures,X4270.Volume level set by participant (left),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",36744,0.00297128061647853,0.0460486252562289,-0.0872840248857302,0.0932265861186872,0.948554030195719
Physical measures,X4270.Volume level set by participant (left),AHNAK2,Protein AHNAK2,35748,-0.0048202986824255,0.0747660042414142,-0.151361666995597,0.141721069630746,0.948596529873748
Physical measures,X4270.Volume level set by participant (left),LYN,Tyrosine-protein kinase Lyn,36770,0.00150765538693938,0.0234130161797022,-0.0443818563252768,0.0473971670991556,0.948658287853304
Physical measures,X4270.Volume level set by participant (left),CSRP3,Cysteine and glycine-rich protein 3,35706,-0.00143660267818558,0.022428355770031,-0.0453961799874463,0.0425229746310752,0.948930020610517
Physical measures,X4270.Volume level set by participant (left),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35903,-0.00181683642875225,0.028465177669423,-0.0576085846608213,0.0539749118033168,0.949110174327017
Physical measures,X4270.Volume level set by participant (left),EP300,Histone acetyltransferase p300,35725,0.00473400507612724,0.0747623769982948,-0.141800253840531,0.151268263992785,0.949513081615252
Physical measures,X4270.Volume level set by participant (left),CPXM2,Inactive carboxypeptidase-like protein X2,35916,-0.00529068006257399,0.0838030656155954,-0.169544688669141,0.158963328543993,0.94966303390764
Physical measures,X4270.Volume level set by participant (left),NDRG1,Protein NDRG1,36639,0.00183365985908624,0.0292846150871608,-0.0555641857117489,0.0592315054299213,0.950074665920717
Physical measures,X4270.Volume level set by participant (left),TMED10,Transmembrane emp24 domain-containing protein 10,35706,0.00292887676807008,0.0469421681167764,-0.0890777727408116,0.0949355262769518,0.950251546303331
Physical measures,X4270.Volume level set by participant (left),LRRC25,Leucine-rich repeat-containing protein 25,36770,-0.00292059171017945,0.0474530414702857,-0.0959285529919395,0.0900873695715806,0.950925219534225
Physical measures,X4270.Volume level set by participant (left),SCARA5,Scavenger receptor class A member 5,36894,-0.00378451337546175,0.0616141791078457,-0.124548304426839,0.116979277675916,0.9510241158055
Physical measures,X4270.Volume level set by participant (left),SIRT2,NAD-dependent protein deacetylase sirtuin-2,36770,-0.00139548518131258,0.0231267436638722,-0.0467239027625021,0.043932932399877,0.951885835215126
Physical measures,X4270.Volume level set by participant (left),SCGB3A2,Secretoglobin family 3A member 2,36853,-0.00130849592294438,0.0217781957191643,-0.0439937595325065,0.0413767676866177,0.952091222461574
Physical measures,X4270.Volume level set by participant (left),S100P,Protein S100-P,36697,-0.00197901638113927,0.0329528635269923,-0.0665666288940442,0.0626085961317656,0.952112652803514
Physical measures,X4270.Volume level set by participant (left),GBP1,Guanylate-binding protein 1,35889,-0.00207971829661682,0.0348034436524125,-0.0702944678553453,0.0661350312621117,0.952351669063613
Physical measures,X4270.Volume level set by participant (left),DNAJA2,DnaJ homolog subfamily A member 2,36885,0.00144608723550869,0.0242800733863381,-0.046142856601714,0.0490350310727314,0.952508738357624
Physical measures,X4270.Volume level set by participant (left),ANXA5,Annexin A5,36628,0.00367653162079741,0.0617500502600805,-0.11735356688896,0.124706630130555,0.952524463669519
Physical measures,X4270.Volume level set by participant (left),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35798,-0.00119252251431732,0.0201294543438282,-0.0406462530282206,0.038261207999586,0.95276062109296
Physical measures,X4270.Volume level set by participant (left),CDH5,Cadherin-5,36933,0.00363332758877931,0.0613901552584234,-0.11669137671773,0.123958031895289,0.952806918152228
Physical measures,X4270.Volume level set by participant (left),FOLR2,Folate receptor beta,36894,0.00371053000744103,0.0627255144277367,-0.119231478270923,0.126652538285805,0.95283015936027
Physical measures,X4270.Volume level set by participant (left),GORASP2,Golgi reassembly-stacking protein 2,35894,0.00276731706669838,0.0468411956083083,-0.089041426325586,0.0945760604589827,0.95289118453527
Physical measures,X4270.Volume level set by participant (left),SCRG1,Scrapie-responsive protein 1,35916,-0.00453442787300516,0.0777111148931765,-0.156848213063631,0.147779357317621,0.95347173699118
Physical measures,X4270.Volume level set by participant (left),LSM1,U6 snRNA-associated Sm-like protein LSm1,36654,-0.00198976457217991,0.0342500804093981,-0.0691199221746001,0.0651403930302403,0.953674370651643
Physical measures,X4270.Volume level set by participant (left),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,36671,0.00145769819781507,0.0252542350524553,-0.0480406025049973,0.0509559989006274,0.953972456457633
Physical measures,X4270.Volume level set by participant (left),GPD1,Glycerol-3-phosphate dehydrogenase,35874,-0.00236989079978652,0.041192639544882,-0.0831074643077553,0.0783676827081823,0.954123217563716
Physical measures,X4270.Volume level set by participant (left),SERPINA5,Plasma serine protease inhibitor,35843,0.00385297239809661,0.0678255177728331,-0.129085042436656,0.136790987232849,0.954700549031454
Physical measures,X4270.Volume level set by participant (left),PLSCR3,Phospholipid scramblase 3,35883,-0.00212131594380776,0.037378760989203,-0.0753836874826456,0.0711410555950301,0.954744521141207
Physical measures,X4270.Volume level set by participant (left),SHC1,SHC-transforming protein 1,35678,0.00112117782116553,0.0197981245611083,-0.0376831463186067,0.0399255019609377,0.954841278597407
Physical measures,X4270.Volume level set by participant (left),CFC1,Cryptic protein,36654,-0.00238531330891608,0.0425805917435355,-0.0858432731262457,0.0810726465084136,0.955328337671856
Physical measures,X4270.Volume level set by participant (left),ANGPTL1,Angiopoietin-related protein 1,36720,0.00369607210995165,0.0662840482829673,-0.126220662524664,0.133612806744568,0.95553359717625
Physical measures,X4270.Volume level set by participant (left),PAMR1,Inactive serine protease PAMR1,36836,-0.00380869876153946,0.0702494006621295,-0.141497524059313,0.133880126536234,0.956763841706331
Physical measures,X4270.Volume level set by participant (left),PDLIM5,PDZ and LIM domain protein 5,35903,-0.00106203230857361,0.0196371090624738,-0.0395507660710222,0.037426701453875,0.956870706751123
Physical measures,X4270.Volume level set by participant (left),DSG2,Desmoglein-2,36836,-0.00368477097159732,0.0684410116485043,-0.137829153802666,0.130459611859471,0.957065131918993
Physical measures,X4270.Volume level set by participant (left),WASL,Neural Wiskott-Aldrich syndrome protein,35725,0.00192251110724142,0.0357395031437154,-0.0681269150544407,0.0719719372689235,0.957102267368989
Physical measures,X4270.Volume level set by participant (left),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,36639,0.00161662298414245,0.0301979717723783,-0.0575714016897189,0.0608046476580038,0.957307752648907
Physical measures,X4270.Volume level set by participant (left),NFE2,Transcription factor NF-E2 45 kDa subunit,35748,0.00160631092849446,0.0303358663292204,-0.0578519870767775,0.0610646089337664,0.957772656462855
Physical measures,X4270.Volume level set by participant (left),CANT1,Soluble calcium-activated nucleotidase 1,36799,-0.00491214815982142,0.0930493172260548,-0.187288809922889,0.177464513603246,0.957899976653262
Physical measures,X4270.Volume level set by participant (left),REG1A,Lithostathine-1-alpha,36756,0.00195151546525315,0.0375505878012609,-0.0716476366252183,0.0755506675557246,0.958553728609034
Physical measures,X4270.Volume level set by participant (left),CRTAM,Cytotoxic and regulatory T-cell molecule,36763,0.00189485524874554,0.0364651696105742,-0.0695768771879799,0.073366587685471,0.958559205321937
Physical measures,X4270.Volume level set by participant (left),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35874,-0.00149010838555703,0.0287369425732337,-0.057814515829095,0.0548342990579809,0.958647051083037
Physical measures,X4270.Volume level set by participant (left),CEP112,Centrosomal protein of 112 kDa,35706,-0.00259906995904425,0.0502041102246918,-0.10099912599944,0.0958009860813516,0.95871349826775
Physical measures,X4270.Volume level set by participant (left),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,36763,-0.00225650990556019,0.0437304736331321,-0.087968238226499,0.0834552184153787,0.958848463273403
Physical measures,X4270.Volume level set by participant (left),RBP2,Retinol-binding protein 2,36770,-0.00126701069376681,0.0245920707228216,-0.0494674693104971,0.0469334479229635,0.958911642491483
Physical measures,X4270.Volume level set by participant (left),CIT,Citron Rho-interacting kinase,35741,0.00246138676579928,0.0477794664458466,-0.09118636746806,0.0961091409996585,0.958916262286287
Physical measures,X4270.Volume level set by participant (left),TNFSF13,Tumor necrosis factor ligand superfamily member 13,36865,-0.00343697883878779,0.0675416368561477,-0.135818587076837,0.128944629399262,0.959417036734997
Physical measures,X4270.Volume level set by participant (left),CRISP2,Cysteine-rich secretory protein 2,36888,0.00161802545170049,0.0320390622097474,-0.0611785364794043,0.0644145873828053,0.959723947365239
Physical measures,X4270.Volume level set by participant (left),SEMA7A,Semaphorin-7A,36909,0.00328564779787595,0.0656495426522532,-0.12538745580054,0.131958751396292,0.960085197306212
Physical measures,X4270.Volume level set by participant (left),MMP3,Stromelysin-1,36836,-0.00186378762879058,0.0373057293568865,-0.0749830171682881,0.0712554419107069,0.960155711226993
Physical measures,X4270.Volume level set by participant (left),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,36739,0.00282858109026875,0.0567495477305209,-0.108400532461552,0.11405769464209,0.960248632147038
Physical measures,X4270.Volume level set by participant (left),CHMP1A,Charged multivesicular body protein 1a,36763,-0.00125519361573357,0.0257459079809948,-0.0517171732584834,0.0492067860270162,0.961117320878513
Physical measures,X4270.Volume level set by participant (left),CPB2,Carboxypeptidase B2,35940,0.00464350619017916,0.0971645523337152,-0.185799016383903,0.195086028764261,0.961884921257949
Physical measures,X4270.Volume level set by participant (left),NEXN,Nexilin,35926,0.00144607431611086,0.0302880370565721,-0.0579184783147705,0.0608106269469922,0.96192162416329
Physical measures,X4270.Volume level set by participant (left),BCL7A,B-cell CLL/lymphoma 7 protein family member A,35678,0.00159023224929037,0.0343377842238223,-0.0657118248294014,0.0688922893279822,0.963063447797338
Physical measures,X4270.Volume level set by participant (left),CSF3,Granulocyte colony-stimulating factor,36697,0.00182674727070205,0.0394831675659928,-0.0755602611586437,0.0792137557000478,0.963099085795631
Physical measures,X4270.Volume level set by participant (left),SLAMF1,Signaling lymphocytic activation molecule,36697,-0.00142693365109769,0.0309623196170284,-0.0621130801004733,0.0592592127982779,0.963242823687089
Physical measures,X4270.Volume level set by participant (left),FAM20A,Pseudokinase FAM20A,35916,0.00366789766773769,0.0796962983774148,-0.152536847151995,0.159872642487471,0.963292936418127
Physical measures,X4270.Volume level set by participant (left),ITGAV,Integrin alpha-V,36888,-0.00528452148030923,0.115043162842311,-0.230769120651239,0.220200077690621,0.963363154660713
Physical measures,X4270.Volume level set by participant (left),GPKOW,G-patch domain and KOW motifs-containing protein,36639,0.00301417840972893,0.0676274825947401,-0.129535687475962,0.13556404429542,0.964450997687712
Physical measures,X4270.Volume level set by participant (left),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,35725,0.00227082473073479,0.0513514202443779,-0.0983779589482459,0.102919608409715,0.964729384639299
Physical measures,X4270.Volume level set by participant (left),BIRC2,Baculoviral IAP repeat-containing protein 2,36654,0.00139273108576097,0.0315632823716976,-0.0604713023627663,0.0632567645342882,0.964805914925495
Physical measures,X4270.Volume level set by participant (left),DDX58,Antiviral innate immune response receptor RIG-I,36654,0.00155281255047152,0.0353032273851712,-0.0676415131244641,0.0707471382254072,0.964917536134881
Physical measures,X4270.Volume level set by participant (left),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,36933,0.00352056795135639,0.0802487028390299,-0.153766889613142,0.160808025515855,0.965008591326604
Physical measures,X4270.Volume level set by participant (left),GLO1,Lactoylglutathione lyase,36697,0.00146103044501674,0.0335686891500287,-0.0643336002890396,0.067255661179073,0.965285305064915
Physical measures,X4270.Volume level set by participant (left),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,36872,0.00268593460009688,0.0618807376783957,-0.118600311249559,0.123972180449752,0.9653798059475
Physical measures,X4270.Volume level set by participant (left),CFI,Complement factor I,35953,0.00441192069170054,0.109176441660109,-0.209573904962113,0.218397746345514,0.967766716779178
Physical measures,X4270.Volume level set by participant (left),ENG,Endoglin,36933,-0.00428461541855583,0.107924786973573,-0.21581719788676,0.207247967049648,0.968333315961468
Physical measures,X4270.Volume level set by participant (left),ABCA2,ATP-binding cassette sub-family A member 2,35706,-0.00236689905633651,0.0616104980565844,-0.123123475247242,0.118389677134569,0.969356274425125
Physical measures,X4270.Volume level set by participant (left),PFDN4,Prefoldin subunit 4,35678,-0.00168510476498288,0.044165532967888,-0.0882495493820433,0.0848793398520775,0.969565836940229
Physical measures,X4270.Volume level set by participant (left),LMNB1,Lamin-B1,35877,-0.00140886879300226,0.0373534538321237,-0.0746216383039647,0.0718039007179602,0.969914265620941
Physical measures,X4270.Volume level set by participant (left),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,36894,-0.00135685945519072,0.036053899940827,-0.0720225033392116,0.0693087844288301,0.969980320548949
Physical measures,X4270.Volume level set by participant (left),NID2,Nidogen-2,36836,-0.000957643876214224,0.02545045699799,-0.0508405395922746,0.0489252518398462,0.969985451631127
Physical measures,X4270.Volume level set by participant (left),LAMTOR5,Ragulator complex protein LAMTOR5,35874,0.00195723862112533,0.0525299054497151,-0.101001376060316,0.104915853302567,0.970279201982946
Physical measures,X4270.Volume level set by participant (left),NUMB,Protein numb homolog,35725,0.0010382475904333,0.0281473182300964,-0.0541304961405556,0.0562069913214222,0.970576871458473
Physical measures,X4270.Volume level set by participant (left),PODXL2,Podocalyxin-like protein 2,36864,-0.00238421901137029,0.0649040678860609,-0.12959619206805,0.124827754045309,0.970697650014481
Physical measures,X4270.Volume level set by participant (left),EPHA10,Ephrin type-A receptor 10,36639,-0.00104320182761572,0.0288540881594614,-0.0575972146201601,0.0555108109649287,0.971160226936262
Physical measures,X4270.Volume level set by participant (left),PLA2G10,Group 10 secretory phospholipase A2,36763,-0.00114103178005923,0.0318613146670622,-0.0635892085275011,0.0613071449673826,0.97143284948408
Physical measures,X4270.Volume level set by participant (left),INHBB,Inhibin beta B chain,35779,0.00146237758704097,0.0412165450229968,-0.0793220506580327,0.0822468058321147,0.971697788062173
Physical measures,X4270.Volume level set by participant (left),SMAD3,Mothers against decapentaplegic homolog 3,35874,-0.00150178206237379,0.0431337029853692,-0.0860438399136973,0.0830402757889497,0.972226780877026
Physical measures,X4270.Volume level set by participant (left),MDM1,Nuclear protein MDM1,35741,-0.00242138562499615,0.0695831746774591,-0.138804407992816,0.133961636742824,0.972241529394316
Physical measures,X4270.Volume level set by participant (left),LIF,Leukemia inhibitory factor,36639,-0.00128963564158245,0.0370679062496153,-0.0739427318908285,0.0713634606076636,0.972247198768083
Physical measures,X4270.Volume level set by participant (left),CD244,Natural killer cell receptor 2B4,36908,0.0023415716757853,0.067417491940141,-0.129796712526891,0.134479855878462,0.972294019561174
Physical measures,X4270.Volume level set by participant (left),KRT17,"Keratin, type I cytoskeletal 17",35706,0.00193352488782873,0.0572274301263119,-0.110232238159743,0.1140992879354,0.973048293416845
Physical measures,X4270.Volume level set by participant (left),NPTX2,Neuronal pentraxin-2,35931,0.00223119327043935,0.0664874927913155,-0.128084292600539,0.132546679141418,0.973230537304337
Physical measures,X4270.Volume level set by participant (left),MAPK9,Mitogen-activated protein kinase 9,36820,-0.00143266883459079,0.0440027355458912,-0.0876780305045376,0.0848126928353561,0.974027412314776
Physical measures,X4270.Volume level set by participant (left),KRT8,"Keratin, type II cytoskeletal 8",35680,0.000973627501449607,0.0299139107451613,-0.0576576375590665,0.0596048925619657,0.974036318765504
Physical measures,X4270.Volume level set by participant (left),MRPL28,"39S ribosomal protein L28, mitochondrial",35903,-0.00183375774535488,0.0569763363501098,-0.11350737699157,0.10983986150086,0.974325834933567
Physical measures,X4270.Volume level set by participant (left),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,35779,-0.00330436100735749,0.106223513079613,-0.211502446643398,0.204893724628683,0.975184653444085
Physical measures,X4270.Volume level set by participant (left),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,35763,-0.00150837532127602,0.0487333481746628,-0.0970257377436151,0.0940089871010631,0.975309075856116
Physical measures,X4270.Volume level set by participant (left),KIF1C,Kinesin-like protein KIF1C,35706,-0.00201988583263279,0.066005249807155,-0.131390175454657,0.127350403789391,0.975587967784743
Physical measures,X4270.Volume level set by participant (left),MICALL2,MICAL-like protein 2,35741,0.00089144947099828,0.0299086417251328,-0.057729488310262,0.0595123872522586,0.976222882602177
Physical measures,X4270.Volume level set by participant (left),CTSV,Cathepsin L2,36883,-0.0013511539968845,0.0458080153146696,-0.091134864013637,0.088432556019868,0.976469761378485
Physical measures,X4270.Volume level set by participant (left),RNF149,E3 ubiquitin-protein ligase RNF149,35748,-0.00201356858450304,0.0696160276377438,-0.138460982754481,0.134433845585475,0.976926147302011
Physical measures,X4270.Volume level set by participant (left),LAYN,Layilin,36748,0.00152363957500122,0.0528645938625525,-0.102090964395602,0.105138243545604,0.977007674672104
Physical measures,X4270.Volume level set by participant (left),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,35706,-0.000978215458254614,0.0345762107619277,-0.0687475885516328,0.0667911576351236,0.977430467465626
Physical measures,X4270.Volume level set by participant (left),PPM1A,Protein phosphatase 1A,36654,0.00162577673201683,0.0580835031782275,-0.112217889497309,0.115469442961343,0.977670608413578
Physical measures,X4270.Volume level set by participant (left),NTproBNP,N-terminal prohormone of brain natriuretic peptide,36828,-0.000447741105245106,0.0163181393261365,-0.0324312941844727,0.0315358119739825,0.978110912082648
Physical measures,X4270.Volume level set by participant (left),AXL,Tyrosine-protein kinase receptor UFO,36863,0.0018227829440848,0.067898686037552,-0.131258641689517,0.134904207577687,0.978583558301232
Physical measures,X4270.Volume level set by participant (left),TFRC,Transferrin receptor protein 1,36866,0.00131805486331324,0.049434947682964,-0.0955744425952963,0.0982105523219227,0.978729688345754
Physical measures,X4270.Volume level set by participant (left),CD300LG,CMRF35-like molecule 9,36836,-0.00133103253460696,0.0500922728597144,-0.0995118873396472,0.0968498222704332,0.978802108152952
Physical measures,X4270.Volume level set by participant (left),STX1B,Syntaxin-1B,35741,-0.0014114525303235,0.0535559329857707,-0.106381081182434,0.103558176121787,0.978975199809355
Physical measures,X4270.Volume level set by participant (left),CBX2,Chromobox protein homolog 2,35706,0.00147329183373188,0.0583422197699764,-0.112877458915422,0.115824042582886,0.979854268065108
Physical measures,X4270.Volume level set by participant (left),CCL26,C-C motif chemokine 26,36820,-0.000489738280602845,0.0196708067015557,-0.039044519415652,0.0380650428544463,0.98013800674691
Physical measures,X4270.Volume level set by participant (left),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35903,-0.000493677799022346,0.0202962845473187,-0.040274395511767,0.0392870399137223,0.980595248005774
Physical measures,X4270.Volume level set by participant (left),NME3,Nucleoside diphosphate kinase 3,36837,-0.00196143566175464,0.0809573940086665,-0.160637927918741,0.156715056595232,0.980671377441936
Physical measures,X4270.Volume level set by participant (left),RPGR,X-linked retinitis pigmentosa GTPase regulator,35741,0.00134949874867886,0.0560388255372174,-0.108486599304267,0.111185596801625,0.980788337397112
Physical measures,X4270.Volume level set by participant (left),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,36855,0.000400415695437542,0.0170976405235569,-0.033110959730734,0.033911791121609,0.981316377176478
Physical measures,X4270.Volume level set by participant (left),PLEKHO1,Pleckstrin homology domain-containing family O member 1,35903,0.000698340015856903,0.0314221827815935,-0.0608891382360663,0.0622858182677801,0.982269593478643
Physical measures,X4270.Volume level set by participant (left),NPL,N-acetylneuraminate lyase,35916,0.0010557890301378,0.0480130350090514,-0.093049759587603,0.0951613376478786,0.982456877988966
Physical measures,X4270.Volume level set by participant (left),ATXN10,Ataxin-10,36639,0.000598834357173686,0.0276925061283204,-0.0536784776543342,0.0548761463686816,0.982748134230501
Physical measures,X4270.Volume level set by participant (left),SPRR1B,Cornifin-B,35798,-0.000561048625078491,0.0260402133211773,-0.051599866734586,0.050477769484429,0.982811183562405
Physical measures,X4270.Volume level set by participant (left),IL13,Interleukin-13,36697,0.000826093808634955,0.0385512784043321,-0.0747344118638559,0.0763865994811258,0.982904455882488
Physical measures,X4270.Volume level set by participant (left),ERI1,3'-5' exoribonuclease 1,35798,-0.00137716404024982,0.0655187876975651,-0.129793987927477,0.127039659846978,0.983230834495403
Physical measures,X4270.Volume level set by participant (left),KLRK1,NKG2-D type II integral membrane protein,35903,-0.000939072781829797,0.04475248307976,-0.0886539396181593,0.0867757940544998,0.983259280789923
Physical measures,X4270.Volume level set by participant (left),TEX101,Testis-expressed protein 101,35741,-0.000853350893666726,0.0425607003067966,-0.0842723234949881,0.0825656217076546,0.984003931683764
Physical measures,X4270.Volume level set by participant (left),STC1,Stanniocalcin-1,36894,0.000809379474492529,0.0417128694378852,-0.0809478446237624,0.0825666035727474,0.984519648368806
Physical measures,X4270.Volume level set by participant (left),RALY,RNA-binding protein Raly,35874,-0.000875432355196781,0.0454398672134094,-0.0899375720934792,0.0881867073830856,0.984629695500808
Physical measures,X4270.Volume level set by participant (left),HARS1,"Histidine--tRNA ligase, cytoplasmic",36836,-0.000486768485982673,0.0258512958786797,-0.0511553084081949,0.0501817714362295,0.984977565550946
Physical measures,X4270.Volume level set by participant (left),DFFA,DNA fragmentation factor subunit alpha,36908,-0.00054086345411608,0.0293368791638151,-0.0580411466151937,0.0569594197069615,0.985291272529133
Physical measures,X4270.Volume level set by participant (left),MYDGF,Myeloid-derived growth factor,35916,-0.000395441288482019,0.0226040527919701,-0.0446993847607435,0.0439085021837794,0.986042827487515
Physical measures,X4270.Volume level set by participant (left),ESM1,Endothelial cell-specific molecule 1,36822,-0.000924146384314103,0.0536515461296119,-0.106081176798353,0.104232884029725,0.986257590968679
Physical measures,X4270.Volume level set by participant (left),PACS2,Phosphofurin acidic cluster sorting protein 2,35706,0.000629120356496078,0.0374753314426532,-0.0728225292711042,0.0740807699840963,0.986606587815887
Physical measures,X4270.Volume level set by participant (left),NRP2,Neuropilin-2,36836,-0.00101853953712681,0.0649316809745106,-0.128284634247168,0.126247555172914,0.987485045310252
Physical measures,X4270.Volume level set by participant (left),PSPN,Persephin,36820,-0.000312749550096104,0.0202226935688997,-0.0399492289451396,0.0393237298449474,0.987661391141603
Physical measures,X4270.Volume level set by participant (left),LAT,Linker for activation of T-cells family member 1,36908,0.000382634536049279,0.0251289301883986,-0.048870068633212,0.0496353377053105,0.987851592162917
Physical measures,X4270.Volume level set by participant (left),AAMDC,Mth938 domain-containing protein,35748,0.000627439748367396,0.0427176860337751,-0.0830992248778318,0.0843541043745666,0.988281495843276
Physical measures,X4270.Volume level set by participant (left),LYPD8,Ly6/PLAUR domain-containing protein 8,36654,0.000531669671723211,0.0367045887177851,-0.0714093242151357,0.0724726635585821,0.988443353266938
Physical measures,X4270.Volume level set by participant (left),GFAP,Glial fibrillary acidic protein,36638,0.000555646064018556,0.0394041296551186,-0.0766764480600139,0.077787740188051,0.988749609978225
Physical measures,X4270.Volume level set by participant (left),TPMT,Thiopurine S-methyltransferase,36654,0.000358314821425414,0.0261823008829233,-0.0509589949091043,0.0516756245519551,0.989081350955245
Physical measures,X4270.Volume level set by participant (left),IFNW1,Interferon omega-1,35706,0.000848732841116138,0.0628288760458879,-0.122295864208824,0.123993329891056,0.989222404319888
Physical measures,X4270.Volume level set by participant (left),ASAH1,Acid ceramidase,35860,-0.00062010694246663,0.0470036910415526,-0.0927473413839097,0.0915071274989764,0.989474425796039
Physical measures,X4270.Volume level set by participant (left),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,35706,-0.000418239782603929,0.0340635616250634,-0.0671828205677282,0.0663463410025204,0.990204023096299
Physical measures,X4270.Volume level set by participant (left),CRHR1,Corticotropin-releasing factor receptor 1,36697,0.000373383708653216,0.0305683995255607,-0.0595406793614457,0.0602874467787521,0.990254649838116
Physical measures,X4270.Volume level set by participant (left),FOXJ3,Forkhead box protein J3,35725,-0.000601281971251086,0.0512518564481311,-0.101054920609588,0.0998523566670859,0.990639866419737
Physical measures,X4270.Volume level set by participant (left),CBS,Cystathionine beta-synthase,35748,0.000498295673865269,0.0443127259128182,-0.0863546471152585,0.087351238462989,0.991028336339359
Physical measures,X4270.Volume level set by participant (left),XIAP,E3 ubiquitin-protein ligase XIAP,35725,-0.000433850030640549,0.0388512340495454,-0.0765822687677495,0.0757145687064684,0.991090584433208
Physical measures,X4270.Volume level set by participant (left),QDPR,Dihydropteridine reductase,36795,0.000496495130681004,0.0452025356799422,-0.0881004748020058,0.0890934650633678,0.991236668630532
Physical measures,X4270.Volume level set by participant (left),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,35662,-0.000452799663885501,0.0418664640505064,-0.082511069202878,0.0816054698751069,0.991371116363307
Physical measures,X4270.Volume level set by participant (left),TJP3,Tight junction protein ZO-3,35680,-0.000573777518409642,0.0531722322392272,-0.104791352707295,0.103643797670476,0.991390587446806
Physical measures,X4270.Volume level set by participant (left),C9,Complement component C9,35926,0.000426549415295234,0.0410845779883985,-0.0800992234419659,0.0809523222725563,0.991716637955517
Physical measures,X4270.Volume level set by participant (left),RANBP2,E3 SUMO-protein ligase RanBP2,35680,0.000670246612534392,0.0675870923340332,-0.131800454362171,0.133140947587239,0.992087985775455
Physical measures,X4270.Volume level set by participant (left),FOSB,Protein fosB,36639,0.00047693255125709,0.0481324287774028,-0.0938626278524524,0.0948164929549666,0.99209435056506
Physical measures,X4270.Volume level set by participant (left),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,35706,0.000468029905661144,0.0477679600526458,-0.0931571717975247,0.0940932316088469,0.992182761896774
Physical measures,X4270.Volume level set by participant (left),ACRV1,Acrosomal protein SP-10,35725,0.000259541779110029,0.0275288497121424,-0.053697003656689,0.0542160872149091,0.992477950151679
Physical measures,X4270.Volume level set by participant (left),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",36770,-0.00046199277817167,0.0533298061791594,-0.104988412889324,0.104064427332981,0.993088290549773
Physical measures,X4270.Volume level set by participant (left),FAM171A2,Protein FAM171A2,35903,0.000118246570439504,0.0137289891554076,-0.0267905721741594,0.0270270653150384,0.993128231943609
Physical measures,X4270.Volume level set by participant (left),CCN4,CCN family member 4,36888,-0.000403507827575322,0.0470395394956038,-0.0926010052389587,0.091793989583808,0.993156007574717
Physical measures,X4270.Volume level set by participant (left),ALCAM,CD166 antigen,36933,-0.000788275702395432,0.0954384846514059,-0.187847705619151,0.18627115421436,0.993410147510991
Physical measures,X4270.Volume level set by participant (left),VWC2,Brorin,36733,0.000340395838383863,0.0468063991507375,-0.0914001464970616,0.0920809381738293,0.994197691237605
Physical measures,X4270.Volume level set by participant (left),EGLN1,Egl nine homolog 1,36820,0.000237379921260626,0.0340226028837958,-0.0664469217309791,0.0669216815735003,0.994433288169756
Physical measures,X4270.Volume level set by participant (left),KLK1,Kallikrein-1,36774,9.62398149216228e-05,0.0146160047485184,-0.0285511294921744,0.0287436091220176,0.99474650047676
Physical measures,X4270.Volume level set by participant (left),KCNC4,Potassium voltage-gated channel subfamily C member 4,35680,-0.000254640829979117,0.0389769061629507,-0.0766493769093626,0.0761400952494043,0.994787562005097
Physical measures,X4270.Volume level set by participant (left),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",36697,0.000130522776673661,0.0204090396447698,-0.0398711949270751,0.0401322404804224,0.994897460692301
Physical measures,X4270.Volume level set by participant (left),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,36654,0.00032085318250551,0.0546329239705582,-0.106759677799788,0.107401384164799,0.995314295342336
Physical measures,X4270.Volume level set by participant (left),NBL1,Neuroblastoma suppressor of tumorigenicity 1,36864,-0.000405751652392584,0.0691159112565929,-0.135872937715315,0.13506143441053,0.99531612103311
Physical measures,X4270.Volume level set by participant (left),MMP13,Collagenase 3,36639,0.000322956096867626,0.0582688043701178,-0.113883900468563,0.114529812662298,0.995577878923904
Physical measures,X4270.Volume level set by participant (left),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",36748,0.000110029909923758,0.0200414318809448,-0.0391711765767281,0.0393912363965757,0.99561968330158
Physical measures,X4270.Volume level set by participant (left),SPINK8,Serine protease inhibitor Kazal-type 8,35706,-0.000335481781556044,0.0661996508267245,-0.130086797401936,0.129415833838824,0.995956711191964
Physical measures,X4270.Volume level set by participant (left),VPS4B,Vacuolar protein sorting-associated protein 4B,35874,0.00010791503725053,0.0242960107768631,-0.0475122660854011,0.0477280961599021,0.996456198677581
Physical measures,X4270.Volume level set by participant (left),CLEC6A,C-type lectin domain family 6 member A,36654,0.000166646579540675,0.0407541326987058,-0.0797114535099228,0.0800447466690041,0.996737511120836
Physical measures,X4270.Volume level set by participant (left),GP5,Platelet glycoprotein V,35779,0.00024872317761107,0.0613018455677008,-0.119902894135082,0.120400340490305,0.996762833167735
Physical measures,X4270.Volume level set by participant (left),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,35741,0.00016898629736323,0.0455173240418474,-0.0890449688246576,0.0893829414193841,0.997037916884192
Physical measures,X4270.Volume level set by participant (left),COMT,Catechol O-methyltransferase,36636,8.82952427959144e-05,0.0240634238129856,-0.0470760154306558,0.0472526059162477,0.99707244962572
Physical measures,X4270.Volume level set by participant (left),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,36763,0.000102935027524414,0.0330776685681447,-0.0647292953660391,0.0649351654210879,0.997517133871234
Physical measures,X4270.Volume level set by participant (left),JPT2,Jupiter microtubule associated homolog 2,35894,6.57035443831376e-05,0.026948914187138,-0.0527541682624074,0.0528855753511737,0.99805477005887
Physical measures,X4270.Volume level set by participant (left),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",36639,5.75648971074458e-05,0.0354915899470841,-0.0695059513991774,0.0696210811933923,0.998705930625704
